Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Bladder Cancer, January 2017

Free Subscription


Retrieve all available abstracts of the following 1741 articles:
HTML format


Single Articles

  1. LI Z, Sun M, Wang F, Shi J, et al
    Association between pioglitazone use and the risk of bladder cancer among subjects with diabetes mellitus: a dose-response meta-analysis.
    Int J Clin Pharmacol Ther. 2016 Dec 27. doi: 10.5414/CP202670.
    Abstract     Related articles   

  2. ALI ZIRAKZADEH A, Kinn J, Krantz D, Rosenblatt R, et al
    Doxorubicin enhances the capacity of B cells to activate T cells in Urothelial Urinary Bladder Cancer.
    Clin Immunol. 2016 Dec 23. pii: S1521-6616(16)30197.
    Abstract     Related articles   

  3. HINSCH A, Chaker A, Burdelski C, Koop C, et al
    betaIII-tubulin overexpression is linked to agressive tumor features and genetic instability in urinary bladder cancer.
    Hum Pathol. 2016 Dec 23. pii: S0046-8177(16)30351.
    Abstract     Related articles   

  4. PAGLIARULO V, Ancona P, Petitti T, Salerno A, et al
    Detection and Clinical Significance of Circulating Tumor Cells in Patients Undergoing Radical Cystectomy for Urothelial Bladder Cancer.
    Clin Genitourin Cancer. 2016 Dec 1. pii: S1558-7673(16)30341.
    Abstract     Related articles   

    Is there a link between urinary microbiota and bladder cancer?
    Eur J Epidemiol. 2016 Dec 24. doi: 10.1007/s10654-016-0213.
    Abstract     Related articles   

  6. SUN X, Deng Q, Liang Z, Liu Z, et al
    Cigarette smoke extract induces epithelial-mesenchymal transition of human bladder cancer T24 cells through activation of ERK1/2 pathway.
    Biomed Pharmacother. 2016;86:457-465.
    Abstract     Related articles   

  7. GOGALIC S, Sauer U, Doppler S, Heinzel A, et al
    Validation of a protein panel for the non-invasive detection of recurrent non-muscle invasive bladder cancer.
    Biomarkers. 2016 Dec 23:1-27. doi: 10.1080/1354750X.2016.1276628.
    Abstract     Related articles   

  8. POLOM W, Markuszewski M, Cytawa W, Czapiewski P, et al
    Fluorescent Versus Radioguided Lymph Node Mapping in Bladder Cancer.
    Clin Genitourin Cancer. 2016 Nov 30. pii: S1558-7673(16)30343.
    Abstract     Related articles   

  9. LISS MA, White M, Natarajan L, Parsons JK, et al
    Exercise Decreases and Smoking Increases Bladder Cancer Mortality.
    Clin Genitourin Cancer. 2016 Dec 1. pii: S1558-7673(16)30342.
    Abstract     Related articles   

  10. PICHLER R, Gruenbacher G, Culig Z, Brunner A, et al
    Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer.
    Cancer Immunol Immunother. 2016 Dec 22. doi: 10.1007/s00262-016-1945.
    Abstract     Related articles   

  11. TACHIBANA H, Gi M, Kato M, Yamano S, et al
    Carbonic anhydrase 2 is a novel invasion-associated factor in urinary bladder cancers.
    Cancer Sci. 2016 Dec 22. doi: 10.1111/cas.13143.
    Abstract     Related articles   

  12. BAI Y, Yang H, Zhang G, Hu L, et al
    Inhibitory effects of resveratrol on the adhesion, migration and invasion of human bladder cancer cells.
    Mol Med Rep. 2016 Dec 15. doi: 10.3892/mmr.2016.6051.
    Abstract     Related articles   

  13. CHENG S, Andrew AS, Andrews PC, Moore JH, et al
    Complex systems analysis of bladder cancer susceptibility reveals a role for decarboxylase activity in two genome-wide association studies.
    BioData Min. 2016;9:40.
    Abstract     Related articles   

  14. LIU D, Li Y, Luo G, Xiao X, et al
    LncRNA SPRY4-IT1 sponges miR-101-3p to promote proliferation and metastasis of bladder cancer cells through up-regulating EZH2.
    Cancer Lett. 2016 Dec 18. pii: S0304-3835(16)30750.
    Abstract     Related articles   

  15. ZARIFMAHMOUDI L, Sadeghi R
    Re: Radio-Guided Lymph Node Mapping in Bladder Cancer Using SPECT/CT and Intraoperative gamma-Probe Methods.
    Clin Nucl Med. 2016 Dec 16. doi: 10.1097/RLU.0000000000001485.
    Abstract     Related articles   

  16. SAMY MD, Tong WL, Yavorski JM, Sexton WJ, et al
    T cell receptor gene recombinations in human tumor specimen exome files: detection of T cell receptor-beta VDJ recombinations associates with a favorable oncologic outcome for bladder cancer.
    Cancer Immunol Immunother. 2016.
    Abstract     Related articles   

  17. TRETTER EM, Ebel JJ, Pohar KS, Zynger DL, et al
    Does the gross prosector impact pT3 subclassification or lymph node counts in bladder cancer?
    Hum Pathol. 2016 Dec 16. pii: S0046-8177(16)30347.
    Abstract     Related articles   

  18. ZHANG XJ, Yu HY, Cai YJ, Ke M, et al
    Lycium barbarum polysaccharides inhibit proliferation and migration of bladder cancer cell lines BIU87 by suppressing Pi3K/AKT pathway.
    Oncotarget. 2016 Dec 15. doi: 10.18632/oncotarget.13963.
    Abstract     Related articles   

  19. WANG X, Ni S, Chen Q, Ma L, et al
    Bladder cancer cells induce immunosuppression of T cells by supporting PD-L1 expression in tumor macrophages partially through interleukin 10.
    Cell Biol Int. 2016 Dec 17. doi: 10.1002/cbin.10716.
    Abstract     Related articles   

  20. ROPERTO S, Munday JS, Corrado F, Goria M, et al
    Detection of bovine papillomavirus type 14 DNA sequences in urinary bladder tumors in cattle.
    Vet Microbiol. 2016;190:1-4.
    Abstract     Related articles   

  21. HARGRAVE C, Mason N, Guidi R, Miller JA, et al
    Automated replication of cone beam CT-guided treatments in the Pinnacle(3) treatment planning system for adaptive radiotherapy.
    J Med Radiat Sci. 2016;63:48-58.
    Abstract     Related articles   

  22. TAKAYAMA T, Kubo T, Morikawa A, Morita T, et al
    Potential of sulfasalazine as a therapeutic sensitizer for CD44 splice variant 9-positive urogenital cancer.
    Med Oncol. 2016;33:45.
    Abstract     Related articles   

  23. MIKAMO H
    [Deep-seated mycosis].
    Med Mycol J. 2016;57:J33-4.
    Abstract     Related articles   

  24. CHEN L, Li H, Gu L, Ma X, et al
    Prognostic role of urinary collecting system invasion in renal cell carcinoma: a systematic review and meta-analysis.
    Sci Rep. 2016;6:21325.
    Abstract     Related articles   

  25. TAN WS, Lamb BW, Kelly JD
    Evolution of the neobladder: A critical review of open and intracorporeal neobladder reconstruction techniques.
    Scand J Urol. 2016;50:95-103.
    Abstract     Related articles   

  26. RUIZ-TAMAYO I, Franch-Nadal J, Mata-Cases M, Mauricio D, et al
    Noninsulin Antidiabetic Drugs for Patients with Type 2 Diabetes Mellitus: Are We Respecting Their Contraindications?
    J Diabetes Res. 2016;2016:7502489.
    Abstract     Related articles   

  27. LI XD, Chen SL, Dong P, Chen JW, et al
    Overexpression of RNF2 Is an Independent Predictor of Outcome in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy.
    Sci Rep. 2016;6:20894.
    Abstract     Related articles   

  28. JIANG T, Liu T, Li L, Yang Z, et al
    Knockout of phospholipase Cepsilon attenuates N-butyl-N-(4-hydroxybutyl) nitrosamine-induced bladder tumorigenesis.
    Mol Med Rep. 2016;13:2039-45.
    Abstract     Related articles   

  29. ZHANG Z, Zhang G, Kong C, Zhan B, et al
    METTL13 is downregulated in bladder carcinoma and suppresses cell proliferation, migration and invasion.
    Sci Rep. 2016;6:19261.
    Abstract     Related articles   

  30. MONTIRONI R, Santoni M, Cheng L, Lopez-Beltran A, et al
    An Overview of Emerging Immunotargets of Genitourinary Tumors.
    Curr Drug Targets. 2016;17:750-6.
    Abstract     Related articles   

  31. ROUANNE M, Loriot Y, Lebret T, Soria JC, et al
    Novel therapeutic targets in advanced urothelial carcinoma.
    Crit Rev Oncol Hematol. 2016;98:106-15.
    Abstract     Related articles   

  32. BAACK KUKREJA JE, Messing EM, Shah JB
    Are we doing "better"? The discrepancy between perception and practice of enhanced recovery after cystectomy principles among urologic oncologists.
    Urol Oncol. 2016;34:120.
    Abstract     Related articles   

  33. PARISER JJ, Anderson BB, Pearce SM, Han Z, et al
    The effect of broader, directed antimicrobial prophylaxis including fungal coverage on perioperative infectious complications after radical cystectomy.
    Urol Oncol. 2016;34:121.
    Abstract     Related articles   

  34. HOLM PS, Retz M, Gschwend JE, Nawroth R, et al
    [YB-1-based virotherapy: A new therapeutic intervention for transitional cell carcinoma of the bladder?].
    Urologe A. 2016;55:356-63.
    Abstract     Related articles   

  35. HIRNER L, Stagge E, Rubben H, Schenck M, et al
    [Narrow band imaging-assisted cystoscopy in bladder tumor follow-up: Can more tumors be identified?].
    Urologe A. 2016;55:370-5.
    Abstract     Related articles   

  36. WANG YL, Fang N, Zeng L, Wu ZJ, et al
    18F-FDG PET/CT Findings of Metastasis to Spongy Body of Penis From Urothelial Carcinoma of Bladder.
    Clin Nucl Med. 2015.
    Abstract     Related articles   

  37. COLLINS JW, Adding C, Hosseini A, Nyberg T, et al
    Introducing an enhanced recovery programme to an established totally intracorporeal robot-assisted radical cystectomy service.
    Scand J Urol. 2016;50:39-46.
    Abstract     Related articles   

  38. LIU SL, Qi L, Han WQ, Zhu BS, et al
    Shorter hemodialysis duration is a risk factor for the recurrence of urothelial carcinoma of the bladder in patients on maintenance hemodialysis.
    Clin Transl Oncol. 2016;18:304-9.
    Abstract     Related articles   

  39. WANG CT, Chen TM, Mei CT, Chang CF, et al
    The Functional Haplotypes of CHRM3 Modulate mRNA Expression and Associate with Bladder Cancer among a Chinese Han Population in Kaohsiung City.
    Biomed Res Int. 2016;2016:4052846.
    Abstract     Related articles   

  40. RAMSEY SA, Xu T, Goodall C, Rhodes AC, et al
    Cross-Species Analysis of the Canine and Human Bladder Cancer Transcriptome and Exome.
    Genes Chromosomes Cancer. 2017 Jan 3. doi: 10.1002/gcc.22441.
    Abstract     Related articles   

    Bladder cancer in 2016: News in diagnosis, treatment, and risk group assessment.
    Nat Rev Urol. 2017 Jan 4. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

  42. WANG C, Wang Q, Li X, Jin Z, et al
    Lycorine induces apoptosis of bladder cancer T24 cells by inhibiting phospho-Akt and activating the intrinsic apoptotic cascade.
    Biochem Biophys Res Commun. 2016 Dec 29. pii: S0006-291X(16)32240.
    Abstract     Related articles   

  43. STEINBERG RL, Brooks NA, Thomas LJ, Mott SL, et al
    Bacillus Calmette-Guerin strain may not effect recurrence-free survival when used intravesically with interferon-alpha2b for non-muscle-invasive bladder cancer.
    Urol Oncol. 2016 Dec 29. pii: S1078-1439(16)30404.
    Abstract     Related articles   

  44. LUO KW, Wei Chen, Lung WY, Wei XY, et al
    EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-kappaB and MMP-9.
    J Nutr Biochem. 2016;41:56-64.
    Abstract     Related articles   

  45. MOSCHINI M, Shariat SF, Luciano R, D'Andrea D, et al
    Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients.
    Clin Genitourin Cancer. 2016 Dec 14. pii: S1558-7673(16)30352.
    Abstract     Related articles   

  46. YANG GL, Zhang LH, Liu Q, Wang ZL, et al
    A novel treatment strategy for newly diagnosed high-grade T1 bladder cancer: Gemcitabine and cisplatin adjuvant chemotherapy-A single-institution experience.
    Urol Oncol. 2016 Dec 28. pii: S1078-1439(16)30254.
    Abstract     Related articles   

  47. FENG C, Ho Y, Sun C, Xia G, et al
    TFPI-2 expression is decreased in bladder cancer and is related to apoptosis.
    J BUON. 2016;21:1518-1523.
    Abstract     Related articles   

  48. KANG M, Jeong CW, Kwak C, Kim HH, et al
    Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
    Oncotarget. 2016 Dec 26. doi: 10.18632/oncotarget.14179.
    Abstract     Related articles   

  49. ZHEN S, Hua L, Liu YH, Sun XM, et al
    Inhibition of long non-coding RNA UCA1 by CRISPR/Cas9 attenuated malignant phenotypes of bladder cancer.
    Oncotarget. 2016 Dec 25. doi: 10.18632/oncotarget.14176.
    Abstract     Related articles   

  50. YU GQ, Dou ZL, Jia ZH
    [Corrigendum] 5bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2one induces apoptosis in T24 human bladder cancer cells through mitochondria-dependent signaling pathways.
    Mol Med Rep. 2016 Dec 27. doi: 10.3892/mmr.2016.6076.
    Abstract     Related articles   

    Checkpoint Inhibitors for Advanced Bladder Cancer.
    Bladder Cancer. 2016;2:473-474.
    Abstract     Related articles   

  52. SHAHAIT M, Bulbul M
    Bladder Cancer Screening in Lebanese Population: There is Nothing more Unequal than the Equal Treatment of Unequal People.
    Bladder Cancer. 2016;2:467-468.
    Abstract     Related articles   

  53. SUI W, Matulay JT, James MB, Onyeji IC, et al
    Micropapillary Bladder Cancer: Insights from the National Cancer Database.
    Bladder Cancer. 2016;2:415-423.
    Abstract     Related articles   

  54. ROSE TL, Deal AM, Ladoire S, Crehange G, et al
    Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer.
    Bladder Cancer. 2016;2:405-413.
    Abstract     Related articles   

  55. RUSSELL CM, Lebastchi AH, Borza T, Spratt DE, et al
    The Role of Transurethral Resection in Trimodal Therapy for Muscle-Invasive Bladder Cancer.
    Bladder Cancer. 2016;2:381-394.
    Abstract     Related articles   

  56. NANDAGOPAL L, Sonpavde G
    Circulating Biomarkers in Bladder Cancer.
    Bladder Cancer. 2016;2:369-379.
    Abstract     Related articles   

  57. CHIANG Y, Cheng JC, Huang CY, Tsai YC, et al
    A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement.
    J Formos Med Assoc. 2016 Dec 26. pii: S0929-6646(16)30350.
    Abstract     Related articles   

  58. YAN X, Wu C, Chen T, Santos MM, et al
    Cathepsin S inhibition changes regulatory T-cell activity in regulating bladder cancer and immune cell proliferation and apoptosis.
    Mol Immunol. 2016;82:66-74.
    Abstract     Related articles   

  59. CHEN A, Liu A, Liu J, Tian S, et al
    Application of dual-energy spectral CT imaging in differential diagnosis of bladder cancer and benign prostate hyperplasia.
    Medicine (Baltimore). 2016;95:e5705.
    Abstract     Related articles   

    Bladder cancer: Atezolizumab: an alternative to cisplatin?
    Nat Rev Urol. 2016 Dec 29. doi: 10.1038/nrurol.2016.
    Abstract     Related articles   

    Differences in cancer survival in Canada by sex.
    Health Rep. 2016;27:19-27.
    Abstract     Related articles   

  62. POURCHET A, Fuhrmann SR, Pilones KA, Demaria S, et al
    CD8(+) T-cell Immune Evasion Enables Oncolytic Virus Immunotherapy.
    EBioMedicine. 2016;5:59-67.
    Abstract     Related articles   

  63. VENKATESH K, Madhusudhan HR
    Anaplastic lymphoma kinase positive inflammatory myofibroblastic tumor of the urachus: A rare neoplasm in an unusual location.
    Indian J Pathol Microbiol. 2016;59:93-5.
    Abstract     Related articles   

  64. RALLABANDI HB, Swain M, Gowrishankar S, Sinha S, et al
    Postradiation angiosarcoma of bladder with extensive osseous metaplasia.
    Indian J Pathol Microbiol. 2016;59:78-80.
    Abstract     Related articles   

  65. SAKATA K, Fukuoka N, Tanabe K, Takenaka M, et al
    Anaphylactic shock due to intravesical administration of pirarubicin hydrochloride for the fifth time.
    J Clin Anesth. 2016;28:2-3.
    Abstract     Related articles   

  66. IWAMOTO H, Yumioka T, Yamaguchi N, Masago T, et al
    Robot-assisted radical cystectomy is a promising alternative to open surgery in the Japanese population with a high rate of octogenarians.
    Int J Clin Oncol. 2016;21:756-63.
    Abstract     Related articles   

  67. KIERAN K, Shnorhavorian M
    Current standards of care in bladder and prostate rhabdomyosarcoma.
    Urol Oncol. 2016;34:93-102.
    Abstract     Related articles   

  68. AKACHA M, Ogundimu EO
    Sensitivity analyses for partially observed recurrent event data.
    Pharm Stat. 2016;15:4-14.
    Abstract     Related articles   

  69. BAUMAN G
    Choosing Wisely? "It's Complicated!".
    Pract Radiat Oncol. 2016;6:71-3.
    Abstract     Related articles   

  70. SHIMURA H, Ihara T, Mitsui T, Takeda M, et al
    Tuberculous Granuloma in the Scrotal Skin After Intravesical Bacillus Calmette-Guerin Therapy for Bladder Cancer: A Case Report.
    Urol Case Rep. 2017;11:4-6.
    Abstract     Related articles   

  71. SONG BN, Kim SK, Chu IS
    Bioinformatic identification of prognostic signature defined by copy number alteration and expression of CCNE1 in non-muscle invasive bladder cancer.
    Exp Mol Med. 2017;49:e282.
    Abstract     Related articles   

  72. WILBORN D, Schmidt S
    [Adjuvant chemotherapy for invasive bladder cancer (individual patient data)].
    Urologe A. 2017 Jan 11. doi: 10.1007/s00120-016-0305.
    Abstract     Related articles   

  73. RINK M, Shariat SF, Soave A
    Liquid biopsies in bladder cancer-did we find the Holy Grail for biomarker analyses?
    Transl Androl Urol. 2016;5:980-983.
    Abstract     Related articles   

  74. GOPALAKRISHNA A, Fantony JJ, Longo TA, Owusu R, et al
    Anticipatory Positive Urine Tests for Bladder Cancer.
    Ann Surg Oncol. 2017 Jan 10. doi: 10.1245/s10434-016-5763.
    Abstract     Related articles   

  75. BREYER J, Wirtz RM, Otto W, Erben P, et al
    In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival.
    Virchows Arch. 2017 Jan 10. doi: 10.1007/s00428-017-2064.
    Abstract     Related articles   

  76. POLOM W, Gruszecka A, Markuszewski M, Cytawa W, et al
    Radio-Guided Lymph Node Mapping in Bladder Cancer Using SPECT/CT and Intraoperative gamma-Probe Methods: Reply.
    Clin Nucl Med. 2017 Jan 9. doi: 10.1097/RLU.0000000000001523.
    Abstract     Related articles   

  77. CRIPPA A, Larsson SC, Discacciati A, Wolk A, et al
    Red and processed meat consumption and risk of bladder cancer: a dose-response meta-analysis of epidemiological studies.
    Eur J Nutr. 2016 Dec 22. doi: 10.1007/s00394-016-1356.
    Abstract     Related articles   

  78. TAN M, Mu X, Liu Z, Tao L, et al
    microRNA-495 promotes bladder cancer cell growth and invasion by targeting phosphatase and tensin homolog.
    Biochem Biophys Res Commun. 2017 Jan 6. pii: S0006-291X(17)30019.
    Abstract     Related articles   

  79. HAMPP C, Pippins J
    Pioglitazone and bladder cancer: FDA's assessment.
    Pharmacoepidemiol Drug Saf. 2017 Jan 9. doi: 10.1002/pds.4154.
    Abstract     Related articles   

  80. EL-SIDDIG AA, Albasri AM, Hussainy AS, Alhujaily AS, et al
    Urinary bladder cancer in adults: a histopathological experience from Madinah, Saudi Arabia.
    J Pak Med Assoc. 2017;67:83-86.
    Abstract     Related articles   

  81. MATSUMOTO K, Kikuchi E, Yanai Y, Hayakawa N, et al
    Characterizing intermediate-risk non-muscle-invasive bladder cancer: Implications for the definition of intermediate risk and treatment strategy.
    Urol Oncol. 2017 Jan 3. pii: S1078-1439(16)30402.
    Abstract     Related articles   

  82. KHARE SR, Aprikian A, Black P, Blais N, et al
    Quality indicators in the management of bladder cancer: A modified Delphi study.
    Urol Oncol. 2017 Jan 3. pii: S1078-1439(16)30410.
    Abstract     Related articles   

  83. MIZUSHIMA T, Tirador KA, Miyamoto H
    Androgen receptor activation: A prospective therapeutic target for bladder cancer?
    Expert Opin Ther Targets. 2017 Jan 9. doi: 10.1080/14728222.2017.1280468.
    Abstract     Related articles   

  84. VAGO R, Bettiga A, Salonia A, Ciuffreda P, et al
    Development of new inhibitors for N-acylethanolamine-hydrolyzing acid amidase as promising tool against bladder cancer.
    Bioorg Med Chem. 2016 Dec 27. pii: S0968-0896(16)31496.
    Abstract     Related articles   

  85. SEGOVIA C, Martinez-Fernandez M, Duenas M, Rubio C, et al
    Opposing roles of PIK3CA gene alterations to EZH2 signaling in non-muscle invasive bladder cancer.
    Oncotarget. 2017 Jan 2. doi: 10.18632/oncotarget.14453.
    Abstract     Related articles   

  86. MOHAMMED AA, El-Tanni H, El-Khatib HM, Mirza AA, et al
    Urinary Bladder Cancer: Biomarkers and Target Therapy, New Era for More Attention.
    Oncol Rev. 2016;10:320.
    Abstract     Related articles   

  87. HUANG C, Zeng X, Jiang G, Liao X, et al
    XIAP BIR domain suppresses miR-200a expression and subsequently promotes EGFR protein translation and anchorage-independent growth of bladder cancer cell.
    J Hematol Oncol. 2017;10:6.
    Abstract     Related articles   

  88. NAKAMOTO R, Nakamoto Y, Ishimori T, Togashi K, et al
    Clinical Significance of Quantitative 123I-MIBG SPECT/CT Analysis of Pheochromocytoma and Paraganglioma.
    Clin Nucl Med. 2016.
    Abstract     Related articles   

  89. YOSHINO T, Wake K, Yamamoto T, Onuma H, et al
    [Liposarcoma of the Spermatic Cord : A Case Report and Review of the Literature].
    Hinyokika Kiyo. 2016;62:393-7.
    Abstract     Related articles   

  90. DE LUCA F, Zacharakis E, Shabbir M, Maurizi A, et al
    Malignant priapism due to penile metastases: Case series and literature review.
    Arch Ital Urol Androl. 2016;88:150-2.
    Abstract     Related articles   

  91. STAMATIOU K, Christopoulos G, Tsavari A, Koulia K, et al
    Lymphoepithelioma-like carcinoma of the bladder: A case report.
    Arch Ital Urol Androl. 2016;88:147-9.
    Abstract     Related articles   

  92. UN S, Turk H, Karabicak M, Divrik RT, et al
    Is a second look necessary in multiple and/or large Ta tumors?
    Arch Ital Urol Androl. 2016;88:86-8.
    Abstract     Related articles   

  93. SCHEPISI G, Santoni M, Massari F, Gurioli G, et al
    Urothelial Cancer: Inflammatory Mediators and Implications for Immunotherapy.
    BioDrugs. 2016;30:263-73.
    Abstract     Related articles   

  94. SHAW N, Marchalik D, Stamatakis L
    Incidentally discovered urachal cancer in a patient with necrotising fasciitis of the abdominal wall.
    BMJ Case Rep. 2016;2016.
    Abstract     Related articles   

  95. GOMELLA PT, Frazier H
    Takotsubo stress-induced cardiomyopathy following robotic radical cystectomy.
    Can J Urol. 2016;23:8234-6.
    Abstract     Related articles   

  96. GREGG JR, McCormick B, Wang L, Cohen P, et al
    Short term complications from transurethral resection of bladder tumor.
    Can J Urol. 2016;23:8198-203.
    Abstract     Related articles   

  97. FENG Y, Kawrakow I, Olsen J, Parikh PJ, et al
    A comparative study of automatic image segmentation algorithms for target tracking in MR-IGRT.
    J Appl Clin Med Phys. 2016;17:5820.
    Abstract     Related articles   

  98. NISHIMOTO K, Akise Y, Miyazawa M, Kutsuki S, et al
    A Case of Severe Rectal Hemorrhage Possibly Caused by Radiation Recall after Administration of Gemcitabine.
    Keio J Med. 2016;65:16-20.
    Abstract     Related articles   

  99. ELSHERIF E, Elbaky TA, Elserafy F, Elkady N, et al
    beta-catenin and SKP2 proteins as predictors of grade and stage of non-muscle invasive urothelial bladder carcinoma.
    Chin Clin Oncol. 2016;5:6.
    Abstract     Related articles   

    [Preneoplastic lesions and precursors of urothelial cancer].
    Pathologe. 2016;37:33-9.
    Abstract     Related articles   

  101. NAYAK JG, Gore JL, Holt SK, Wright JL, et al
    Patient-centered risk stratification of disposition outcomes following radical cystectomy.
    Urol Oncol. 2016;34:235.
    Abstract     Related articles   

  102. AGAIMY A, Hartmann A
    [Mesenchymal tumors of the urinary bladder].
    Pathologe. 2016;37:61-70.
    Abstract     Related articles   

  103. THOMAS S, Hao L, Ricke WA, Li L, et al
    Biomarker discovery in mass spectrometry-based urinary proteomics.
    Proteomics Clin Appl. 2016;10:358-70.
    Abstract     Related articles   

    Multiple outputation for the analysis of longitudinal data subject to irregular observation.
    Stat Med. 2016;35:1800-18.
    Abstract     Related articles   

  105. ABDI H, Pourmalek F, Gleave ME, So AI, et al
    Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy.
    World J Urol. 2016;34:41-8.
    Abstract     Related articles   

  106. PATEL HR, Santos PB, de Oliveira MC, Muller S, et al
    Is robotic-assisted radical cystectomy (RARC) with intracorporeal diversion becoming the new gold standard of care?
    World J Urol. 2016;34:25-32.
    Abstract     Related articles   

  107. KHURRAM SA, Farthing PM, Whitworth A, McKechnie AJ, et al
    High-grade urothelial carcinoma with squamous differentiation metastasizing to the tongue.
    Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121:e111-5.
    Abstract     Related articles   

  108. SIDDIQUI KM, Izawa JI
    Ileal conduit: standard urinary diversion for elderly patients undergoing radical cystectomy.
    World J Urol. 2016;34:19-24.
    Abstract     Related articles   

  109. HUGEN CM, Daneshmand S
    Orthotopic urinary diversion in the elderly.
    World J Urol. 2016;34:13-8.
    Abstract     Related articles   

  110. RAUP VT, Eswara JR, Geminiani J, Madison K, et al
    Gracilis muscle interposition flap repair of urinary fistulae: pelvic radiation is associated with persistent urinary incontinence and decreased quality of life.
    World J Urol. 2016;34:131-6.
    Abstract     Related articles   

  111. MOBLEY A, Zhang S, Bondaruk J, Wang Y, et al
    Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive Behavior.
    Sci Rep. 2017;7:40714.
    Abstract     Related articles   

  112. ELSEN S, Lerut E, Van Der Aa F, Van Cleynenbreugel B, et al
    Evans blue-mediated white-light detection of non-muscle-invasive bladder cancer: A preclinical feasibility and safety study using a rat bladder urothelial cell carcinoma model.
    Mol Clin Oncol. 2016;5:678-688.
    Abstract     Related articles   

  113. CEYLAN GG, Onalan EE, Kuloglu T, Aydog G, et al
    Potential role of melastatin-related transient receptor potential cation channel subfamily M gene expression in the pathogenesis of urinary bladder cancer.
    Oncol Lett. 2016;12:5235-5239.
    Abstract     Related articles   

  114. QI P, He Z, Zhang L, Fan Y, et al
    Rottlerin-induced autophagy leads to apoptosis in bladder cancer cells.
    Oncol Lett. 2016;12:4577-4583.
    Abstract     Related articles   

  115. GONG YQ, Peng D, Ning XH, Yang XY, et al
    UBE2T silencing suppresses proliferation and induces cell cycle arrest and apoptosis in bladder cancer cells.
    Oncol Lett. 2016;12:4485-4492.
    Abstract     Related articles   

  116. WANG S, Meng Q, Xie Q, Zhang M, et al
    Effect and mechanism of resveratrol on drug resistance in human bladder cancer cells.
    Mol Med Rep. 2017 Jan 12. doi: 10.3892/mmr.2017.6111.
    Abstract     Related articles   

  117. ITAI S, Suga Y, Hara Y, Izumi K, et al
    Co-administration of dexamethasone increases severity and accelerates onset day of neutropenia in bladder cancer patients on methotrexate, vinblastine, adriamycin and cisplatin chemotherapy: a retrospective cohort study.
    J Pharm Health Care Sci. 2017;3:3.
    Abstract     Related articles   

  118. STONE L
    Bladder cancer: Genetic urinary biomarker panel is promising.
    Nat Rev Urol. 2017 Jan 17. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  119. LV D, Wu H, Xing R, Shu F, et al
    HnRNP-L mediates bladder cancer progression by inhibiting apoptotic signaling and enhancing MAPK signaling pathways.
    Oncotarget. 2017 Jan 11. doi: 10.18632/oncotarget.14600.
    Abstract     Related articles   

  120. LLORETA J, Font-Tello A, Juanpere N, Frances A, et al
    FOXO1 downregulation is associated with worse outcome in bladder cancer and adds significant prognostic information to p53 overexpression.
    Hum Pathol. 2017 Jan 10. pii: S0046-8177(17)30011.
    Abstract     Related articles   

  121. MOSCHINI M, Dell'Oglio P, Luciano' R, Gandaglia G, et al
    Incidence and effect of variant histology on oncological outcomes in patients with bladder cancer treated with radical cystectomy.
    Urol Oncol. 2017 Jan 10. pii: S1078-1439(16)30413.
    Abstract     Related articles   

  122. RIPPY SB, Gardner HL, Nguyen SM, Warry EE, et al
    A pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma.
    BMC Vet Res. 2016;12:257.
    Abstract     Related articles   

  123. SHAH BK, Rajwani T, Jha S, Fortna RR, et al
    Chronic lymphocytic leukemia presenting with hematuria.
    Acta Oncol. 2017;56:113-115.
    Abstract     Related articles   

  124. ANZIVINO E, Zingaropoli MA, Iannetta M, Pietropaolo VA, et al
    Archetype and Rearranged Non-coding Control Regions in Urothelial Bladder Carcinoma of Immunocompetent Individuals.
    Cancer Genomics Proteomics. 2016;13:499-509.
    Abstract     Related articles   

  125. ABDEL-GAWAD M, Elsobky E, Shalaby MM, Abd-Elhameed M, et al
    Quantitative Evaluation of Heavy Metals and Trace Elements in the Urinary Bladder: Comparison Between Cancerous, Adjacent Non-cancerous and Normal Cadaveric Tissue.
    Biol Trace Elem Res. 2016;174:280-286.
    Abstract     Related articles   

  126. ROPERTO S, Russo V, Leonardi L, Martano M, et al
    Bovine Papillomavirus Type 13 Expression in the Urothelial Bladder Tumours of Cattle.
    Transbound Emerg Dis. 2016;63:628-634.
    Abstract     Related articles   

  127. ZHU L, Zhou L, Wang L, Li Z, et al
    A20 SNP rs77191406 may be related to secondary cancer for rheumatoid arthritis and systemic lupus erythematosus patients.
    Asia Pac J Clin Oncol. 2016;12:409-414.
    Abstract     Related articles   

  128. FUJII T, Asano A, Shimada K, Tatsumi Y, et al
    Evaluation of RNA and DNA extraction from liquid-based cytology specimens.
    Diagn Cytopathol. 2016;44:833-40.
    Abstract     Related articles   

  129. LIN DM, Barkan GA, Chatt G, Park JW, et al
    Vaginal fine-needle aspiration: A useful alternative to biopsy.
    Diagn Cytopathol. 2016;44:665-9.
    Abstract     Related articles   

  130. CSOMA E, Bidiga L, Mehes G, Gergely L, et al
    No Evidence of Human Polyomavirus 9, WU and KI DNA in Kidney and Urinary Bladder Tumour Tissue Samples.
    Pathobiology. 2016;83:252-7.
    Abstract     Related articles   

  131. ISHIKAWA R, Kadota K, Hayashi T, Motoyama M, et al
    Cytopathological features of villous adenoma of the urinary bladder in urine: A rare case report.
    Diagn Cytopathol. 2016;44:632-5.
    Abstract     Related articles   

  132. MITRA S, Chatterjee D, Gupta K, Dass Radotra B, et al
    Urine cytology of urothelial carcinoma with villoglandular differentiation.
    Diagn Cytopathol. 2016;44:653-6.
    Abstract     Related articles   

  133. ABUSANAD OZ, Floyd MS Jr, Khattak AQ
    Acute Urinary Retention in a Female Following Bladder Tumor Resection Due To a Stone in a Urethral Diverticulum.
    Urol J. 2016;13:2656.
    Abstract     Related articles   

  134. LIANG J, Li H, Gao L, Yin L, et al
    Bladder Paraganglioma: Clinicopathology and Magnetic Resonance Imaging Study of Five Patients.
    Urol J. 2016;13:2605-11.
    Abstract     Related articles   

  135. THORNQVIST S, Hysing LB, Tuomikoski L, Vestergaard A, et al
    Adaptive radiotherapy strategies for pelvic tumors - a systematic review of clinical implementations.
    Acta Oncol. 2016;55:943-58.
    Abstract     Related articles   

  136. RUAN HJ, Huang AH, Cheng S, Fu GX, et al
    [Clinicopathologic features of solitary fibrous tumor in urogenital system].
    Zhonghua Bing Li Xue Za Zhi. 2016;45:248-51.
    Abstract     Related articles   

  137. GLASS R, Cocker R, Rosen L, Coutsouvelis C, et al
    The impact of subdividing the "atypical" category for urinary cytology on patient management.
    Diagn Cytopathol. 2016;44:477-82.
    Abstract     Related articles   

  138. YANG H, Liu ZM, Lei YH, Qin Y, et al
    [Analysis of life-threatening complications during perioperative period in patients undergoing radical cystectomy with orthotopic neobladder].
    Zhonghua Zhong Liu Za Zhi. 2016;38:236-9.
    Abstract     Related articles   

  139. SEO GH, Kim JH, Ku JH
    Clinical Practice Pattern of Immediate Intravesical Chemotherapy following Transurethral Resection of a Bladder Tumor in Korea: National Health Insurance Database Study.
    Sci Rep. 2016;6:22716.
    Abstract     Related articles   

  140. TONE K, Kojima K, Hoshiai K, Kumagai N, et al
    An ancillary method in urine cytology: Nucleolar/nuclear volume ratio for discrimination between benign and malignant urothelial cells.
    Diagn Cytopathol. 2016;44:483-91.
    Abstract     Related articles   

  141. ALME AK, Karir BS, Faltas BM, Drake CG, et al
    Blocking immune checkpoints in prostate, kidney, and urothelial cancer: An overview.
    Urol Oncol. 2016;34:171-81.
    Abstract     Related articles   

  142. GAI JW, Qin W, Liu M, Wang HF, et al
    Expression profile of hydrogen sulfide and its synthases correlates with tumor stage and grade in urothelial cell carcinoma of bladder.
    Urol Oncol. 2016;34:166.
    Abstract     Related articles   

  143. KIM HC, Hong WP, Lim YJ, Park HP, et al
    The effect of sevoflurane versus desflurane on postoperative catheter-related bladder discomfort in patients undergoing transurethral excision of a bladder tumour: a randomized controlled trial.
    Can J Anaesth. 2016;63:596-602.
    Abstract     Related articles   

  144. SAIDI S, Popov Z, Janevska V, Panov S, et al
    Overexpression of UHRF1 gene correlates with the major clinicopathological parameters in urinary bladder cancer.
    Int Braz J Urol. 2017;43.
    Abstract     Related articles   

  145. KATA SG, Zreik A, Ahmad S, Chlosta P, et al
    Concurrent bladder cancer in patients undergoing photodynamic diagnostic ureterorenoscopy: how many lesions do we miss under white light cystoscopy?
    Cent European J Urol. 2016;69:334-340.
    Abstract     Related articles   

  146. PIOTROWICZ S, Poletajew S, Czarniecki SW, Kowalski F, et al
    Extent of lymphadenectomy in patients with bladder cancer undergoing radical cystectomy - a multi-institutional analysis.
    Cent European J Urol. 2016;69:323-326.
    Abstract     Related articles   

  147. KRISHNA SR, Konety BR
    Current Concepts in the Management of Muscle Invasive Bladder Cancer.
    Indian J Surg Oncol. 2017;8:74-81.
    Abstract     Related articles   

  148. PRACK MC CORMICK B, Belgorosky D, Langle Y, Balarino N, et al
    Bacillus Calmette-Guerin improves local and systemic response to radiotherapy in invasive bladder cancer.
    Nitric Oxide. 2017 Jan 23. pii: S1089-8603(16)30143.
    Abstract     Related articles   

  149. ARRUDA RP, Mariano MB, Pereira CF, Lima GC, et al
    Laparoscopic Cystoprostatectomy for Bladder Cancer in a Male patient combined with open ileal conduit urinary diversion.
    Int Braz J Urol. 2017;43:169-170.
    Abstract     Related articles   

  150. CIMEN HI, Halis F, Saglam HS, Gokce A, et al
    Can neutrophil to lymphocyte ratio predict lamina propria invasion in patients with non muscle invasive bladder cancer?
    Int Braz J Urol. 2017;43:67-72.
    Abstract     Related articles   

  151. SO A
    Bladder cancer, ESMO 2016.
    Can Urol Assoc J. 2016;10.
    Abstract     Related articles   

  152. WANG H, Li Q, Niu X, Wang G, et al
    miR-143 inhibits bladder cancer cell proliferation and enhances their sensitivity to gemcitabine by repressing IGF-1R signaling.
    Oncol Lett. 2017;13:435-440.
    Abstract     Related articles   

  153. MATSUO T, Miyata Y, Mitsunari K, Yasuda T, et al
    Pathological significance and prognostic implications of heme oxygenase 1 expression in non-muscle-invasive bladder cancer: Correlation with cell proliferation, angiogenesis, lymphangiogenesis and expression of VEGFs and COX-2.
    Oncol Lett. 2017;13:275-280.
    Abstract     Related articles   

  154. MUKHERJEE N, Cardenas E, Bedolla R, Ghosh R, et al
    SETD6 regulates NF-kappaB signaling in urothelial cell survival: Implications for bladder cancer.
    Oncotarget. 2017 Jan 19. doi: 10.18632/oncotarget.14750.
    Abstract     Related articles   

  155. RUSSO V, Inglese C, Avallone L, Roperto F, et al
    Sigma 2 receptor expression levels in blood and bladder from healthy and bladder cancer cattle.
    Vet Comp Oncol. 2017 Jan 25. doi: 10.1111/vco.12295.
    Abstract     Related articles   

  156. WAN YP, Xi M, He HC, Wan S, et al
    Expression and Clinical Significance of SOX9 in Renal Cell Carcinoma, Bladder Cancer and Penile Cancer.
    Oncol Res Treat. 2017;40.
    Abstract     Related articles   

  157. ROBINSON AG, Wei X, Vera-Badillo FE, Mackillop WJ, et al
    Palliative Chemotherapy for Bladder Cancer: Treatment Delivery and Outcomes in the General Population.
    Clin Genitourin Cancer. 2016 Dec 29. pii: S1558-7673(16)30371.
    Abstract     Related articles   

    Physical activity in the prevention and management of bladder cancer.
    J Sports Med Phys Fitness. 2017 Jan 23. doi: 10.23736/S0022-4707.17.06830.
    Abstract     Related articles   

  159. ZHANG Z, Zeng S, Zhao J, Lu X, et al
    A Pilot Study of Vela Laser for En Bloc Resection of Papillary Bladder Cancer.
    Clin Genitourin Cancer. 2016 Jun 23. pii: S1558-7673(16)30150.
    Abstract     Related articles   

  160. JIANG Z, Zhang Y, Cao R, Li L, et al
    MiR-5195-3p inhibits proliferation and invasion of human bladder cancer cells by directly targeting oncogene KLF5.
    Oncol Res. 2017 Jan 20. doi: 10.3727/096504016X14831120463349.
    Abstract     Related articles   

  161. LU J, Zheng X, Li F, Yu Y, et al
    Tunneling nanotubes promote intercellular mitochondria transfer followed by increased invasiveness in bladder cancer cells.
    Oncotarget. 2017 Jan 17. doi: 10.18632/oncotarget.14695.
    Abstract     Related articles   

  162. TAKAI T, Yoshikawa Y, Inamoto T, Minami K, et al
    A Novel Combination RNAi toward Warburg Effect by Replacement with miR-145 and Silencing of PTBP1 Induces Apoptotic Cell Death in Bladder Cancer Cells.
    Int J Mol Sci. 2017;18.
    Abstract     Related articles   

  163. FANTONY JJ, Longo TA, Gopalakrishna A, Owusu R, et al
    Urinary NID2 and TWIST1 methylation to augment conventional urine cytology for the detection of bladder cancer.
    Cancer Biomark. 2017 Jan 13. doi: 10.3233/CBM-160261.
    Abstract     Related articles   

  164. CHA KH, Hadjiiski LM, Samala RK, Chan HP, et al
    Bladder Cancer Segmentation in CT for Treatment Response Assessment: Application of Deep-Learning Convolution Neural Network-A Pilot Study.
    Tomography. 2016;2:421-429.
    Abstract     Related articles   

  165. TAKEUCHI H, Tokuyama N, Kuroda I, Aoyagi T, et al
    Annular rectal constriction caused by infiltrating bladder cancer: A case report.
    Mol Clin Oncol. 2016;5:842-844.
    Abstract     Related articles   

  166. LI R, Choi W, Ferguson Rd JE, Metcalfe MJ, et al
    New discoveries in the molecular landscape of bladder cancer.
    F1000Res. 2016;5:2875.
    Abstract     Related articles   

  167. SHENG Z, Liu Y, Qin C, Liu Z, et al
    Involvement of cancer-derived IgG in the proliferation, migration and invasion of bladder cancer cells.
    Oncol Lett. 2016;12:5113-5121.
    Abstract     Related articles   

  168. FALTAS BM, Tagawa ST
    Immune-checkpoint blockade in cisplatin-ineligible patients with urothelial cancer.
    Lancet. 2017;389:6-7.
    Abstract     Related articles   

  169. LIU J, Li D, Cao L, Wang Z, et al
    Elevated preoperative plasma fibrinogen level is an independent predictor of malignancy and advanced stage disease in patients with bladder urothelial tumors.
    Int J Surg. 2016;36.
    Abstract     Related articles   

  170. DURING VA, Sole GM, Jha AK, Anderson JA, et al
    Prediction of histological stage based on cytoscopic appearances of newly diagnosed bladder tumours.
    Ann R Coll Surg Engl. 2016;98:547-551.
    Abstract     Related articles   

  171. SHARMA A, Sharma S, Patnaik N, Pradhan D, et al
    Cytomorphologic and Immunophenotypic Profile of a Cohort of Small Cell Carcinoma of the Urinary Bladder.
    Acta Cytol. 2016;60:475-480.
    Abstract     Related articles   

  172. MOROZUMI K, Namiki S, Nakamura Y
    [Inflammatory Myofibroblastic Tumor of the Bladder : A Case Report].
    Hinyokika Kiyo. 2016;62:427-30.
    Abstract     Related articles   

  173. GAYE AM, Doh K, Thiam I, Bentefouet L, et al
    [Schistosomiasis and cancer: A fortuitous association or relationships cause and effect].
    Bull Cancer. 2016;103:806-7.
    Abstract     Related articles   

  174. WASHIO M, Mori M, Mikami K, Miki T, et al
    Risk Factors for Upper and Lower Urinary Tract Cancer Death in a Japanese Population: Findings from the Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC Study).
    Asian Pac J Cancer Prev. 2016;17:3545-9.
    Abstract     Related articles   

  175. XIN Z, Zhao C, Huang T, Zhang Z, et al
    Intestinal metaplasia of the bladder in 89 patients: a study with emphasis on long-term outcome.
    BMC Urol. 2016;16:24.
    Abstract     Related articles   

  176. ALRASHIDY M, Atef A, Baky TA
    Immunohistochemical Differentiation between Urothelial Papillomas and Papillary Neoplasms of Low Malignant Potential of the Urinary Bladder.
    Asian Pac J Cancer Prev. 2016;17:1769-72.
    Abstract     Related articles   

  177. ALBERTI C
    Whyever bladder tissue engineering clinical applications still remain unusual even though many intriguing technological advances have been reached?
    G Chir. 2016;37:6-12.
    Abstract     Related articles   

  178. ALEXANDER RE, Wang L, Lopez-Beltran A, Emerson RE, et al
    Human papillomavirus (HPV)-induced neoplasia in the urinary bladder: a missing link?
    Histol Histopathol. 2016;31:595-600.
    Abstract     Related articles   

  179. YE W, Chen C, Gao Y, Zheng ZS, et al
    Overexpression of SLC34A2 is an independent prognostic indicator in bladder cancer and its depletion suppresses tumor growth via decreasing c-Myc expression and transcriptional activity.
    Cell Death Dis. 2017;8:e2581.
    Abstract     Related articles   

  180. ZARGAR H, Almassi N, Kovac E, Ercole C, et al
    Change in Psoas Muscle Volume as a Predictor of Outcomes in Patients Treated with Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer.
    Bladder Cancer. 2017;3:57-63.
    Abstract     Related articles   

  181. MATULEWICZ RS, DeLancey JO, Pavey E, Schaeffer EM, et al
    Dipstick Urinalysis as a Test for Microhematuria and Occult Bladder Cancer.
    Bladder Cancer. 2017;3:45-49.
    Abstract     Related articles   

  182. VON RUNDSTEDT FC, Mata DA, Kryvenko ON, Shah AA, et al
    Utility of Clinical Risk Stratification in the Selection of Muscle-Invasive Bladder Cancer Patients for Neoadjuvant Chemotherapy: A Retrospective Cohort Study.
    Bladder Cancer. 2017;3:35-44.
    Abstract     Related articles   

  183. BAUMANN BC, Sargos P, Eapen LJ, Efstathiou JA, et al
    The Rationale for Post-Operative Radiation in Localized Bladder Cancer.
    Bladder Cancer. 2017;3:19-30.
    Abstract     Related articles   

  184. FRANTZI M, Vlahou A
    Ten Years of Proteomics in Bladder Cancer: Progress and Future Directions.
    Bladder Cancer. 2017;3:1-18.
    Abstract     Related articles   

  185. VERMA A, Kapoor R, Mittal RD
    Cluster of Differentiation 44 (CD44) Gene Variants: A Putative Cancer Stem Cell Marker in Risk Prediction of Bladder Cancer in North Indian Population.
    Indian J Clin Biochem. 2017;32:74-83.
    Abstract     Related articles   

  186. HADAMI K, Ameziane El Hassani R, Ameur A, Dakka N, et al
    Association between GPX1 Pro189Leu polymorphism and the occurrence of bladder cancer in Morocco.
    Cell Mol Biol (Noisy-le-grand). 2016;62:38-43.
    Abstract     Related articles   

  187. WILDE L, Ali SM, Solomides CC, Ross JS, et al
    Response to Pembrolizumab in a Patient With Chemotherapy Refractory Bladder Cancer With Small Cell Variant Histology: A Case Report and Review of the Literature.
    Clin Genitourin Cancer. 2016 Dec 22. pii: S1558-7673(16)30358.
    Abstract     Related articles   

  188. WU Y, Zhang X, Li Z, Yan H, et al
    Formononetin inhibits human bladder cancer cell proliferation and invasiveness via regulation of miR-21 and PTEN.
    Food Funct. 2017 Jan 31. doi: 10.1039/c6fo01535.
    Abstract     Related articles   

  189. CUI X, Shen D, Kong C, Zhang Z, et al
    NF-kappaB suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo.
    Sci Rep. 2017;7:40723.
    Abstract     Related articles   

  190. LEE D, Yoo S, You D, Hong B, et al
    Lymph node density vs. the American Joint Committee on Cancer TNM nodal staging system in node-positive bladder cancer in patients undergoing extended or super-extended pelvic lymphadenectomy.
    Urol Oncol. 2017 Jan 27. pii: S1078-1439(16)30366.
    Abstract     Related articles   

  191. TAO S, Meng S, Zheng X, Xie L, et al
    ATM participates in the regulation of viability and cell cycle via ellipticine in bladder cancer.
    Mol Med Rep. 2017 Jan 24. doi: 10.3892/mmr.2017.6141.
    Abstract     Related articles   

  192. BUTTIGLIERO C, Tucci M, Vignani F, Scagliotti GV, et al
    Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer.
    Cancer Treat Rev. 2017;54:1-9.
    Abstract     Related articles   

  193. ASAI K, Murata M, Saso K, Yamada M, et al
    [A Case of Metachronous Liver Metastases of Gall Bladder Cancer Successfully Treated by Liver Resection].
    Gan To Kagaku Ryoho. 2016;43:2092-2094.
    Abstract     Related articles   

  194. ABBAOUI B, Telu KH, Lucas CR, Thomas-Ahner JM, et al
    The impact of cruciferous vegetable isothiocyanates on histone acetylation and histone phosphorylation in bladder cancer.
    J Proteomics. 2017 Jan 26. pii: S1874-3919(17)30026.
    Abstract     Related articles   

  195. LIU D, Plimack ER, Hoffman-Censits J, Garraway LA, et al
    Clinical Validation of Chemotherapy Response Biomarker ERCC2 in Muscle-Invasive Urothelial Bladder Carcinoma.
    JAMA Oncol. 2016;2:1094-6.
    Abstract     Related articles   

  196. LI J, Wang P, Wang B
    Unique Case Report of Pineal Gland Metastasis From Bladder Carcinoma.
    Medicine (Baltimore). 2016;95:e3622.
    Abstract     Related articles   

  197. LIEDBERG F, Hoglund M
    [Not Available].
    Lakartidningen. 2016;113.
    Abstract     Related articles   

  198. OGAWA Y
    Chemical poisonings, new and old.
    Ind Health. 2016;54:99-100.
    Abstract     Related articles   

  199. ALLEEMUDDER DI, Alleemudder AI, Harry D, Fountain S, et al
    Bladder squamous cell carcinoma in pregnancy.
    J Obstet Gynaecol. 2016;36:388-9.
    Abstract     Related articles   

  200. XU WJ, Wen LP, Jiang XX, Ye LY, et al
    Association between N-Acetyltransferase 2 Polymorphism and Bladder Cancer Risk: a Meta-Analysis in a Single Ethnic Group.
    Clin Lab. 2017;63:287-293.
    Abstract     Related articles   

  201. HUI K, Gao Y, Huang J, Xu S, et al
    RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial-mesenchymal transition via MAPK/SOX2 pathway in bladder cancer.
    Cell Death Dis. 2017;8:e2600.
    Abstract     Related articles   

  202. PANEBIANCO V, De Berardinis E, Barchetti G, Simone G, et al
    An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer.
    Eur Radiol. 2017 Feb 8. doi: 10.1007/s00330-017-4758.
    Abstract     Related articles   

  203. YANG Y, Li C, Li H, Wu M, et al
    Differential sensitivities of bladder cancer cell lines to resveratol are unrelated to its metabolic profile.
    Oncotarget. 2017 Feb 2. doi: 10.18632/oncotarget.15041.
    Abstract     Related articles   

  204. DONG Q, Fu L, Zhao Y, Tan S, et al
    Derlin-1 overexpression confers poor prognosis in muscle invasive bladder cancer and contributes to chemoresistance and invasion through PI3K/AKT and ERK/MMP signaling.
    Oncotarget. 2017 Feb 2. doi: 10.18632/oncotarget.15001.
    Abstract     Related articles   

  205. Bladder cancer: Risk factors, diagnosis, and management.
    Nurse Pract. 2017;42:33-34.
    Abstract     Related articles   

  206. SHIN SS, Won SY, Noh DH, Hwang B, et al
    Morin Inhibits Proliferation, Migration, and Invasion of Bladder Cancer EJ Cells via Modulation of Signaling Pathways, Cell Cycle Regulators, and Transcription Factor-Mediated MMP-9 Expression.
    Drug Dev Res. 2017 Feb 8. doi: 10.1002/ddr.21377.
    Abstract     Related articles   

    Bladder cancer: Risk factors, diagnosis, and management.
    Nurse Pract. 2017;42:26-33.
    Abstract     Related articles   

  208. LEE M, Shin SJ, Oh YT, Jung DC, et al
    Non-contrast magnetic resonance imaging for bladder cancer: fused high b value diffusion-weighted imaging and T2-weighted imaging helps evaluate depth of invasion.
    Eur Radiol. 2017 Feb 6. doi: 10.1007/s00330-017-4759.
    Abstract     Related articles   

  209. PIRZADA MT, Ghauri R, Ahmed MJ, Shah MF, et al
    Outcomes of BCG Induction in High-Risk Non-Muscle-Invasive Bladder Cancer Patients (NMIBC): A Retrospective Cohort Study.
    Cureus. 2017;9:e957.
    Abstract     Related articles   

  210. WENG H, Zeng XT, Li S, Kwong JS, et al
    Tea Consumption and Risk of Bladder Cancer: A Dose-Response Meta-Analysis.
    Front Physiol. 2017;7:693.
    Abstract     Related articles   

  211. OLKHOV-MITSEL E, Savio AJ, Kron KJ, Pethe VV, et al
    Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder Cancer.
    Transl Oncol. 2017;10:168-177.
    Abstract     Related articles   

  212. KANG M, Lee KH, Lee HS, Jeong CW, et al
    Concurrent Autophagy Inhibition Overcomes the Resistance of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Human Bladder Cancer Cells.
    Int J Mol Sci. 2017;18.
    Abstract     Related articles   

  213. MANIKANDAN R, Rodriguez O, Parada R, Palou Redorta J, et al
    Nonmuscle-invasive bladder cancer: what's changing and what has changed.
    Urologia. 2017;84:1-8.
    Abstract     Related articles   

  214. YANG D, Huo Q, Luan T, Wang J, et al
    Effects of Angiotensin Inhibitor Valsartan on the Expression of the Angiotensin II 1 Receptor, Matrix Metalloproteinases -2 and -9 in Human Bladder Cancer Cell Lines.
    Clin Lab. 2016;62:1435-1442.
    Abstract     Related articles   

  215. THONG AE, Petruzella S, Orlow I, Zabor EC, et al
    Accuracy of Self-reported Smoking Exposure Among Bladder Cancer Patients Undergoing Surveillance at a Tertiary Referral Center.
    Eur Urol Focus. 2016;2:441-444.
    Abstract     Related articles   

  216. FEBER A, Dhami P, Dong L, de Winter P, et al
    UroMark-a urinary biomarker assay for the detection of bladder cancer.
    Clin Epigenetics. 2017;9:8.
    Abstract     Related articles   

  217. KANG M, Balpukov UJ, Jeong CW, Kwak C, et al
    Can the Preoperative Neutrophil-to-Lymphocyte Ratio Significantly Predict the Conditional Survival Probability in Muscle-invasive Bladder Cancer Patients Undergoing Radical Cystectomy?
    Clin Genitourin Cancer. 2017 Jan 9. pii: S1558-7673(16)30324.
    Abstract     Related articles   

  218. ZHOU Y, Song R, Ma C, Zhou L, et al
    Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method.
    Oncotarget. 2017 Feb 1. doi: 10.18632/oncotarget.14988.
    Abstract     Related articles   

  219. CHEN M, Li J, Zhuang C, Cai Z, et al
    Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer.
    Oncotarget. 2017 Feb 1. doi: 10.18632/oncotarget.14945.
    Abstract     Related articles   

  220. NAKAMURA T, Noma Y, Sakurai Y, Harashima H, et al
    Modifying Cationic Liposomes with Cholesteryl-PEG Prevents Their Aggregation in Human Urine and Enhances Cellular Uptake by Bladder Cancer Cells.
    Biol Pharm Bull. 2017;40:234-237.
    Abstract     Related articles   

  221. RAMAN SP, Fishman EK
    Upper and Lower Tract Urothelial Imaging Using Computed Tomography Urography.
    Radiol Clin North Am. 2017;55:225-241.
    Abstract     Related articles   

  222. STROJAN FLEZAR M, Srebotnik-Kirbis I, Gutnik H
    Use of vimentin immunocytochemical staining for evaluation of atypical cells in voided urine samples.
    Diagn Cytopathol. 2017;45:85-90.
    Abstract     Related articles   

  223. LI X, Liu S
    Suppression of HBXIP Reduces Cell Proliferation, Migration and Invasion In Vitro, and Tumorigenesis In Vivo in Human Urothelial Carcinoma of the Bladder.
    Cancer Biother Radiopharm. 2016;31:311-316.
    Abstract     Related articles   

  224. SHEN KH, Li CF, Chien LH, Huang CH, et al
    Role of galectin-1 in urinary bladder urothelial carcinoma cell invasion through the JNK pathway.
    Cancer Sci. 2016;107:1390-1398.
    Abstract     Related articles   

  225. DE ALMEIDA EF, Abdalla TE, Arrym TP, de Oliveira Delgado P, et al
    Plasma and urine DNA levels are related to microscopic hematuria in patients with bladder urothelial carcinoma.
    Clin Biochem. 2016;49.
    Abstract     Related articles   

  226. KURTZHALTS K, Gee ME, Feuz L, Krajewski KC, et al
    Evidence of a clinically significant interaction between warfarin and intravesical gemcitabine.
    Am J Health Syst Pharm. 2016;73:1508-11.
    Abstract     Related articles   

  227. LIN DM, Park JW, Gattuso P
    Metastatic Signet-Ring Cell Carcinoma of the Bladder in Cerebrospinal Fluid.
    Diagn Cytopathol. 2017;45:73-76.
    Abstract     Related articles   

  228. ZHAO XR, Gao C, Zhang Y, Kong L, et al
    Urachal adenocarcinoma that metastasized to breast was misinterpreted as primary breast mucinous carcinoma: A rare case report and literature review.
    Medicine (Baltimore). 2016;95:e4612.
    Abstract     Related articles   

  229. KIM TK, Xu ML, Podoltsev NA, Prebet T, et al
    Single agent blinatumumab as frontline therapy for an 85-year-old patient with B cell precursor acute lymphoblastic leukemia.
    Ann Hematol. 2016.
    Abstract     Related articles   

  230. XIN J, Lai HP, Lin SK, Zhang QQ, et al
    Bladder leiomyoma presenting as dyspareunia: Case report and literature review.
    Medicine (Baltimore). 2016;95:e3971.
    Abstract     Related articles   

  231. ALBERTI C
    Urology pertinent neuroendocrine tumors: focusing on renal pelvis, bladder, prostate located sympathetic functional paragangliomas.
    G Chir. 2016;37:55-60.
    Abstract     Related articles   

  232. GOLDMAN H, Sowter S
    Urachal adenocarcinoma incidentally discovered in a young woman at elective caesarean section.
    BMJ Case Rep. 2016;2016.
    Abstract     Related articles   

  233. KONG YG, Kim JY, Yu J, Lim J, et al
    Efficacy and Safety of Stroke Volume Variation-Guided Fluid Therapy for Reducing Blood Loss and Transfusion Requirements During Radical Cystectomy: A Randomized Clinical Trial.
    Medicine (Baltimore). 2016;95:e3685.
    Abstract     Related articles   

  234. GONZALEZ-DEL VECCHIO M, Ruiz-Serrano MJ, Gijon P, Sanchez-Somolinos M, et al
    Differences between a probable and proven BCG infection following intravesical instillations: 16 years experience in a tertiary care hospital.
    Diagn Microbiol Infect Dis. 2016;85:338-43.
    Abstract     Related articles   

  235. LI WM, Wei YC, Huang CN, Ke HL, et al
    Matrix metalloproteinase-11 as a marker of metastasis and predictor of poor survival in urothelial carcinomas.
    J Surg Oncol. 2016;113:700-7.
    Abstract     Related articles   

  236. WENG WC, Huang YH, Yang SF, Wang SS, et al
    Effect of CD44 gene polymorphisms on risk of transitional cell carcinoma of the urinary bladder in Taiwan.
    Tumour Biol. 2016;37:6971-7.
    Abstract     Related articles   

  237. SCHUBERT M, Junker K, Heinzelmann J
    Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development?
    J Cancer Res Clin Oncol. 2016;142:1673-95.
    Abstract     Related articles   

  238. STEINESTEL K, Eder S, Ehinger K, Schneider J, et al
    The small conductance calcium-activated potassium channel 3 (SK3) is a molecular target for Edelfosine to reduce the invasive potential of urothelial carcinoma cells.
    Tumour Biol. 2016;37:6275-83.
    Abstract     Related articles   

  239. NOLAN CP, Forde EJ
    A review of the use of fiducial markers for image-guided bladder radiotherapy.
    Acta Oncol. 2016;55:533-8.
    Abstract     Related articles   

  240. JAEGER MT, Siemens DR, Wei X, Peng P, et al
    Association Between Anesthesiology Volumes and Early and Late Outcomes After Cystectomy for Bladder Cancer: A Population-Based Study.
    Anesth Analg. 2017 Feb 15. doi: 10.1213/ANE.0000000000001781.
    Abstract     Related articles   

  241. ZHAN L, Zhang B, Tan Y, Yang C, et al
    Quantitative assessment of the relationship between RASSF1A gene promoter methylation and bladder cancer (PRISMA).
    Medicine (Baltimore). 2017;96:e6097.
    Abstract     Related articles   

  242. SHAO YH, Kao CC, Tang SH, Cha TL, et al
    Unusual presentation of direct intraperitoneal metastases complicated with massive ascites from plasmacytoid variant of bladder cancer and adenocarcinoma of colon: A case report and literature review.
    Medicine (Baltimore). 2017;96:e5816.
    Abstract     Related articles   

  243. FU D, Li P, Cheng W, Tian F, et al
    Impact of vascular endothelial growth factor gene-gene and gene-smoking interaction and haplotype combination on bladder cancer risk in Chinese population.
    Oncotarget. 2017 Feb 11. doi: 10.18632/oncotarget.15287.
    Abstract     Related articles   

  244. KISS B, Wyatt AW, Douglas J, Skuginna V, et al
    Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapy.
    Sci Rep. 2017;7:42713.
    Abstract     Related articles   

  245. WANG CY, Hua R, Liu L, Zhan X, et al
    Immunotherapy against metastatic bladder cancer by combined administration of granulocyte macrophage-colony stimulating factor and interleukin-2 surface modified MB49 bladder cancer stem cells vaccine.
    Cancer Med. 2017 Feb 16. doi: 10.1002/cam4.1023.
    Abstract     Related articles   

  246. MATSUDA T, Okuyama A
    Incidence rate for bladder cancer in Japanese in Japan and in the United States from the Cancer Incidence in Five Continents.
    Jpn J Clin Oncol. 2017 Feb 16:1-2. doi: 10.1093.
    Abstract     Related articles   

  247. PEI Z, Du X, Song Y, Fan L, et al
    Down-regulation of lncRNA CASC2 promotes cell proliferation and metastasis of bladder cancer by activation of the Wnt/beta-catenin signaling pathway.
    Oncotarget. 2017 Feb 9. doi: 10.18632/oncotarget.15210.
    Abstract     Related articles   

  248. ZHANG X, Xu X, Tian Q, Li B, et al
    Radiomics assessment of bladder cancer grade using texture features from diffusion-weighted imaging.
    J Magn Reson Imaging. 2017 Feb 15. doi: 10.1002/jmri.25669.
    Abstract     Related articles   

  249. DOMINGOS-PEREIRA S, Cesson V, Chevalier MF, Derre L, et al
    Preclinical efficacy and safety of the Ty21a vaccine strain for intravesical immunotherapy of non-muscle-invasive bladder cancer.
    Oncoimmunology. 2016;6:e1265720.
    Abstract     Related articles   

  250. SMITH SG, Baltz JL, Koppolu BP, Ravindranathan S, et al
    Immunological mechanisms of intravesical chitosan/interleukin-12 immunotherapy against murine bladder cancer.
    Oncoimmunology. 2016;6:e1259050.
    Abstract     Related articles   

  251. BETTIGA A, Aureli M, Colciago G, Murdica V, et al
    Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism.
    Sci Rep. 2017;7:42157.
    Abstract     Related articles   

  252. GUPTA S, De S, Leekha N, Sahay SC, et al
    Chemoradiation for organ preservation in the treatment of muscle invasive bladder cancer: Our Institutional Experience.
    Gulf J Oncolog. 2016;1:55-60.
    Abstract     Related articles   

  253. RICHARD PO, Ahmad AE, Bashir S, Hamilton RJ, et al
    Effect of statins as a secondary chemopreventive agent among individuals with non-muscle-invasive bladder cancer: A population-based analysis.
    Urol Oncol. 2017 Feb 9. pii: S1078-1439(16)30417.
    Abstract     Related articles   

  254. TRAINOR S, Choudhury A, Huddart R, Kiltie AE, et al
    The National Institute for Health and Care Excellence (NICE) Guidance on Bladder Cancer; a Step in the Right Direction?
    Clin Oncol (R Coll Radiol). 2017 Feb 9. pii: S0936-6555(17)30068.
    Abstract     Related articles   

  255. BUSETTO GM, Ferro M, Del Giudice F, Antonini G, et al
    The Prognostic Role of Circulating Tumor Cells (CTC) in High-risk Non-muscle-invasive Bladder Cancer.
    Clin Genitourin Cancer. 2017 Jan 18. pii: S1558-7673(17)30011.
    Abstract     Related articles   

  256. SARGOS P, Larre S, Chapet O, Latorzeff I, et al
    [Adjuvant radiotherapy for bladder cancer in patients with risk of locoregional recurrence: Who, what and how?]
    Cancer Radiother. 2017 Feb 7. pii: S1278-3218(17)30004.
    Abstract     Related articles   

  257. DONG F, Xu T, Shen Y, Zhong S, et al
    Dysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedure.
    Oncotarget. 2017 Feb 7. doi: 10.18632/oncotarget.15173.
    Abstract     Related articles   

  258. REZAEI G, Habibi-Anbouhi M, Mahmoudi M, Azadmanesh K, et al
    Development of anti-CD47 single-chain variable fragment targeted magnetic nanoparticles for treatment of human bladder cancer.
    Nanomedicine (Lond). 2017 Feb 10. doi: 10.2217/nnm-2016-0302.
    Abstract     Related articles   

  259. UKAI R, Hashimoto K, Nakayama H, Iwamoto T, et al
    Lymphovascular invasion predicts poor prognosis in high-grade pT1 bladder cancer patients who underwent transurethral resection in one piece.
    Jpn J Clin Oncol. 2017 Feb 10:1-6. doi: 10.1093.
    Abstract     Related articles   

  260. Nivolumab Gets FDA Nod for Bladder Cancer.
    Cancer Discov. 2017 Feb 9. doi: 10.1158/2159-8290.CD-NB2017.
    Abstract     Related articles   

  261. AOUN F, El Rassy E, Peltier A
    Bladder cancer immunotherapy: swinging for the fences.
    Future Oncol. 2017 Feb 10. doi: 10.2217/fon-2017-0013.
    Abstract     Related articles   

  262. SOLINAS C, Chanza NM, Awada A, Scartozzi M, et al
    The immune infiltrate in prostate, bladder and testicular tumors: An old friend for new challenges.
    Cancer Treat Rev. 2017;53:138-145.
    Abstract     Related articles   

  263. SU X, Fang D, Li X, Xiong G, et al
    The Influence of Tumor Size on Oncologic Outcomes for Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy.
    Biomed Res Int. 2016;2016:4368943.
    Abstract     Related articles   

  264. PATEL R, Bock M, Polotti CF, Elsamra S, et al
    Pharmacokinetic drug evaluation of atezolizumab for the treatment of locally advanced or metastatic urothelial carcinoma.
    Expert Opin Drug Metab Toxicol. 2017;13:225-232.
    Abstract     Related articles   

  265. GRAPIN-DAGORNO C, Peycelon M, Philippe-Chomette P, Berrebi D, et al
    [Urothelial tumors in children].
    Bull Cancer. 2017;104:195-201.
    Abstract     Related articles   

  266. MANLEY KV, Hubbard R, Swallow D, Finch W, et al
    Risk factors for development of primary bladder squamous cell carcinoma.
    Ann R Coll Surg Engl. 2017;99:155-160.
    Abstract     Related articles   

  267. GRANADOS R, Duarte JA, Corrales T, Camarmo E, et al
    Applying the Paris System for Reporting Urine Cytology Increases the Rate of Atypical Urothelial Cells in Benign Cases: A Need for Patient Management Recommendations.
    Acta Cytol. 2017;61:71-76.
    Abstract     Related articles   

  268. BREYER J, Wirtz RM, Laible M, Schlombs K, et al
    ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC).
    Virchows Arch. 2016;469:547-552.
    Abstract     Related articles   

  269. SHANMUGAM V, Geraghty B, DeSimone R, Hoda RS, et al
    Diagnostic value of positive urinary cytology in the detection of recurrent urothelial carcinoma: 10-Year Experience at the Papanicolaou Cytology Laboratory.
    Diagn Cytopathol. 2016 Sep 26. doi: 10.1002/dc.23598.
    Abstract     Related articles   

  270. PRABHU B, Balakrishnan D, Sundaresan S
    Antiproliferative and anti-inflammatory properties of diindolylmethane and lupeol against N-butyl-N-(4-hydroxybutyl) nitrosamine induced bladder carcinogenesis in experimental rats.
    Hum Exp Toxicol. 2016;35:685-92.
    Abstract     Related articles   

  271. DE OLIVEIRA DT, Savio AL, Marcondes JP, Barros TM, et al
    Cytotoxic and toxicogenomic effects of silibinin in bladder cancer cells with different TP53 status.
    J Biosci. 2017;42:91-101.
    Abstract     Related articles   

  272. TANG M, Zhao Y, Liu N, Chen E, et al
    Overexpression of HepaCAM inhibits bladder cancer cell proliferation and viability through the AKT/FoxO pathway.
    J Cancer Res Clin Oncol. 2017 Feb 22. doi: 10.1007/s00432-016-2333.
    Abstract     Related articles   

  273. TEKE K, Ozkan TA, Cebeci OO, Yilmaz H, et al
    Preventive effect of intravesical ozone supplementation on n-methyl-n-nitrosourea-induced non-muscle invasive bladder cancer in male rats.
    Exp Anim. 2017 Feb 22. doi: 10.1538/expanim.16-0093.
    Abstract     Related articles   

  274. LER LD, Ghosh S, Chai X, Thike AA, et al
    Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2.
    Sci Transl Med. 2017;9.
    Abstract     Related articles   

  275. JIANG G, Huang C, Li J, Huang H, et al
    Role of STAT3 and FOXO1 in the divergent therapeutic responses of non-metastatic and metastatic bladder cancer cells to miR-145.
    Mol Cancer Ther. 2017 Feb 21. pii: molcanther.0631.2016.
    Abstract     Related articles   

  276. GUO J, Cao R, Yu X, Xiao Z, et al
    MicroRNA-223-3p inhibits human bladder cancer cell migration and invasion.
    Tumour Biol. 2017;39:1010428317691678.
    Abstract     Related articles   

  277. ZHI Y, Ji H, Pan J, He P, et al
    Downregulated XPA promotes carcinogenesis of bladder cancer via impairment of DNA repair.
    Tumour Biol. 2017;39:1010428317691679.
    Abstract     Related articles   

  278. LI P, Yang X, Cheng Y, Zhang X, et al
    MicroRNA-218 Increases the Sensitivity of Bladder Cancer to Cisplatin by Targeting Glut1.
    Cell Physiol Biochem. 2017;41:921-932.
    Abstract     Related articles   

  279. POZZAR RA, Berry DL
    Gender Differences in Bladder Cancer Treatment Decision Making.
    Oncol Nurs Forum. 2017;44:204-209.
    Abstract     Related articles   

  280. Atezolizumab (Tecentriq) for bladder cancer and NSCLC.
    Med Lett Drugs Ther. 2017;59:e40-e41.
    Abstract     Related articles   

  281. SIDAWAY P
    Bladder cancer: Mutations in DNA-damage-repair pathways confer platinum sensitivity.
    Nat Rev Urol. 2017 Feb 14. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  282. DEMIRDAG C, Citgez S, Talat Z, Onal B, et al
    Management of Bladder Cancer After Renal Transplantation.
    Transplant Proc. 2017;49:293-296.
    Abstract     Related articles   

  283. EL-ASHMAWY NE, Khedr EG, El-Bahrawy HA, Al-Tantawy SM, et al
    Chemopreventive effect of omega-3 polyunsaturated fatty acids and atorvastatin in rats with bladder cancer.
    Tumour Biol. 2017;39:1010428317692254.
    Abstract     Related articles   

  284. XU X, Liu Y, Zhang X, Tian Q, et al
    Preoperative prediction of muscular invasiveness of bladder cancer with radiomic features on conventional MRI and its high-order derivative maps.
    Abdom Radiol (NY). 2017 Feb 20. doi: 10.1007/s00261-017-1079.
    Abstract     Related articles   

  285. CANYILMAZ E, Yoney A, Serdar L, Uslu GH, et al
    Corrigendum to "Long-term results of a concomitant boost radiotherapy technique for elderly patients with muscle-invasive bladder cancer" [J Geriatr Oncol6 (4) (July 2015)316-323].
    J Geriatr Oncol. 2017 Feb 16. pii: S1879-4068(17)30026.
    Abstract     Related articles   

  286. BELLMUNT J, Powles T, Vogelzang NJ
    A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now.
    Cancer Treat Rev. 2017;54:58-67.
    Abstract     Related articles   

  287. ABUFARAJ M, Shariat SF, Haitel A, Moschini M, et al
    Prognostic role of N-cadherin expression in patients with non-muscle-invasive bladder cancer.
    Urol Oncol. 2017 Feb 14. pii: S1078-1439(17)30014.
    Abstract     Related articles   

  288. EDMONDSON AJ, Birtwistle JC, Catto JW, Twiddy M, et al
    The patients' experience of a bladder cancer diagnosis: a systematic review of the qualitative evidence.
    J Cancer Surviv. 2017 Feb 17. doi: 10.1007/s11764-017-0603.
    Abstract     Related articles   

  289. LIN T, Yuan A, Zhao X, Lian H, et al
    Self-assembled tumor-targeting hyaluronic acid nanoparticles for photothermal ablation in orthotopic bladder cancer.
    Acta Biomater. 2017 Feb 14. pii: S1742-7061(17)30126.
    Abstract     Related articles   

  290. INGELMO-TORRES M, Lozano JJ, Izquierdo L, Carrion A, et al
    Urinary cell microRNA-based prognostic classifier for non-muscle invasive bladder cancer.
    Oncotarget. 2017 Feb 14. doi: 10.18632/oncotarget.15315.
    Abstract     Related articles   

  291. GENG J, Fan J, Wang Q, Zhang XP, et al
    Decreased REG1alpha expression suppresses growth, invasion and angiogenesis of bladder cancer.
    Eur J Surg Oncol. 2017 Feb 2. pii: S0748-7983(17)30108.
    Abstract     Related articles   

  292. PATEL S, Hafez O, Sexton WJ, Edwards DA, et al
    Perioperative Management of a Patient With an Intrathecal Drug Delivery Device Infusing Ziconotide: A Case Report.
    A A Case Rep. 2017;8:78-80.
    Abstract     Related articles   

  293. LIU Y, Bui MM, Xu B
    Urothelial Carcinoma With Squamous Differentiation Is Associated With High Tumor Stage and Pelvic Lymph-Node Metastasis.
    Cancer Control. 2017;24:78-82.
    Abstract     Related articles   

  294. COURTADE-SAIDI M, Aziza J, d'Aure D, Berard E, et al
    Immunocytochemical staining for p53 and Ki-67 helps to characterise urothelial cells in urine cytology.
    Cytopathology. 2016;27:456-464.
    Abstract     Related articles   

  295. VAN DE GOOR RM, Leunis N, van Hooren MR, Francisca E, et al
    Feasibility of electronic nose technology for discriminating between head and neck, bladder, and colon carcinomas.
    Eur Arch Otorhinolaryngol. 2017;274:1053-1060.
    Abstract     Related articles   

  296. XU X, Wei M, Liu Y, Liu X, et al
    A simple, fast, label-free colorimetric method for detection of telomerase activity in urine by using hemin-graphene conjugates.
    Biosens Bioelectron. 2017;87:600-606.
    Abstract     Related articles   

  297. KISHIMOTO N, Takao T, Kuribayashi S, Yamamichi G, et al
    The neutrophil-to-lymphocyte ratio as a predictor of intravesical recurrence in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
    Int J Clin Oncol. 2017;22:153-158.
    Abstract     Related articles   

  298. NGUYEN D, Taheri D, Springer S, Cowan M, et al
    High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma.
    Virchows Arch. 2016;469:427-34.
    Abstract     Related articles   

    A Review of Outcomes for Stage Ta Bladder Tumors.
    Am J Clin Pathol. 2016;146:215-20.
    Abstract     Related articles   

  300. SMITH DM
    BCG-osis following intravesical BCG treatment leading to miliary pulmonary nodules, penile granulomas and a mycotic aortic aneurysm.
    BMJ Case Rep. 2016;2016.
    Abstract     Related articles   

  301. ZHOU AG, Liu Y, Cyr MS, Garver J, et al
    Role of Tetrasomy for the Diagnosis of Urothelial Carcinoma Using UroVysion Fluorescent In Situ Hybridization.
    Arch Pathol Lab Med. 2016;140:552-9.
    Abstract     Related articles   

  302. PHAM HV, Pantanowitz L, Liu Y
    Quantitative phase imaging to improve the diagnostic accuracy of urine cytology.
    Cancer Cytopathol. 2016;124:641-50.
    Abstract     Related articles   

    High apoptotic index in urine cytology is associated with high-grade urothelial carcinoma.
    Cancer Cytopathol. 2016;124:538-9.
    Abstract     Related articles   

  304. YANG CS, Chen S, Cramer HM, Wu HH, et al
    High apoptotic index in urine cytology is associated with high-grade urothelial carcinoma.
    Cancer Cytopathol. 2016;124:546-51.
    Abstract     Related articles   

  305. SANFRANCESCO J, McKenney JK, Leivo MZ, Gupta S, et al
    Sarcomatoid Urothelial Carcinoma of the Bladder: Analysis of 28 Cases With Emphasis on Clinicopathologic Features and Markers of Epithelial-to-Mesenchymal Transition.
    Arch Pathol Lab Med. 2016;140:543-51.
    Abstract     Related articles   

  306. ZHANG ML, Rosenthal DL, VandenBussche CJ
    The cytomorphological features of low-grade urothelial neoplasms vary by specimen type.
    Cancer Cytopathol. 2016;124:552-64.
    Abstract     Related articles   

  307. LOVDAHL S, Henriksson KM, Baghaei F, Holmstrom M, et al
    Malignancies in Swedish persons with haemophilia: a longitudinal registry study.
    Blood Coagul Fibrinolysis. 2016;27:631-6.
    Abstract     Related articles   

  308. BRIMO F, Auger M
    The atypical urothelial cell category in the Paris System: Strengthening the Achilles' heel.
    Cancer Cytopathol. 2016;124:305-6.
    Abstract     Related articles   

  309. BAGAYOGO T, Jakhal N, Slaoui A, Ziouziou I, et al
    [Neoplastic Vesico-vaginal Fistula (VVF) secondary to bladder cancer: a rare entity].
    Pan Afr Med J. 2016;25:59.
    Abstract     Related articles   

  310. KAMAT AM, Colombel M, Sundi D, Lamm D, et al
    BCG-unresponsive non-muscle-invasive bladder cancer: recommendations from the IBCG.
    Nat Rev Urol. 2017 Feb 21. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  311. YARMOSHCHUK SV, Kudryavtsev AS, Zeravin AA, Drobyazgin EA, et al
    [Robot-assisted cystprostatectomy for urinary bladder cancer (the first experience)].
    Urologiia. 2016;:132-135.
    Abstract     Related articles   

  312. PAVLOV VN, Pushkaryev AM, Safiullin RI, Kazikhinurov AA, et al
    [Experience with radical surgery for muscle-invasive bladder cancer in patients with end-stage chronic kidney disease].
    Urologiia. 2016;:124-127.
    Abstract     Related articles   

  313. ALYAEV YG, Pshikhachev AM, Perekalina AN
    [The risk of bladder cancer in patients with prostatic hyperplasia and strategies to manage this combination].
    Urologiia. 2016;:115-118.
    Abstract     Related articles   

  314. GLYBOCHKO PV, Alyaev YG, Pshikhachev AM, Sorokin NI, et al
    [Choosing treatment for patients with bladder cancer combined with prostatic hyperplasia].
    Urologiia. 2016;:92-96.
    Abstract     Related articles   

  315. ROLEVICH AI, Evmenenko AA
    [A systematic review and meta-analysis to assess the recurrence-free survival in non-muscle invasive bladder cancer after transurethral resection guided by 5-aminolevulinic acid-induced photodynamic diagnosis compared with white-light transurethral re
    Urologiia. 2016;:137-146.
    Abstract     Related articles   

  316. GLYBOCHKO PV, Alyaev JG, Potoldykova NV, Polyakovsky KA, et al
    [The role of telomerase activity in non-invasive diagnostics of bladder cancer].
    Urologiia. 2016;:76-81.
    Abstract     Related articles   

  317. MIKHAILENKO DS, Nemtsova MV
    [Point somatic mutations in bladder cancer: key carcinogenesis events, diagnostic markers and therapeutic targets].
    Urologiia. 2016;:100-105.
    Abstract     Related articles   

    [The criteria of patient selection for repeat transurethral resection of non-muscle invasive bladder cancer].
    Urologiia. 2016;:71-76.
    Abstract     Related articles   

  319. KOSOVA IV
    [The role of viruses in the etiology of bladder cancer].
    Urologiia. 2016;:100-103.
    Abstract     Related articles   

  320. FENG S, Chen J, Zheng Y
    [Research progress on the effect of glucocorticoid receptor signaling pathways in bladder cancer].
    Zhejiang Da Xue Xue Bao Yi Xue Ban. 2016;45:655-660.
    Abstract     Related articles   

  321. YOSHIDA S, Takahara T, Kwee TC, Waseda Y, et al
    DWI as an Imaging Biomarker for Bladder Cancer.
    AJR Am J Roentgenol. 2017 Feb 28:1-11. doi: 10.2214/AJR.17.17798.
    Abstract     Related articles   

  322. REDDY AV, Christodouleas JP, Wu T, Smith ND, et al
    External Validation and Optimization of International Consensus Clinical Target Volumes for Adjuvant Radiation Therapy in Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2017;97:740-746.
    Abstract     Related articles   

  323. THOMPSON C, Joseph N, Sanderson B, Logue J, et al
    Tolerability of Concurrent Chemoradiation Therapy With Gemcitabine (GemX), With and Without Prior Neoadjuvant Chemotherapy, in Muscle Invasive Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2017;97:732-739.
    Abstract     Related articles   

  324. PARK SJ, Myung SK, Lee Y, Lee YJ, et al
    Effects of Vitamin and Antioxidant Supplements in Prevention of Bladder Cancer: a Meta-Analysis of Randomized Controlled Trials.
    J Korean Med Sci. 2017;32:628-635.
    Abstract     Related articles   

  325. SOLANKI AA, Martin B, Korpics M, Small C, et al
    Adjuvant Radiotherapy Use by US Radiation Oncologists After Radical Cystectomy for Muscle-invasive Bladder Cancer.
    Clin Oncol (R Coll Radiol). 2017 Feb 24. pii: S0936-6555(17)30080.
    Abstract     Related articles   

  326. LI P, Chen J, Miyamoto H
    Androgen Receptor Signaling in Bladder Cancer.
    Cancers (Basel). 2017;9.
    Abstract     Related articles   

  327. MIGITA T, Ueda A, Ohishi T, Hatano M, et al
    Epithelial-mesenchymal transition promotes SOX2 and NANOG expression in bladder cancer.
    Lab Invest. 2017 Feb 27. doi: 10.1038/labinvest.2017.
    Abstract     Related articles   

  328. COGORNO WASYLKOWSKI L, Rios-Gonzalez E, Linares Espinos E, Leibar Tamayo A, et al
    Indication for early cystectomy in nonmuscle-invasive bladder cancer. Literature review.
    Actas Urol Esp. 2017 Feb 18. pii: S0210-4806(17)30004.
    Abstract     Related articles   

  329. APFELTHALER C, Anzengruber M, Gabor F, Wirth M, et al
    Poly - (L) - glutamic acid drug delivery system for the intravesical therapy of bladder cancer using WGA as targeting moiety.
    Eur J Pharm Biopharm. 2017 Feb 22. pii: S0939-6411(16)30583.
    Abstract     Related articles   

  330. HENON C, Huillard O, Preta LH, Blanchet B, et al
    Cytidine Deaminase Activity Assessment to Select Perioperative Chemotherapy Regimen in Localized Bladder Cancer.
    Clin Genitourin Cancer. 2017 Feb 1. pii: S1558-7673(17)30033.
    Abstract     Related articles   

  331. ISMAIL AF, Oskay S, Babteen N, De Piano M, et al
    PAK5 mediates cell:cell adhesion integrity via interaction with E-cadherin in bladder cancer cells.
    Biochem J. 2017 Feb 23. pii: BCJ20160875. doi: 10.1042/BCJ20160875.
    Abstract     Related articles   

  332. YU HT, Kim TH, Uhm JS, Kim JY, et al
    Clinical Significance of Hematuria in Atrial Fibrillation With Oral Anticoagulation Therapy.
    Circ J. 2017;81:158-164.
    Abstract     Related articles   

  333. WU YP, Lin TT, Chen SH, Xu N, et al
    Comparison of the efficacy and feasibility of en bloc transurethral resection of bladder tumor versus conventional transurethral resection of bladder tumor: A meta-analysis.
    Medicine (Baltimore). 2016;95:e5372.
    Abstract     Related articles   

  334. KIM C, Gao J, Shannon VR, Siefker-Radtke A, et al
    Systemic sarcoidosis first manifesting in a tattoo in the setting of immune checkpoint inhibition.
    BMJ Case Rep. 2016;2016.
    Abstract     Related articles   

  335. KEHILA M, Mekni K, Abouda HS, Chtourou M, et al
    [Leiomyoma of the bladder causing the destruction of a kidney].
    Pan Afr Med J. 2016;24:10.
    Abstract     Related articles   

  336. KITAYAMA H, Yokota T, Kondo T, Sugiyama J, et al
    Unusual Development of Pulmonary Tumor Embolism from Controlled Liver Metastases of Transitional Cell Carcinoma: An Autopsy Case.
    Intern Med. 2016;55:2453-6.
    Abstract     Related articles   

  337. GUO XG, Long JJ
    Cytokeratin-19 fragment in the diagnosis of bladder carcinoma.
    Tumour Biol. 2016;37:14329-14330.
    Abstract     Related articles   

  338. KOUBA E, Cheng L
    Neuroendocrine Tumors of the Urinary Bladder According to the 2016 World Health Organization Classification: Molecular and Clinical Characteristics.
    Endocr Pathol. 2016;27:188-99.
    Abstract     Related articles   

  339. HASSAN M, Qureshi A, Nasir H
    Recurrent verrucous carcinoma of the urinary bladder after transurethral resection followed by intravesical mitomycin, and a review of the literature.
    BMJ Case Rep. 2016;2016.
    Abstract     Related articles   

  340. XING QW, Wu Y, Cai B, Ma LM, et al
    [Clinical research of second resection on early stage primary bladder adenocarcinoma and literature review].
    Zhonghua Yi Xue Za Zhi. 2016;96:1585-7.
    Abstract     Related articles   

  341. GUPTA S, Zhang J, Rivera M, Erickson LA, et al
    Urinary Bladder Paragangliomas: Analysis of Succinate Dehydrogenase and Outcome.
    Endocr Pathol. 2016;27:243-52.
    Abstract     Related articles   

  342. OU X, Hong F, Zhang Z, Cheng Y, et al
    A highly sensitive and facile graphene oxide-based nucleic acid probe: Label-free detection of telomerase activity in cancer patient's urine using AIEgens.
    Biosens Bioelectron. 2017;89.
    Abstract     Related articles   

  343. RIZOS CV, Kei A, Elisaf MS
    The current role of thiazolidinediones in diabetes management.
    Arch Toxicol. 2016;90:1861-81.
    Abstract     Related articles   

  344. KIM M, Kim YY, Jee HJ, Bae SS, et al
    Akt3 knockdown induces mitochondrial dysfunction in human cancer cells.
    Acta Biochim Biophys Sin (Shanghai). 2016;48:447-53.
    Abstract     Related articles   

  345. CANDIDO S, Di Maso M, Serraino D, McCubrey JA, et al
    Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder.
    Tumour Biol. 2016;37:9855-63.
    Abstract     Related articles   

  346. ISLAM SS, Mokhtari RB, Akbari P, Hatina J, et al
    Simultaneous Targeting of Bladder Tumor Growth, Survival, and Epithelial-to-Mesenchymal Transition with a Novel Therapeutic Combination of Acetazolamide (AZ) and Sulforaphane (SFN).
    Target Oncol. 2016;11:209-27.
    Abstract     Related articles   

  347. KAHOKEHR A, Glasson J, Studd R
    Surgical waiting time for radical cystectomy: a New Zealand experience.
    ANZ J Surg. 2016;86:1042-1045.
    Abstract     Related articles   

  348. SINGLA M, Shikha D, Lee S, Baumstein D, et al
    Ileal Neobladder With Mucous Plugs as a Cause of Obstructive Acute Kidney Injury Requiring Emergent Hemodialysis.
    Am J Ther. 2016;23:e1099-101.
    Abstract     Related articles   

  349. YAO HH, Chu K, Hallot C, Lewin J, et al
    Metachronous primary urothelial carcinoma following small cell carcinoma of the urinary bladder.
    ANZ J Surg. 2017;87.
    Abstract     Related articles   

  350. WU C, Zhou X, Miao C, Zhang J, et al
    Assessing the Feasibility of Replacing Standard-Dose Bacillus Calmette-Guerin Immunotherapy with Other Intravesical Instillation Therapies in Bladder Cancer Patients: A Network Meta-Analysis.
    Cell Physiol Biochem. 2017;41:1298-1312.
    Abstract     Related articles   

  351. QIU W, Lin J, Zhu Y, Zhang J, et al
    Kaempferol Modulates DNA Methylation and Downregulates DNMT3B in Bladder Cancer.
    Cell Physiol Biochem. 2017;41:1325-1335.
    Abstract     Related articles   

  352. ATTA MA, Kotb AF, Sharafeldeen M, Elabbady A, et al
    The value of extended good quality transurethral resection of bladder tumour in the treatment of the newly diagnosed bladder cancer.
    Arab J Urol. 2016;15:60-63.
    Abstract     Related articles   

  353. BUISAN O, Orsola A, Oliveira M, Martinez R, et al
    Role of Inflammation in the Perioperative Management of Urothelial Bladder Cancer With Squamous-Cell Features: Impact of Neutrophil-to-Lymphocyte Ratio on Outcomes and Response to Neoadjuvant Chemotherapy.
    Clin Genitourin Cancer. 2017 Feb 6. pii: S1558-7673(17)30040.
    Abstract     Related articles   

  354. YIN X, Li F, Jin Y, Yin Z, et al
    [Establishment of a human bladder cancer cell line stably co-expressing hSPRY2 and luciferase genes and its subcutaneous tumor xenograft model in nude mice].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017;33:337-341.
    Abstract     Related articles   

  355. ISMAILI N
    Neoadjuvant Chemotherapy: A New Standard for Muscle Invasive Bladder Cancer?
    Gulf J Oncolog. 2017;1:82-85.
    Abstract     Related articles   

  356. KILINC MF, Bayar G, Dalkilic A, Sonmez NC, et al
    Applicability of the EORTC risk tables to predict outcomes in non-muscle-invasive bladder cancer in Turkish patients.
    Turk J Urol. 2017;43:48-54.
    Abstract     Related articles   

  357. KAMAT AM, Bagcioglu M, Huri E
    What is new in non-muscle-invasive bladder cancer in 2016?
    Turk J Urol. 2017;43:9-13.
    Abstract     Related articles   

  358. YUAN Q, Sun T, Ye F, Kong W, et al
    MicroRNA-124-3p affects proliferation, migration and apoptosis of bladder cancer cells through targeting AURKA.
    Cancer Biomark. 2017 Feb 27. doi: 10.3233/CBM-160427.
    Abstract     Related articles   

  359. SHEPHERD AR, Shepherd E, Brook NR
    Intravesical Bacillus Calmette-Guerin with interferon-alpha versus intravesical Bacillus Calmette-Guerin for treating non-muscle-invasive bladder cancer.
    Cochrane Database Syst Rev. 2017;3:CD012112.
    Abstract     Related articles   

  360. SHANG A, Yang M, Shen F, Wang J, et al
    MiR-1-3p Suppresses the Proliferation, Invasion and Migration of Bladder Cancer Cells by Up-Regulating SFRP1 Expression.
    Cell Physiol Biochem. 2017;41:1179-1188.
    Abstract     Related articles   

  361. HWANG EC, Jung SI, Lee HJ, Lee JJ, et al
    Generation of potent cytotoxic T lymphocytes against in male patients with non-muscle invasive bladder cancer by dendritic cells loaded with dying T24 bladder cancer cells.
    Int Braz J Urol. 2017;43.
    Abstract     Related articles   

  362. SIDAWAY P
    Bladder cancer: Pembrolizumab is superior to chemotherapy.
    Nat Rev Urol. 2017 Mar 7. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  363. TYSON MD, Chang SS, Keegan KA
    Role of consolidative surgical therapy in patients with locally advanced or regionally metastatic bladder cancer.
    Bladder (San Franc). 2016;3.
    Abstract     Related articles   

  364. YURUK E, Saitz TR, Gonultas S, Serefoglu EC, et al
    Neutrophil-to-lymphocyte ratio is elevated in recurringnonmuscle invasive bladder cancer.
    Turk J Med Sci. 2017;47:234-239.
    Abstract     Related articles   

  365. MAHDAVINEZHAD A, Yadegarazari R, Mousavi-Bahar SH, Poorolajal J, et al
    Evaluation of zinc finger E-box binding homeobox 1 and transforming growth factor-beta2 expression in bladder cancer tissue in comparison with healthy adjacent tissue.
    Investig Clin Urol. 2017;58:140-145.
    Abstract     Related articles   

  366. ZHAO ZF, Wang K, Guo FF, Lu H, et al
    Inhibition of T24 and RT4 Human Bladder Cancer Cell Lines by Heterocyclic Molecules.
    Med Sci Monit. 2017;23:1156-1164.
    Abstract     Related articles   

  367. MUPPA P, Gupta S, Frank I, Boorjian SA, et al
    Prognostic significance of lymphatic, vascular and perineural invasion for bladder cancer patients treated by radical cystectomy.
    Pathology. 2017 Mar 1. pii: S0031-3025(16)40358.
    Abstract     Related articles   

  368. YIN H, Qin C, Zhao Y, Du Y, et al
    SOX10 is over-expressed in bladder cancer and contributes to the malignant bladder cancer cell behaviors.
    Clin Transl Oncol. 2017 Mar 3. doi: 10.1007/s12094-017-1641.
    Abstract     Related articles   

  369. MIYAKE M, Hori S, Morizawa Y, Tatsumi Y, et al
    Corrigendum to "CXCL1-Mediated Interaction of Cancer Cells with Tumor-Associated Macrophages and Cancer-Associated Fibroblasts Promotes Tumor Progression in Human Bladder Cancer" [Neoplasia 18 (2016) 636-646].
    Neoplasia. 2017;19:250-251.
    Abstract     Related articles   

  370. SANGUEDOLCE F, Loizzi D, Sollitto F, Di Bisceglie M, et al
    Bladder Metastases from Lung Cancer: Clinical and Pathological Implications: A Systematic Review.
    Oncology. 2017;92:125-134.
    Abstract     Related articles   

  371. KUMAR V, Garg R, Gupta N, Bharati SJ, et al
    Cautious use and optimal dose of morphine for relieving malignant pain in a complex patient with multiple comorbidities.
    BMJ Case Rep. 2016;2016.
    Abstract     Related articles   

  372. TORRES-BLANCO A, Gomez-Palones F, Edo-Fleta G
    Arteriocutaneous Fistula Associated with Bilateral Femoral Pseudoaneurysms Caused by Bacillus Calmette-Guerin. Apropos of a Case and Review of Literature.
    Ann Vasc Surg. 2017;39:291.
    Abstract     Related articles   

  373. PIVOVARCIKOVA K, Pitra T, Vanecek T, Alaghehbandan R, et al
    Comparative study of TERT gene mutation analysis on voided liquid-based urine cytology and paraffin-embedded tumorous tissue.
    Ann Diagn Pathol. 2016;24:7-10.
    Abstract     Related articles   

  374. ALONGI P, Caobelli F, Gentile R, Stefano A, et al
    Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/CT.
    Eur J Nucl Med Mol Imaging. 2017;44:224-233.
    Abstract     Related articles   

  375. MADANCHI M, Zeitz J, Barthel C, Samaras P, et al
    Malignancies in Patients with Inflammatory Bowel Disease: A Single-Centre Experience.
    Digestion. 2016;94:1-8.
    Abstract     Related articles   

  376. YU R, Gohla G, Haider EA
    Chromophobe renal cell carcinoma mimicking cortical invasion by synchronous invasive urothelial carcinoma of the intra-renal collecting system on CT urography.
    Int Braz J Urol. 2016;42:392-4.
    Abstract     Related articles   

  377. ARISTA-NASR J, Martinez-Benitez B, Bornstein-Quevedo L, Aguilar-Ayala E, et al
    Low grade urothelial carcinoma mimicking basal cell hyperplasia and transitional metaplasia in needle prostate biopsy.
    Int Braz J Urol. 2016;42:247-52.
    Abstract     Related articles   

  378. POLAT H, Utangac MM, Gulpinar MT, Cift A, et al
    Urothelial neoplasm of the bladder in childhood and adolescence: a rare disease.
    Int Braz J Urol. 2016;42:242-6.
    Abstract     Related articles   

  379. DING XL, Yang X, Liang G, Wang K, et al
    Isoform switching and exon skipping induced by the DNA methylation inhibitor 5-Aza-2'-deoxycytidine.
    Sci Rep. 2016;6:24545.
    Abstract     Related articles   

  380. DAHM HH, von der Haar C, Rubben H
    DNA cytophotometric and histological analysis of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced precancerous lesions of the bladder urothelium.
    J Cancer Res Clin Oncol. 2016;142:1253-60.
    Abstract     Related articles   

  381. TAMAS A, Javorhazy A, Reglodi D, Sarlos DP, et al
    Examination of PACAP-Like Immunoreactivity in Urogenital Tumor Samples.
    J Mol Neurosci. 2016;59:177-83.
    Abstract     Related articles   

  382. DAVARPANAH NN, Yuno A, Trepel JB, Apolo AB, et al
    Immunotherapy: a new treatment paradigm in bladder cancer.
    Curr Opin Oncol. 2017 Mar 16. doi: 10.1097/CCO.0000000000000366.
    Abstract     Related articles   

  383. LI QQ, Hao JJ, Zhang Z, Krane LS, et al
    Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics.
    Sci Rep. 2017;7:201.
    Abstract     Related articles   

  384. ROUDNICKY F, Dieterich LC, Poyet C, Buser L, et al
    High expression of insulin receptor on tumor-associated blood vessels in invasive bladder cancer predicts poor overall and progression-free survival.
    J Pathol. 2017 Mar 14. doi: 10.1002/path.4892.
    Abstract     Related articles   

  385. BOMAN K, Andersson G, Wennersten C, Nodin B, et al
    Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study.
    Biomark Res. 2017;5:10.
    Abstract     Related articles   

  386. SEILER R, Black PC, Thalmann G, Stenzl A, et al
    Is The Cancer Genome Atlas (TCGA) bladder cancer cohort representative of invasive bladder cancer?
    Urol Oncol. 2017 Mar 10. pii: S1078-1439(17)30059.
    Abstract     Related articles   

  387. NGUYEN DP, Thalmann GN
    Contemporary update on neoadjuvant therapy for bladder cancer.
    Nat Rev Urol. 2017 Mar 14. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  388. POTTS KG, Irwin CR, Favis NA, Pink DB, et al
    Deletion of F4L (ribonucleotide reductase) in vaccinia virus produces a selective oncolytic virus and promotes anti-tumor immunity with superior safety in bladder cancer models.
    EMBO Mol Med. 2017 Mar 13. pii: e201607296. doi: 10.15252/emmm.201607296.
    Abstract     Related articles   

  389. Immunotherapy Beats Chemo for Bladder Cancer.
    Cancer Discov. 2017 Mar 13. doi: 10.1158/2159-8290.CD-NB2017.
    Abstract     Related articles   

  390. DURIEZ E, Masselon CD, Mesmin C, Court M, et al
    Large-Scale SRM Screen of Urothelial Bladder Cancer Candidate Biomarkers in Urine.
    J Proteome Res. 2017 Mar 13. doi: 10.1021/acs.jproteome.6b00979.
    Abstract     Related articles   

  391. TYSON MD, Lee D, Clark P
    New developments in the management of nonmuscle invasive bladder cancer.
    Curr Opin Oncol. 2017 Mar 9. doi: 10.1097/CCO.0000000000000362.
    Abstract     Related articles   

  392. LI J, Qu W, Jiang Y, Sun Y, et al
    miR-489 Suppresses Proliferation and Invasion of Human Bladder Cancer Cells.
    Oncol Res. 2016;24:391-398.
    Abstract     Related articles   

  393. CICCARESE C, Massari F, Blanca A, Tortora G, et al
    Tp53 and its potential therapeutic role as a target in bladder cancer.
    Expert Opin Ther Targets. 2017;21:401-414.
    Abstract     Related articles   

  394. AZER SA, Alghofaili MM, Alsultan RM, Alrumaih NS, et al
    Accuracy and Readability of Websites on Kidney and Bladder Cancers.
    J Cancer Educ. 2017 Mar 9. doi: 10.1007/s13187-017-1181.
    Abstract     Related articles   

  395. PARK J, Shin DW, Kim TH, Jung SI, et al
    Development and Validation of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Patients with Non-muscle invasive bladder Cancer - EORTC QLQ-NMIBC24.
    Cancer Res Treat. 2017 Mar 10. doi: 10.4143/crt.2016.
    Abstract     Related articles   

  396. PATEL A, Desai P, Malczewski F, Stephens D, et al
    Mullerianosis of the urinary bladder: a rare and problematic bladder tumour.
    BMJ Case Rep. 2017;2017.
    Abstract     Related articles   

  397. ZHANG YG, Song QX, Song B, Zhang DL, et al
    Diagnosis and Treatment of Urinary Incontinence after Orthotopic Ileal Neobladder in China.
    Chin Med J (Engl). 2017;130:231-235.
    Abstract     Related articles   

  398. LIANG X, Men QL, Li YW, Li HC, et al
    Silencing of Armadillo Repeat-Containing Protein 8 (ARMc8) Inhibits TGF-beta-Induced EMT in Bladder Carcinoma UMUC3 Cells.
    Oncol Res. 2017;25:99-105.
    Abstract     Related articles   

  399. KUMAR AV, Mogili HK, Boju SL, Guptha R, et al
    Pheochromocytoma of Urinary Bladder in a Dialysis PatientPheochromocytoma of Urinary Bladder.
    Nephrology (Carlton). 2017;22:183.
    Abstract     Related articles   

  400. KIM CJ, Fujiwara R, Yamashita H
    [Modified Toyoda Method for Complete Duplex Ureters in Tubeless Cutaneous Ureterostomy : Report of a Case].
    Hinyokika Kiyo. 2016;62:591-594.
    Abstract     Related articles   

  401. OWARI T, Yamamoto T, Mizobuchi S, Itami Y, et al
    [Bladder Metastasis of Renal Cell Carcinoma 7 Years after Ex Vivo Partial Nephrectomy and Auto-Transplantation : A Case Report].
    Hinyokika Kiyo. 2016;62:575-579.
    Abstract     Related articles   

  402. TOPAL CS, Kir G, Das T, Sarbay B, et al
    Metastatic malignant melanoma of the urinary bladder: A case report and review of the literature.
    Indian J Pathol Microbiol. 2016;59:532-534.
    Abstract     Related articles   

  403. SINGH JP, Priyadarshi V, Pal DK
    A clinicoepidemiological study of young age bladder tumors: An eastern Indian scenario.
    J Cancer Res Ther. 2016;12:751-4.
    Abstract     Related articles   

  404. WANG HJ, Pui MH, Guo Y, Guan J, et al
    Preliminary study of diffusion-weighted MRI in the preoperative diagnosis of cystitis glandularis.
    Clin Radiol. 2016;71:937.
    Abstract     Related articles   

  405. SARSIK B, Doganavsargil B, Simsir A, Yazici A, et al
    P21 and p27 Immunoexpression in Upper Urinary Tract Urothelial Carcinomas.
    Pathol Oncol Res. 2016;22:839-45.
    Abstract     Related articles   

    A review of the Paris system for reporting urinary cytology.
    Cytopathology. 2016;27:153-6.
    Abstract     Related articles   

  407. PRABHU B, Sivakumar A, Sundaresan S
    Diindolylmethane and Lupeol Modulates Apoptosis and Cell Proliferation in N-Butyl-N-(4-Hydroxybutyl) Nitrosamine Initiated and Dimethylarsinic Acid Promoted rat Bladder Carcinogenesis.
    Pathol Oncol Res. 2016;22:747-54.
    Abstract     Related articles   

  408. WU D, Wang Y, Zhang Y, Ma H, et al
    Sensitive Electrochemical Immunosensor for Detection of Nuclear Matrix Protein-22 based on NH2-SAPO-34 Supported Pd/Co Nanoparticles.
    Sci Rep. 2016;6:24551.
    Abstract     Related articles   

  409. ROSS EM, Markowetz F
    OncoNEM: inferring tumor evolution from single-cell sequencing data.
    Genome Biol. 2016;17:69.
    Abstract     Related articles   

  410. WU CL, Svendsen SG, Riviere A, Desgrandchamps F, et al
    Multiplex bead-based immunoassay for the free soluble forms of the HLA-G receptors, ILT2 and ILT4.
    Hum Immunol. 2016;77:720-6.
    Abstract     Related articles   

  411. FUJII N, Hoshii Y, Hirata H, Mori J, et al
    Impact of divergent differentiation in urothelial carcinoma on oncological outcome in patients with T1 high-grade bladder cancer.
    Jpn J Clin Oncol. 2017 Mar 8:1-8. doi: 10.1093.
    Abstract     Related articles   

    Updated Review Confirms Potential Risk of Bladder Cancer with Pioglitazone.
    Am J Nurs. 2017;117:25.
    Abstract     Related articles   

  413. MICHAELSON MD, Hu C, Pham HT, Dahl DM, et al
    A Phase 1/2 Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation After Transurethral Surgery for Noncystectomy Candidates With Muscle-Invasive Bladder Cancer (Trial NRG Oncology RTOG 05
    Int J Radiat Oncol Biol Phys. 2017;97:995-1001.
    Abstract     Related articles   

  414. VASHISTHA V, Wang H, Mazzone A, Liss MA, et al
    Radical Cystectomy Compared to Combined Modality Treatment for Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
    Int J Radiat Oncol Biol Phys. 2017;97:1002-1020.
    Abstract     Related articles   

  415. CHEN W, Zhao K, Miao C, Xu A, et al
    Silencing Trim59 inhibits invasion/migration and epithelial-to-mesenchymal transition via TGF-beta/Smad2/3 signaling pathway in bladder cancer cells.
    Onco Targets Ther. 2017;10:1503-1512.
    Abstract     Related articles   

  416. AYDIN AM, Woldu SL, Hutchinson RC, Boegemann M, et al
    Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer.
    Onco Targets Ther. 2017;10:1487-1502.
    Abstract     Related articles   

  417. MITIN T
    Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? | Opinion: No.
    Int Braz J Urol. 2017;43:188-191.
    Abstract     Related articles   

  418. MONTEIRO LL, Kassouf W
    Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? | Opinion: Yes.
    Int Braz J Urol. 2017;43:184-187.
    Abstract     Related articles   

  419. MURPHY DR, Meyer AN, Vaghani V, Russo E, et al
    Application of Electronic Algorithms to Improve Diagnostic Evaluation for Bladder Cancer.
    Appl Clin Inform. 2017;8:279-290.
    Abstract     Related articles   

  420. GEE JR, Saltzstein DR, Kim K, Kolesar JM, et al
    A phase II randomized, double-blind, presurgical trial of Polyphenon E in bladder cancer patients to evaluate pharmacodynamics and bladder tissue biomarkers.
    Cancer Prev Res (Phila). 2017 Mar 21. pii: canprevres.0167.2016.
    Abstract     Related articles   

    The Impact of Blue Light Cystoscopy on the Diagnosis and Treatment of Bladder Cancer.
    Curr Urol Rep. 2017;18:39.
    Abstract     Related articles   

  422. SUN X, Hoadley KA, Kim WY, Furberg H, et al
    Age at diagnosis, obesity, smoking, and molecular subtypes in muscle-invasive bladder cancer.
    Cancer Causes Control. 2017 Mar 20. doi: 10.1007/s10552-017-0885.
    Abstract     Related articles   

  423. CAO W, Ma E, Zhou L, Yuan T, et al
    Exploring the FGFR3-related oncogenic mechanism in bladder cancer using bioinformatics strategy.
    World J Surg Oncol. 2017;15:66.
    Abstract     Related articles   

  424. YASUI M, Morikawa T, Nakagawa T, Miyakawa J, et al
    Urinary bladder carcinoma with divergent differentiation featuring small cell carcinoma, sarcomatoid carcinoma, and liposarcomatous component.
    Pathol Res Pract. 2016;212:833-7.
    Abstract     Related articles   

  425. NIKOLEISHVILI D, Tchanturaia Z, Managadze G, Koberidze G, et al
    Georgian Med News. 2016;:7-11.
    Abstract     Related articles   

  426. NIU HT, Dong P, Wang JN, Huang J, et al
    [Analysis of treatment and prognosis in post-operative patients with urachal carcinoma].
    Zhonghua Yi Xue Za Zhi. 2016;96:1923-5.
    Abstract     Related articles   

  427. MAKBOUL R, Refaiy A, Abdelkawi IF, Hameed DA, et al
    Alterations of mTOR and PTEN protein expression in schistosomal squamous cell carcinoma and urothelial carcinoma.
    Pathol Res Pract. 2016;212:385-92.
    Abstract     Related articles   

  428. PYUN JH, Kim HK, Cho S, Kang SG, et al
    Robot-Assisted Radical Cystectomy with Total Intracorporeal Urinary Diversion: Comparative Analysis with Extracorporeal Urinary Diversion.
    J Laparoendosc Adv Surg Tech A. 2016;26:349-55.
    Abstract     Related articles   

  429. TURATI F, Bosetti C, Polesel J, Serraino D, et al
    Family history of cancer and the risk of bladder cancer: A case-control study from Italy.
    Cancer Epidemiol. 2017;48:29-35.
    Abstract     Related articles   

  430. WOLDU SL, Sanli O, Lotan Y
    Tackling Non-Muscle Invasive Bladder Cancer in the Clinic.
    Expert Rev Anticancer Ther. 2017 Mar 31. doi: 10.1080/14737140.2017.1313119.
    Abstract     Related articles   

  431. KASMANN L, Manig L, Janssen S, Rades D, et al
    Chemoradiation Including Paclitaxel for Locally Recurrent Muscle-invasive Bladder Cancer in Elderly Patients.
    In Vivo. 2017;31:239-241.
    Abstract     Related articles   

  432. AOUN F, Rassy EE, Assi T, Albisinni S, et al
    Advances in urothelial bladder cancer immunotherapy, dawn of a new age of treatment.
    Immunotherapy. 2017;9:451-460.
    Abstract     Related articles   

  433. CHENG N, Xu Y, Luo Y, Zhu L, et al
    Specific and relative detection of urinary microRNA signatures in bladder cancer for point-of-care diagnostics.
    Chem Commun (Camb). 2017 Mar 30. doi: 10.1039/c7cc01007.
    Abstract     Related articles   

  434. WANG H, Zuo Y, Ding M, Ke C, et al
    LASS2 inhibits growth and invasion of bladder cancer by regulating ATPase activity.
    Oncol Lett. 2017;13:661-668.
    Abstract     Related articles   

  435. TSAI JL, Tsai SF
    Calcium oxalate crystal related kidney injury in a patient receiving Roux-en Y hepaticojejunostomy due to gall bladder cancer.
    BMC Nephrol. 2017;18:106.
    Abstract     Related articles   

  436. SUNDAR RAJAN V, Laurent VM, Verdier C, Duperray A, et al
    Unraveling the Receptor-Ligand Interactions between Bladder Cancer Cells and the Endothelium Using AFM.
    Biophys J. 2017;112:1246-1257.
    Abstract     Related articles   

  437. SIDAWAY P
    Bladder cancer: TCGA cohort is representative of invasive disease.
    Nat Rev Urol. 2017 Mar 29. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  438. SON SK, Lee NR, Kang SH, Lee SH, et al
    Safety and Effectiveness of Robot-Assisted Versus Open Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis.
    J Laparoendosc Adv Surg Tech A. 2017 Mar 28. doi: 10.1089/lap.2016.0437.
    Abstract     Related articles   

  439. CHIU M, McBeth L, Sindhwani P, Hinds TD, et al
    Deciphering the Roles of Thiazolidinediones and PPARgamma in Bladder Cancer.
    PPAR Res. 2017;2017:4810672.
    Abstract     Related articles   

  440. OLIVEIRA MB, Villa Nova M, Bruschi ML
    A review of recent developments on micro/nanostructured pharmaceutical systems for intravesical therapy of the bladder cancer.
    Pharm Dev Technol. 2017 Mar 27:1-43. doi: 10.1080/10837450.2017.1312441.
    Abstract     Related articles   

  441. MOUW KW
    DNA Repair Pathway Alterations in Bladder Cancer.
    Cancers (Basel). 2017;9.
    Abstract     Related articles   

  442. VALE N, Gouveia MJ, Rinaldi G, Santos J, et al
    The role of estradiol metabolism in urogenital schistosomiasis-induced bladder cancer.
    Tumour Biol. 2017;39:1010428317692247.
    Abstract     Related articles   

  443. ZHANG H, Fan Y, Xia L, Gao C, et al
    The impact of advanced proteomics in the search for markers and therapeutic targets of bladder cancer.
    Tumour Biol. 2017;39:1010428317691183.
    Abstract     Related articles   

  444. QU K, Gu J, Ye Y, Williams SB, et al
    High baseline levels of interleukin-8 in leukocytes and urine predict tumor recurrence in non-muscle invasive bladder cancer patients receiving bacillus Calmette-Guerin therapy: A long-term survival analysis.
    Oncoimmunology. 2017;6:e1265719.
    Abstract     Related articles   

  445. SORIA F, Lucca I, Moschini M, Mathieu R, et al
    Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer.
    Urol Oncol. 2017 Mar 22. pii: S1078-1439(17)30093.
    Abstract     Related articles   

  446. SIKIC D, Breyer J, Hartmann A, Burger M, et al
    High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder Cancer.
    Transl Oncol. 2017;10:340-345.
    Abstract     Related articles   

  447. SATO A, Asano T, Okubo K, Isono M, et al
    Ritonavir and ixazomib kill bladder cancer cells by causing ubiquitinated protein accumulation.
    Cancer Sci. 2017 Mar 25. doi: 10.1111/cas.13242.
    Abstract     Related articles   

  448. SEITZ AK, Christensen LL, Christensen E, Faarkrog K, et al
    Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer.
    Sci Rep. 2017;7:395.
    Abstract     Related articles   

  449. DONIN NM, Chamie K, Lenis AT, Pantuck AJ, et al
    A phase 2 study of TMX-101, intravesical imiquimod, for the treatment of carcinoma in situ bladder cancer.
    Urol Oncol. 2017;35:39.
    Abstract     Related articles   

  450. MENG FM, Meng FM, Song XL
    MiR-576-3p is a novel marker correlated with poor clinical outcome in bladder cancer.
    Eur Rev Med Pharmacol Sci. 2017;21:973-977.
    Abstract     Related articles   

  451. WANG R, Wu Y, Huang W, Chen W, et al
    MicroRNA-940 Targets INPP4A or GSK3beta and Activates the Wnt/beta-Catenin Pathway to Regulate the Malignant Behavior of Bladder Cancer Cells.
    Oncol Res. 2017 Mar 23. doi: 10.3727/096504017X14902261600566.
    Abstract     Related articles   

  452. FINA E, Necchi A, Bottelli S, Reduzzi C, et al
    Detection of Circulating Tumour Cells in Urothelial Cancers and Clinical Correlations: Comparison of Two Methods.
    Dis Markers. 2017;2017:3414910.
    Abstract     Related articles   

  453. MD NOH MS, Abdul Aziz AF, Mohd Ghani KA, Lee Kheng Siang C, et al
    Giant Intradiverticular Bladder Tumor.
    Am J Case Rep. 2017;18:212-216.
    Abstract     Related articles   

  454. CHO A, Lee SM, Noh JW, Choi DK, et al
    Acid-base disorders after orthotopic bladder replacement: comparison of an ileal neobladder and an ileal conduit.
    Ren Fail. 2017;39:379-384.
    Abstract     Related articles   

  455. LOBO J, Henrique R, Monteiro P, Lobo C, et al
    ALK-negative anaplastic large cell lymphoma with urinary bladder involvement diagnosed in urine cytology: A case report and literature review.
    Diagn Cytopathol. 2017;45:354-358.
    Abstract     Related articles   

  456. ISHIBASHI N, Maebayashi T, Aizawa T, Sakaguchi M, et al
    Refractory Haematuria Resulting From Peritoneal Dissemination of Metastatic Gastric Cancer: Radiation Therapy For A Nodule Infiltrating The Urinary Bladder.
    Urol J. 2017;14:2982-2984.
    Abstract     Related articles   

  457. LEE J, Park S, Cho MS, Sung SH, et al
    Urine cytology findings of primary paraganglioma of the urinary bladder: Case report.
    Diagn Cytopathol. 2017;45:350-353.
    Abstract     Related articles   

  458. LIU X, Wei M, Xu E, Yang H, et al
    A sensitive, label-free electrochemical detection of telomerase activity without modification or immobilization.
    Biosens Bioelectron. 2017;91:347-353.
    Abstract     Related articles   

  459. LV M, Zhong Z, Chi H, Huang M, et al
    Genome-Wide Screen of miRNAs and Targeting mRNAs Reveals the Negatively Regulatory Effect of miR-130b-3p on PTEN by PI3K and Integrin beta1 Signaling Pathways in Bladder Carcinoma.
    Int J Mol Sci. 2016;18.
    Abstract     Related articles   

  460. POLLARD RE, Watson KD, Hu X, Ingham E, et al
    Feasibility of quantitative contrast ultrasound imaging of bladder tumors in dogs.
    Can Vet J. 2017;58:70-72.
    Abstract     Related articles   

  461. BROWN KG, Solomon MJ, Latif ER, Koh CE, et al
    Urological complications after cystectomy as part of pelvic exenteration are higher than that after cystectomy for primary bladder malignancy.
    J Surg Oncol. 2017;115:307-311.
    Abstract     Related articles   

  462. WANG ZY, Zhang W, Yang JJ, Song DK, et al
    Expression of miRNA-630 in bladder urothelial carcinoma and its clinical significance.
    J Huazhong Univ Sci Technolog Med Sci. 2016;36:705-709.
    Abstract     Related articles   

  463. ARAKAWA K, Ishihara S, Kawai K, Shibata J, et al
    Asynchronous bilateral anastomosis site sigmoid colon cancer after ureterosigmoidostomy: a case report.
    World J Surg Oncol. 2016;14:180.
    Abstract     Related articles   

  464. HEDEGAARD J, Lamy P, Nordentoft I, Algaba F, et al
    Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma.
    Cancer Cell. 2016;30:27-42.
    Abstract     Related articles   

  465. SAUER M, Degen O, Beyersdorff D
    [Not Available].
    Rofo. 2016;188:782-3.
    Abstract     Related articles   

  466. PANG C, Guan Y, Li H, Chen W, et al
    Urologic cancer in China.
    Jpn J Clin Oncol. 2016;46:497-501.
    Abstract     Related articles   

  467. ISMAILI N
    External beam radiation therapy for small cell carcinoma of the bladder.
    Pract Radiat Oncol. 2016;6:e215-6.
    Abstract     Related articles   

  468. KONG V, Kwan M, Chen S, Moseley J, et al
    Impact of image registration surrogates on the planning target volume geometry for bladder radiation therapy.
    Pract Radiat Oncol. 2016;6:e187-94.
    Abstract     Related articles   

  469. SALAH S, Lee JL, Rozzi A, Kitamura H, et al
    Second-Line Chemotherapy for Metastatic Urothelial Carcinoma: Importance of Lymph Node-Only Metastasis as a Prognostic Factor and Construction of a Prognostic Model.
    Clin Genitourin Cancer. 2016;14:255-60.
    Abstract     Related articles   

  470. JAN AS, Dolan DE, Lombardi K, Gupta S, et al
    Tolerability of Gemcitabine Plus Cisplatin for Treatment of Urothelial Cancer in the Elderly Population.
    Clin Genitourin Cancer. 2016;14:e257-63.
    Abstract     Related articles   

  471. ANTONELLI A, Belotti S, Cristinelli L, De Luca V, et al
    Comparison of Perioperative Morbidity of Radical Cystectomy With Neobladder Versus Ileal Conduit: A Matched Pair Analysis of 170 Patients.
    Clin Genitourin Cancer. 2016;14:244-8.
    Abstract     Related articles   

  472. TAGUCHI S, Akamatsu N, Nakagawa T, Gonoi W, et al
    Sarcopenia Evaluated Using the Skeletal Muscle Index Is a Significant Prognostic Factor for Metastatic Urothelial Carcinoma.
    Clin Genitourin Cancer. 2016;14:237-43.
    Abstract     Related articles   

  473. TAJIMA S, Suzuki T, Yamada Y, Morikawa T, et al
    Invasive urothelial carcinoma with chordoid features may be an ominous sign predicting sarcomatoid change: a case report of a bladder carcinoma.
    Med Mol Morphol. 2016;49:182-7.
    Abstract     Related articles   

  474. DU L, Jiang X, Duan W, Wang R, et al
    Cell-free microRNA expression signatures in urine serve as novel noninvasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
    Oncotarget. 2017 Mar 28. doi: 10.18632/oncotarget.16586.
    Abstract     Related articles   

  475. KIM YJ, Byun SJ, Ahn H, Kim CS, et al
    Comparison of outcomes between trimodal therapy and radical cystectomy in muscle-invasive bladder cancer: a propensity score matching analysis.
    Oncotarget. 2017 Mar 25. doi: 10.18632/oncotarget.16576.
    Abstract     Related articles   

  476. CHLOSTA PL, Golabek T, Nyirady P
    New Insights into Diagnosis and Treatment of Renal Cell Carcinoma, Bladder Cancer, and Prostate Cancer.
    Biomed Res Int. 2017;2017:6467072.
    Abstract     Related articles   

  477. YU H, Duan P, Zhu H, Rao D, et al
    miR-613 inhibits bladder cancer proliferation and migration through targeting SphK1.
    Am J Transl Res. 2017;9:1213-1221.
    Abstract     Related articles   

  478. TAN G, Wang H, Yuan J, Qin W, et al
    Three serum metabolite signatures for diagnosing low-grade and high-grade bladder cancer.
    Sci Rep. 2017;7:46176.
    Abstract     Related articles   

  479. WU J, Wan F, Sheng H, Shi G, et al
    NR1H3 Expression is a Prognostic Factor of Overall Survival for Patients with Muscle-Invasive Bladder Cancer.
    J Cancer. 2017;8:852-860.
    Abstract     Related articles   

  480. LI Y, Guo G, Song J, Cai Z, et al
    B7-H3 Promotes the Migration and Invasion of Human Bladder Cancer Cells via the PI3K/Akt/STAT3 Signaling Pathway.
    J Cancer. 2017;8:816-824.
    Abstract     Related articles   

  481. EISSA S, Matboli M, Awad N, Kotb Y, et al
    Identification and validation of a novel autophagy gene expression signature for human bladder cancer patients.
    Tumour Biol. 2017;39:1010428317698360.
    Abstract     Related articles   

  482. MINAMI K, Taniguchi K, Sugito N, Kuranaga Y, et al
    MiR-145 negatively regulates Warburg effect by silencing KLF4 and PTBP1 in bladder cancer cells.
    Oncotarget. 2017 Mar 23. doi: 10.18632/oncotarget.16524.
    Abstract     Related articles   

  483. WANG X, Zhang F, Wu XR
    Inhibition of Pyruvate Kinase M2 Markedly Reduces Chemoresistance of Advanced Bladder Cancer to Cisplatin.
    Sci Rep. 2017;7:45983.
    Abstract     Related articles   

  484. KUMARI N, Agrawal U, Mishra AK, Kumar A, et al
    Predictive role of serum and urinary cytokines in invasion and recurrence of bladder cancer.
    Tumour Biol. 2017;39:1010428317697552.
    Abstract     Related articles   

  485. JIANG H, Hu X, Zhang H, Li W, et al
    Down-regulation of LncRNA TUG1 enhances radiosensitivity in bladder cancer via suppressing HMGB1 expression.
    Radiat Oncol. 2017;12:65.
    Abstract     Related articles   

    New insight for metformin against bladder cancer.
    Genes Environ. 2017;39:13.
    Abstract     Related articles   

  487. LEVINE JJ, Somer RA, Hosoya H, Squillante C, et al
    Atezolizumab-induced Encephalitis in Metastatic Bladder Cancer: A Case Report and Review of the Literature.
    Clin Genitourin Cancer. 2017 Mar 16. pii: S1558-7673(17)30063.
    Abstract     Related articles   

  488. LI Y, Shan Z, Liu C, Yang D, et al
    MicroRNA-294 Promotes Cellular Proliferation and Motility through the PI3K/AKT and JAK/STAT Pathways by Upregulation of NRAS in Bladder Cancer.
    Biochemistry (Mosc). 2017;82:474-482.
    Abstract     Related articles   

  489. KLUMPER N, Syring I, Vogel W, Schmidt D, et al
    Mediator Complex Subunit MED1 Protein Expression Is Decreased during Bladder Cancer Progression.
    Front Med (Lausanne). 2017;4:30.
    Abstract     Related articles   

  490. KONG DB, Chen F, Sima N
    Focal adhesion kinases crucially regulate TGFbeta-induced migration and invasion of bladder cancer cells via Src kinase and E-cadherin.
    Onco Targets Ther. 2017;10:1783-1792.
    Abstract     Related articles   

  491. LUO F, Wang YS, Su YH, Zhang ZH, et al
    Prognostic impact of preoperative anemia on non-muscle-invasive bladder carcinoma treated with GreenLight laser vaporization.
    Lasers Med Sci. 2017;32:397-403.
    Abstract     Related articles   

    Georgian Med News. 2016;.
    Abstract     Related articles   

  493. FAGHIH Z, Shobeiri SS, Ariafar A, Sarkarian M, et al
    CD8+ T Lymphocyte Subsets in Bladder Tumor Draining Lymph Nodes.
    Iran J Immunol. 2016;13:237-248.
    Abstract     Related articles   

  494. LENOS M, Katafigiotis I, Vrettou K, Papaioannou D, et al
    Evaluation of double immunocytochemical staining for CK20 and P53 as a potential adjunct to cytology for urothelial cancer diagnosis.
    Cytopathology. 2017;28:96-102.
    Abstract     Related articles   

    Development of a Drug Delivery System for Cancer Immunotherapy.
    Yakugaku Zasshi. 2016;136:1477-1484.
    Abstract     Related articles   

  496. MIKI Y, Neat M, Chandra A
    Application of The Paris System to atypical urine cytology samples: correlation with histology and UroVysion(R) FISH.
    Cytopathology. 2017;28:88-95.
    Abstract     Related articles   

  497. LEIVO MZ, Elson PJ, Tacha DE, Delahunt B, et al
    A combination of p40, GATA-3 and uroplakin II shows utility in the diagnosis and prognosis of muscle-invasive urothelial carcinoma.
    Pathology. 2016;48:543-9.
    Abstract     Related articles   

  498. TIAN DW, Hu HL, Sun Y, Tang Y, et al
    Biological effects of eukaryotic recombinant plasmid pReceiver-M61-BAI-1 transfection on T24 cells and HUVECs.
    Mol Med Rep. 2016;14:1553-9.
    Abstract     Related articles   

  499. HINRICHSEN S, Planer-Friedrich B
    Cytotoxic activity of selenosulfate versus selenite in tumor cells depends on cell line and presence of amino acids.
    Environ Sci Pollut Res Int. 2016;23:8349-57.
    Abstract     Related articles   

  500. SANLI O, Dobruch J, Knowles MA, Burger M, et al
    Bladder cancer.
    Nat Rev Dis Primers. 2017;3:17022.
    Abstract     Related articles   

  501. Bladder cancer.
    Nat Rev Dis Primers. 2017;3:17023.
    Abstract     Related articles   

  502. DAVIES BJ, Hwang TJ, Kesselheim AS
    Ensuring Access to Injectable Generic Drugs - The Case of Intravesical BCG for Bladder Cancer.
    N Engl J Med. 2017;376:1401-1403.
    Abstract     Related articles   

  503. WANG LH, Lei S, Dong Yuan S, Che X, et al
    Long-term floating control-released intravesical preparation of 5-fluorouracil for the local treatment of bladder cancer.
    Drug Dev Ind Pharm. 2017 Apr 12:1-21. doi: 10.1080/03639045.2017.1318898.
    Abstract     Related articles   

  504. NIEDERSUSS-BEKE D, Puntus T, Kunit T, Grunberger B, et al
    Neoadjuvant Chemotherapy with Gemcitabine plus Cisplatin in Patients with Locally Advanced Bladder Cancer.
    Oncology. 2017 Apr 12. doi: 10.1159/000463389.
    Abstract     Related articles   

  505. PANER GP, Montironi R, Amin MB
    Challenges in Pathologic Staging of Bladder Cancer: Proposals for Fresh Approaches of Assessing Pathologic Stage in Light of Recent Studies and Observations Pertaining to Bladder Histoanatomic Variances.
    Adv Anat Pathol. 2017;24:113-127.
    Abstract     Related articles   

  506. PATSCHAN O, Holmang S, Hosseini A, Jancke G, et al
    Second-look resection for primary stage T1 bladder cancer: a population-based study.
    Scand J Urol. 2017 Apr 11:1-7. doi: 10.1080/21681805.2017.1303846.
    Abstract     Related articles   

  507. KUSAKA A, Hatakeyama S, Hosogoe S, Hamano I, et al
    Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer.
    Med Oncol. 2017;34:90.
    Abstract     Related articles   

  508. ZHAO L, Tian X, Duan X, Ye Y, et al
    Association of body mass index with bladder cancer risk: a dose-response meta-analysis of prospective cohort studies.
    Oncotarget. 2017 Mar 30. doi: 10.18632/oncotarget.16722.
    Abstract     Related articles   

  509. LI Y, Wen JM, Du CJ, Hu SM, et al
    Thymol inhibits bladder cancer cell proliferation via inducing cell cycle arrest and apoptosis.
    Biochem Biophys Res Commun. 2017 Apr 4. pii: S0006-291X(17)30666.
    Abstract     Related articles   

  510. MALMSTROM PU, Hemdan T, Segersten U
    Validation of the ezrin, CK20, and Ki-67 as potential predictive markers for BCG instillation therapy of non-muscle-invasive bladder cancer.
    Urol Oncol. 2017 Apr 4. pii: S1078-1439(17)30110.
    Abstract     Related articles   

  511. CHALA B, Choi MH, Moon KC, Kim HS, et al
    Development of Urinary Bladder Pre-Neoplasia by Schistosoma haematobium Eggs and Chemical Carcinogen in Mice.
    Korean J Parasitol. 2017;55:21-29.
    Abstract     Related articles   

  512. SHARMA A, Mete UK, Sood A, Kakkar N, et al
    Utility of early dynamic and delayed post-diuretic 18F-FDG PET/CT SUVmax in predicting tumor grade and T-stage of urinary bladder carcinoma: Results from a prospective single center study.
    Br J Radiol. 2017 Mar 3:20160787. doi: 10.1259/bjr.20160787.
    Abstract     Related articles   

  513. AI XL, Chi Q, Qiu Y, Li HY, et al
    Gap junction protein connexin43 deregulation contributes to bladder carcinogenesis via targeting MAPK pathway.
    Mol Cell Biochem. 2017;428.
    Abstract     Related articles   

  514. LEMBO F, Subba E, Lagana AS, Vitale SG, et al
    Intradiverticular Sarcomatoid Carcinoma of The Bladder: An Overview Starting From A Peculiar Case.
    Urol J. 2016;13:2800-2.
    Abstract     Related articles   

  515. WU SW, Liou JH, Yeh KT, Hung TW, et al
    The Prevalence and Prognostic Significance of Polyomavirus Infection in Patients with Urothelial Carcinoma of the Bladder.
    Urol J. 2016;13:2773-8.
    Abstract     Related articles   

  516. BARNES SC, Shepherd DE, Espino DM, Bryan RT, et al
    Design of an improved surgical instrument for the removal of bladder tumours.
    Proc Inst Mech Eng H. 2016;230:579-87.
    Abstract     Related articles   

  517. SHRADER S, Lauridson J, King Z, Loch J, et al
    Urachal Adenocarcinoma in a Dog.
    J Comp Pathol. 2016;154:304-8.
    Abstract     Related articles   

  518. GUO S, Fan C, Rohr J, Fan L, et al
    A clinicopathologic study of paragangliomas of the urinary bladder: can the clinical behavior of the tumor be predicted?
    Histol Histopathol. 2016;31:785-91.
    Abstract     Related articles   

  519. NOVOTNY V, Froehner M, Koch R, Zastrow S, et al
    Age, American Society of Anesthesiologists physical status classification and Charlson score are independent predictors of 90-day mortality after radical cystectomy.
    World J Urol. 2016;34:1123-9.
    Abstract     Related articles   

  520. COMBERG D, Gauer A, Tschernig T
    First findings of gap junction proteins in human urothelial carcinoma.
    World J Urol. 2016;34:145-7.
    Abstract     Related articles   

  521. HUANG XL, Zhang H, Yang XY, Dong XY, et al
    Activation of a c-Jun N-terminal kinase-mediated autophagy pathway attenuates the anticancer activity of gemcitabine in human bladder cancer cells.
    Anticancer Drugs. 2017 Apr 20. doi: 10.1097/CAD.0000000000000499.
    Abstract     Related articles   

  522. BACCHETTI T, Sartini D, Pozzi V, Cacciamani T, et al
    Exploring the role of paraoxonase-2 in bladder cancer: analyses performed on tissue samples, urines and cell cultures.
    Oncotarget. 2017 Feb 24. doi: 10.18632/oncotarget.15674.
    Abstract     Related articles   

  523. EICH ML, Dyrskjot L, Netto GJ
    Toward personalized management in bladder cancer: the promise of novel molecular taxonomy.
    Virchows Arch. 2017 Apr 21. doi: 10.1007/s00428-017-2119.
    Abstract     Related articles   

  524. HAU AM, Nakasaki M, Nakashima K, Krish G, et al
    Differential mTOR pathway profiles in bladder cancer cell line subtypes to predict sensitivity to mTOR inhibition.
    Urol Oncol. 2017 Apr 18. pii: S1078-1439(17)30134.
    Abstract     Related articles   

  525. YANG LL, Wang XY, Zheng LY, Fang SJ, et al
    [The role of FOXO3a-Bim signaling in triptolide induced bladder cancer T24 cells apoptosis].
    Zhonghua Yi Xue Za Zhi. 2017;97:1187-1190.
    Abstract     Related articles   

  526. OZGOZ A, Samli M, Dincel D, Sahin A, et al
    Association of B7-H4 gene polymorphisms in urothelial bladder cancer.
    Turk J Med Sci. 2017;47:443-446.
    Abstract     Related articles   

  527. LIU X, Liu X, Wu Y, Wu Q, et al
    MicroRNAs in biofluids are novel tools for bladder cancer screening.
    Oncotarget. 2017 Mar 8. doi: 10.18632/oncotarget.16026.
    Abstract     Related articles   

  528. LEONE A, Diorio G, Sexton W, Schell M, et al
    Sulforaphane for the chemoprevention of bladder cancer: molecular mechanism targeted approach.
    Oncotarget. 2017 Mar 8. doi: 10.18632/oncotarget.16015.
    Abstract     Related articles   

  529. POYET C, Thomas L, Benoit TM, Delmo DA, et al
    Implication of vascular endothelial growth factor A and C in revealing diagnostic lymphangiogenic markers in node-positive bladder cancer.
    Oncotarget. 2017;8:21871-21883.
    Abstract     Related articles   

  530. CHEN L, Pan XW, Huang H, Gao Y, et al
    Epithelial-mesenchymal transition induced by GRO-alpha-CXCR2 promotes bladder cancer recurrence after intravesical chemotherapy.
    Oncotarget. 2017 Apr 3. doi: 10.18632/oncotarget.16786.
    Abstract     Related articles   

  531. STYRKE J, Henriksson H, Ljungberg B, Hasan M, et al
    Evaluation of the diagnostic accuracy of UBC(R) Rapid in bladder cancer: a Swedish multicentre study.
    Scand J Urol. 2017 Apr 19:1-8. doi: 10.1080/21681805.2017.1313309.
    Abstract     Related articles   

  532. SUN F, Zhao R, Zhu Y, Cui D, et al
    A prospective comparison of intra-arterial chemotherapy combined with intravesical chemotherapy and intravesical chemotherapy alone after transurethral resection with a thulium laser in high-risk non-muscle invasive bladder cancer.
    Cancer Chemother Pharmacol. 2017 Apr 18. doi: 10.1007/s00280-017-3305.
    Abstract     Related articles   

  533. D'ANDREA D, Moschini M, Gust K, Abufaraj M, et al
    Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Primary Non-muscle-invasive Bladder Cancer.
    Clin Genitourin Cancer. 2017 Mar 27. pii: S1558-7673(17)30069.
    Abstract     Related articles   

  534. YANG G, Shen W, Zhang Y, Liu M, et al
    Accumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancer.
    Oncotarget. 2017 Mar 20. doi: 10.18632/oncotarget.16386.
    Abstract     Related articles   

  535. DUDEK AM, Boer SJ, Boon N, Witjes JA, et al
    Identification of long non-coding RNAs that stimulate cell survival in bladder cancer.
    Oncotarget. 2017 Mar 16. doi: 10.18632/oncotarget.16284.
    Abstract     Related articles   

  536. CHEN C, Hu L, Chen Y, Hou J, et al
    The prognostic value of histological subtype in patients with metastatic bladder cancer.
    Oncotarget. 2017 Mar 10. doi: 10.18632/oncotarget.16083.
    Abstract     Related articles   

  537. CUI X, Jing X, Long C, Yi Q, et al
    Accuracy of the urine UCA1 for diagnosis of bladder cancer: a meta-analysis.
    Oncotarget. 2017 Mar 22. doi: 10.18632/oncotarget.16473.
    Abstract     Related articles   

  538. SHAO CH, Chen CL, Lin JY, Chen CJ, et al
    Metabolite marker discovery for the detection of bladder cancer by comparative metabolomics.
    Oncotarget. 2017 Mar 21. doi: 10.18632/oncotarget.16393.
    Abstract     Related articles   

  539. WEI Y, Gao L, Wang L, Shi L, et al
    Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy.
    Drug Deliv. 2017;24:681-691.
    Abstract     Related articles   

  540. LEONE AR, Zargar-Shoshtari K, Diorio GJ, Sharma P, et al
    Neoadjuvant Chemotherapy in Elderly Patients With Bladder Cancer: Oncologic Outcomes From a Single Institution Experience.
    Clin Genitourin Cancer. 2017 Feb 1. pii: S1558-7673(17)30030.
    Abstract     Related articles   

  541. SURYAVANSHI M, Sanz-Ortega J, Sirohi D, Divatia MK, et al
    S100P as a Marker for Urothelial Histogenesis: A Critical Review and Comparison With Novel and Traditional Urothelial Immunohistochemical Markers.
    Adv Anat Pathol. 2017;24:151-160.
    Abstract     Related articles   

  542. ELHAWARY NA, Nassir A, Saada H, Dannoun A, et al
    Combined Genetic Biomarkers Confer Susceptibility to Risk of Urothelial Bladder Carcinoma in a Saudi Population.
    Dis Markers. 2017;2017:1474560.
    Abstract     Related articles   

  543. AMAYA CN, Wians FH Jr, Bryan BA, Torabi A, et al
    Enhanced expression of Programmed cell death 1 (PD-1) protein in benign vascular anomalies.
    Pathology. 2017;49:292-296.
    Abstract     Related articles   

  544. BIGOT F, Bonnet C, Massard C
    [Immunotherapy for the treatment of patients with genitourinary cancers: Review and perspectives].
    Bull Cancer. 2017;104:370-379.
    Abstract     Related articles   

  545. FUKUSHIMA K, Hirosako S, Tenjin Y, Mukasa Y, et al
    Pulmonary Mucosa-associated Lymphoid Tissue Lymphoma with Spontaneous Regression after Computed Tomography-guided Needle Biopsy: A Case Report and Summary of 8 Reported Cases.
    Intern Med. 2016;55:3655-3660.
    Abstract     Related articles   

  546. WANG H, Yuan G, Zhao B, Zhao Y, et al
    High expression of B23 is associated with tumorigenesis and poor prognosis in bladder urothelial carcinoma.
    Mol Med Rep. 2017;15:743-749.
    Abstract     Related articles   

  547. PASCHKE L, Juszczak M, Slupski M
    Surgical treatment of recurrent urachal carcinoma with liver metastasis: a case report and literature review.
    World J Surg Oncol. 2016;14:296.
    Abstract     Related articles   

  548. CHO MH, Kim SH, Park WS, Joung JY, et al
    Bladder chondrosarcoma plus urothelial carcinoma in recurred transitional cell carcinoma of the upper urinary tract: a case report and literature review.
    World J Surg Oncol. 2016;14:270.
    Abstract     Related articles   

  549. SEVINC C, Ozkaptan O, Balaban M, Yucetas U, et al
    Radical Cystoprostatectomy in Patients with Behcet's Disease: The Report of Four Cases and Review of The Literature.
    Urol J. 2016;13:2871-2875.
    Abstract     Related articles   

  550. MAI KT, Bateman J, Djordjevic B, Flood TA, et al
    Clear Cell Urothelial Carcinoma.
    Int J Surg Pathol. 2017;25:18-25.
    Abstract     Related articles   

  551. RAIS-BAHRAMI S, Tracht JP, McIntosh ER, Lai WS, et al
    Complete Tissue Submission to Increase Lymph Node Detection in Pelvic Lymph Node Packets Submitted for Patients Undergoing Radical Prostatectomy and Radical Cystectomy.
    Int J Surg Pathol. 2017;25:12-17.
    Abstract     Related articles   

  552. YIKILMAZ TN, Dirim A, Ayva ES, Ozdemir H, et al
    Clinical Use of Tumor Markers for the Detection and Prognosis of Bladder Carcinoma: A Comparison of CD44, Cytokeratin 20 and Survivin.
    Urol J. 2016;13:2677-83.
    Abstract     Related articles   

  553. GOTO K
    CD138 Expression Is Observed in the Urothelial Epithelium and in Various Urothelial Carcinomas, and Cannot Be Evidence for Plasmacytoid Urothelial Carcinoma.
    Int J Surg Pathol. 2016;24:614-9.
    Abstract     Related articles   

  554. MAY M, Fritsche HM, Vetterlein MW, Bastian PJ, et al
    Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011.
    World J Urol. 2017;35:245-250.
    Abstract     Related articles   

  555. GOLABEK T, Palou J, Rodriguez O, Gaya JM, et al
    Is it possible to stop follow-up of patients with primary T1G3 urothelial carcinoma of the bladder managed with intravesical bacille Calmette-Guerin immunotherapy?
    World J Urol. 2017;35:237-243.
    Abstract     Related articles   

  556. LIU CW, Wu YT, Lin KJ, Yu TJ, et al
    A Hydrogel-Based Epirubicin Delivery System for Intravesical Chemotherapy.
    Molecules. 2016;21.
    Abstract     Related articles   

  557. ANGELINI L, Bisogno G, Alaggio R, Scarzello G, et al
    Prognostic factors in children undergoing salvage surgery for bladder/prostate rhabdomyosarcoma.
    J Pediatr Urol. 2016;12:265.
    Abstract     Related articles   

  558. SHAO IH, Chang YH, Yu KJ, Lin PH, et al
    Outcomes and prognostic factors of simple partial cystectomy for localized bladder urothelial cell carcinoma.
    Kaohsiung J Med Sci. 2016;32:191-5.
    Abstract     Related articles   

  559. LODH B, Sinam RS, Singh KA
    Adenocarcinoma of urinary bladder in patient with primary gastric cancer: An unusual synchronous distant metastasis.
    Indian J Cancer. 2016;53:53-5.
    Abstract     Related articles   

  560. DOGANTEKIN E, Girgin C, Gorgel SN, Soylemez H, et al
    Can immediate second resection be an alternative to standardized second transurethral resection of bladder tumors?
    Kaohsiung J Med Sci. 2016;32:147-51.
    Abstract     Related articles   

  561. KURTIS B, Zhuge J, Ojaimi C, Ye F, et al
    Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications.
    Ann Diagn Pathol. 2016;21:7-11.
    Abstract     Related articles   

  562. MITRA S, Sundaram AK, Gupta K, Devana SK, et al
    Urothelial Carcinoma With Villoglandular Differentiation: A Rare Entity.
    Int J Surg Pathol. 2016;24:356-9.
    Abstract     Related articles   

  563. VILLA L, Cloutier J, Letendre J, Ploumidis A, et al
    Early repeated ureteroscopy within 6-8 weeks after a primary endoscopic treatment in patients with upper tract urothelial cell carcinoma: preliminary findings.
    World J Urol. 2016;34:1201-6.
    Abstract     Related articles   

  564. BREYER J, Gierth M, Shalekenov S, Aziz A, et al
    Epithelial-mesenchymal transformation markers E-cadherin and survivin predict progression of stage pTa urothelial bladder carcinoma.
    World J Urol. 2016;34:709-16.
    Abstract     Related articles   

  565. GRIMM T, Buchner A, Schneevoigt B, Kretschmer A, et al
    Impact of preoperative hemoglobin and CRP levels on cancer-specific survival in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: results of a single-center study.
    World J Urol. 2016;34:703-8.
    Abstract     Related articles   

  566. ZARGAR-SHOSHTARI K, Zargar H, Dinney CP, Ercole CE, et al
    Clinical and therapeutic factors associated with adverse pathological outcomes in clinically node-negative patients treated with neoadjuvant cisplatin-based chemotherapy and radical cystectomy.
    World J Urol. 2016;34:695-701.
    Abstract     Related articles   

  567. MATEU L, Garcia-Cruz E, Asiain I, Castaneda R, et al
    A higher Charlson comorbidity index is related to more aggressive characteristics in de novo vesical tumours.
    Actas Urol Esp. 2016;40:23-8.
    Abstract     Related articles   

  568. HANAZONO K, Nishimori T, Fukumoto S, Kawamura Y, et al
    Immunohistochemical expression of p63, Ki67 and beta-catenin in canine transitional cell carcinoma and polypoid cystitis of the urinary bladder.
    Vet Comp Oncol. 2016;14:263-9.
    Abstract     Related articles   

  569. LI G, Niu HM, Wu HT, Lei BY, et al
    Effect of cisplatin-based neoadjuvant chemotherapy on survival in patients with bladder cancer: a meta-analysis.
    Clin Invest Med. 2017;40:E81-E94.
    Abstract     Related articles   

  570. Nod for Atezolizumab in Advanced Bladder Cancer.
    Cancer Discov. 2017 Apr 26. doi: 10.1158/2159-8290.CD-NB2017.
    Abstract     Related articles   

  571. CORMIO L, Sanguedolce F, Cormio A, Massenio P, et al
    Human epidermal growth factor receptor 2 expression is more important than Bacillus Calmette Guerin treatment in predicting the outcome of T1G3 bladder cancer.
    Oncotarget. 2017;8:25433-25441.
    Abstract     Related articles   

  572. LIN J, Zhan Y, Liu Y, Chen Z, et al
    Increased expression of ZEB1-AS1 correlates with higher histopathological grade and promotes tumorigenesis in bladder cancer.
    Oncotarget. 2017;8:24202-24212.
    Abstract     Related articles   

  573. ZHU XX, Yan YW, Ai CZ, Jiang S, et al
    Jarid2 is essential for the maintenance of tumor initiating cells in bladder cancer.
    Oncotarget. 2017;8:24483-24490.
    Abstract     Related articles   

  574. KIM TS, Chung JI, Noh GH, Hwang H, et al
    Toward Better Predictions of Chemosensitivity: Comparative Study of Conventional and Simulated Chemosensitivity Tests for Bladder Cancer Cell Lines.
    Ann Lab Med. 2017;37:343-345.
    Abstract     Related articles   

  575. ZHANG YX, Qin CP, Zhang XQ, Wang QR, et al
    Knocking down glycoprotein nonmetastatic melanoma protein B suppresses the proliferation, migration, and invasion in bladder cancer cells.
    Tumour Biol. 2017;39:1010428317699119.
    Abstract     Related articles   

  576. MCPHERSON VA, Rodrigues G, Bauman G, Winquist E, et al
    Supplementary data: Chemoradiotherapy in octogenarians as primary treatment for muscle-invasive bladder cancer.
    Can Urol Assoc J. 2017;11.
    Abstract     Related articles   

  577. MCPHERSON VA, Rodrigues G, Bauman G, Winquist E, et al
    Chemoradiotherapy in octogenarians as primary treatment for muscle-invasive bladder cancer.
    Can Urol Assoc J. 2017;11.
    Abstract     Related articles   

  578. SIDAWAY P
    Bladder cancer: Targeting oncofetal glycosaminoglycans.
    Nat Rev Urol. 2017 Apr 25. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  579. TERRACCIANO D, Ferro M, Terreri S, Lucarelli G, et al
    Urinary long noncoding RNAs in nonmuscle-invasive bladder cancer: new architects in cancer prognostic biomarkers.
    Transl Res. 2017 Apr 7. pii: S1931-5244(16)30227.
    Abstract     Related articles   

  580. LIANG LG, Kong MQ, Zhou S, Sheng YF, et al
    An integrated double-filtration microfluidic device for isolation, enrichment and quantification of urinary extracellular vesicles for detection of bladder cancer.
    Sci Rep. 2017;7:46224.
    Abstract     Related articles   

  581. ZHOU Q, Song W, Xiao W
    Dioscin induces demethylation of DAPK-1 and RASSF-1alpha genes via the antioxidant capacity, resulting in apoptosis of bladder cancer T24 cells.
    EXCLI J. 2017;16:101-112.
    Abstract     Related articles   

  582. LIN YC, Lin JF, Wen SI, Yang SC, et al
    Chloroquine and hydroxychloroquine inhibit bladder cancer cell growth by targeting basal autophagy and enhancing apoptosis.
    Kaohsiung J Med Sci. 2017;33:215-223.
    Abstract     Related articles   

  583. LI Z, Liao H, Tan Z, Mao D, et al
    Micropapillary bladder cancer: a clinico-pathological characterization and treatment analysis.
    Clin Transl Oncol. 2017 Apr 21. doi: 10.1007/s12094-017-1658.
    Abstract     Related articles   

  584. HOY NY, Cohn JA, Kowalik CG, Kaufman MR, et al
    Management of Voiding Dysfunction After Female Neobladder Creation.
    Curr Urol Rep. 2017;18:33.
    Abstract     Related articles   

  585. ZAINFELD D, Daneshmand S
    Transurethral Resection of Bladder Tumors: Improving Quality Through New Techniques and Technologies.
    Curr Urol Rep. 2017;18:34.
    Abstract     Related articles   

  586. AUTORINO R, Porpiglia F, Dasgupta P, Rassweiler J, et al
    Precision surgery and genitourinary cancers.
    Eur J Surg Oncol. 2017;43:893-908.
    Abstract     Related articles   

  587. TSUKADA H, Miyakawa H
    Henoch Schonlein Purpura Nephritis Associated with Intravesical Bacillus Calmette-Guerin (BCG) Therapy.
    Intern Med. 2017;56:541-544.
    Abstract     Related articles   

  588. XU A, Ahsanul Kabir Khan M, Chen F, Zhong Z, et al
    Overexpression of autotaxin is associated with human renal cell carcinoma and bladder carcinoma and their progression.
    Med Oncol. 2016;33:131.
    Abstract     Related articles   

  589. GAJASINGHE DG, Nazeer I, Maddumage HP, Perera C, et al
    Metachronous bladder metastases of a type 2 papillary renal cell carcinoma: a case report and review of the literature.
    World J Surg Oncol. 2016;14:219.
    Abstract     Related articles   

  590. LI AY, Filson CP, Hollingsworth JM, He C, et al
    Patient-Reported Convalescence and Quality of Life Recovery: A Comparison of Open and Robotic-Assisted Radical Cystectomy.
    Surg Innov. 2016;23:598-605.
    Abstract     Related articles   

  591. BEQUET E, Stiennon L, Lhomme A, Piette C, et al
    [Rectal prolapse revealing a tumor: The role of abdominal ultrasound].
    Arch Pediatr. 2016 Jun 2. pii: S0929-693X(16)30200.
    Abstract     Related articles   

  592. ZARGAR-SHOSHTARI K, Kongnyuy M, Sharma P, Fishman MN, et al
    Clinical role of additional adjuvant chemotherapy in patients with locally advanced urothelial carcinoma following neoadjuvant chemotherapy and cystectomy.
    World J Urol. 2016;34:1567-1573.
    Abstract     Related articles   

  593. GOONEWARDENE SS, Persad R, Gillatt D
    Robotic radical cystectomy and enhanced recovery: a new pathway.
    World J Urol. 2016;34:1599-1600.
    Abstract     Related articles   

  594. PARKER WP, Ho PL, Boorjian SA, Melquist JJ, et al
    The importance of clinical stage among patients with a complete pathologic response at radical cystectomy after neoadjuvant chemotherapy.
    World J Urol. 2016;34:1561-1566.
    Abstract     Related articles   

  595. SONG YP, Ma JB, Wang L, Chen EC, et al
    Efficacy and safety of late-course hypofractionated radiation therapy for muscle-invasive bladder carcinoma after bladder-conserving surgery.
    Asia Pac J Clin Oncol. 2017;13:e111-e116.
    Abstract     Related articles   

  596. HUANG Z, Liu H, Wang Y, Zhang C, et al
    Determining the optimal maintenance schedules for adjuvant intravesical bacillus Calmette-Guerin immunotherapy in non-muscle-invasive bladder cancer: a systematic review and network meta-analysis.
    Curr Med Res Opin. 2017 May 4:1-19. doi: 10.1080/03007995.2017.1326889.
    Abstract     Related articles   

  597. NAN YH, Wang Y, Sun PH, Han Y, et al
    MiR-6838 Promotes Growth and Invasion in Bladder Cancer Via Suppression of Rb.
    Oncol Res. 2017 May 4. doi: 10.3727/096504017X14928634401169.
    Abstract     Related articles   

  598. ZHANG Q, Huang S, Luo H, Zhao X, et al
    Eight-plex iTRAQ labeling and quantitative proteomic analysis for human bladder cancer.
    Am J Cancer Res. 2017;7:935-945.
    Abstract     Related articles   

  599. NAN YH, Wang J, Wang Y, Sun PH, et al
    Erratum: MiR-4295 promotes cell growth in bladder cancer by targeting BTG1.
    Am J Transl Res. 2017;9:1960.
    Abstract     Related articles   

  600. BIJALWAN P, Pooleri GK, Thomas A
    Comparison of sterile water irrigation versus intravesical mitomycin C in preventing recurrence of nonmuscle invasive bladder cancer after transurethral resection.
    Indian J Urol. 2017;33:144-148.
    Abstract     Related articles   

  601. MITASH N, Tiwari S, Agnihotri S, Mandhani A, et al
    Bladder cancer: Micro RNAs as biomolecules for prognostication and surveillance.
    Indian J Urol. 2017;33:127-133.
    Abstract     Related articles   

  602. PINTO IG
    Systemic therapy in bladder cancer.
    Indian J Urol. 2017;33:118-126.
    Abstract     Related articles   

  603. SMELSER WW, Austenfeld MA, Holzbeierlein JM, Lee EK, et al
    Where are we with bladder preservation for muscle-invasive bladder cancer in 2017?
    Indian J Urol. 2017;33:111-117.
    Abstract     Related articles   

  604. KUKREJA JB, Shah JB
    Advances in surgical management of muscle invasive bladder cancer.
    Indian J Urol. 2017;33:106-110.
    Abstract     Related articles   

  605. KAMAT AM
    Bladder cancer: 2017 and beyond.
    Indian J Urol. 2017;33:104-105.
    Abstract     Related articles   

  606. TAE BS, Kim JK, Kang M, Jeong CW, et al
    Prognostic value of impaired estimated glomerular filtration rate in intravesical BCG-treated non-muscle-invasive bladder cancer patients.
    Sci Rep. 2017;7:1380.
    Abstract     Related articles   

  607. ECKE TH, Weiss S, Stephan C, Hallmann S, et al
    UBC(R) Rapid Test for detection of carcinoma in situ for bladder cancer.
    Tumour Biol. 2017;39:1010428317701624.
    Abstract     Related articles   

  608. SEVERINO PF, Silva M, Carrascal M, Malagolini N, et al
    Expression of sialyl-Tn sugar antigen in bladder cancer cells affects response to Bacillus Calmette Guerin (BCG) and to oxidative damage.
    Oncotarget. 2017 Apr 17. doi: 10.18632/oncotarget.17138.
    Abstract     Related articles   

  609. POLETAJEW S, Radziszewski P
    Endoscopic appearance of a tumor can predict the stage of bladder cancer.
    Cent European J Urol. 2017;70:27-28.
    Abstract     Related articles   

  610. SCHULZ WA, Kramer MW, Fuessel S, Stohr R, et al
    [The 6th symposium of the German Association for Bladder Cancer Research].
    Urologe A. 2017 May 2. doi: 10.1007/s00120-017-0405.
    Abstract     Related articles   

  611. CHEN Y, Peng Y, Xu Z, Ge B, et al
    LncROR Promotes Bladder Cancer Cell Proliferation, Migration, and Epithelial-Mesenchymal Transition.
    Cell Physiol Biochem. 2017;41:2399-2410.
    Abstract     Related articles   

  612. OMAR NN, Tash RF, Shoukry Y, ElSaeed KO, et al
    Breaking the ritual metabolic cycle in order to save acetyl CoA: A potential role for mitochondrial humanin in T2 bladder cancer aggressiveness.
    J Egypt Natl Canc Inst. 2017 Apr 24. pii: S1110-0362(17)30028.
    Abstract     Related articles   

  613. GRZEGOLKOWSKI P, Kaczmarek K, Leminski A, Soczawa M, et al
    Assessment of the infiltrative character of bladder cancer at the time of transurethral resection: a single center study.
    Cent European J Urol. 2017;70:22-26.
    Abstract     Related articles   

  614. CAMPODONICO F, Di Stasi S, Lev GM, Terrone C, et al
    Intravesical chemotherapy and chemohypherthermia in non-muscle-invasive bladder cancer; an overview on drug administration technologies and pharmacokinetics.
    Curr Drug Metab. 2017 Apr 26. doi: 10.2174/1389200218666170427092421.
    Abstract     Related articles   

  615. YONG C, Daihui C, Bo Z
    Laparoscopic versus open radical cystectomy for patients with bladder cancer over 75-year-old: a prospective randomized controlled trial.
    Oncotarget. 2017;8:26565-26572.
    Abstract     Related articles   

  616. GUERRERO-RAMOS F, Lara-Isla A, Justo-Quintas J, Duarte-Ojeda JM, et al
    Adjuvant intravesical treatment for nonmuscle invasive bladder cancer: The importance of the strain and maintenance.
    Actas Urol Esp. 2017 Apr 27. pii: S0210-4806(17)30062.
    Abstract     Related articles   

  617. WU J, Yu C, Cai L, Lu Y, et al
    Effects of increased Kindlin-2 expression in bladder cancer stromal fibroblasts.
    Oncotarget. 2017 Apr 10. doi: 10.18632/oncotarget.17021.
    Abstract     Related articles   

  618. RUTHERFORD C, Costa DSJ, King MT, Smith DP, et al
    A conceptual framework for patient-reported outcomes in non-muscle invasive bladder cancer.
    Support Care Cancer. 2017 Apr 27. doi: 10.1007/s00520-017-3717.
    Abstract     Related articles   

  619. DROCAS AI, Tomescu PI, Mitroi G, Dragoescu PO, et al
    The cadherin switch assessment in the epithelial-mesenchymal transition of urothelial bladder carcinomas.
    Rom J Morphol Embryol. 2016;57:1037-1044.
    Abstract     Related articles   

  620. OBARA W, Eto M, Mimata H, Kohri K, et al
    A phase I/II study of cancer peptide vaccine S-288310 in patients with advanced urothelial carcinoma of the bladder.
    Ann Oncol. 2017;28:798-803.
    Abstract     Related articles   

  621. FINKEL ML
    Shale gas development and cancer incidence in southwest Pennsylvania.
    Public Health. 2016;141:198-206.
    Abstract     Related articles   

  622. DUVNJAK P, Laguna M
    Left Anterior Descending Coronary Artery and Multiple Peripheral Mycotic Aneurysms Due to Mycobacterium Bovis Following Intravesical Bacillus Calmette-Guerin Therapy: A Case Report.
    J Radiol Case Rep. 2016;10:12-27.
    Abstract     Related articles   

  623. ROSATI Y, Fabiani A, Taccari T, Ranaldi R, et al
    Intravesical BCG therapy as cause of miliary pulmonary tuberculosis.
    Urologia. 2016;83:49-53.
    Abstract     Related articles   

  624. RINALDETTI S, Wirtz RM, Worst TS, Eckstein M, et al
    FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes.
    Oncotarget. 2017 Apr 24. doi: 10.18632/oncotarget.17394.
    Abstract     Related articles   

  625. KASAHARA R, Kawahara T, Ohtake S, Saitoh Y, et al
    A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy.
    Biomed Res Int. 2017;2017:7981549.
    Abstract     Related articles   

  626. SANKIN A, Narasimhulu D, John P, Gartrell B, et al
    The expanding repertoire of targets for immune checkpoint inhibition in bladder cancer: What lies beneath the tip of the iceberg, PD-L1.
    Urol Oncol. 2017 May 8. pii: S1078-1439(17)30176.
    Abstract     Related articles   

    No Bridge Over Troubled Water: Slow Progress in Bladder Cancer.
    J Oncol Pract. 2017;13:317-318.
    Abstract     Related articles   

  628. WU Z, Wang S, Xue P, Wang S, et al
    Inhibitory member of the apoptosis-stimulating protein of p53 is overexpressed in bladder cancer and correlated to its progression.
    Medicine (Baltimore). 2017;96:e6640.
    Abstract     Related articles   

  629. YEH HL, Hsu SW, Chang YC, Chan TC, et al
    Spatial Analysis of Ambient PM2.5 Exposure and Bladder Cancer Mortality in Taiwan.
    Int J Environ Res Public Health. 2017;14.
    Abstract     Related articles   

  630. PAPARO SR, Fallahi P
    Bladder cancer and Th1 chemokines
    Clin Ter. 2017;168:e59-e63.
    Abstract     Related articles   

  631. LATOSINSKA A, Mokou M, Makridakis M, Mullen W, et al
    Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention.
    Oncotarget. 2017 Apr 20. doi: 10.18632/oncotarget.17279.
    Abstract     Related articles   

  632. FULKERSON CM, Dhawan D, Ratliff TL, Hahn NM, et al
    Naturally Occurring Canine Invasive Urinary Bladder Cancer: A Complementary Animal Model to Improve the Success Rate in Human Clinical Trials of New Cancer Drugs.
    Int J Genomics. 2017;2017:6589529.
    Abstract     Related articles   

  633. PRADO K, Zhang KX, Pellegrini M, Chin AI, et al
    Sequencing of cancer cell subpopulations identifies micrometastases in a bladder cancer patient.
    Oncotarget. 2017 Apr 21. doi: 10.18632/oncotarget.17312.
    Abstract     Related articles   

  634. SALOMO K, Huebner D, Boehme MU, Herr A, et al
    Urinary transcript quantitation of CK20 and IGF2 for the non-invasive bladder cancer detection.
    J Cancer Res Clin Oncol. 2017 May 8. doi: 10.1007/s00432-017-2433.
    Abstract     Related articles   

  635. OSTWAL V, Pinninti R, Ramaswamy A, Shetty N, et al
    Treatment of advanced Gall bladder cancer in the real world-can continuation chemotherapy improve outcomes?
    J Gastrointest Oncol. 2017;8:368-376.
    Abstract     Related articles   

  636. MOWLDS DS, Foster CE, Ichii H
    Invasive squamous cell bladder cancer of the ureterovesical junction in a renal transplant patient: a case report.
    J Surg Case Rep. 2017;2017:rjx066.
    Abstract     Related articles   

  637. XIA L, Taylor BL, Guzzo TJ
    Characteristics and Associated Factors of Postoperative Pulmonary Complications in Patients Undergoing Radical Cystectomy for Bladder Cancer: A National Surgical Quality Improvement Program Study.
    Clin Genitourin Cancer. 2017 Apr 13. pii: S1558-7673(17)30093.
    Abstract     Related articles   

  638. ZAKARIA AS, Santos F, Dragomir A, Kassouf W, et al
    Health care services utilization during the last 6 months of life among patients with bladder cancer who underwent radical cystectomy in Quebec, Canada.
    Urol Oncol. 2017 May 4. pii: S1078-1439(17)30174.
    Abstract     Related articles   

  639. NECCHI A, Raggi D, Giannatempo P, Sonpavde G, et al
    From the Uncertainties to the Evidence: A Brief History of Immunotherapy as Salvage Therapy for Advanced Bladder Cancer Through a Meta-analysis.
    Clin Genitourin Cancer. 2017 Apr 13. pii: S1558-7673(17)30092.
    Abstract     Related articles   

  640. WILLIAMS SB, Huo J, Kosarek CD, Chamie K, et al
    Population-based assessment of racial/ethnic differences in utilization of radical cystectomy for patients diagnosed with bladder cancer.
    Cancer Causes Control. 2017 May 5. doi: 10.1007/s10552-017-0902.
    Abstract     Related articles   

  641. SRINIVASAN A, Apostolov R, Leong A, Johnson D, et al
    Atraumatic chylous ascites: an unusual presentation of bladder cancer.
    BMJ Case Rep. 2017;2017.
    Abstract     Related articles   

  642. GILL DM, Sonpavde G, Pal SK, Agarwal N, et al
    Which checkpoint inhibitor? An embarrassment of riches for bladder cancer.
    Immunotherapy. 2017;9:463-466.
    Abstract     Related articles   

  643. MITHQAL A, Darvishi P, Rehm P
    MIBG Localization of a Subclinical Paraganglioma of the Bladder.
    Clin Nucl Med. 2017;42:e196-e198.
    Abstract     Related articles   

  644. SJODAHL G, Eriksson P, Liedberg F, Hoglund M, et al
    Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification.
    J Pathol. 2017;242:113-125.
    Abstract     Related articles   

  645. CHEN Z, Liu Q, Chen R, Liu Z, et al
    Clinical analysis of small cell carcinoma of the bladder in Chinese: nine case reports and literature reviews.
    World J Surg Oncol. 2017;15:33.
    Abstract     Related articles   

  646. BLANCA A, Cheng L, Montironi R, Moch H, et al
    Mirna Expression in Bladder Cancer and Their Potential Role in Clinical Practice.
    Curr Drug Metab. 2017 May 18. doi: 10.2174/1389200218666170518164507.
    Abstract     Related articles   

  647. COHEN T, Ricchiuti D, Memo M
    Bladder cancer that metastasized to the skin: A unique presentation that signifies poor prognosis.
    Rev Urol. 2017;19:67-71.
    Abstract     Related articles   

  648. GAO F, Xu T, Wang X, Zhong S, et al
    CIP2A mediates fibronectin-induced bladder cancer cell proliferation by stabilizing beta-catenin.
    J Exp Clin Cancer Res. 2017;36:70.
    Abstract     Related articles   

  649. HAO L, Zhao Y, Li ZG, He HG, et al
    Tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and induces apoptosis of prostate and bladder cancer cells.
    Oncol Lett. 2017;13:3638-3640.
    Abstract     Related articles   

  650. CHEN J, Zhang N, Wen J, Zhang Z, et al
    Silencing TAK1 alters gene expression signatures in bladder cancer cells.
    Oncol Lett. 2017;13:2975-2981.
    Abstract     Related articles   

  651. YAN L, Wang Y, Liang J, Liu Z, et al
    MiR-301b Promotes the Proliferation, Mobility and Epithelial-to-Mesenchymal Transition of Bladder Cancer Cells by Targeting EGR1.
    Biochem Cell Biol. 2017 May 18. doi: 10.1139/bcb-2016-0232.
    Abstract     Related articles   

  652. BACHIR BG, Souhami L, Mansure JJ, Cury F, et al
    Phase I Clinical Trial of Everolimus Combined with Trimodality Therapy in Patients with Muscle-Invasive Bladder Cancer.
    Bladder Cancer. 2017;3:105-112.
    Abstract     Related articles   

  653. PAN Q, Sathe A, Black PC, Goebell PJ, et al
    CDK4/6 Inhibitors in Cancer Therapy: A Novel Treatement Strategy for Bladder Cancer.
    Bladder Cancer. 2017;3:79-88.
    Abstract     Related articles   

  654. ZHOU L, Xu L, Chen L, Fu Q, et al
    Tumor-infiltrating neutrophils predict benefit from adjuvant chemotherapy in patients with muscle invasive bladder cancer.
    Oncoimmunology. 2017;6:e1293211.
    Abstract     Related articles   

  655. ANIL H, Karamik K, Ates M, Yuksel M, et al
    A Rare Clinical Entity in Bladder Cancer: Paraneoplastic Cerebellar Degeneration.
    Clin Genitourin Cancer. 2017 Apr 26. pii: S1558-7673(17)30110.
    Abstract     Related articles   

  656. NISHIZAWA T, Yoshida S, Koga F, Tanaka H, et al
    Standardization of the apparent diffusion coefficient value of bladder cancer across different centers: Applicability in predicting aggressive pathologic phenotypes.
    Clin Imaging. 2017;44:121-126.
    Abstract     Related articles   

  657. LIU Q, Liu H, Cheng H, Li Y, et al
    Downregulation of long noncoding RNA TUG1 inhibits proliferation and induces apoptosis through the TUG1/miR-142/ZEB2 axis in bladder cancer cells.
    Onco Targets Ther. 2017;10:2461-2471.
    Abstract     Related articles   

  658. ZHANG K, Wang W, Wu K, Ding C, et al
    [Knock-down of DAB2 interacting protein (DAB2IP) promotes proliferation and inhibits apoptosis of bladder cancer cells].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017;33:668-676.
    Abstract     Related articles   

  659. SCHMID SC, Sathe A, Guerth F, Seitz AK, et al
    Wntless promotes bladder cancer growth and acts synergistically as a molecular target in combination with cisplatin.
    Urol Oncol. 2017 May 10. pii: S1078-1439(17)30187.
    Abstract     Related articles   

  660. IBANEZ MUNOZ D, Quintana Martinez I, Fernandez Militino A, Sanchez Zalabardo D, et al
    Virtual cystoscopy, computed tomography urography and optical cystoscopy for the detection and follow-up for bladder cancer.
    Radiologia. 2017 May 10. pii: S0033-8338(17)30054.
    Abstract     Related articles   

  661. AVELLINI C, Licini C, Lazzarini R, Gesuita R, et al
    The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancer.
    Oncotarget. 2017 Apr 25. doi: 10.18632/oncotarget.17407.
    Abstract     Related articles   

  662. NORO D, Hatakeyama S, Yoneyama T, Hashimoto Y, et al
    Post-chemotherapy PD-L1 expression correlates with clinical outcomes in Japanese bladder cancer patients treated with total cystectomy.
    Med Oncol. 2017;34:117.
    Abstract     Related articles   

  663. SROUGI V, Gallucci FP, Mattedi RL, Srougi M, et al
    Carcinosarcoma of the bladder following local schistosomiasis infection.
    BMJ Case Rep. 2017;2017.
    Abstract     Related articles   

  664. ERBAY G, Akyol F, Karabakan M, Celebi B, et al
    Effect of obturator nerve block during transurethral resection of lateral bladder wall tumors on the presence of detrusor muscle in tumor specimens and recurrence of the disease.
    Kaohsiung J Med Sci. 2017;33:86-90.
    Abstract     Related articles   

  665. TAO T, He C, Deng J, Huang Y, et al
    A novel synthetic derivative of quercetin, 8-trifluoromethyl- 3,5,7,3',4'-O-pentamethyl-quercetin, inhibits bladder cancer growth by targeting the AMPK/mTOR signaling pathway.
    Oncotarget. 2017 May 11. doi: 10.18632/oncotarget.17799.
    Abstract     Related articles   

  666. YIN H, Yang X, Gu W, Liu Y, et al
    HMGB1-mediated autophagy attenuates gemcitabine-induced apoptosis in bladder cancer cells involving JNK and ERK activation.
    Oncotarget. 2017 May 11. doi: 10.18632/oncotarget.17796.
    Abstract     Related articles   

  667. WANG YN, Wang FD, Zhu L
    [Ileo-vaginal fistula caused by bladder cancer recurrence after posterior colporrhaphy: a case report].
    Zhonghua Fu Chan Ke Za Zhi. 2017;52:343.
    Abstract     Related articles   

  668. MIKHAIL AS, Negussie AH, Pritchard WF, Haemmerich D, et al
    Lyso-thermosensitive liposomal doxorubicin for treatment of bladder cancer.
    Int J Hyperthermia. 2017 May 10:1-8. doi: 10.1080/02656736.2017.1315459.
    Abstract     Related articles   

  669. WARD DG, Bryan RT
    Liquid biopsies for bladder cancer.
    Transl Androl Urol. 2017;6:331-335.
    Abstract     Related articles   

  670. EL SAYED I, Elkhwsky F, La Vecchia C, Alicandro G, et al
    The frequency of bladder cancer in Alexandria, Egypt, over the last two decades.
    Eur J Cancer Prev. 2017 May 19. doi: 10.1097/CEJ.0000000000000368.
    Abstract     Related articles   

  671. KUTWIN P, Konecki T, Cichocki M, Falkowski P, et al
    Photodynamic Diagnosis and Narrow-Band Imaging in the Management of Bladder Cancer: A Review.
    Photomed Laser Surg. 2017 May 22. doi: 10.1089/pho.2016.4217.
    Abstract     Related articles   

  672. YURUK E, Tuken M, Colakerol A, Serefoglu EC, et al
    The awareness of patients with non - muscle invasive bladder cancer regarding the importance of smoking cessation and their access to smoking cessation programs.
    Int Braz J Urol. 2017;43.
    Abstract     Related articles   

  673. MALMSTROM PU, Agrawal S, Blackberg M, Bostrom PJ, et al
    Non-muscle-invasive bladder cancer: a vision for the future.
    Scand J Urol. 2017 Feb 7:1-8. doi: 10.1080/21681805.2017.1283359.
    Abstract     Related articles   

  674. JOHN BA, Said N
    Insights from animal models of bladder cancer: recent advances, challenges, and opportunities.
    Oncotarget. 2017 May 9. doi: 10.18632/oncotarget.17714.
    Abstract     Related articles   

  675. KOLLBERG P, Almquist H, Blackberg M, Cwikiel M, et al
    [18F]Fluorodeoxyglucose-positron emission tomography/computed tomography response evaluation can predict histological response at surgery after induction chemotherapy for oligometastatic bladder cancer.
    Scand J Urol. 2017 May 22:1-6. doi: 10.1080/21681805.2017.1321579.
    Abstract     Related articles   

  676. GOPALAKRISHNA A, Longo TA, Fantony JJ, Harrison MR, et al
    Physical activity patterns and associations with health-related quality of life in bladder cancer survivors.
    Urol Oncol. 2017 May 17. pii: S1078-1439(17)30188.
    Abstract     Related articles   

  677. PARIDA GK, Tripathy S, Roy SG, Singhal A, et al
    Incidentally Detected Penile Metastases in a Patient of Carcinoma Urinary Bladder on Follow-up FDG PET/CT.
    Clin Nucl Med. 2017 Mar 10. doi: 10.1097/RLU.0000000000001607.
    Abstract     Related articles   

  678. RICARDO HUPPES R, Crivellenti LZ, Barboza De Nardi A, Roque Lima B, et al
    Radical Cystectomy and Cutaneous Ureterostomy in 4 Dogs with Trigonal Transitional Cell Carcinoma: Description of Technique and Case Series.
    Vet Surg. 2017;46:111-119.
    Abstract     Related articles   

  679. This Month in AJP.
    Am J Pathol. 2017;187:1.
    Abstract     Related articles   

  680. MAKINO K, Nakagawa T, Kanatani A, Kawai T, et al
    Biphasic decline in renal function after radical cystectomy with urinary diversion.
    Int J Clin Oncol. 2017;22:359-365.
    Abstract     Related articles   

  681. NGUYEN HT, Shah ZK, Mortazavi A, Pohar KS, et al
    Non-invasive quantification of tumour heterogeneity in water diffusivity to differentiate malignant from benign tissues of urinary bladder: a phase I study.
    Eur Radiol. 2017;27:2146-2152.
    Abstract     Related articles   

  682. TAN M, Zhang D, Zhang E, Xu D, et al
    SENP2 suppresses epithelial-mesenchymal transition of bladder cancer cells through deSUMOylation of TGF-betaRI.
    Mol Carcinog. 2017 Jun 2. doi: 10.1002/mc.22687.
    Abstract     Related articles   

  683. AYATI M, Nowroozi MR, Mortazavi A, Ohadian Moghadam S, et al
    Management of Hepatic Granulomatous Tuberculosis After BCG Therapy for Bladder Cancer.
    Urol Case Rep. 2017;13:158-159.
    Abstract     Related articles   

  684. ARAGON-CHING JB, Pagliaro LC
    New Developments and Challenges in Rare Genitourinary Tumors: Non-Urothelial Bladder Cancers and Squamous Cell Cancers of the Penis.
    Am Soc Clin Oncol Educ Book. 2017;37:330-336.
    Abstract     Related articles   

  685. SATO A, Asano T, Okubo K, Isono M, et al
    Nelfinavir and Ritonavir Kill Bladder Cancer Cells Synergistically By Inducing Endoplasmic Reticulum Stress.
    Oncol Res. 2017 May 26. doi: 10.3727/096504017X14957929842972.
    Abstract     Related articles   

  686. KIM JK, Jeong CW, Kwak C, Kim HH, et al
    Progression to T1 High Grade (T1HG) from a Lower Stage/Grade is Associated with Poorer Survival Outcomes than Initial Diagnosis with T1HG Bladder Cancer.
    Ann Surg Oncol. 2017 May 30. doi: 10.1245/s10434-017-5902.
    Abstract     Related articles   

  687. XIE X, Rui W, He W, Shao Y, et al
    Discoidin domain receptor 1 activity drives an aggressive phenotype in bladder cancer.
    Am J Transl Res. 2017;9:2500-2507.
    Abstract     Related articles   

  688. MULLARD A
    Immuno-oncology upset in bladder cancer.
    Nat Rev Drug Discov. 2017;16:375.
    Abstract     Related articles   

  689. CUMBERBATCH K, He T, Thorogood Z, Gartrell BA, et al
    Emerging Drugs for Urothelial (Bladder) Cancer.
    Expert Opin Emerg Drugs. 2017 May 30. doi: 10.1080/14728214.2017.1336536.
    Abstract     Related articles   

  690. NICOLAZZO C, Busetto GM, Del Giudice F, Sperduti I, et al
    The long-term prognostic value of survivin expressing circulating tumor cells in patients with high-risk non-muscle invasive bladder cancer (NMIBC).
    J Cancer Res Clin Oncol. 2017 May 29. doi: 10.1007/s00432-017-2449.
    Abstract     Related articles   

  691. WANG Y, Kang XL, Zeng FC, Xu CJ, et al
    Correlations of Foxo3 and Foxo4 expressions with clinicopathological features and prognosis of bladder cancer.
    Pathol Res Pract. 2017 Apr 20. pii: S0344-0338(16)30606.
    Abstract     Related articles   

  692. YU D, Zhang C, Gui J
    RNA-binding protein HuR promotes bladder cancer progression by competitively binding to the long noncoding HOTAIR with miR-1.
    Onco Targets Ther. 2017;10:2609-2619.
    Abstract     Related articles   

  693. LIN JF, Lin YC, Tsai TF, Chen HE, et al
    Cisplatin induces protective autophagy through activation of BECN1 in human bladder cancer cells.
    Drug Des Devel Ther. 2017;11:1517-1533.
    Abstract     Related articles   

  694. WU Z, Wang S, Jiang F, Li Q, et al
    Mass spectrometric detection combined with bioinformatic analysis identified possible protein markers and key pathways associated with bladder cancer.
    Gene. 2017 May 25. pii: S0378-1119(17)30411-0. doi: 10.1016/j.gene.2017.
    Abstract     Related articles   

  695. VETTERLEIN MW, Meyer CP, Leyh-Bannurah SR, Mayr R, et al
    Effect of Hospital and Surgeon Case Volume on Perioperative Quality of Care and Short-term Outcomes After Radical Cystectomy for Muscle-invasive Bladder Cancer: Results From a European Tertiary Care Center Cohort.
    Clin Genitourin Cancer. 2017 Apr 26. pii: S1558-7673(17)30105.
    Abstract     Related articles   

  696. LIANG Z, Wang X, Xu X, Xie B, et al
    MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.
    Mol Cancer. 2017;16:96.
    Abstract     Related articles   

  697. MALVIYA K, Fernandes G, Naik L, Kothari K, et al
    Utility of the Paris System in Reporting Urine Cytology.
    Acta Cytol. 2017;61:145-152.
    Abstract     Related articles   

  698. PAGLIARULO V, Alba S, Gallone MF, Di Stasi S, et al
    Diagnostic Accuracy of Hexaminolevulinate in a Cohort of Patients Undergoing Radical Cystectomy.
    J Endourol. 2017;31:405-411.
    Abstract     Related articles   

  699. XU X, Zhang X, Tian Q, Zhang G, et al
    Three-dimensional texture features from intensity and high-order derivative maps for the discrimination between bladder tumors and wall tissues via MRI.
    Int J Comput Assist Radiol Surg. 2017;12:645-656.
    Abstract     Related articles   

  700. LADURNER C, Comploj E, Trenti E, Palermo S, et al
    Radical cystectomy: do we need standardization?
    Expert Rev Anticancer Ther. 2017;17:101-107.
    Abstract     Related articles   

  701. ZHANG H, Guo Y, Song Y, Shang C, et al
    Long noncoding RNA GAS5 inhibits malignant proliferation and chemotherapy resistance to doxorubicin in bladder transitional cell carcinoma.
    Cancer Chemother Pharmacol. 2017;79:49-55.
    Abstract     Related articles   

  702. DENG T, Liu B, Duan X, Zhang T, et al
    Systematic Review and Cumulative Analysis of the Combination of Mitomycin C plus Bacillus Calmette-Guerin (BCG) for Non-Muscle-Invasive Bladder Cancer.
    Sci Rep. 2017;7:3172.
    Abstract     Related articles   

  703. PEI N, Mao Y, Wan P, Chen X, et al
    Angiotensin II type 2 receptor promotes apoptosis and inhibits angiogenesis in bladder cancer.
    J Exp Clin Cancer Res. 2017;36:77.
    Abstract     Related articles   

  704. LIU ZH, Zheng FF, Mao YL, Ye LF, et al
    Effects of programmed death-ligand 1 expression on OK-432 immunotherapy following transurethral resection in non-muscle invasive bladder cancer.
    Oncol Lett. 2017;13:4818-4824.
    Abstract     Related articles   

  705. KIM CJ, Tambe Y, Mukaisho KI, Sugihara H, et al
    Periostin suppresses in vivo invasiveness via PDK1/Akt/mTOR signaling pathway in a mouse orthotopic model of bladder cancer.
    Oncol Lett. 2017;13:4276-4284.
    Abstract     Related articles   

  706. LIU S, Liang B, Jia H, Jiao Y, et al
    Evaluation of cell death pathways initiated by antitumor drugs melatonin and valproic acid in bladder cancer cells.
    FEBS Open Bio. 2017;7:798-810.
    Abstract     Related articles   

  707. RAMMANT E, Bultijnck R, Sundahl N, Ost P, et al
    Rehabilitation interventions to improve patient-reported outcomes and physical fitness in survivors of muscle invasive bladder cancer: a systematic review protocol.
    BMJ Open. 2017;7:e016054.
    Abstract     Related articles   

  708. GU W, Lin Y, Gou X, He W, et al
    Tea Polyphenol inhibits autophagy to sensitize Epirubicin-induced apoptosis in human bladder cancer cells.
    Neoplasma. 2017 Jun 8. doi: 10.4149/neo_2017.
    Abstract     Related articles   

  709. WANG M, Teng XD
    [Research progress in molecular classification of muscle invasive bladder cancer].
    Zhonghua Bing Li Xue Za Zhi. 2017;46:439-442.
    Abstract     Related articles   

  710. HUANG Y, Fang C, Shi JW, Wen Y, et al
    Identification of hMex-3A and its effect on human bladder cancer cell proliferation.
    Oncotarget. 2017 May 22. doi: 10.18632/oncotarget.18050.
    Abstract     Related articles   

  711. WANG XC, Wang J, Tao HH, Zhang C, et al
    Combined effects of NQO1 Pro187Ser or SULT1A1 Arg213His polymorphism and smoking on bladder cancer risk: Two meta-analyses.
    Int J Occup Med Environ Health. 2017 Jun 7. pii: 65296.
    Abstract     Related articles   

  712. SHIVAKUMAR M, Lee Y, Bang L, Garg T, et al
    Identification of epigenetic interactions between miRNA and DNA methylation associated with gene expression as potential prognostic markers in bladder cancer.
    BMC Med Genomics. 2017;10.
    Abstract     Related articles   

  713. SUZUKI K, Hanashima F, Shirotake S, Kodaira K, et al
    Determining the optimum way to maintain quality of life for very elderly patients with advanced bladder cancer and poor performance status: A case report.
    Mol Clin Oncol. 2017;6:968-970.
    Abstract     Related articles   

  714. LI S, Zhang Y, Liu Q, Zhao Q, et al
    Oxymatrine inhibits proliferation of human bladder cancer T24 cells by inducing apoptosis and cell cycle arrest.
    Oncol Lett. 2017;13:4453-4458.
    Abstract     Related articles   

  715. KATES M, Nirschl T, Sopko NA, Matsui H, et al
    Intravesical BCG induces CD4+ T-Cell Expansion in an Immune Competent Model of Bladder Cancer.
    Cancer Immunol Res. 2017 Jun 6. pii: canimm.0267.2016.
    Abstract     Related articles   

  716. SCHULZ GB, Grimm T, Buchner A, Jokisch F, et al
    Prognostic Value of the Preoperative Platelet-to-leukocyte Ratio for Oncologic Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer.
    Clin Genitourin Cancer. 2017 May 10. pii: S1558-7673(17)30133.
    Abstract     Related articles   

  717. HAFEEZ S, McDonald F, Lalondrelle S, McNair H, et al
    Clinical Outcomes of Image Guided Adaptive Hypofractionated Weekly Radiation Therapy for Bladder Cancer in Patients Unsuitable for Radical Treatment.
    Int J Radiat Oncol Biol Phys. 2017;98:115-122.
    Abstract     Related articles   

  718. LOPEZ JI, Angulo JC, Martin A, Sanchez-Chapado M, et al
    A DNA hypermethylation profile reveals new potential biomarkers for the evaluation of prognosis in urothelial bladder cancer.
    APMIS. 2017 Jun 6. doi: 10.1111/apm.12719.
    Abstract     Related articles   

  719. HE H, Chang R, Zhang T, Yang C, et al
    ATM mediates DAB2IP-deficient bladder cancer cell resistance to ionizing radiation through the p38MAPK and NF-kappaB signaling pathway.
    Mol Med Rep. 2017 Jun 6. doi: 10.3892/mmr.2017.6689.
    Abstract     Related articles   

  720. SHEN M, Zhou L, Zhou P, Zhou W, et al
    Lymphotoxin beta receptor activation promotes mRNA expression of RelA and pro-inflammatory cytokines TNFalpha and IL-1beta in bladder cancer cells.
    Mol Med Rep. 2017 Jun 1. doi: 10.3892/mmr.2017.6676.
    Abstract     Related articles   

  721. WEINHAUS B, Guin S
    Involvement of glycogen debranching enzyme in bladder cancer.
    Biomed Rep. 2017;6:595-598.
    Abstract     Related articles   

  722. CHOE J, Braschi-Amirfarzan M, Tirumani SH, Shinagare AB, et al
    Updates for the radiologist in non-muscle-invasive, muscle-invasive, and metastatic bladder cancer.
    Abdom Radiol (NY). 2017 Jun 3. doi: 10.1007/s00261-017-1195.
    Abstract     Related articles   

  723. SHAO Y, Zhu W, Da J, Xu M, et al
    Bisdemethoxycurcumin in combination with alpha-PD-L1 antibody boosts immune response against bladder cancer.
    Onco Targets Ther. 2017;10:2675-2683.
    Abstract     Related articles   

  724. MEARINI E, Poli G, Cochetti G, Boni A, et al
    Expression of urinary miRNAs targeting NLRs inflammasomes in bladder cancer.
    Onco Targets Ther. 2017;10:2665-2673.
    Abstract     Related articles   

  725. MOKHTAR A, Al MM, Al WM, Othman KA, et al
    Is survival after radical cystectomy for bladder cancer in Saudi patients different from that of Western patients?
    Ann Saudi Med. 2017;37:194-200.
    Abstract     Related articles   

  726. DA SILVA GN, Filoni LT, Salvadori MC, Salvadori DMF, et al
    Gemcitabine/Cisplatin Treatment Induces Concomitant SERTAD1, CDKN2B and GADD45A Modulation and Cellular Changes in Bladder Cancer Cells Regardless of the Site of TP53 Mutation.
    Pathol Oncol Res. 2017 Jun 2. doi: 10.1007/s12253-017-0255.
    Abstract     Related articles   

    Highlight report: N-acetyltransferase 2 and urinary bladder cancer risk.
    Arch Toxicol. 2017 Jun 2. doi: 10.1007/s00204-017-2001.
    Abstract     Related articles   

  728. APPUNNI S, Anand V, Khandelwal M, Seth A, et al
    Altered expression of small leucine-rich proteoglycans (Decorin, Biglycan and Lumican): Plausible diagnostic marker in urothelial carcinoma of bladder.
    Tumour Biol. 2017;39:1010428317699112.
    Abstract     Related articles   

  729. LHUNGAY TP, Colvin A, Warncke J, Somerset H, et al
    Seventy-Year-Old Man With Large Bladder Mass: Diagnostic and Clinical Challenges of an Uncommon Neoplasm.
    Oncology (Williston Park). 2017;31:210-2.
    Abstract     Related articles   

  730. AKINGBOYE A, Schultz H, Taylor GA
    Papillary transitional cell bladder carcinoma and systematized epidermal nevus syndrome.
    Cutis. 2017;99:61-64.
    Abstract     Related articles   

  731. NASELLI A, Puppo P
    En Bloc Transurethral Resection of Bladder Tumors: A New Standard?
    J Endourol. 2017;31.
    Abstract     Related articles   

  732. BLACK PC, Sridhar S
    New research in bladder cancer, ASCO-GU 2017.
    Can Urol Assoc J. 2017;11.
    Abstract     Related articles   

  733. HAMANO I, Hatakeyama S, Iwamura H, Fujita N, et al
    Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer.
    Oncotarget. 2017 May 29. doi: 10.18632/oncotarget.18248.
    Abstract     Related articles   

  734. POLO A, Crispo A, Cerino P, Falzone L, et al
    Environment and bladder cancer: molecular analysis by interaction networks.
    Oncotarget. 2017 May 26. doi: 10.18632/oncotarget.18222.
    Abstract     Related articles   

  735. LIU Q, Liao B, Tian Y, Chen Y, et al
    Total fluid consumption and risk of bladder cancer: a meta-analysis with updated data.
    Oncotarget. 2017 May 23. doi: 10.18632/oncotarget.18100.
    Abstract     Related articles   

  736. GU W, Yin H, Liu Y, Gou X, et al
    [The mechanism underlying the effects of tea polyphenol on epirubicin-induced autophagy and apoptosis in T24 bladder cancer cells].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017;33:772-777.
    Abstract     Related articles   

  737. RAEISI SHAHRAKI H, Bemani P, Jalali M
    Classification of Bladder Cancer Patients via Penalized Linear Discriminant Analysis
    Asian Pac J Cancer Prev. 2017;18:1453-1457.
    Abstract     Related articles   

  738. MARTINI T, Wezel F, Lobig N, Mitterberger MJ, et al
    [Systematic review on conservative treatment options in non-muscle-invasive bladder cancer patients refractory to Bacillus Calmette-Guerin instillation therapy].
    Aktuelle Urol. 2017 Jun 13. doi: 10.1055/s-0043-108944.
    Abstract     Related articles   

  739. YASAR O, Akcay T, Obek C, Turegun FA, et al
    Significance of S100A8, S100A9 and calprotectin levels in bladder cancer.
    Scand J Clin Lab Invest. 2017 Jun 13:1-5. doi: 10.1080/00365513.2017.1336567.
    Abstract     Related articles   

  740. HUANG J, Schisler J, Wong HC, Rosser CJ, et al
    Intravesical ALT-803 for BCG-unresponsive Bladder Cancer - A Case Report.
    Urol Case Rep. 2017;14:15-17.
    Abstract     Related articles   

  741. WU CT, Lin WY, Chang YH, Chen WC, et al
    Impact of CD44 expression on radiation response for bladder cancer.
    J Cancer. 2017;8:1137-1144.
    Abstract     Related articles   

  742. XU Z, Li X, Qin Z, Xue J, et al
    Association of N-acetyltransferase 1 polymorphism and bladder cancer risk: an updated meta-analysis and trial sequential analysis.
    Int J Biol Markers. 2017 Jun 7:0. doi: 10.5301/ijbm.5000269.
    Abstract     Related articles   

  743. MERTENS LS, Horenblas S
    Related to: [18F]Fluorodeoxyglucose-positron emission tomography/computed tomography response evaluation can predict histological response at surgery after induction chemotherapy for oligometastatic bladder cancer.
    Scand J Urol. 2017 Jun 12:1-2. doi: 10.1080/21681805.2017.1329229.
    Abstract     Related articles   

  744. BOTE HE, Alaoui AE, Oussama Z, Sayegh HE, et al
    [Neuroendocrine carcinoma of the bladder: about 5 cases].
    Pan Afr Med J. 2017;26:92.
    Abstract     Related articles   

  745. MBETHE D, Moudouni S, Dahami Z, Lakmichi MA, et al
    [Leiomyosarcoma of the urinary bladder treated using laparoscopic cystectomy and bladder replacement by enterocystoplasty: about a case].
    Pan Afr Med J. 2017;26:26.
    Abstract     Related articles   

  746. KONDO M, Hotta Y, Ando R, Yasui T, et al
    The impact of a solitary kidney on tolerability to gemcitabine plus cisplatin chemotherapy in urothelial carcinoma patients: a retrospective study.
    Cancer Chemother Pharmacol. 2017;79:995-1001.
    Abstract     Related articles   

  747. BONIOL M, Koechlin A, Sorahan T, Jakobsson K, et al
    Cancer incidence in cohorts of workers in the rubber manufacturing industry first employed since 1975 in the UK and Sweden.
    Occup Environ Med. 2017;74:417-421.
    Abstract     Related articles   

  748. NAITO A, Taguchi S, Nakagawa T, Matsumoto A, et al
    Prognostic significance of serum neuron-specific enolase in small cell carcinoma of the urinary bladder.
    World J Urol. 2017;35:97-103.
    Abstract     Related articles   

  749. PINEDA S, Van Steen K, Malats N
    Integrative eQTL analysis of tumor and host omics data in individuals with bladder cancer.
    Genet Epidemiol. 2017 Jun 23. doi: 10.1002/gepi.22053.
    Abstract     Related articles   

  750. LI T, Sun X, Jiang X
    UCA1 involved in the metformin-regulated bladder cancer cell proliferation and glycolysis.
    Tumour Biol. 2017;39:1010428317710823.
    Abstract     Related articles   

  751. WANG Z, Wang X, Zhang D, Yu Y, et al
    Long non-coding RNA urothelial carcinoma-associated 1 as a tumor biomarker for the diagnosis of urinary bladder cancer.
    Tumour Biol. 2017;39:1010428317709990.
    Abstract     Related articles   

  752. PHILLIPS RM, Hendriks HR, Sweeney JB, Reddy G, et al
    Efficacy, pharmacokinetic and pharmacodynamic evaluation of Apaziquone in the treatment of non-muscle invasive bladder cancer.
    Expert Opin Drug Metab Toxicol. 2017 Jun 21. doi: 10.1080/17425255.2017.1341490.
    Abstract     Related articles   

  753. ZHANG Z, Fan W, Deng Q, Tang S, et al
    The prognostic and diagnostic value of circulating tumor cells in bladder cancer and upper tract urothelial carcinoma: a meta-analysis of 30 published studies.
    Oncotarget. 2017 Jun 16. doi: 10.18632/oncotarget.18521.
    Abstract     Related articles   

  754. BEANE FREEMAN LE, Cantor KP, Baris D, Nuckols JR, et al
    Bladder Cancer and Water Disinfection By-product Exposures through Multiple Routes: A Population-Based Case-Control Study (New England, USA).
    Environ Health Perspect. 2017;125:067010.
    Abstract     Related articles   

  755. DUAN R, Zhang Z, Zheng F, Wang L, et al
    Combining protein and miRNA quantification for bladder cancer analysis.
    ACS Appl Mater Interfaces. 2017 Jun 21. doi: 10.1021/acsami.7b05639.
    Abstract     Related articles   

  756. WU JH, Deng YL, Liu Q, Yu JC, et al
    Induction of apoptosis and autophagy by calcifying nanoparticles in human bladder cancer cells.
    Tumour Biol. 2017;39:1010428317707688.
    Abstract     Related articles   

  757. KHETRAPAL P, Tan WS, Lamb B, Tan M, et al
    The Role of Robotics in the Invasive Management of Bladder Cancer.
    Curr Urol Rep. 2017;18:57.
    Abstract     Related articles   

  758. Targeting Nectin-4 in Bladder Cancer.
    Cancer Discov. 2017 Jun 20. doi: 10.1158/2159-8290.CD-NB2017.
    Abstract     Related articles   

    Immunotherapy: The Wave of the Future in Bladder Cancer?
    Clin Genitourin Cancer. 2017;15.
    Abstract     Related articles   

  760. VOELKER R
    Immunotherapy for Bladder Cancer.
    JAMA. 2017;317:2363.
    Abstract     Related articles   

  761. MERTENS LS, Horenblas S
    Bladder cancer: oligometastases and imaging.
    Nat Rev Urol. 2017 Jun 20. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  762. YUAN H, Yu S, Cui Y, Men C, et al
    Knockdown of mediator subunit Med19 suppresses bladder cancer cell proliferation and migration by downregulating Wnt/beta-catenin signalling pathway.
    J Cell Mol Med. 2017 Jun 19. doi: 10.1111/jcmm.13229.
    Abstract     Related articles   

  763. LIBERAL J, Carmo A, Gomes C, Cruz MT, et al
    Urolithins impair cell proliferation, arrest the cell cycle and induce apoptosis in UMUC3 bladder cancer cells.
    Invest New Drugs. 2017 Jun 20. doi: 10.1007/s10637-017-0483.
    Abstract     Related articles   

  764. ZHONGBO L, U-Syn H, Ke Y, Chunli W, et al
    Kavalactone yangonin induces autophagy and sensitizes bladder cancer cells to flavokawain A and docetaxel via inhibition of the mTOR pathway.
    J Biomed Res. 2017 Jun 20. doi: 10.7555/JBR.31.20160160.
    Abstract     Related articles   

  765. SLAVYANSKAYA T, -Salnikova S, Sepiashvili R
    Georgian Med News. 2017;:26-34.
    Abstract     Related articles   

  766. SLAVYANSKAYA T, -Salnikova S
    Georgian Med News. 2017;:19-26.
    Abstract     Related articles   

  767. DETTLAFF K, Stawny M, Ogrodowczyk M, Jelinska A, et al
    Formulation and characterization of EGCG for the treatment of superficial bladder cancer.
    Int J Mol Med. 2017 Jun 14. doi: 10.3892/ijmm.2017.3024.
    Abstract     Related articles   

  768. LIN Y, Ge Y, Wang Y, Ma G, et al
    The association of rs710886 in lncRNA PCAT1 with bladder cancer risk in a Chinese population.
    Gene. 2017 Jun 13. pii: S0378-1119(17)30473-0. doi: 10.1016/j.gene.2017.
    Abstract     Related articles   

  769. LYNCH HN, Zu K, Kennedy EM, Lam T, et al
    Quantitative assessment of lung and bladder cancer risk and oral exposure to inorganic arsenic: Meta-regression analyses of epidemiological data.
    Environ Int. 2017 Jun 16. pii: S0160-4120(16)30336.
    Abstract     Related articles   

  770. SUGIURA S, Noto N, Koizumi M, Takamoto D, et al
    [Post-Operative Single Immediate Intravesical Instillation Chemotherapy as Prophylaxis for Reccurence after Transurethral Resection of Low Risk Non-Muscle-Invasive Bladder Cancer].
    Hinyokika Kiyo. 2017;63:183-187.
    Abstract     Related articles   

  771. ZHU J, Li Y, Tian Z, Hua X, et al
    ATG7 Overexpression Is Crucial for Tumorigenic Growth of Bladder Cancer In Vitro and In Vivo by Targeting the ETS2/miRNA196b/FOXO1/p27 Axis.
    Mol Ther Nucleic Acids. 2017;7:299-313.
    Abstract     Related articles   

  772. DEL BENE G, Sternberg CN
    Systemic chemotherapy in muscle invasive and metastatic bladder cancer: present and future.
    Urologia. 2017 Jun 14:0. doi: 10.5301/uj.5000230.
    Abstract     Related articles   

  773. FILIPOVA E, Uzunova K, Kalinov K, Vekov T, et al
    Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis.
    Diabetes Ther. 2017 Jun 16. doi: 10.1007/s13300-017-0273.
    Abstract     Related articles   

  774. ZHANG S, Zhang G, Guo H
    DCAMKL1 is associated with the malignant status and poor outcome in bladder cancer.
    Tumour Biol. 2017;39:1010428317703822.
    Abstract     Related articles   

  775. RAILKAR R, Krane LS, Li QQ, Sanford T, et al
    Epidermal Growth Factor Receptor (EGFR) Targeted Photoimmunotherapy (PIT) for the Treatment of EGFR expressing Bladder Cancer.
    Mol Cancer Ther. 2017 Jun 15. pii: molcanther.0924.2016.
    Abstract     Related articles   

  776. WANG W, Shen F, Wang C, Lu W, et al
    MiR-1-3p inhibits the proliferation and invasion of bladder cancer cells by suppressing CCL2 expression.
    Tumour Biol. 2017;39:1010428317698383.
    Abstract     Related articles   

  777. DA COSTA E, Melo T, Moreira AS, Bernardo C, et al
    Valorization of Lipids from Gracilaria sp. through Lipidomics and Decoding of Antiproliferative and Anti-Inflammatory Activity.
    Mar Drugs. 2017;15.
    Abstract     Related articles   

  778. HIGASHINO T, Nakatsuji H, Fukuda R, Okamoto H, et al
    Hexaphyrin as a Potential Theranostic Dye for Photothermal Therapy and 19 F Magnetic Resonance Imaging.
    Chembiochem. 2017;18:951-959.
    Abstract     Related articles   

  779. PATEL R, Barker HE, Kyula J, McLaughlin M, et al
    An orally bioavailable Chk1 inhibitor, CCT244747, sensitizes bladder and head and neck cancer cell lines to radiation.
    Radiother Oncol. 2017 Jan 25. pii: S0167-8140(16)34478.
    Abstract     Related articles   

  780. DOWNES MR, Weening B, van Rhijn BW, Have CL, et al
    Analysis of papillary urothelial carcinomas of the bladder with grade heterogeneity: supportive evidence for an early role of CDKN2A deletions in the FGFR3 pathway.
    Histopathology. 2017;70:281-289.
    Abstract     Related articles   

  781. APFELBECK M, Grimm T, Kretschmer A, Buchner A, et al
    Follow-up of high-risk bladder cancer-Is it safe to perform fluorescence endoscopy multiple times in the same patient?
    Urol Oncol. 2017 Jun 27. pii: S1078-1439(17)30262.
    Abstract     Related articles   

  782. GARRY EM, Buse JB, Lund JL, Pate V, et al
    Comparative Safety of Pioglitazone versus Clinically Meaningful Treatment Alternatives on the Risk of Bladder Cancer in Older US Adults with Type 2 Diabetes.
    Diabetes Obes Metab. 2017 Jun 29. doi: 10.1111/dom.13049.
    Abstract     Related articles   

  783. NOROHEIMER S, Ozalvo R, Abramovich A, Fenig E, et al
    Harefuah. 2017;:349-352.
    Abstract     Related articles   

  784. WANG SC, Sung WW, Kao YL, Hsieh TY, et al
    The gender difference and mortality-to-incidence ratio relate to health care disparities in bladder cancer: National estimates from 33 countries.
    Sci Rep. 2017;7:4360.
    Abstract     Related articles   

  785. SOMASEKAR R, Naganathbabu O, Prabhakaran R, Gnanasekar M, et al
    Salvage Surgery for Metastatic Gall Bladder Cancer with Vanishing Liver Metastasis Following Palliative 5-Fluorouracil Metronomic Chemotherapy.
    J Clin Diagn Res. 2017;11:XD03-XD05.
    Abstract     Related articles   

  786. WEI Z, Hu X, Liu J, Zhu W, et al
    MicroRNA-497 upregulation inhibits cell invasion and metastasis in T24 and BIU-87 bladder cancer cells.
    Mol Med Rep. 2017 Jun 19. doi: 10.3892/mmr.2017.6805.
    Abstract     Related articles   

  787. MENG XY, Shi MJ, Chen JF, Liao Y, et al
    Association between the TACC3 rs798766 Polymorphism and Risk of Urinary Bladder Cancer: A Synthesis Based on Current Evidence.
    Dis Markers. 2017;2017:7850708.
    Abstract     Related articles   

  788. WHANG YM, Jin SB, Park SI, Chang IH, et al
    MEK inhibition enhances efficacy of bacillus Calmette-Guerin on bladder cancer cells by reducing release of toll-like receptor 2-activated antimicrobial peptides.
    Oncotarget. 2017 May 26. doi: 10.18632/oncotarget.18230.
    Abstract     Related articles   

  789. KUNATH F
    [Intravesical Bacillus Calmette-Guerin with interferon-alpha versus intravesical Bacillus Calmette-Guerin for treating non-muscle-invasive bladder cancer : Comment on a recently published Cochrane Review].
    Urologe A. 2017 Jun 26. doi: 10.1007/s00120-017-0436.
    Abstract     Related articles   

  790. TRABOULSI SL, Brimo F, Yang Y, Maedler C, et al
    Pathology review impacts clinical management of patients with T1-T2 bladder cancer.
    Can Urol Assoc J. 2017;11:188-193.
    Abstract     Related articles   

  791. KLAASSEN Z, Li K, Kassouf W, Black PC, et al
    Contemporary cost-consequence analysis of blue light cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer.
    Can Urol Assoc J. 2017;11:173-181.
    Abstract     Related articles   

  792. MANIG L, Janssen S, Schild SE, Rades D, et al
    A New Prognostic Tool for Patients Undergoing Radiotherapy plus Upfront Transurethral Resection for Bladder Cancer.
    In Vivo. 2017;31:745-748.
    Abstract     Related articles   

  793. CHEVALIER MF, Trabanelli S, Racle J, Salome B, et al
    ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrence.
    J Clin Invest. 2017 Jun 26. pii: 89717. doi: 10.1172/JCI89717.
    Abstract     Related articles   

  794. ATTALLA K, Kent M, Waingankar N, Mehrazin R, et al
    Robotic-assisted radical cystectomy versus open radical cystectomy for management of bladder cancer: review of literature and randomized trials.
    Future Oncol. 2017;13:1195-1204.
    Abstract     Related articles   

  795. LI C, Cui Y, Liu LF, Ren WB, et al
    High Expression of Long Noncoding RNA MALAT1 Indicates a Poor Prognosis and Promotes Clinical Progression and Metastasis in Bladder Cancer.
    Clin Genitourin Cancer. 2017 May 10. pii: S1558-7673(17)30125.
    Abstract     Related articles   

  796. MIYAKE M, Morizawa Y, Hori S, Marugami N, et al
    Integrative Assessment of Pretreatment Inflammation-, Nutrition-, and Muscle-Based Prognostic Markers in Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy.
    Oncology. 2017 Jun 24. doi: 10.1159/000477405.
    Abstract     Related articles   

  797. WILLIAMS SB, Huo J, Dafashy TJ, Ghaffary CK, et al
    Survival differences among patients with bladder cancer according to sex: Critical evaluation of radical cystectomy use and delay to treatment.
    Urol Oncol. 2017 Jun 21. pii: S1078-1439(17)30252.
    Abstract     Related articles   

  798. YANG Y, Guo JX, Shao ZQ, Gao JP, et al
    Matrine inhibits bladder cancer cell growth and invasion in vitro through PI3K/AKT signaling pathway: An experimental study.
    Asian Pac J Trop Med. 2017;10:515-519.
    Abstract     Related articles   

  799. FITZPATRICK R, Paterson NR, Belanger EC, McCurdy A, et al
    Primary amyloidosis of the bladder; a mimicker of bladder cancer.
    Can J Urol. 2017;24:8868-8870.
    Abstract     Related articles   

  800. MORALES A
    BCG: A throwback from the stone age of vaccines opened the path for bladder cancer immunotherapy.
    Can J Urol. 2017;24:8788-8793.
    Abstract     Related articles   

  801. CAKIR E, Kucuk U, Pala EE, Sezer O, et al
    Cytopathologic differential diagnosis of low-grade urothelial carcinoma and reactive urothelial proliferation in bladder washings: a logistic regression analysis.
    APMIS. 2017;125:431-436.
    Abstract     Related articles   

  802. ESKAROS AR, Egloff SA, Boyd KL, Richardson JE, et al
    Larger core size has superior technical and analytical accuracy in bladder tissue microarray.
    Lab Invest. 2017;97:335-342.
    Abstract     Related articles   

  803. ZIMMERMANN M, Wang SS, Zhang H, Lin TY, et al
    Microdose-Induced Drug-DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice.
    Mol Cancer Ther. 2017;16:376-387.
    Abstract     Related articles   

  804. BI H, Zhang Z, Guo L, Fu C, et al
    Effect of wound fluid on chemotherapy sensitivity of T24 bladder cancer cells with different enhancer of zeste homolog 2 status.
    Oncotarget. 2017 Jun 28. doi: 10.18632/oncotarget.18791.
    Abstract     Related articles   

  805. VAN OSCH FHM, Pauwels CGGM, Jochems SHJ, Fayokun R, et al
    Tar, nicotine and carbon monoxide yield of UK cigarettes and the risk of non-muscle-invasive and muscle-invasive bladder cancer.
    Eur J Cancer Prev. 2017 Jul 4. doi: 10.1097/CEJ.0000000000000404.
    Abstract     Related articles   

  806. SHIN SS, Song JH, Hwang B, Park SL, et al
    Angiopoietin-like protein 4 potentiates DATS-induced inhibition of proliferation, migration, and invasion of bladder cancer EJ cells; involvement of G2/M-phase cell cycle arrest, signaling pathways, and transcription factors-mediated MMP-9 expression.
    Food Nutr Res. 2017;61:1338918.
    Abstract     Related articles   

  807. KIKUCHI K, Shigihara T, Hashimoto Y, Miyajima M, et al
    Apparent diffusion coefficient on magnetic resonance imaging (MRI) in bladder cancer: relations with recurrence/progression risk.
    Fukushima J Med Sci. 2017 Jul 5. doi: 10.5387/fms.2017.
    Abstract     Related articles   

  808. LIU Q, Diao R, Feng G, Mu X, et al
    Risk score based on three mRNA expression predicts the survival of bladder cancer.
    Oncotarget. 2017 Jun 27. doi: 10.18632/oncotarget.18642.
    Abstract     Related articles   

  809. GOZEN AS, Umari P, Scheitlin W, Su FE, et al
    Effectivity of intravescical thermo-chemotherapy prophylaxis for patients with high recurrence and progression risk for non-muscle invasive bladder cancer.
    Arch Ital Urol Androl. 2017;89:102-105.
    Abstract     Related articles   

  810. ROBINSON ARL, Radhakrishnan R, Horvath R, Pandey S, et al
    A case of disseminated Mycobacterium bovis 2 years post-intravesicular Bacillus Calmette-Guerin therapy for superficial urinary bladder cancer.
    Intern Med J. 2017;47:820-823.
    Abstract     Related articles   

  811. TRINH TW, Glazer DI, Sadow CA, Sahni VA, et al
    Bladder cancer diagnosis with CT urography: test characteristics and reasons for false-positive and false-negative results.
    Abdom Radiol (NY). 2017 Jul 4. doi: 10.1007/s00261-017-1249.
    Abstract     Related articles   

  812. MBATCHI LC, Gassiot M, Pourquier P, Goberna A, et al
    Association of NR1I2, CYP3A5 and ABCB1 genetic polymorphisms with variability of temsirolimus pharmacokinetics and toxicity in patients with metastatic bladder cancer.
    Cancer Chemother Pharmacol. 2017 Jul 4. doi: 10.1007/s00280-017-3379.
    Abstract     Related articles   

  813. LOBO N, Mount C, Omar K, Nair R, et al
    Landmarks in the treatment of muscle-invasive bladder cancer.
    Nat Rev Urol. 2017 Jul 4. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  814. DAVIS RL 3RD, Le W, Cui Z
    Granulocytes as an effector mechanism of BCG therapy for bladder cancer.
    Med Hypotheses. 2017;104:166-169.
    Abstract     Related articles   

  815. CHEN Y, Xie H, Zou Y, Lai X, et al
    Tetracycline-controllable artificial microRNA-HOTAIR + EZH2 suppressed the progression of bladder cancer cells.
    Mol Biosyst. 2017 Jul 3. doi: 10.1039/c7mb00202.
    Abstract     Related articles   

  816. FARINA MS, Lundgren KT, Bellmunt J
    Immunotherapy in Urothelial Cancer: Recent Results and Future Perspectives.
    Drugs. 2017;77:1077-1089.
    Abstract     Related articles   

  817. KE K, Li H, Yao H, Shi XN, et al
    In silico prediction and in vitro and in vivo validation of acaricide fluazuron as a potential inhibitor of FGFR3 and a candidate anticancer drug for bladder carcinoma.
    Chem Biol Drug Des. 2017;89:505-513.
    Abstract     Related articles   

  818. CHEN MC, Hsu WL, Chang WL, Chou TC, et al
    Antiangiogenic activity of phthalides-enriched Angelica Sinensis extract by suppressing WSB-1/pVHL/HIF-1alpha/VEGF signaling in bladder cancer.
    Sci Rep. 2017;7:5376.
    Abstract     Related articles   

  819. CORFIELD JM, Lawrentschuk N
    Health information quality on the internet for bladder cancer and urinary diversion: a multi-lingual analysis.
    Minerva Urol Nefrol. 2017 Jul 12. doi: 10.23736/S0393-2249.17.02952.
    Abstract     Related articles   

  820. POURSANI EM, Mehravar M, Mohammad Soltani B, Mowla SJ, et al
    A Novel Variant of OCT4 Entitled OCT4B3 is Expressed in Human Bladder Cancer and Astrocytoma Cell Lines.
    Avicenna J Med Biotechnol. 2017;9:142-145.
    Abstract     Related articles   

  821. YE T, Ding W, Wang N, Huang H, et al
    Long noncoding RNA linc00346 promotes the malignant phenotypes of bladder cancer.
    Biochem Biophys Res Commun. 2017 Jul 10. pii: S0006-291X(17)31387.
    Abstract     Related articles   

  822. SHI J, Wang Y, Jia Z, Gao Y, et al
    Curcumin inhibits bladder cancer progression via regulation of beta-catenin expression.
    Tumour Biol. 2017;39:1010428317702548.
    Abstract     Related articles   

  823. POP-BICA C, Gulei D, Cojocneanu-Petric R, Braicu C, et al
    Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets.
    Int J Mol Sci. 2017;18.
    Abstract     Related articles   

  824. HUANG X, Zhuang C, Zhuang C, Xiong T, et al
    An enhanced hTERT promoter-driven CRISPR/Cas9 system selectively inhibits the progression of bladder cancer cells.
    Mol Biosyst. 2017 Jul 12. doi: 10.1039/c7mb00354.
    Abstract     Related articles   

  825. SONG Y, Zhang P, Sun Y, Li X, et al
    AMPK activation-dependent autophagy compromises oleanolic acid-induced cytotoxicity in human bladder cancer cells.
    Oncotarget. 2017 Jul 4. doi: 10.18632/oncotarget.18980.
    Abstract     Related articles   

  826. HOHNE S, Gerullis H, Blaszkewicz M, Selinski S, et al
    N-acetyltransferase 1*10 genotype in bladder cancer patients.
    J Toxicol Environ Health A. 2017 Jul 11:1-6. doi: 10.1080/10937404.2017.1304727.
    Abstract     Related articles   

  827. EBBINGHAUS D, Banfi G, Selinski S, Blaszkewicz M, et al
    Polymorphisms of xenobiotic metabolizing enzymes in bladder cancer patients of the Semmelweis University Budapest, Hungary.
    J Toxicol Environ Health A. 2017 Jul 11:1-7. doi: 10.1080/10937404.2017.1304736.
    Abstract     Related articles   

  828. KRECH E, Selinski S, Blaszkewicz M, Burger H, et al
    Urinary bladder cancer risk factors in an area of former coal, iron, and steel industries in Germany.
    J Toxicol Environ Health A. 2017 Jul 11:1-9. doi: 10.1080/10937404.2017.1304719.
    Abstract     Related articles   

  829. LUKAS C, Selinski S, Prager HM, Blaszkewicz M, et al
    Occupational bladder cancer: Polymorphisms of xenobiotic metabolizing enzymes, exposures, and prognosis.
    J Toxicol Environ Health A. 2017 Jul 11:1-14. doi: 10.1080/10937404.2017.1304731
    Abstract     Related articles   

  830. YAMAMOTO Y, Suehiro Y, Suzuki A, Nawata R, et al
    Germline DNA copy number variations as potential prognostic markers for non-muscle invasive bladder cancer progression.
    Oncol Lett. 2017;14:1193-1199.
    Abstract     Related articles   

  831. SHI J, Zhang X, Shi T, Li H, et al
    Antitumor effects of curcumin in human bladder cancer in vitro.
    Oncol Lett. 2017;14:1157-1161.
    Abstract     Related articles   

  832. ZHANG DQ, Zhou CK, Chen SZ, Yang Y, et al
    Identification of hub genes and pathways associated with bladder cancer based on co-expression network analysis.
    Oncol Lett. 2017;14:1115-1122.
    Abstract     Related articles   

  833. SHIGEMATSU Y, Oue N, Nishioka Y, Sakamoto N, et al
    Overexpression of the transmembrane protein BST-2 induces Akt and Erk phosphorylation in bladder cancer.
    Oncol Lett. 2017;14:999-1004.
    Abstract     Related articles   

  834. SI L, Yang X, Yan X, Wang Y, et al
    Isoliquiritigenin induces apoptosis of human bladder cancer T24 cells via a cyclin-dependent kinase-independent mechanism.
    Oncol Lett. 2017;14:241-249.
    Abstract     Related articles   

  835. AUDENET F, Retinger C, Chien C, Benfante NE, et al
    Is restaging transurethral resection necessary in patients with non-muscle invasive bladder cancer and limited lamina propria invasion?
    Urol Oncol. 2017 Jul 6. pii: S1078-1439(17)30302.
    Abstract     Related articles   

  836. ROVE KO, Husmann DA, Wilcox DT, Vricella GJ, et al
    Systematic review of bladder cancer outcomes in patients with spina bifida.
    J Pediatr Urol. 2017 Jun 1. pii: S1477-5131(17)30234.
    Abstract     Related articles   

  837. ZHONG Z, Huang M, Lv M, He Y, et al
    Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway.
    Cancer Lett. 2017 Jul 4. pii: S0304-3835(17)30409.
    Abstract     Related articles   

  838. VALVERDE MARTINEZ S, Salcedo Mercado W, Rodriguez Cruz I, Prieto Nogal SB, et al
    [Urinary tract lymphoepithelial carcinoma. Report of two cases and bibliographic review.]
    Arch Esp Urol. 2017;70:361-366.
    Abstract     Related articles   

  839. ORTIZ SANCHEZ L, Alonso Prieto MA, Campanario Perez F, Alvarez-Silva I, et al
    Treatment of urachal disorders: The open and laparoscopic surgery approach.
    Arch Esp Urol. 2017;70:357-360.
    Abstract     Related articles   

  840. BALSARA ZR, Li X
    Sleeping beauty: awakening urothelium from its slumber.
    Am J Physiol Renal Physiol. 2017;312:F732-F743.
    Abstract     Related articles   

  841. NAKAI Y, Ozawa T, Mizuno F, Onishi S, et al
    Spectrophotometric photodynamic detection involving extracorporeal treatment with hexaminolevulinate for bladder cancer cells in voided urine.
    J Cancer Res Clin Oncol. 2017 Jul 19. doi: 10.1007/s00432-017-2476.
    Abstract     Related articles   

  842. KANG M, Ku JH
    Emerging role of liquid biopsy of cell-free tumor DNA for bladder cancer surveillance.
    Transl Androl Urol. 2017;6:590-592.
    Abstract     Related articles   

  843. CHEN C, Hu L, Li X, Hou J, et al
    Preoperative Anemia as a Simple Prognostic Factor in Patients with Urinary Bladder Cancer.
    Med Sci Monit. 2017;23:3528-3535.
    Abstract     Related articles   

  844. WARRICK JI, Kaag M, Raman JD, Chan W, et al
    FOXA1 and CK14 as markers of luminal and basal subtypes in histologic variants of bladder cancer and their associated conventional urothelial carcinoma.
    Virchows Arch. 2017 Jul 18. doi: 10.1007/s00428-017-2190.
    Abstract     Related articles   

  845. SMITH AB, Crowell K, Woods ME, Wallen EM, et al
    Functional Outcomes Following Radical Cystectomy in Women with Bladder Cancer: A Systematic Review.
    Eur Urol Focus. 2017;3:136-143.
    Abstract     Related articles   

  846. PAL SK, Pham A, Vuong W, Liu X, et al
    Prognostic Significance of Neutrophilic Infiltration in Benign Lymph Nodes in Patients with Muscle-invasive Bladder Cancer.
    Eur Urol Focus. 2017;3:130-135.
    Abstract     Related articles   

  847. LUO H, Yang R, Li C, Tong Y, et al
    MicroRNA-139-5p inhibits bladder cancer proliferation and self-renewal by targeting the Bmi1 oncogene.
    Tumour Biol. 2017;39:1010428317718414.
    Abstract     Related articles   

  848. EL HAMDANI W, Hadami K, Bensaid M, El Ahanidi H, et al
    Identification of G2607A mutation in EGFR gene with a significative rate in Moroccan patients with Bladder Cancer.
    Cell Mol Biol (Noisy-le-grand). 2017;63:75-81.
    Abstract     Related articles   

  849. SRIVASTAVA A, Douglass LM, Chernyak V, Watts KL, et al
    Advances in Imaging in Prostate and Bladder Cancer.
    Curr Urol Rep. 2017;18:69.
    Abstract     Related articles   

  850. UTANGAC MM, Yeni E, Savas M, Altunkol A, et al
    Paraoxonase and arylesterase activity in bladder cancer.
    Turk J Urol. 2017;43:147-151.
    Abstract     Related articles   

  851. PATEL KM, van der Vos KE, Smith CG, Mouliere F, et al
    Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer.
    Sci Rep. 2017;7:5554.
    Abstract     Related articles   

  852. XIE Y, Ma X, Chen L, Li H, et al
    MicroRNAs with prognostic significance in bladder cancer: a systematic review and meta-analysis.
    Sci Rep. 2017;7:5619.
    Abstract     Related articles   

  853. LAURIDSEN SV, Thomsen T, Thind P, Tonnesen H, et al
    STOP smoking and alcohol drinking before OPeration for bladder cancer (the STOP-OP study), perioperative smoking and alcohol cessation intervention in relation to radical cystectomy: study protocol for a randomised controlled trial.
    Trials. 2017;18:329.
    Abstract     Related articles   

  854. LIU T, Li L, Yin L, Yu H, et al
    Superantigen staphylococcal enterotoxin C1 inhibits the growth of bladder cancer.
    Biosci Biotechnol Biochem. 2017 Jul 17:1-6. doi: 10.1080/09168451.2017.1350564.
    Abstract     Related articles   

  855. CAO HL, Liu ZJ, Chang Z
    Cordycepin induces apoptosis in human bladder cancer cells via activation of A3 adenosine receptors.
    Tumour Biol. 2017;39:1010428317706915.
    Abstract     Related articles   

  856. GOURD E
    TERT mutations in urine could predict bladder cancer recurrence.
    Lancet Oncol. 2017 Jul 13. pii: S1470-2045(17)30538.
    Abstract     Related articles   

  857. MONTANO R, Khan N, Hou H, Seigne J, et al
    Cell cycle perturbation induced by gemcitabine in human tumor cells in cell culture, xenografts and bladder cancer patients: implications for clinical trial designs combining gemcitabine with a Chk1 inhibitor.
    Oncotarget. 2017 Jun 28. doi: 10.18632/oncotarget.18834.
    Abstract     Related articles   

  858. YUAN D, Zheng S, Wang L, Li J, et al
    MiR-200c inhibits bladder cancer progression by targeting lactate dehydrogenase A.
    Oncotarget. 2017 Jun 28. doi: 10.18632/oncotarget.18801.
    Abstract     Related articles   

  859. KUSAKA A, Hatakeyama S, Hosogoe S, Hamano I, et al
    Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer.
    Oncotarget. 2017 Jul 6. doi: 10.18632/oncotarget.19043.
    Abstract     Related articles   

  860. LI C, Ge Q, Liu J, Zhang Q, et al
    Effects of miR-1236-3p and miR-370-5p on activation of p21 in various tumors and its inhibition on the growth of lung cancer cells.
    Tumour Biol. 2017;39:1010428317710824.
    Abstract     Related articles   

  861. NAGAI T, Kamimura T, Itou K, Fujii M, et al
    Myopericytoma in urinary bladder: a case report.
    J Med Case Rep. 2017;11:46.
    Abstract     Related articles   

  862. JORGENSEN KR, Hoyer S, Sorensen MM, Jensen JB, et al
    Human papillomavirus types 44, 52, 66 and 67 detected in a woman with squamous cell carcinoma of the urinary bladder.
    Scand J Urol. 2017;51:85-86.
    Abstract     Related articles   

  863. ANDREASSEN BK, Myklebust TA, Haug ES
    Crude mortality and loss of life expectancy of patients diagnosed with urothelial carcinoma of the urinary bladder in Norway.
    Scand J Urol. 2017;51:38-43.
    Abstract     Related articles   

  864. LIEDBERG F, Ahlgren G, Baseckas G, Gudjonsson S, et al
    Long-term functional outcomes after radical cystectomy with ileal bladder substitute: does the definition of continence matter?
    Scand J Urol. 2017;51:44-49.
    Abstract     Related articles   

  865. YANG YB, Bai YJ, Tang Y, Liu ZH, et al
    [Detection of Circulating Tumor Cells in Bladder Cancer by Subtraction Enrichment and Immunostaining-fluorescence in situ Hybridization].
    Sichuan Da Xue Xue Bao Yi Xue Ban. 2017;48:605-609.
    Abstract     Related articles   

  866. TANG X, Du P, Yang Y
    The clinical use of neutrophil-to-lymphocyte ratio in bladder cancer patients: a systematic review and meta-analysis.
    Int J Clin Oncol. 2017 Jul 27. doi: 10.1007/s10147-017-1171.
    Abstract     Related articles   

  867. HE X, Hou J, Ping J, Wen D, et al
    Opa interacting protein 5 acts as an oncogene in bladder cancer.
    J Cancer Res Clin Oncol. 2017 Jul 27. doi: 10.1007/s00432-017-2485.
    Abstract     Related articles   

  868. DZOMBETA T, Kruslin B
    High Grade T1 Papillary Urothelial Bladder Cancer Shows Prominent Peritumoral Retraction Clefting.
    Pathol Oncol Res. 2017 Jul 27. doi: 10.1007/s12253-017-0279.
    Abstract     Related articles   

  869. TESSMANN JW, Buss J, Begnini KR, Berneira LM, et al
    Antitumor potential of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-1H-pyrazoles in human bladder cancer cells.
    Biomed Pharmacother. 2017;94:37-46.
    Abstract     Related articles   

  870. LI H, Xu Y, Li H
    CD147 as a novel biomarker for predicting the prognosis and clinicopathological features of bladder cancer: a meta-analysis.
    Oncotarget. 2017 Jul 15. doi: 10.18632/oncotarget.19257.
    Abstract     Related articles   

  871. WANG X, Cui MM, Xu Y, Liu L, et al
    Decreased mean platelet volume predicts poor prognosis in invasive bladder cancer.
    Oncotarget. 2017 Jul 12. doi: 10.18632/oncotarget.19242.
    Abstract     Related articles   

  872. CAO JY, Yin HS, Li HS, Yu XQ, et al
    Interleukin-27 augments the inhibitory effects of sorafenib on bladder cancer cells.
    Braz J Med Biol Res. 2017;50:e6207.
    Abstract     Related articles   

  873. WEN W, Li J, Wang L, Xing Y, et al
    Inhibition of NEDD4 inhibits cell growth and invasion and induces cell apoptosis in bladder cancer cells.
    Cell Cycle. 2017 Jul 26:1-6. doi: 10.1080/15384101.2017.1338220.
    Abstract     Related articles   

  874. ZHANG GH, Yuan JM, Qian G, Gu CX, et al
    Phthalazino[1,2-b]quinazolinones as p53 Activators: Cell Cycle Arrest, Apoptotic Response and Bak-Bcl-xl Complex Reorganization in Bladder Cancer Cells.
    J Med Chem. 2017 Jul 26. doi: 10.1021/acs.jmedchem.6b01769.
    Abstract     Related articles   

  875. ZUIVERLOON TC, Theodorescu D
    Pharmacogenomic considerations in the treatment of muscle-invasive bladder cancer.
    Pharmacogenomics. 2017 Jul 26. doi: 10.2217/pgs-2017-0055.
    Abstract     Related articles   

  876. LI MZ, Lai DH, Zhao HB, Chen Z, et al
    SOCS3 overexpression enhances ADM resistance in bladder cancer T24 cells.
    Eur Rev Med Pharmacol Sci. 2017;21:3005-3011.
    Abstract     Related articles   

  877. KORPAL M, Puyang X, Jeremy Wu Z, Seiler R, et al
    Evasion of immunosurveillance by genomic alterations of PPARgamma/RXRalpha in bladder cancer.
    Nat Commun. 2017;8:103.
    Abstract     Related articles   

    Nivolumab for the treatment of bladder cancer.
    Expert Opin Biol Ther. 2017 Jul 24:1-7. doi: 10.1080/14712598.2017.1353076.
    Abstract     Related articles   

  879. WANG CY, Nie QW, Zhou X, Huang DX, et al
    [S100A4, a potential therapeutic target on bladder cancer stem cells].
    Nan Fang Yi Ke Da Xue Xue Bao. 2017;37:869-874.
    Abstract     Related articles   

  880. MARTINEZ RODRIGUEZ RH, Buisan Rueda O, Ibarz L
    Bladder cancer: Present and future.
    Med Clin (Barc). 2017 Jul 20. pii: S0025-7753(17)30478.
    Abstract     Related articles   

  881. CHARGARI C, Haie-Meder C, Guerin F, Minard-Colin V, et al
    Brachytherapy Combined With Surgery for Conservative Treatment of Children With Bladder Neck and/or Prostate Rhabdomyosarcoma.
    Int J Radiat Oncol Biol Phys. 2017;98:352-359.
    Abstract     Related articles   

  882. PAN ZJ, Deng N, Zou ZH, Chen GX, et al
    The effect of curcumin on bladder tumor in rat model.
    Eur Rev Med Pharmacol Sci. 2017;21:884-889.
    Abstract     Related articles   

  883. WEWERING F, Jouy F, Caliskan S, Kalkhof S, et al
    Hepatic co-cultures in vitro reveal suitable to detect Nrf2-mediated oxidative stress responses on the bladder carcinogen o-anisidine.
    Toxicol In Vitro. 2017;40:153-160.
    Abstract     Related articles   

  884. MA Y, Luo W, Bunch BL, Pratt RN, et al
    1,25D3 differentially suppresses bladder cancer cell migration and invasion through the induction of miR-101-3p.
    Oncotarget. 2017 Jul 27. doi: 10.18632/oncotarget.19629.
    Abstract     Related articles   

  885. SHI HB, Yu JX, Yu JX, Feng Z, et al
    Diagnostic significance of microRNAs as novel biomarkers for bladder cancer: a meta-analysis of ten articles.
    World J Surg Oncol. 2017;15:147.
    Abstract     Related articles   

  886. ZHU J, Li Y, Chen C, Ma J, et al
    NF-kappaB p65 Overexpression Promotes Bladder Cancer Cell Migration via FBW7-Mediated Degradation of RhoGDIalpha Protein.
    Neoplasia. 2017;19:672-683.
    Abstract     Related articles   

  887. LIU H, Chang JK, Hou JQ, Zhao ZH, et al
    Inhibition of miR-221 influences bladder cancer cell proliferation and apoptosis.
    Eur Rev Med Pharmacol Sci. 2017;21:3193-3199.
    Abstract     Related articles   

  888. GERACE C, Montorsi F, Tambaro R, Carteni G, et al
    Cost of illness of urothelial bladder cancer in Italy.
    Clinicoecon Outcomes Res. 2017;9:433-442.
    Abstract     Related articles   

  889. LOFTFIELD E, Freedman ND, Inoue-Choi M, Graubard BI, et al
    A Prospective Investigation of Coffee Drinking and Bladder Cancer Incidence in the United States.
    Epidemiology. 2017;28:685-693.
    Abstract     Related articles   

  890. AZEVEDO R, Peixoto A, Gaiteiro C, Fernandes E, et al
    Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?
    Oncotarget. 2017 Jul 21. doi: 10.18632/oncotarget.19433.
    Abstract     Related articles   

  891. CHENG TC, Din ZH, Su JH, Wu YJ, et al
    Sinulariolide Suppresses Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 and Urokinase through the PI3K/AKT/mTOR Signaling Pathway in Human Bladder Cancer Cells.
    Mar Drugs. 2017;15.
    Abstract     Related articles   

  892. SAHU D, Lotan Y, Wittmann B, Neri B, et al
    Metabolomics analysis reveals distinct profiles of nonmuscle-invasive and muscle-invasive bladder cancer.
    Cancer Med. 2017 Aug 1. doi: 10.1002/cam4.1109.
    Abstract     Related articles   

  893. RACHAKONDA T, Kendall B, Spivak AM, Boltax J, et al
    Pleural Effusion Caused by Bacillus Calmette-Guerin Immunotherapy for Bladder Cancer.
    Open Forum Infect Dis. 2017;4:ofx126.
    Abstract     Related articles   

  894. YOON HJ, Yoo J, Kim Y, Lee DH, et al
    Enhanced Application of 18F-FDG PET/CT in Bladder Cancer by Adding Early Dynamic Acquisition to a Standard Delayed PET Protocol.
    Clin Nucl Med. 2017 Jul 29. doi: 10.1097/RLU.0000000000001780.
    Abstract     Related articles   

  895. HU R, Zhong P, Xiong L, Duan L, et al
    Long Noncoding RNA Cancer Susceptibility Candidate 8 Suppresses the Proliferation of Bladder Cancer Cells via Regulating Glycolysis.
    DNA Cell Biol. 2017 Jul 31. doi: 10.1089/dna.2017.3785.
    Abstract     Related articles   

  896. HUANG SY, Chang SF, Liao KF, Chiu SC, et al
    Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
    Int J Mol Sci. 2017;18.
    Abstract     Related articles   

  897. PAVAN GRANDHI TS, Potta T, Nitiyanandan R, Deshpande I, et al
    Chemomechanically engineered 3D organotypic platforms of bladder cancer dormancy and reactivation.
    Biomaterials. 2017;142:171-185.
    Abstract     Related articles   

  898. PACKIAM VT, Lamm DL, Barocas DA, Trainer A, et al
    An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non-muscle-invasive bladder cancer: Interim results.
    Urol Oncol. 2017 Jul 26. pii: S1078-1439(17)30350.
    Abstract     Related articles   

  899. NECCHI A, Mariani L, Lo Vullo S, Yu EY, et al
    Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based Analysis.
    Eur Urol Focus. 2017 Jun 3. pii: S2405-4569(17)30125.
    Abstract     Related articles   

  900. NECCHI A, Pond GR, Smaldone MC, Pal SK, et al
    Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist's Perspective from a Multicentre Study.
    Eur Urol Focus. 2017 Mar 31. pii: S2405-4569(17)30079.
    Abstract     Related articles   

  901. NASELLI A, Hurle R, Paparella S, Buffi NM, et al
    Role of Restaging Transurethral Resection for T1 Non-muscle invasive Bladder Cancer: A Systematic Review and Meta-analysis.
    Eur Urol Focus. 2017 Jan 13. pii: S2405-4569(17)30006.
    Abstract     Related articles   

  902. KUKREJA JB, Porten S, Golla V, Ho PL, et al
    Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy.
    Eur Urol Focus. 2017 Jan 18. pii: S2405-4569(16)30181.
    Abstract     Related articles   

  903. KRAMER MW, Altieri V, Hurle R, Lusuardi L, et al
    Current Evidence of Transurethral En-bloc Resection of Nonmuscle Invasive Bladder Cancer: Update 2016.
    Eur Urol Focus. 2017 Jan 11. pii: S2405-4569(16)30180.
    Abstract     Related articles   

  904. VIND-KEZUNOVIC S, Bouchelouche K, Ipsen P, Hoyer S, et al
    Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Results from a High-volume Centre Including Long-term Follow-up.
    Eur Urol Focus. 2017 Jun 23. pii: S2405-4569(17)30156.
    Abstract     Related articles   

  905. DRAY EV, Cameron AP
    Identifying Patients with High-Risk Neurogenic Bladder: Beyond Detrusor Leak Point Pressure.
    Urol Clin North Am. 2017;44:441-452.
    Abstract     Related articles   

  906. KRISHNAMURTHY A, Jimeno A
    Atezolizumab: A novel PD-L1 inhibitor in cancer therapy with a focus in bladder and non-small cell lung cancers.
    Drugs Today (Barc). 2017;53:217-237.
    Abstract     Related articles   

  907. MUSAYEV T
    Georgian Med News. 2017;:29-35.
    Abstract     Related articles   

  908. XING NZ, Kang N, Song LM, Niu YN, et al
    Laparoscopic radical cystectomy with novel orthotopic neobladder with bilateral isoperistaltic afferent limbs: initial experience.
    Int Braz J Urol. 2017;43:57-66.
    Abstract     Related articles   

  909. SEDAGHAT S, Gheytanchi E, Asgari M, Roudi R, et al
    Expression of Cancer Stem Cell Markers OCT4 and CD133 in Transitional Cell Carcinomas.
    Appl Immunohistochem Mol Morphol. 2017;25:196-202.
    Abstract     Related articles   

  910. YAN L, Li Q, Yang J, Qiao B, et al
    TPX2-p53-GLIPR1 regulatory circuitry in cell proliferation, invasion and tumor growth of bladder cancer.
    J Cell Biochem. 2017 Aug 11. doi: 10.1002/jcb.26340.
    Abstract     Related articles   

  911. FAIREY AS, Jacobsen NE
    Taking it to the HILT: High-intensity local treatment with radical cystectomy for metastatic bladder cancer.
    Can Urol Assoc J. 2017;11:249-250.
    Abstract     Related articles   

  912. CHANG SS, Bochner BH, Chou R, Dreicer R, et al
    Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer: American Urological Association/American Society of Clinical Oncology/American Society for Radiation Oncology/Society of Urologic Oncology Clinical Practice Guideline Summary.
    J Oncol Pract. 2017 Aug 10:JOP2017024919. doi: 10.1200/JOP.2017.024919.
    Abstract     Related articles   

  913. CHEN Z, Zhou L, Wang L, Kazobinka G, et al
    HBO1 promotes cell proliferation in bladder cancer via activation of Wnt/beta-catenin signaling.
    Mol Carcinog. 2017 Aug 10. doi: 10.1002/mc.22715.
    Abstract     Related articles   

  914. LI Y, Zheng F, Xiao X, Xie F, et al
    CircHIPK3 sponges miR-558 to suppress heparanase expression in bladder cancer cells.
    EMBO Rep. 2017 Aug 9. pii: e201643581. doi: 10.15252/embr.201643581.
    Abstract     Related articles   

  915. JIN H, Xie Q, Guo X, Xu J, et al
    p63alpha protein upregulates heat shock protein 70 expression via E2F1 transcription factor 1, promoting Wasf3/Wave3/MMP9 signaling and bladder cancer invasion.
    J Biol Chem. 2017 Aug 9. pii: jbc.M117.792010. doi: 10.1074/jbc.M117.792010.
    Abstract     Related articles   

  916. ZHU F, Qian W, Zhang H, Liang Y, et al
    SOX2 Is a Marker for Stem-like Tumor Cells in Bladder Cancer.
    Stem Cell Reports. 2017;9:429-437.
    Abstract     Related articles   

  917. GAO L, Li SH, Tian YX, Zhu QQ, et al
    Role of downregulated miR-133a-3p expression in bladder cancer: a bioinformatics study.
    Onco Targets Ther. 2017;10:3667-3683.
    Abstract     Related articles   

  918. CAO W, Tian J, Li C, Gao Y, et al
    A novel bladder cancer - specific oncolytic adenovirus by CD46 and its effect combined with cisplatin against cancer cells of CAR negative expression.
    Virol J. 2017;14:149.
    Abstract     Related articles   

  919. COLLARILE P, Bidoli E, Barbone F, Zanier L, et al
    Residence in Proximity of a Coal-Oil-Fired Thermal Power Plant and Risk of Lung and Bladder Cancer in North-Eastern Italy. A Population-Based Study: 1995-2009.
    Int J Environ Res Public Health. 2017;14.
    Abstract     Related articles   

  920. GARAPATI SS, Hadjiiski L, Cha KH, Chan HP, et al
    Urinary Bladder Cancer Staging in CT Urography using Machine Learning.
    Med Phys. 2017 Aug 8. doi: 10.1002/mp.12510.
    Abstract     Related articles   

  921. SIDAWAY P
    Bladder cancer: PPARgamma-RXRalpha alterations promote immune evasion.
    Nat Rev Urol. 2017 Aug 8. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

    Bayesian nonparametric areal wombling for small-scale maps with an application to urinary bladder cancer data from Connecticut.
    Stat Med. 2017 Aug 7. doi: 10.1002/sim.7408.
    Abstract     Related articles   

  923. XIA J, Zeng M, Zhu H, Chen X, et al
    Emerging role of Hippo signalling pathway in bladder cancer.
    J Cell Mol Med. 2017 Aug 7. doi: 10.1111/jcmm.13293.
    Abstract     Related articles   

  924. AVIRMED S, Wang BS, Selenge B, Sanjaajamts A, et al
    Association between MDM2-SNP309 and p53R72P polymorphisms and the risk of bladder cancer in the Mongolian population.
    Mol Clin Oncol. 2017;7:412-420.
    Abstract     Related articles   

  925. KANG HW, Seo SP, Jeong P, Ha YS, et al
    Long-term validation of a molecular progression-associated gene classifier for prediction of muscle invasion in primary non-muscle-invasive bladder cancer.
    Oncol Lett. 2017;14:2468-2474.
    Abstract     Related articles   

  926. WU H, Hao A, Cui H, Wu W, et al
    TRAF6 expression is associated with poorer prognosis and high recurrence in urothelial bladder cancer.
    Oncol Lett. 2017;14:2432-2438.
    Abstract     Related articles   

  927. LI S, Wang F, Zhai Z, Fu S, et al
    Synergistic effect of bladder cancer-specific oncolytic adenovirus in combination with chemotherapy.
    Oncol Lett. 2017;14:2081-2088.
    Abstract     Related articles   

  928. TRUTA A, Popon TAH, Saraci G, Ghervan L, et al
    Health Related Quality of life in bladder cancer. Current approach and future perspectives.
    Clujul Med. 2017;90:262-267.
    Abstract     Related articles   

  929. HADKHALE K, MacLeod J, Demers PA, Martinsen JI, et al
    Occupational variation in incidence of bladder cancer: a comparison of population-representative cohorts from Nordic countries and Canada.
    BMJ Open. 2017;7:e016538.
    Abstract     Related articles   

  930. MIAO X, Gao H, Liu S, Chen M, et al
    Down-regulation of microRNA-224 -inhibites growth and epithelial-to-mesenchymal transition phenotype -via modulating SUFU expression in bladder cancer cells.
    Int J Biol Macromol. 2017 Aug 2. pii: S0141-8130(17)30303.
    Abstract     Related articles   

  931. LV M, Zhong Z, Huang M, Tian Q, et al
    lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA.
    Biochim Biophys Acta. 2017;1864:1887-1899.
    Abstract     Related articles   

  932. SIDDIQUI MR, Grant C, Sanford T, Agarwal PK, et al
    Current clinical trials in non-muscle invasive bladder cancer.
    Urol Oncol. 2017;35:516-527.
    Abstract     Related articles   

  933. STAPF M, Teichgraber U, Hilger I
    Methotrexate-coupled nanoparticles and magnetic nanochemothermia for the relapse-free treatment of T24 bladder tumors.
    Int J Nanomedicine. 2017;12:2793-2811.
    Abstract     Related articles   

  934. D'ANDREA D, Moschini M, Gust KM, Abufaraj M, et al
    Lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cystectomy.
    J Surg Oncol. 2017;115:455-461.
    Abstract     Related articles   

  935. PARK S, Kang SY, Kwon GY, Kwon JE, et al
    Clinicopathologic Characteristics and Mutational Status of Succinate Dehydrogenase Genes in Paraganglioma of the Urinary Bladder: A Multi-Institutional Korean Study.
    Arch Pathol Lab Med. 2017;141:671-677.
    Abstract     Related articles   

  936. WANG F, Wu LM, Hua XL, Zhao ZZ, et al
    Intravoxel incoherent motion diffusion-weighted imaging in assessing bladder cancer invasiveness and cell proliferation.
    J Magn Reson Imaging. 2017 Aug 17. doi: 10.1002/jmri.25839.
    Abstract     Related articles   

  937. WANG Y, Zhang H, Li X, Chen W, et al
    Differential expression profile analysis of lncRNA UCA1alpha regulated mRNAs in bladder cancer.
    J Cell Biochem. 2017 Aug 16. doi: 10.1002/jcb.26345.
    Abstract     Related articles   

  938. GECIT I, Eryilmaz R, Kavak S, Meral I, et al
    The Prolidase Activity, Oxidative Stress, and Nitric Oxide Levels of Bladder Tissues with or Without Tumor in Patients with Bladder Cancer.
    J Membr Biol. 2017 Aug 16. doi: 10.1007/s00232-017-9971.
    Abstract     Related articles   

  939. LOPEZ-BELTRAN A, Cheng L, Montorsi F, Scarpelli M, et al
    Concomitant bladder cancer and prostate cancer: challenges and controversies.
    Nat Rev Urol. 2017 Aug 16. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  940. THOMA C
    Bladder cancer: The promise of liquid biopsy ctDNA analysis.
    Nat Rev Urol. 2017 Aug 16. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  941. AVITAN O, Bahouth Z, Halachmi S, Shprits S, et al
    Histopathologic Differences between Jewish and Arab Population in Israel at First-Time Presentation with Bladder Cancer.
    Biomed Res Int. 2017;2017:8239601.
    Abstract     Related articles   

  942. VERMA A, Kapoor R, Mittal RD
    Genetic Variation in CD166 Gene and Its Association with Bladder Cancer Risk in North Indian Population.
    Indian J Clin Biochem. 2017;32:292-300.
    Abstract     Related articles   

  943. HUSSEIN S, Mosaad H, Rashed HE, Ahmed S, et al
    Molecular factors regulating E-cadherin expression in urothelial bladder cancer and their correlations with the clinicopathological features.
    Mol Biol Rep. 2017 Aug 14. doi: 10.1007/s11033-017-4118.
    Abstract     Related articles   

  944. CORMIO A, Sanguedolce F, Musicco C, Pesce V, et al
    Mitochondrial dysfunctions in bladder cancer: Exploring their role as disease markers and potential therapeutic targets.
    Crit Rev Oncol Hematol. 2017;117:67-72.
    Abstract     Related articles   

  945. MASTRANGELO G, Carta A, Arici C, Pavanello S, et al
    An etiologic prediction model incorporating biomarkers to predict the bladder cancer risk associated with occupational exposure to aromatic amines: a pilot study.
    J Occup Med Toxicol. 2017;12:23.
    Abstract     Related articles   

  946. FEKI-TOUNSI M, Khlifi R, Louati I, Fourati M, et al
    Polymorphisms in XRCC1, ERCC2, and ERCC3 DNA repair genes, CYP1A1 xenobiotic metabolism gene, and tobacco are associated with bladder cancer susceptibility in Tunisian population.
    Environ Sci Pollut Res Int. 2017 Aug 12. doi: 10.1007/s11356-017-9767.
    Abstract     Related articles   

  947. OUGHTON JB, Poad H, Twiddy M, Collinson M, et al
    Radical cystectomy (bladder removal) against intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer (BRAVO): a protocol for a randomised controlled feasibility study.
    BMJ Open. 2017;7:e017913.
    Abstract     Related articles   

  948. STEINBERG RL, Nepple KG, Velaer KN, Thomas LJ, et al
    Quadruple immunotherapy of Bacillus Calmette-Guerin, interferon, interleukin-2, and granulocyte-macrophage colony-stimulating factor as salvage therapy for non-muscle-invasive bladder cancer.
    Urol Oncol. 2017 Aug 8. pii: S1078-1439(17)30386.
    Abstract     Related articles   

  949. LEE Y, Kischuk E, Crist S, Ratliff TL, et al
    Targeting and Internalization of Liposomes by Bladder Tumor Cells Using a Fibronectin Attachment Protein-Derived Peptide-Lipopolymer Conjugate.
    Bioconjug Chem. 2017;28:1481-1490.
    Abstract     Related articles   

  950. GERULLIS H, Ecke TH, Barski D, Bantel C, et al
    Retrospective analysis of a surgical innovation using the IDEAL framework: radical cystectomy with epidural anaesthesia.
    J Int Med Res. 2017;45:714-722.
    Abstract     Related articles   

  951. SHIGETA K, Kikuchi E, Hagiwara M, Ando T, et al
    Prolonged pneumoperitoneum time is an independent risk factor for intravesical recurrence after laparoscopic radical nephroureterectomy in upper tract urothelial carcinoma.
    Surg Oncol. 2017;26:73-79.
    Abstract     Related articles   

  952. NISHIOKA K, Shimizu S, Shinohara N, Ito YM, et al
    Analysis of inter- and intra fractional partial bladder wall movement using implanted fiducial markers.
    Radiat Oncol. 2017;12:44.
    Abstract     Related articles   

  953. KRENGLI M, Pisani C, Deantonio L, Surico D, et al
    Intraoperative radiotherapy in gynaecological and genito-urinary malignancies: focus on endometrial, cervical, renal, bladder and prostate cancers.
    Radiat Oncol. 2017;12:18.
    Abstract     Related articles   

  954. ROIFE D, Kang Y, Wang L, Fang B, et al
    Generation of patient-derived xenografts from fine needle aspirates or core needle biopsy.
    Surgery. 2017;161:1246-1254.
    Abstract     Related articles   

  955. ZHUANG J, Shen L, Yang L, Huang X, et al
    TGFbeta1 Promotes Gemcitabine Resistance through Regulating the LncRNA-LET/NF90/miR-145 Signaling Axis in Bladder Cancer.
    Theranostics. 2017;7:3053-3067.
    Abstract     Related articles   

  956. PAN Y, Chang T, Marcq G, Liu C, et al
    In vivo biodistribution and toxicity of intravesical administration of quantum dots for optical molecular imaging of bladder cancer.
    Sci Rep. 2017;7:9309.
    Abstract     Related articles   

  957. MIYAKE M, Morizawa Y, Hori S, Tatsumi Y, et al
    Diagnostic and prognostic role of urinary collagens in primary human bladder cancer.
    Cancer Sci. 2017 Aug 24. doi: 10.1111/cas.13384.
    Abstract     Related articles   

  958. YUAN GJ, Chen X, Lu J, Feng ZH, et al
    CBX8 is a predictor of muscle invasive bladder cancer and promotes cell proliferation by repressing the p53 pathway.
    Cancer Sci. 2017 Aug 24. doi: 10.1111/cas.13383.
    Abstract     Related articles   

  959. LI J, Xu X, Meng S, Liang Z, et al
    MET/SMAD3/SNAIL circuit mediated by miR-323a-3p is involved in regulating epithelial-mesenchymal transition progression in bladder cancer.
    Cell Death Dis. 2017;8:e3010.
    Abstract     Related articles   

  960. DILIZIA EM, Sadeghi F
    Surgical and pathological outcomes of robotic-assisted radical cystectomy for bladder cancer in the community setting.
    J Robot Surg. 2017 Aug 23. doi: 10.1007/s11701-017-0740.
    Abstract     Related articles   

  961. REN H, Tang P, Zhao Q, Ren G, et al
    Symptom clusters and related factors in bladder cancer patients three months after radical cystectomy.
    BMC Urol. 2017;17:65.
    Abstract     Related articles   

  962. BOEGEMANN M, Aydin AM, Bagrodia A, Krabbe LM, et al
    Prospects and progress of immunotherapy for bladder cancer.
    Expert Opin Biol Ther. 2017 Aug 23:1-15. doi: 10.1080/14712598.2017.1366445.
    Abstract     Related articles   

  963. LIANG LG, Sheng YF, Zhou S, Inci F, et al
    An Integrated Double-Filtration Microfluidic Device for Detection of Extracellular Vesicles from Urine for Bladder Cancer Diagnosis.
    Methods Mol Biol. 2017;1660:355-364.
    Abstract     Related articles   

  964. HUO J, Chu Y, Chamie K, Smaldone MC, et al
    Increased Utilization of Positron Emission Tomography/Computed Tomography (PET/CT) Imaging and Its Economic Impact for Patients Diagnosed With Bladder Cancer.
    Clin Genitourin Cancer. 2017 Jul 26. pii: S1558-7673(17)30215.
    Abstract     Related articles   

  965. MOSSANEN M, Kibel AS, Goldman RH
    Exploring exposure to Agent Orange and increased mortality due to bladder cancer.
    Urol Oncol. 2017 Aug 17. pii: S1078-1439(17)30392.
    Abstract     Related articles   

  966. FLAIG TW, Kamat AM, Hansel D, Ingersoll MA, et al
    Proceedings of the 3rd Annual Albert Institute for Bladder Cancer Research Symposium.
    Bladder Cancer. 2017;3:211-223.
    Abstract     Related articles   

  967. YANG X, Su LJ, La Rosa FG, Smith EE, et al
    The Antineoplastic Activity of Photothermal Ablative Therapy with Targeted Gold Nanorods in an Orthotopic Urinary Bladder Cancer Model.
    Bladder Cancer. 2017;3:201-210.
    Abstract     Related articles   

  968. KATES M, Chappidi MR, Brant A, Milbar N, et al
    High dose-rate Intra-Operative Radiation Therapy During High Risk Genitourinary Surgery: Initial Observations and a Proposal for its Study in Bladder Cancer.
    Bladder Cancer. 2017;3:191-199.
    Abstract     Related articles   

  969. SUI W, Lim EA, Joel Decastro G, McKiernan JM, et al
    Use of Adjuvant Chemotherapy in Patients with Advanced Bladder Cancer after Neoadjuvant Chemotherapy.
    Bladder Cancer. 2017;3:181-189.
    Abstract     Related articles   

  970. BREYER J, Shalekenov S, Aziz A, van Rhijn BWG, et al
    Increased Proliferation as Independent Predictor of Disease Recurrence in Initial Stage pTa Urothelial Bladder Cancer.
    Bladder Cancer. 2017;3:173-180.
    Abstract     Related articles   

  971. LI R, Sylvester R, Dinney CP, Kamat AM, et al
    Letter to the Editor: Bacillus Calmette-Guerin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease.
    Bladder Cancer. 2017;3:147-148.
    Abstract     Related articles   

  972. KAMAT AM, Lerner S, Black P, Bellmunt J, et al
    Once BCG Unresponsive, Always BCG Unresponsive: An Open Letter to the FDA to Enhance Recruitment into Clinical Trials in Bladder Cancer.
    Bladder Cancer. 2017;3:145-146.
    Abstract     Related articles   

  973. MIRSAIDI N, Burns MP, McClain SA, Forsyth E, et al
    Enhanced Mortality to Metastatic Bladder Cancer Cell Line MB49 in Vasoactive Intestinal Peptide Gene Knockout Mice.
    Front Endocrinol (Lausanne). 2017;8:162.
    Abstract     Related articles   

  974. LIU J, Duan X
    PA-MSHA induces apoptosis and suppresses metastasis by tumor associated macrophages in bladder cancer cells.
    Cancer Cell Int. 2017;17:76.
    Abstract     Related articles   

  975. PICHLER R, Tulchiner G, Fritz J, Schaefer G, et al
    Urinary UBC Rapid and NMP22 Test for Bladder Cancer Surveillance in Comparison to Urinary Cytology: Results from a Prospective Single-Center Study.
    Int J Med Sci. 2017;14:811-819.
    Abstract     Related articles   

  976. CHA KH, Hadjiiski L, Chan HP, Weizer AZ, et al
    Bladder Cancer Treatment Response Assessment in CT using Radiomics with Deep-Learning.
    Sci Rep. 2017;7:8738.
    Abstract     Related articles   

  977. WU Z, Wang S, Jiang F, Li Q, et al
    Erratum to "Mass spectrometric detection combined with bioinformatic analysis identified possible protein markers and key pathways associated with bladder cancer" [Gene 626C (2017) 407-413].
    Gene. 2017 Aug 15. pii: S0378-1119(17)30624-8. doi: 10.1016/j.gene.2017.
    Abstract     Related articles   

  978. CAO R, Wang G, Qian K, Chen L, et al
    Silencing of HJURP induces dysregulation of cell cycle and ROS metabolism in bladder cancer cells via PPARgamma-SIRT1 feedback loop.
    J Cancer. 2017;8:2282-2295.
    Abstract     Related articles   

  979. CHEN W, Luo K, Ke Z, Kuai B, et al
    TBK1 Promote Bladder Cancer Cell Proliferation and Migration via Akt Signaling.
    J Cancer. 2017;8:1892-1899.
    Abstract     Related articles   

  980. HUANG CP, Chen CC, Shyr CR
    The anti-tumor effect of intravesical administration of normal urothelial cells on bladder cancer.
    Cytotherapy. 2017 Aug 14. pii: S1465-3249(17)30633.
    Abstract     Related articles   

  981. YANG Z, Yang X, Lu X, Gao L, et al
    Primary malignant mesenchymoma of bladder: Case report and review of the literature.
    Medicine (Baltimore). 2017;96:e7579.
    Abstract     Related articles   

  982. RICKMAN DS, Beltran H, Demichelis F, Rubin MA, et al
    Biology and evolution of poorly differentiated neuroendocrine tumors.
    Nat Med. 2017;23:1-10.
    Abstract     Related articles   

  983. DAL MORO F, Haber GP, Wiklund P, Canda AE, et al
    Robotic intracorporeal urinary diversion: practical review of current surgical techniques.
    Minerva Urol Nefrol. 2017;69:14-25.
    Abstract     Related articles   

  984. AUTENRIETH ME, Horn T, Kurtz F, Nguyen K, et al
    [Intravesical radioimmunotherapy of carcinoma in situ of the urinary bladder after BCG failure].
    Urologe A. 2017;56:40-43.
    Abstract     Related articles   

  985. HANLEY KZ, Cohen C, Osunkoya AO
    Hepatocyte Nuclear Factor-1beta Expression in Clear Cell Renal Cell Carcinoma and Urothelial Carcinoma With Clear Cell Features: A Potential Diagnostic Pitfall.
    Appl Immunohistochem Mol Morphol. 2017;25:134-138.
    Abstract     Related articles   

  986. GUSTAFSON TL, Kitchell BE, Biller B
    Hedgehog signaling is activated in canine transitional cell carcinoma and contributes to cell proliferation and survival.
    Vet Comp Oncol. 2017;15:174-183.
    Abstract     Related articles   

  987. YANG X, Shi L, Yi C, Yang Y, et al
    MiR-210-3p inhibits the tumor growth and metastasis of bladder cancer via targeting fibroblast growth factor receptor-like 1.
    Am J Cancer Res. 2017;7:1738-1753.
    Abstract     Related articles   

  988. KUS T, Aktas G
    Maintenance treatment with gemcitabine have a promising activity on metastatic bladder cancer survival.
    Turk J Urol. 2017;43:273-278.
    Abstract     Related articles   

  989. SUN M, Zhao W, Zeng Y, Zhang D, et al
    Fibrous sheath interacting protein 1 overexpression is associated with unfavorable prognosis in bladder cancer: a potential therapeutic target.
    Onco Targets Ther. 2017;10:3949-3956.
    Abstract     Related articles   

  990. CHENG B, Qiu X, Li H, Yang G, et al
    The safety and efficacy of front-firing green-light laser endoscopic en bloc photoselective vapo-enucleation of non-muscle-invasive bladder cancer.
    Ther Clin Risk Manag. 2017;13:983-988.
    Abstract     Related articles   

  991. BOUSTANI J, Bertaut A, Galsky MD, Rosenberg JE, et al
    Radical cystectomy or bladder preservation with radiochemotherapy in elderly patients with muscle-invasive bladder cancer: Retrospective International Study of Cancers of the Urothelial Tract (RISC) Investigators.
    Acta Oncol. 2017 Aug 30:1-7. doi: 10.1080/0284186X.2017.1369565.
    Abstract     Related articles   

  992. VERMA N, Pink M, Boland S, Rettenmeier AW, et al
    Benzo[a]pyrene-induced metabolic shift from glycolysis to pentose phosphate pathway in the human bladder cancer cell line RT4.
    Sci Rep. 2017;7:9773.
    Abstract     Related articles   

  993. JIN F, Thaiparambil J, Donepudi SR, Vantaku VR, et al
    Tobacco-specific carcinogens induce hypermethylation, DNA adducts and DNA damage in Bladder Cancer.
    Cancer Prev Res (Phila). 2017 Aug 29. pii: canprevres.0198.2017.
    Abstract     Related articles   

  994. ABUFARAJ M, Haitel A, Moschini M, Gust K, et al
    Prognostic Role of N-cadherin Expression in Patients With Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2017 Aug 15. pii: S1558-7673(17)30198.
    Abstract     Related articles   

  995. WOJTCZYK-MIASKOWSKA A, Presler M, Michajlowski J, Matuszewski M, et al
    Gene Expression, DNA Methylation and Prognostic Significance of DNA Repair Genes in Human Bladder Cancer.
    Cell Physiol Biochem. 2017;42:2404-2417.
    Abstract     Related articles   

  996. HUANG H, Jin H, Zhao H, Wang J, et al
    RhoGDIbeta Promotes Sp1/MMP-2 Expression and Bladder Cancer Invasion Through Perturbing miR-200c-Targeted JNK2 Protein Translation.
    Mol Oncol. 2017 Aug 28. doi: 10.1002/1878-0261.12132.
    Abstract     Related articles   

  997. LORAN OB, Sinyakova LA, Gundorova LV, Kosov VA, et al
    [High oncogenic risk human papillomavirus and urinary bladder cancer].
    Urologiia. 2017;:60-66.
    Abstract     Related articles   

  998. PARKER WP, Smelser W, Lee EK, Habermann EB, et al
    Utilization and Outcomes of Radical Cystectomy for High-grade Non-muscle-invasive Bladder Cancer in Elderly Patients.
    Clin Genitourin Cancer. 2017 Aug 1. pii: S1558-7673(17)30208.
    Abstract     Related articles   

  999. HE X, Ding X, Wen D, Hou J, et al
    Exploration of the pathways and interaction network involved in bladder cancer cell line with knockdown of Opa interacting protein 5.
    Pathol Res Pract. 2017 Aug 1. pii: S0344-0338(17)30130.
    Abstract     Related articles   

    Validation of the Eighth AJCC New Substages for Bladder Cancer Among Different Staging Contexts.
    Clin Genitourin Cancer. 2017 Aug 3. pii: S1558-7673(17)30235.
    Abstract     Related articles   

  1001. KUHN C, Lehmann ML, Kress A, Truss MC, et al
    Micro-brushing-based technique to gain fresh urothelial cells for gene expression analysis.
    J Toxicol Environ Health A. 2017;80.
    Abstract     Related articles   

  1002. LEE CH, Tan CH, Faria SC, Kundra V, et al
    Role of Imaging in the Local Staging of Urothelial Carcinoma of the Bladder.
    AJR Am J Roentgenol. 2017 Feb 22:1-13. doi: 10.2214/AJR.16.17114.
    Abstract     Related articles   

  1003. GOTTLIEB J, Princenthal R, Cohen MI
    Multi-parametric MRI findings of granulomatous prostatitis developing after intravesical bacillus calmette-guerin therapy.
    Abdom Radiol (NY). 2017;42:1963-1967.
    Abstract     Related articles   

  1004. PAN S, Smith AD, Motamedinia P
    Minimally Invasive Therapy for Upper Tract Urothelial Cell Cancer.
    J Endourol. 2017;31:238-245.
    Abstract     Related articles   

  1005. SHAH TS, Kaag M, Raman JD, Chan W, et al
    Clinical significance of prominent retraction clefts in invasive urothelial carcinoma.
    Hum Pathol. 2017;61:90-96.
    Abstract     Related articles   

  1006. YE JR, Liu L, Zheng F
    Long Noncoding RNA Bladder Cancer Associated Transcript 1 Promotes the Proliferation, Migration, and Invasion of Nonsmall Cell Lung Cancer Through Sponging miR-144.
    DNA Cell Biol. 2017 Sep 8. doi: 10.1089/dna.2017.3854.
    Abstract     Related articles   

  1007. ACHARYA AP, Theisen KM, Correa A, Meyyappan T, et al
    An Inexpensive, Point-of-Care Urine Test for Bladder Cancer in Patients Undergoing Hematuria Evaluation.
    Adv Healthc Mater. 2017 Sep 8. doi: 10.1002/adhm.201700808.
    Abstract     Related articles   

  1008. KATAFIGIOTIS I, Sfoungaristos S, Martini A, Stravodimos K, et al
    Bladder cancer to patients younger than 30 years: a retrospective study and review of the literature.
    Urologia. 2017 Sep 5:0. doi: 10.5301/uj.5000264.
    Abstract     Related articles   

  1009. WHANG YM, Jin SB, Park SI, Chang IH, et al
    MEK inhibition enhances efficacy of bacillus Calmette-Guerin on bladder cancer cells by reducing release of Toll-like receptor 2-activated antimicrobial peptides.
    Oncotarget. 2017;8:53168-53179.
    Abstract     Related articles   

  1010. WU J, Yu C, Cai L, Lu Y, et al
    Effects of increased Kindlin-2 expression in bladder cancer stromal fibroblasts.
    Oncotarget. 2017;8:50692-50703.
    Abstract     Related articles   

  1011. ECKE TH, Stier K, Weickmann S, Zhao Z, et al
    miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy.
    Cancer Med. 2017 Sep 6. doi: 10.1002/cam4.1161.
    Abstract     Related articles   

  1012. BROWNE C, Davis NF, Nolan WJ, MacCraith ED, et al
    Neoadjuvant Platinum-Based Chemotherapy is an Independent Predictor for Preoperative Thromboembolic Events in Bladder Cancer Patients Undergoing Radical Cystectomy.
    Curr Urol. 2017;10:132-135.
    Abstract     Related articles   

  1013. SCHROECK FR, Sirovich B, Seigne JD, Robertson DJ, et al
    Assembling and validating data from multiple sources to study care for Veterans with bladder cancer.
    BMC Urol. 2017;17:78.
    Abstract     Related articles   

  1014. CLINTON T, Lotan Y
    Review of the Clinical Approaches to the Use of Urine-based Tumor Markers in Bladder Cancer.
    Rambam Maimonides Med J. 2017 Aug 22. doi: 10.5041/RMMJ.10314.
    Abstract     Related articles   

  1015. VRIELING A
    Lifestyle and bladder cancer prevention: no consistent evidence from cohort studies.
    Eur J Epidemiol. 2017 Sep 4. doi: 10.1007/s10654-017-0306.
    Abstract     Related articles   

  1016. WANG D, Kong X, Li Y, Qian W, et al
    Curcumin inhibits bladder cancer stem cells by suppressing Sonic Hedgehog pathway.
    Biochem Biophys Res Commun. 2017 Sep 4. pii: S0006-291X(17)31732.
    Abstract     Related articles   

  1017. MORENO-LONDONO AP, Bello-Alvarez C, Pedraza-Chaverri J
    Isoliquiritigenin pretreatment attenuates cisplatin induced proximal tubular cells (LLC-PK1) death and enhances the toxicity induced by this drug in bladder cancer T24 cell line.
    Food Chem Toxicol. 2017 Sep 1. pii: S0278-6915(17)30506.
    Abstract     Related articles   

  1018. XIONG Y, Wang L, Li Y, Chen M, et al
    The Long Non-Coding RNA XIST Interacted with MiR-124 to Modulate Bladder Cancer Growth, Invasion and Migration by Targeting Androgen Receptor (AR).
    Cell Physiol Biochem. 2017;43:405-418.
    Abstract     Related articles   

  1019. KOLAWOLE OM, Lau WM, Mostafid H, Khutoryanskiy VV, et al
    Advances in intravesical drug delivery systems to treat bladder cancer.
    Int J Pharm. 2017 Aug 31. pii: S0378-5173(17)30834.
    Abstract     Related articles   

  1020. LIEM EIML, Baard J, Cauberg ECC, Bus MTJ, et al
    Fluorescence in situ hybridization as prognostic predictor of tumor recurrence during treatment with Bacillus Calmette-Guerin therapy for intermediate- and high-risk non-muscle-invasive bladder cancer.
    Med Oncol. 2017;34:172.
    Abstract     Related articles   

  1021. BAGRODIA A, Sukhu R, Winer AG, Levy E, et al
    Incidence and Effect of Thromboembolic Events in Radical Cystectomy Patients Undergoing Preoperative Chemotherapy for Muscle-invasive Bladder Cancer.
    Clin Genitourin Cancer. 2017 Aug 10. pii: S1558-7673(17)30232.
    Abstract     Related articles   

  1022. HADEN TD, Prunty MC, Jones AB, Deroche CB, et al
    Comparative Perioperative Outcomes in Septuagenarians and Octogenarians Undergoing Radical Cystectomy for Bladder Cancer-Do Outcomes Differ?
    Eur Urol Focus. 2017 Aug 30. pii: S2405-4569(17)30197.
    Abstract     Related articles   

  1023. KATZ H, Wassie E, Alsharedi M
    Checkpoint inhibitors: the new treatment paradigm for urothelial bladder cancer.
    Med Oncol. 2017;34:170.
    Abstract     Related articles   

  1024. Local Delivery of IFNalpha Has Antitumor Activity in Bladder Cancer.
    Cancer Discov. 2017 Sep 1. doi: 10.1158/2159-8290.CD-RW2017.
    Abstract     Related articles   

  1025. HUANG RF, He C, Zhu WF, Li Y, et al
    [Application of immunohistochemistry for p16 and GATA3 and molecular HPV typing in diagnosis of secondary bladder involvement by cervical carcinoma].
    Zhonghua Bing Li Xue Za Zhi. 2017;46:388-392.
    Abstract     Related articles   

  1026. SLUSSER-NORE A, Garrett SH, Zhou XD, Sens DA, et al
    The expression of keratin 6 is regulated by the activation of the ERK1/2 pathway in arsenite transformed human urothelial cells.
    Toxicol Appl Pharmacol. 2017;331:41-53.
    Abstract     Related articles   

  1027. NARANG SK, Alam NN, Campain NJ, Pathak S, et al
    Parastomal hernia following cystectomy and ileal conduit urinary diversion: a systematic review.
    Hernia. 2017;21:163-175.
    Abstract     Related articles   

  1028. OWEIDA A, Bhatia S, Hirsch K, Calame D, et al
    Ephrin-B2 overexpression predicts for poor prognosis and response to therapy in solid tumors.
    Mol Carcinog. 2017;56:1189-1196.
    Abstract     Related articles   

  1029. GORDETSKY J, Collingwood R, Lai WS, Del Carmen Rodriquez Pena M, et al
    Second Opinion Expert Pathology Review in Bladder Cancer: Implications for Patient Care.
    Int J Surg Pathol. 2017 Sep 1:1066896917730903. doi: 10.1177/1066896917730903.
    Abstract     Related articles   

  1030. LIU Q, Liao B, Tian Y, Chen Y, et al
    Total fluid consumption and risk of bladder cancer: a meta-analysis with updated data.
    Oncotarget. 2017;8:55467-55477.
    Abstract     Related articles   

  1031. SEVERINO PF, Silva M, Carrascal M, Malagolini N, et al
    Expression of sialyl-Tn sugar antigen in bladder cancer cells affects response to Bacillus Calmette Guerin (BCG) and to oxidative damage.
    Oncotarget. 2017;8:54506-54517.
    Abstract     Related articles   

  1032. VETTERLEIN MW, Seisen T, Leow JJ, Preston MA, et al
    Effect of Nonurothelial Histologic Variants on the Outcomes of Radical Cystectomy for Nonmetastatic Muscle-invasive Urinary Bladder Cancer.
    Clin Genitourin Cancer. 2017 Aug 24. pii: S1558-7673(17)30248.
    Abstract     Related articles   

  1033. JUNG JH, Gudeloglu A, Kiziloz H, Kuntz GM, et al
    Intravesical electromotive drug administration for non-muscle invasive bladder cancer.
    Cochrane Database Syst Rev. 2017;9:CD011864.
    Abstract     Related articles   

  1034. SIDAWAY P
    Bladder cancer: IFNalpha-2b gene transfer: a new approach for BCG-resistant disease.
    Nat Rev Urol. 2017 Sep 12. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  1035. MOSCHINI M, D'Andrea D, Korn S, Irmak Y, et al
    Characteristics and clinical significance of histological variants of bladder cancer.
    Nat Rev Urol. 2017 Sep 12. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  1036. LIANG Z, Zhang Q, Wang C, Shi F, et al
    Hyaluronic acid/ Hyaluronidase as biomarkers for bladder cancer: a diagnostic meta-analysis.
    Neoplasma. 2017 Sep 12. doi: 10.4149/neo_2017.
    Abstract     Related articles   

  1037. YANG L, Xue Y, Liu J, Zhuang J, et al
    Long noncoding RNA ASAP1-IT1 promotes cancer stemness and predicts a poor prognosis in patients with bladder cancer.
    Neoplasma. 2017 Sep 12. doi: 10.4149/neo_2017.
    Abstract     Related articles   

  1038. SZYMANSKA B, Dlugosz A
    The role of the BLCA-4 nuclear matrix protein in bladder cancer.
    Postepy Hig Med Dosw (Online). 2017;71:681-689.
    Abstract     Related articles   

  1039. SHEN J, Zhang J, Xiao M, Yang J, et al
    MiR-203 Suppresses Bladder Cancer Cell Growth and Targets the Twist1.
    Oncol Res. 2017 Sep 6. doi: 10.3727/096504017X15041934685237.
    Abstract     Related articles   

  1040. IMAOKA Y, Kuranishi F, Miyazaki T, Yasuda H, et al
    Long-lasting complete response status of advanced stage IV gall bladder cancer and colon cancer after combined treatment including autologous formalin-fixed tumor vaccine: two case reports.
    World J Surg Oncol. 2017;15:170.
    Abstract     Related articles   

  1041. GANJI SM, Saidijam M, Amini R, Mousavi-Bahar SH, et al
    Evaluation of MicroRNA-99a and MicroRNA-205 Expression Levels in Bladder Cancer.
    Int J Mol Cell Med. 2017;6:87-95.
    Abstract     Related articles   

  1042. SATHE A, Nawroth R
    Targeting the PI3K/AKT/mTOR Pathway in Bladder Cancer.
    Methods Mol Biol. 2018;1655:335-350.
    Abstract     Related articles   

  1043. BERNARDO C, Santos LL
    Patient-Derived Bladder Cancer Xenografts.
    Methods Mol Biol. 2018;1655:169-175.
    Abstract     Related articles   

  1044. OLIVEIRA PA, Vasconcelos-Nobrega C, Gil da Costa RM, Arantes-Rodrigues R, et al
    The N-butyl-N-4-hydroxybutyl Nitrosamine Mouse Urinary Bladder Cancer Model.
    Methods Mol Biol. 2018;1655:155-167.
    Abstract     Related articles   

  1045. TOMMASI S, Besaratinia A
    A Versatile Assay for Detection of Aberrant DNA Methylation in Bladder Cancer.
    Methods Mol Biol. 2018;1655:29-41.
    Abstract     Related articles   

  1046. UHLIG A, Strauss A, Seif Amir Hosseini A, Lotz J, et al
    Gender-specific Differences in Recurrence of Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis.
    Eur Urol Focus. 2017 Sep 6. pii: S2405-4569(17)30199.
    Abstract     Related articles   

  1047. ZHANG Q, Zhang S, Zhang S, Wang W, et al
    Transperineal cryotherapy for unresectable muscle invasive bladder cancer: preliminary experience with 7 male patients.
    BMC Urol. 2017;17:81.
    Abstract     Related articles   

  1048. RINGUETTE GOULET C, Bernard G, Chabaud S, Couture A, et al
    Tissue-engineered human 3D model of bladder cancer for invasion study and drug discovery.
    Biomaterials. 2017;145:233-241.
    Abstract     Related articles   

  1049. NI W, Li M, Cui J, Xing Z, et al
    808nm light triggered black TiO2 nanoparticles for killing of bladder cancer cells.
    Mater Sci Eng C Mater Biol Appl. 2017;81:252-260.
    Abstract     Related articles   

  1050. MOSCHINI M, Shariat SF, Abufaraj M, Foerster B, et al
    Predicting local failure after radical cystectomy in patients with bladder cancer: Implications for the selection of candidates at adjuvant radiation therapy.
    Urol Oncol. 2017 Sep 5. pii: S1078-1439(17)30423.
    Abstract     Related articles   

  1051. LIANG L, Zhou N, Xu H, Liu D, et al
    Urachal mucinous adenocarcinoma with pseudomyxoma peritonei: A case report.
    Medicine (Baltimore). 2017;96:e7548.
    Abstract     Related articles   

  1052. INOUE S, Mizushima T, Fujita K, Meliti A, et al
    GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator.
    Hum Pathol. 2017;64:83-90.
    Abstract     Related articles   

  1053. FURUDOI A, Varinot J, Phe V, Roupret M, et al
    Urothelial carcinoma in first histological diagnosis of patients over 80 years has distinctive histological features: a retrospective single-institution study of 185 patients.
    Virchows Arch. 2017;470:561-565.
    Abstract     Related articles   

  1054. SWERDLOW AJ, Cooke R, Beckers D, Borgstrom B, et al
    Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study.
    J Clin Endocrinol Metab. 2017;102:1661-1672.
    Abstract     Related articles   

  1055. TAN WS, Lamb BW, Khetrapal P, Tan MY, et al
    Blood Transfusion Requirement and Not Preoperative Anemia Are Associated with Perioperative Complications Following Intracorporeal Robot-Assisted Radical Cystectomy.
    J Endourol. 2017;31:141-148.
    Abstract     Related articles   

  1056. SUMA TL, Ramanathan S, Padma M, Appaji L, et al
    A Case of Urachal Yolk Sac Tumor With Spontaneous Rupture in a Child.
    J Pediatr Hematol Oncol. 2017;39:e82-e84.
    Abstract     Related articles   

  1057. WESSELIUS A, Zeegers M
    Re: Lifestyle and bladder cancer prevention: no consistent evidence from cohort studies.
    Eur J Epidemiol. 2017 Sep 19. doi: 10.1007/s10654-017-0307.
    Abstract     Related articles   

  1058. SZYMANSKA B, Sawicka E, Guzik A, Zdrojowy R, et al
    The Diagnostic Value of Nuclear Matrix Proteins in Bladder Cancer in the Aspect of Environmental Risk from Carcinogens.
    Biomed Res Int. 2017;2017:9643139.
    Abstract     Related articles   

  1059. KANG HW, Kim YH, Jeong P, Park C, et al
    Expression levels of FGFR3 as a prognostic marker for the progression of primary pT1 bladder cancer and its association with mutation status.
    Oncol Lett. 2017;14:3817-3824.
    Abstract     Related articles   

  1060. JIANG B, Dong Y, He H, Han C, et al
    Application of pirarubicin photosensitizer fluorescence cystoscopy in early detection of bladder cancer.
    Oncol Lett. 2017;14:3309-3312.
    Abstract     Related articles   

  1061. HORIKAWA Y, Watanabe M, Sadahira T, Ariyoshi Y, et al
    Overexpression of REIC/Dkk-3 suppresses the expression of CD147 and inhibits the proliferation of human bladder cancer cells.
    Oncol Lett. 2017;14:3223-3228.
    Abstract     Related articles   

  1062. CHRISTOPH F, Konig F, Lebentrau S, Blaschke S, et al
    [Thermochemotherapy with Mitomycin C: an update on alternative treatment strategies in non-muscleinvasive bladder cancer].
    Aktuelle Urol. 2017 Sep 19. doi: 10.1055/s-0043-109414.
    Abstract     Related articles   

  1063. STONE L
    Bladder cancer: Shields up, red alert: the blebbishield emergency programme.
    Nat Rev Urol. 2017 Sep 19. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  1064. ALIMI Q, Hascoet J, Manunta A, Kammerer-Jacquet SF, et al
    Reliability of urinary cytology and cystoscopy for the screening and diagnosis of bladder cancer in patients with neurogenic bladder: A systematic review.
    Neurourol Urodyn. 2017 Sep 19. doi: 10.1002/nau.23395.
    Abstract     Related articles   

  1065. DEKALO S, Matzkin H, Mabjeesh NJ
    Can urologists accurately stage and grade urothelial bladder cancer by assessing endoscopic photographs?
    J Telemed Telecare. 2017 Jan 1:1357633X17727773. doi: 10.1177/1357633X17727773.
    Abstract     Related articles   

  1066. THOMSEN MBH, Nordentoft I, Lamy P, Vang S, et al
    Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer.
    Sci Rep. 2017;7:11702.
    Abstract     Related articles   

  1067. JOHN BA, Said N
    Insights from animal models of bladder cancer: recent advances, challenges, and opportunities.
    Oncotarget. 2017;8:57766-57781.
    Abstract     Related articles   

  1068. KOHLER S, Lee J, George JT, Inzucchi SE, et al
    Bladder cancer in the EMPA-REG OUTCOME trial.
    Diabetologia. 2017 Sep 14. doi: 10.1007/s00125-017-4430.
    Abstract     Related articles   

  1069. LIMA L, Neves M, Oliveira MI, Dieguez L, et al
    Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases.
    Urol Oncol. 2017 Sep 11. pii: S1078-1439(17)30422.
    Abstract     Related articles   

  1070. NGUYEN S, Choi C
    Neobladder Stone.
    N Engl J Med. 2017;377:977.
    Abstract     Related articles   

  1071. HAFERTEPE M, Nguyen BD
    Gastrointestinal: Recurrent urothelial cancer of the remnant ureter invading the ileal conduit: PET/CT imaging.
    J Gastroenterol Hepatol. 2017;32:291.
    Abstract     Related articles   

  1072. MATSUSHIMA M, Kikuchi E, Akita H, Miyajima A, et al
    Natural course of asymptomatic abnormal prostate findings incidentally detected by CT after intravesical BCG therapy.
    Int J Clin Oncol. 2017;22:554-562.
    Abstract     Related articles   

  1073. HAN B, Shen Y, Zhang P, Jayabal P, et al
    Overlooked FANCD2 variant encodes a promising, portent tumor suppressor, and alternative polyadenylation contributes to its expression.
    Oncotarget. 2017;8:22490-22500.
    Abstract     Related articles   

  1074. TSUDA Y, Nakagawa T, Shinoda Y, Kanatani A, et al
    Skeletal-related events and prognosis in urothelial cancer patients with bone metastasis.
    Int J Clin Oncol. 2017;22:548-553.
    Abstract     Related articles   

  1075. PPARG-Activated Bladder Cancer Cells Exhibit a PPARG Dependency.
    Cancer Discov. 2017 Sep 29. doi: 10.1158/2159-8290.CD-RW2017.
    Abstract     Related articles   

  1076. HAGGSTROM C, Liedberg F, Hagberg O, Aljabery F, et al
    Cohort profile: The Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe).
    BMJ Open. 2017;7:e016606.
    Abstract     Related articles   

  1077. DEMATEI A, Fernandes R, Soares R, Alves H, et al
    Angiogenesis in Schistosoma haematobium-associated urinary bladder cancer.
    APMIS. 2017 Sep 28. doi: 10.1111/apm.12756.
    Abstract     Related articles   

  1078. LIU Z, Ha US, Yu K, Wu C, et al
    Kavalactone yangonin induces autophagy and sensitizes bladder cancer cells to flavokawain A and docetaxel via inhibition of the mTOR pathway.
    J Biomed Res. 2017;31:408-418.
    Abstract     Related articles   

  1079. GOSNELL ME, Polikarpov DM, Goldys EM, Zvyagin AV, et al
    Computer-assisted cystoscopy diagnosis of bladder cancer.
    Urol Oncol. 2017 Sep 25. pii: S1078-1439(17)30460.
    Abstract     Related articles   

  1080. ZHANG M, Ren B, Li Z, Niu W, et al
    Expression of N-Myc Downstream-Regulated Gene 2 in Bladder Cancer and Its Potential Utility as a Urinary Diagnostic Biomarker.
    Med Sci Monit. 2017;23:4644-4649.
    Abstract     Related articles   

  1081. KOMYAKOV BK, Sergeev AV, Fadeev VA, Ismailov KI, et al
    [Concomitant oncopathological changes in the prostate of urinary bladder cancer patients undergoing radical cystoprostateectomy].
    Urologiia. 2017;:42-45.
    Abstract     Related articles   

  1082. NASR R, Temraz S, Mukherji D, Shamseddine A, et al
    Distribution and Role of N-acetyltransferase 2 Genetic Polymorphisms in Bladder Cancer Risk in a Lebanese Population
    Asian Pac J Cancer Prev. 2017;18:2561-2568.
    Abstract     Related articles   

  1083. ASAI A, Miyata Y, Takehara K, Kanda S, et al
    Pathological significance and prognostic significance of FES expression in bladder cancer vary according to tumor grade.
    J Cancer Res Clin Oncol. 2017 Sep 26. doi: 10.1007/s00432-017-2524.
    Abstract     Related articles   

  1084. WALKER M, Doiron RC, French SD, Feldman-Stewart D, et al
    Bladder-sparing Radiotherapy for Muscle-invasive Bladder Cancer: A Qualitative Study to Identify Barriers and Enablers.
    Clin Oncol (R Coll Radiol). 2017 Sep 23. pii: S0936-6555(17)30396.
    Abstract     Related articles   

  1085. WU P, Liu S, Su J, Chen J, et al
    Apoptosis triggered by isoquercitrin in bladder cancer cells by activating the AMPK-activated protein kinase pathway.
    Food Funct. 2017 Sep 26. doi: 10.1039/c7fo00778.
    Abstract     Related articles   

  1086. MA Y, Luo W, Bunch BL, Pratt RN, et al
    1,25D3 differentially suppresses bladder cancer cell migration and invasion through the induction of miR-101-3p.
    Oncotarget. 2017;8:60080-60093.
    Abstract     Related articles   

  1087. GHEIBI P, Zeng S, Son KJ, Vu T, et al
    Microchamber Cultures of Bladder Cancer: A Platform for Characterizing Drug Responsiveness and Resistance in PDX and Primary Cancer Cells.
    Sci Rep. 2017;7:12277.
    Abstract     Related articles   

  1088. RIEKEN M, Shariat SF, Kluth L, Crivelli JJ, et al
    Comparison of the EORTC tables and the EAU categories for risk stratification of patients with nonmuscle-invasive bladder cancer.
    Urol Oncol. 2017 Sep 22. pii: S1078-1439(17)30461.
    Abstract     Related articles   

  1089. WANG J, Ma W, Liu Y
    Long non-coding RNA HULC promotes bladder cancer cells proliferation but inhibits apoptosis via regulation of ZIC2 and PI3K/AKT signaling pathway.
    Cancer Biomark. 2017 Sep 15. doi: 10.3233/CBM-170188.
    Abstract     Related articles   

  1090. SHEN L, Zhang F, Huang R, Yan J, et al
    Honokiol inhibits bladder cancer cell invasion through repressing SRC-3 expression and epithelial-mesenchymal transition.
    Oncol Lett. 2017;14:4294-4300.
    Abstract     Related articles   

  1091. CHANG Y, Xu J, Zhang Q
    Microplate magnetic chemiluminescence immunoassay for detecting urinary survivin in bladder cancer.
    Oncol Lett. 2017;14:4043-4052.
    Abstract     Related articles   

  1092. PATKAR S, Ostwal V, Ramaswamy A, Engineer R, et al
    Emerging role of multimodality treatment in gall bladder cancer: Outcomes following 510 consecutive resections in a tertiary referral center.
    J Surg Oncol. 2017 Sep 20. doi: 10.1002/jso.24837.
    Abstract     Related articles   

  1093. ZHANG Z, Fan W, Deng Q, Tang S, et al
    The prognostic and diagnostic value of circulating tumor cells in bladder cancer and upper tract urothelial carcinoma: a meta-analysis of 30 published studies.
    Oncotarget. 2017;8:59527-59538.
    Abstract     Related articles   

  1094. AVELLINI C, Licini C, Lazzarini R, Gesuita R, et al
    The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancer.
    Oncotarget. 2017;8:58642-58653.
    Abstract     Related articles   

  1095. GEERDES-FENGE HF, Stubbe F, Lobermann M, Warnke P, et al
    [BCGitis with Involvement of Lung, Liver and Bone Marrow after Immunotherapy of Urothelial Cancer].
    Dtsch Med Wochenschr. 2017;142:1375-1378.
    Abstract     Related articles   

  1096. SOLANKI AA, Martin B, Korpics M, Small C, et al
    Bladder-Preserving Therapy Patterns of Care: A Survey of US Radiation Oncologists.
    Int J Radiat Oncol Biol Phys. 2017;99:383-387.
    Abstract     Related articles   

  1097. ANNAN AC, Stevens KA, Osunkoya AO
    Urothelial carcinoma involving the ureteral orifice: a clinicopathologic analysis of 93 cases.
    Hum Pathol. 2017;65:101-106.
    Abstract     Related articles   

  1098. WARSCHKOW R, Guller U, Cerny T, Schmied BM, et al
    Secondary malignancies after rectal cancer resection with and without radiation therapy: A propensity-adjusted, population-based SEER analysis.
    Radiother Oncol. 2017;123:139-146.
    Abstract     Related articles   

  1099. BERRY A, Iriart X, Fillaux J, Magnaval JF, et al
    [Urinary schistosomiasis and cancer].
    Bull Soc Pathol Exot. 2017;110:68-75.
    Abstract     Related articles   

  1100. THAM SM, Esuvaranathan K, Mahendran R
    A Murine Orthotopic Bladder Tumor Model and Tumor Detection System.
    J Vis Exp. 2017;.
    Abstract     Related articles   

  1101. SUTOH YONEYAMA M, Tobisawa Y, Hatakeyama S, Sato M, et al
    A mechanism for evasion of CTL immunity by altered O-glycosylation of HLA class I.
    J Biochem. 2017;161:479-492.
    Abstract     Related articles   

  1102. CHUANG YW, Yu MC, Huang ST, Yang CK, et al
    Spironolactone and the risk of urinary tract cancer in patients with hypertension: a nationwide population-based retrospective case-control study.
    J Hypertens. 2017;35:170-177.
    Abstract     Related articles   

  1103. PASCIUTI K, Kuthpady S, Anderson A, Best B, et al
    Bladder radiotherapy treatment: A retrospective comparison of 3-dimensional conformal radiotherapy, intensity-modulated radiation therapy, and volumetric-modulated arc therapy plans.
    Med Dosim. 2017;42:1-6.
    Abstract     Related articles   

  1104. WARRICK JI
    Clinical Significance of Histologic Variants of Bladder Cancer.
    J Natl Compr Canc Netw. 2017;15:1268-1274.
    Abstract     Related articles   

  1105. SPIESS PE, Agarwal N, Bangs R, Boorjian SA, et al
    Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.
    J Natl Compr Canc Netw. 2017;15:1240-1267.
    Abstract     Related articles   

  1106. PENCE S, Ozbek E, Ozan Tiryakioglu N, Ersoy Tunali N, et al
    rs3918242 variant genotype frequency and increased TIMP-2 and MMP-9 expression are positively correlated with cancer invasion in urinary bladder cancer.
    Cell Mol Biol (Noisy-le-grand). 2017;63:46-52.
    Abstract     Related articles   

  1107. LATOSINSKA A, Frantzi M, Vlahou A, Merseburger AS, et al
    Clinical Proteomics for Precision Medicine: The Bladder Cancer Case.
    Proteomics Clin Appl. 2017 Oct 5. doi: 10.1002/prca.201700074.
    Abstract     Related articles   

  1108. TILLEY SK, Kim WY, Fry RC
    Analysis of bladder cancer tumor CpG methylation and gene expression within The Cancer Genome Atlas identifies GRIA1 as a prognostic biomarker for basal-like bladder cancer.
    Am J Cancer Res. 2017;7:1850-1862.
    Abstract     Related articles   

  1109. TERVAHARTIALA M, Taimen P, Mirtti T, Koskinen I, et al
    Immunological tumor status may predict response to neoadjuvant chemotherapy and outcome after radical cystectomy in bladder cancer.
    Sci Rep. 2017;7:12682.
    Abstract     Related articles   

  1110. Targeting Angiogenesis in Bladder Cancer.
    Cancer Discov. 2017 Oct 4. doi: 10.1158/2159-8290.CD-NB2017.
    Abstract     Related articles   

  1111. KIM YJ, Byun SJ, Ahn H, Kim CS, et al
    Comparison of outcomes between trimodal therapy and radical cystectomy in muscle-invasive bladder cancer: a propensity score matching analysis.
    Oncotarget. 2017;8:68996-69004.
    Abstract     Related articles   

  1112. YANG J, Liu Y, He A, Liu Y, et al
    Hsa-miR-429 promotes bladder cancer cell proliferation via inhibiting CDKN2B.
    Oncotarget. 2017;8:68721-68729.
    Abstract     Related articles   

  1113. WANG X, Cui MM, Xu Y, Liu L, et al
    Decreased mean platelet volume predicts poor prognosis in invasive bladder cancer.
    Oncotarget. 2017;8:68115-68122.
    Abstract     Related articles   

  1114. SONG Y, Zhang P, Sun Y, Li X, et al
    AMPK activation-dependent autophagy compromises oleanolic acid-induced cytotoxicity in human bladder cancer cells.
    Oncotarget. 2017;8:67942-67954.
    Abstract     Related articles   

  1115. MONTANO R, Khan N, Hou H, Seigne J, et al
    Cell cycle perturbation induced by gemcitabine in human tumor cells in cell culture, xenografts and bladder cancer patients: implications for clinical trial designs combining gemcitabine with a Chk1 inhibitor.
    Oncotarget. 2017;8:67754-67768.
    Abstract     Related articles   

  1116. YUAN D, Zheng S, Wang L, Li J, et al
    MiR-200c inhibits bladder cancer progression by targeting lactate dehydrogenase A.
    Oncotarget. 2017;8:67663-67669.
    Abstract     Related articles   

  1117. PICHLER R, Heidegger I, Fritz J, Danzl M, et al
    PD-L1 expression in bladder cancer and metastasis and its influence on oncologic outcome after cystectomy.
    Oncotarget. 2017;8:66849-66864.
    Abstract     Related articles   

  1118. LI H, Xu Y, Li H
    CD147 as a novel biomarker for predicting the prognosis and clinicopathological features of bladder cancer: a meta-analysis.
    Oncotarget. 2017;8:62573-62588.
    Abstract     Related articles   

  1119. XIE Y, Li P, Gao Y, Gu L, et al
    Reduced E-cadherin expression is correlated with poor prognosis in patients with bladder cancer: a systematic review and meta-analysis.
    Oncotarget. 2017;8:62489-62499.
    Abstract     Related articles   

  1120. LIU Q, Diao R, Feng G, Mu X, et al
    Risk score based on three mRNA expression predicts the survival of bladder cancer.
    Oncotarget. 2017;8:61583-61591.
    Abstract     Related articles   

  1121. HAMANO I, Hatakeyama S, Iwamurau H, Fujita N, et al
    Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer.
    Oncotarget. 2017;8:61404-61414.
    Abstract     Related articles   

  1122. HUANG Y, Fang C, Shi JW, Wen Y, et al
    Identification of hMex-3A and its effect on human bladder cancer cell proliferation.
    Oncotarget. 2017;8:61215-61225.
    Abstract     Related articles   

  1123. THOMA C
    Bladder cancer: Drug sequencing in metastatic disease.
    Nat Rev Urol. 2017 Oct 4. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  1124. WALKER M, French SD, Doiron RC, Brennan K, et al
    Bladder-sparing radiotherapy for muscle-invasive bladder cancer: A survey of providers to determine barriers and enablers.
    Radiother Oncol. 2017 Sep 30. pii: S0167-8140(17)32561.
    Abstract     Related articles   

  1125. TANAKA T, Koie T, Ohyama C, Hashimoto Y, et al
    Incidental prostate cancer in patients with muscle-invasive bladder cancer who underwent radical cystoprostatectomy.
    Jpn J Clin Oncol. 2017 Aug 18:1-5. doi: 10.1093.
    Abstract     Related articles   

  1126. GEDERAAS OA, Johnsson A, Berg K, Manandhar R, et al
    Photochemical internalization in bladder cancer - development of an orthotopic in vivo model.
    Photochem Photobiol Sci. 2017 Oct 3. doi: 10.1039/c7pp00176.
    Abstract     Related articles   

  1127. LAVDANITI M, Zyga S
    Quality of Life in Elderly Bladder Cancer Patients Following a Cystectomy.
    Adv Exp Med Biol. 2017;989:297-300.
    Abstract     Related articles   

  1128. FARZANEH F, Mehrparvar AH, Lotfi MH
    Occupations and the Risk of Bladder Cancer in Yazd Province: A Case-Control Study.
    Int J Occup Environ Med. 2017;8:191-198.
    Abstract     Related articles   

  1129. DUEX JE, Swain KE, Dancik GM, Paucek RD, et al
    Functional Impact of Chromatin Remodeling Gene Mutations and Predictive Signature for Therapeutic Response in Bladder Cancer.
    Mol Cancer Res. 2017 Oct 2. pii: molcanres.0260.2017.
    Abstract     Related articles   

  1130. BI H, Zhang Z, Guo L, Fu C, et al
    Effect of wound fluid on chemotherapy sensitivity of T24 bladder cancer cells with different enhancer of zeste homolog 2 status.
    Oncotarget. 2017;8:63258-63264.
    Abstract     Related articles   

  1131. FAN B, Zhang X, Ma Y, Zhang A, et al
    Fangchinoline Induces Apoptosis, Autophagy and Energetic Impairment in Bladder Cancer.
    Cell Physiol Biochem. 2017;43:1003-1011.
    Abstract     Related articles   

  1132. HE X, Ping J, Wen D
    MicroRNA-186 regulates the invasion and metastasis of bladder cancer via vascular endothelial growth factor C.
    Exp Ther Med. 2017;14:3253-3258.
    Abstract     Related articles   

  1133. SONG M, Glasgow M, Murugan P, Rivard C, et al
    Aggressive Angiomyxoma of the Vulva and Bladder.
    Obstet Gynecol. 2017;130:885-888.
    Abstract     Related articles   

  1134. RADAN M, Carev I, Tesevic V, Politeo O, et al
    Qualitative HPLC-DAD/ESI-TOF-MS Analysis, Cytotoxic, and Apoptotic Effects of Croatian Endemic Centaurea ragusina L. Aqueous Extracts.
    Chem Biodivers. 2017;14.
    Abstract     Related articles   

  1135. JENSEN BT, Kiesbye B, Soendergaard I, Jensen JB, et al
    Efficacy of preoperative uro-stoma education on self-efficacy after Radical Cystectomy; secondary outcome of a prospective randomized controlled trial.
    Eur J Oncol Nurs. 2017;28:41-46.
    Abstract     Related articles   

  1136. LEEMAN M, Burgers P, Brehm V, van Brussel JP, et al
    Psoas abscess after bacille Calmette-Guerin instillations causing iliac artery contained rupture.
    J Vasc Surg. 2017;66:1236-1238.
    Abstract     Related articles   

  1137. BAUR B, Bozdag S
    ProcessDriver: A computational pipeline to identify copy number drivers and associated disrupted biological processes in cancer.
    Genomics. 2017;109.
    Abstract     Related articles   

  1138. FOX MD, Xiao L, Zhang M, Kamat AM, et al
    Plasmacytoid Urothelial Carcinoma of the Urinary Bladder: A Clinicopathologic and Immunohistochemical Analysis of 49 Cases.
    Am J Clin Pathol. 2017;147:500-506.
    Abstract     Related articles   

  1139. SCHIFFMANN J, Sun M, Gandaglia G, Tian Z, et al
    Use of adjuvant chemotherapy in radical cystectomy patients aged >65 years: a population-based study from the surveillance epidemiology and end results (SEER)-medicare database.
    Minerva Urol Nefrol. 2017;69:173-180.
    Abstract     Related articles   

  1140. CORONA MONTES VE, Pastore AL, Gausa L, Rodriguez-Faba O, et al
    Robot assisted retroperitoneal lymph-node dissection after adjuvant therapy: different indications.
    Minerva Urol Nefrol. 2017;69:153-158.
    Abstract     Related articles   

  1141. SORIA F, Shariat SF, Lerner SP, Fritsche HM, et al
    Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC).
    World J Urol. 2017;35:379-387.
    Abstract     Related articles   

  1142. HAYAKAWA M, Kodama M, Sato S, Tomoeda-Mori K, et al
    Electrochemical telomerase assay for screening for oral cancer.
    Br J Oral Maxillofac Surg. 2016 Jan 25. pii: S0266-4356(16)00005.
    Abstract     Related articles   

  1143. SKRZYPCZYK MA, Nyk L, Szostek P, Szemplinski S, et al
    The role of endoscopic bladder tumour assessment in the management of patients subjected to transurethral bladder tumour resection.
    Eur J Cancer Care (Engl). 2017;26.
    Abstract     Related articles   

  1144. FANG Y, Wolfson B, Godbey WT
    Non-invasive Detection of Bladder Cancer via Expression-targeted Gene Delivery.
    J Gene Med. 2017 Oct 11. doi: 10.1002/jgm.2992.
    Abstract     Related articles   

  1145. NAZARI A, Khorramdelazad H, Hassanshahi G
    Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
    Int J Clin Oncol. 2017 Oct 11. doi: 10.1007/s10147-017-1187.
    Abstract     Related articles   

  1146. MITASH N, Agnihotri S, Tiwari S, Agrawal V, et al
    MicroRNA-21 could be a molecular marker to predict the recurrence of nonmuscle invasive bladder cancer.
    Indian J Urol. 2017;33:283-290.
    Abstract     Related articles   

  1147. THOMA C
    Bladder cancer: Combination therapy effective in advanced disease.
    Nat Rev Urol. 2017 Oct 10. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  1148. THOMA C
    Bladder cancer: Benefit of adjuvant chemotherapy in UTUC unclear.
    Nat Rev Urol. 2017 Oct 10. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  1149. STONE L
    Bladder cancer: Mastering the immune microenvironment.
    Nat Rev Urol. 2017 Oct 10. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  1150. AHAMAD A, Martinez A, Salenius S, Ross R, et al
    Routine bladder cancer treatment dictates divergence from trial-derived regimens: Results of treatment at 44 radiotherapy centers.
    Urol Oncol. 2017 Oct 6. pii: S1078-1439(17)30473.
    Abstract     Related articles   

  1151. WU X, Yan T, Wang Z, Wu X, et al
    LncRNA ZEB2-AS1 promotes bladder cancer cell proliferation and inhibits apoptosis by regulating miR-27b.
    Biomed Pharmacother. 2017;96:299-304.
    Abstract     Related articles   

  1152. AUGUSTIN LSA, Taborelli M, Montella M, Libra M, et al
    Associations of dietary carbohydrates, glycaemic index and glycaemic load with risk of bladder cancer: a case-control study.
    Br J Nutr. 2017 Oct 9:1-8. doi: 10.1017/S0007114517002574.
    Abstract     Related articles   

  1153. CHEN L, Yuan L, Wang G, Cao R, et al
    Identification and bioinformatics analysis of miRNAs associated with human muscle invasive bladder cancer.
    Mol Med Rep. 2017 Oct 4. doi: 10.3892/mmr.2017.7726.
    Abstract     Related articles   

  1154. ROBERTSON AG, Kim J, Al-Ahmadie H, Bellmunt J, et al
    Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.
    Cell. 2017 Oct 4. pii: S0092-8674(17)31056-5. doi: 10.1016/j.cell.2017.
    Abstract     Related articles   

  1155. WOO S, Suh CH, Kim SY, Cho JY, et al
    Diagnostic performance of MRI for prediction of muscle-invasiveness of bladder cancer: A systematic review and meta-analysis.
    Eur J Radiol. 2017;95:46-55.
    Abstract     Related articles   

  1156. PIETERS BR, van der Steen-Banasik E, Smits GA, De Brabandere M, et al
    GEC-ESTRO/ACROP recommendations for performing bladder-sparing treatment with brachytherapy for muscle-invasive bladder carcinoma.
    Radiother Oncol. 2017;122:340-346.
    Abstract     Related articles   

  1157. FEDERICO A, Zappavigna S, Dallio M, Misso G, et al
    Urotensin-II Receptor: A Double Identity Receptor Involved in Vasoconstriction and in the Development of Digestive Tract Cancers and other Tumors.
    Curr Cancer Drug Targets. 2017;17:109-121.
    Abstract     Related articles   

  1158. NGUYEN VP, Oh J, Park S, Wook Kang H, et al
    Feasibility of photoacoustic evaluations on dual-thermal treatment of ex vivo bladder tumors.
    J Biophotonics. 2017;10:577-588.
    Abstract     Related articles   

  1159. CALLAHAN S, Kim RH, Brinster N, Latkowski JA, et al
    Kaposi's sarcoma in an HIV-negative patient.
    Dermatol Online J. 2016;22.
    Abstract     Related articles   

  1160. REN R, Tyryshkin K, Graham CH, Koti M, et al
    Comprehensive immune transcriptomic analysis in bladder cancer reveals subtype specific immune gene expression patterns of prognostic relevance.
    Oncotarget. 2017;8:70982-71001.
    Abstract     Related articles   

  1161. YUAN L, Shu B, Chen L, Qian K, et al
    Overexpression of COL3A1 confers a poor prognosis in human bladder cancer identified by co-expression analysis.
    Oncotarget. 2017;8:70508-70520.
    Abstract     Related articles   

  1162. LATOSINSKA A, Mokou M, Makridakis M, Mullen W, et al
    Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention.
    Oncotarget. 2017;8:69435-69455.
    Abstract     Related articles   

  1163. QUAN Y, Jeong CW, Kwak C, Kim HH, et al
    Dose, duration and strain of bacillus Calmette-Guerin in the treatment of nonmuscle invasive bladder cancer: Meta-analysis of randomized clinical trials.
    Medicine (Baltimore). 2017;96:e8300.
    Abstract     Related articles   

  1164. MIYAKE M, Tatsumi Y, Gotoh D, Ohnishi S, et al
    Regulatory T Cells and Tumor-Associated Macrophages in the Tumor Microenvironment in Non-Muscle Invasive Bladder Cancer Treated with Intravesical Bacille Calmette-Guerin: A Long-Term Follow-Up Study of a Japanese Cohort.
    Int J Mol Sci. 2017;18.
    Abstract     Related articles   

  1165. NAKAGAWA M, Karashima T, Kamada M, Yoshida E, et al
    Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-gamma2 as a promising diagnostic tool of non-muscle invasive bladder cancer.
    Biomark Res. 2017;5:29.
    Abstract     Related articles   

  1166. FENG C, Ho Y, Sun C, Xia G, et al
    Epigallocatechin gallate inhibits the growth and promotes the apoptosis of bladder cancer cells.
    Exp Ther Med. 2017;14:3513-3518.
    Abstract     Related articles   

  1167. ZHANG B, Wu Z, Xie W, Tian D, et al
    The expression of vasohibin-1 and its prognostic significance in bladder cancer.
    Exp Ther Med. 2017;14:3477-3484.
    Abstract     Related articles   

  1168. LIU D, Qiu XY, Wu X, Hu DX, et al
    Piperlongumine suppresses bladder cancer invasion via inhibiting epithelial mesenchymal transition and F-actin reorganization.
    Biochem Biophys Res Commun. 2017 Oct 13. pii: S0006-291X(17)32039.
    Abstract     Related articles   

  1169. CARAMES MASANA F, de Reijke TM
    The efficacy of Apaziquone in the treatment of bladder cancer.
    Expert Opin Pharmacother. 2017 Oct 20:1-8. doi: 10.1080/14656566.2017.1392510.
    Abstract     Related articles   

  1170. HOLZ S, Albisinni S, Gilsoul J, Pirson M, et al
    Risk factor assessment in high-risk, bacillus Calmette-Guerin-treated, non-muscle-invasive bladder cancer.
    Res Rep Urol. 2017;9:195-202.
    Abstract     Related articles   

  1171. SEEGOBIN K, Maharaj S, Baldeo C, Isache C, et al
    Mycobacteria Bovis osteomyelitis following intravesical BCG for bladder cancer.
    IDCases. 2017;10:75-78.
    Abstract     Related articles   

  1172. SALEHI S, Mansoori B, Mohammadi A, Davoudian S, et al
    An analysis of suppressing migratory effect on human urinary bladder cancer cell line by silencing of snail-1.
    Biomed Pharmacother. 2017;96:545-550.
    Abstract     Related articles   

  1173. LI Y, Lin K, Yang Z, Han N, et al
    Bladder cancer stem cells: clonal origin and therapeutic perspectives.
    Oncotarget. 2017;8:66668-66679.
    Abstract     Related articles   

  1174. WANG X, Xu T, Gao F, He H, et al
    Targeting of CCN2 suppresses tumor progression and improves chemo-sensitivity in urothelial bladder cancer.
    Oncotarget. 2017;8:66316-66327.
    Abstract     Related articles   

  1175. XU L, Li H, Wu L, Huang S, et al
    YBX1 promotes tumor growth by elevating glycolysis in human bladder cancer.
    Oncotarget. 2017;8:65946-65956.
    Abstract     Related articles   

  1176. KUSAKA A, Hatakeyama S, Hosogoe S, Hamano I, et al
    Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer.
    Oncotarget. 2017;8:65492-65505.
    Abstract     Related articles   

  1177. POLO A, Crispo A, Cerino P, Falzone L, et al
    Environment and bladder cancer: molecular analysis by interaction networks.
    Oncotarget. 2017;8:65240-65252.
    Abstract     Related articles   

  1178. VERMA H, Sharma T, Gupta S, Banerjee BD, et al
    CYP1A1 expression and organochlorine pesticides level in the etiology of bladder cancer in North Indian population.
    Hum Exp Toxicol. 2017 Jan 1:960327117734623. doi: 10.1177/0960327117734623.
    Abstract     Related articles   

  1179. TANG JQ, Zhao Z, Liang Y, Liao G, et al
    Robotic-assisted versus open radical cystectomy in bladder cancer: A meta-analysis of four randomized controlled trails.
    Int J Med Robot. 2017 Oct 12. doi: 10.1002/rcs.1867.
    Abstract     Related articles   

  1180. WALLIS CJD, Juvet T, Lee Y, Matta R, et al
    Association Between Use of Antithrombotic Medication and Hematuria-Related Complications.
    JAMA. 2017;318:1260-1271.
    Abstract     Related articles   

  1181. URREA YR, Epstein JI
    Sarcomatoid carcinoma associated with small cell carcinoma of the urinary bladder: a series of 28 cases.
    Hum Pathol. 2017;67:169-175.
    Abstract     Related articles   

  1182. WANG G, Huang H, Kamat AM, Siefker-Radtke A, et al
    High-grade neuroendocrine carcinoma of the urachus-report of 3 cases.
    Hum Pathol. 2017;67:126-133.
    Abstract     Related articles   

  1183. GIANNICO GA, Gown AM, Epstein JI, Revetta F, et al
    Role of SATB2 in distinguishing the site of origin in glandular lesions of the bladder/urinary tract.
    Hum Pathol. 2017;67:152-159.
    Abstract     Related articles   

  1184. DELL'OGLIO P, Tian Z, Leyh-Bannurah SR, Trudeau V, et al
    Short-Form Charlson Comorbidity Index for Assessment of Perioperative Mortality After Radical Cystectomy.
    J Natl Compr Canc Netw. 2017;15:327-333.
    Abstract     Related articles   

  1185. GOMELLA LG, Mann MJ, Cleary RC, Hubosky SG, et al
    Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.
    Can J Urol. 2017;24:8620-8626.
    Abstract     Related articles   

  1186. HOLMANG S

    Lakartidningen. 2017;114.
    Abstract     Related articles   

  1187. LLORENTE C, Lopez B, Hernandez V, Guijarro A, et al
    Variability in complications and operative mortality after radical cystectomy in Spain.
    Actas Urol Esp. 2017;41:32-38.
    Abstract     Related articles   

  1188. SHARMA P, Zargar-Shoshtari K, Poch MA, Pow-Sang JM, et al
    Surgical control and margin status after robotic and open cystectomy in high-risk cases: Caution or equivalence?
    World J Urol. 2017;35:657-663.
    Abstract     Related articles   

  1189. PACKIAM VT, Agrawal VA, Pariser JJ, Cohen AJ, et al
    Redefining the implications of nasogastric tube placement following radical cystectomy in the alvimopan era.
    World J Urol. 2017;35:625-631.
    Abstract     Related articles   

  1190. HAKOZAKI K, Kikuchi E, Fukumoto K, Shirotake S, et al
    Significance of a frozen section analysis of the ureteral margin in bladder cancer patients treated with radical cystectomy and neoadjuvant chemotherapy.
    Med Oncol. 2017;34:187.
    Abstract     Related articles   

  1191. GIRIDHAR KV, Kohli M
    Management of Muscle-Invasive Urothelial Cancer and the Emerging Role of Immunotherapy in Advanced Urothelial Cancer.
    Mayo Clin Proc. 2017;92:1564-1582.
    Abstract     Related articles   

  1192. BORHAN WM, Cimino-Mathews AM, Montgomery EA, Epstein JI, et al
    Immunohistochemical Differentiation of Plasmacytoid Urothelial Carcinoma From Secondary Carcinoma Involvement of the Bladder.
    Am J Surg Pathol. 2017;41:1570-1575.
    Abstract     Related articles   

  1193. UEMURA K, Namura K, Umemoto S, Matsubara O, et al
    [A Case of Squamous Cell Carcinoma in Bladder Diverticulum Producing Granulocyte Colony Stimulating Factor].
    Hinyokika Kiyo. 2017;63:211-215.
    Abstract     Related articles   

  1194. BI X, Wu Z, Han H, Zhou F, et al
    Clinical comparison of patients with benign urachal masses versus urachal carcinomas.
    Chin J Cancer. 2017;36:2.
    Abstract     Related articles   

  1195. KHORRAMI MH, Javid A, Izadpanahi MH, Alizadeh F, et al
    Efficacy of Long-Acting Octreotide on Reducing Mucus Production in Patients With Ileal Neobladder.
    Clin Genitourin Cancer. 2017;15:e9-e13.
    Abstract     Related articles   

  1196. MONN MF, Jaqua KR, Bihrle R, Cheng L, et al
    Primary Choriocarcinoma of the Bladder: A Case Report and Review of Literature.
    Clin Genitourin Cancer. 2017;15:188-191.
    Abstract     Related articles   

  1197. CARAS RJ, Lustik MB, Kern SQ, McMann LP, et al
    Preoperative Albumin Is Predictive of Early Postoperative Morbidity and Mortality in Common Urologic Oncologic Surgeries.
    Clin Genitourin Cancer. 2017;15:e255-e262.
    Abstract     Related articles   

  1198. SINGH R, Ansari JA, Maurya N, Mandhani A, et al
    Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder.
    Clin Genitourin Cancer. 2017;15:e187-e197.
    Abstract     Related articles   

  1199. BACH T, Bastian PJ, Blana A, Kaminsky A, et al
    Optimised photodynamic diagnosis for transurethral resection of the bladder (TURB) in German clinical practice: results of the noninterventional study OPTIC III.
    World J Urol. 2017;35:737-744.
    Abstract     Related articles   

  1200. MOSCHINI M, Soria F, Klatte T, Wirth GJ, et al
    Validation of Preoperative Risk Grouping of the Selection of Patients Most Likely to Benefit From Neoadjuvant Chemotherapy Before Radical Cystectomy.
    Clin Genitourin Cancer. 2017;15:e267-e273.
    Abstract     Related articles   

  1201. MAO XW, Xiao JQ, Xu G, Li ZY, et al
    CUL4B promotes bladder cancer metastasis and induces epithelial-to-mesenchymal transition by activating the Wnt/beta-catenin signaling pathway.
    Oncotarget. 2017;8:77241-77253.
    Abstract     Related articles   

  1202. ZHAN Y, Li Y, Guan B, Wang Z, et al
    Long non-coding RNA HNF1A-AS1 promotes proliferation and suppresses apoptosis of bladder cancer cells through upregulating Bcl-2.
    Oncotarget. 2017;8:76656-76665.
    Abstract     Related articles   

  1203. AL-AMER M, Abdeen Y, Shaaban H, Alderink C, et al
    Solitary pulmonary adenofibroma in a middle-aged man with bladder cancer.
    Lung India. 2017;34:570-572.
    Abstract     Related articles   

  1204. NIWA N, Kikuchi E, Matsumoto K, Kosaka T, et al
    Purified protein derivative skin test reactions are associated with clinical outcomes of patients with nonmuscle invasive bladder cancer treated with induction bacillus Calmette-Guerin therapy.
    Urol Oncol. 2017 Oct 30. pii: S1078-1439(17)30535.
    Abstract     Related articles   

  1205. DEGEORGE KC, Holt HR, Hodges SC
    Bladder Cancer: Diagnosis and Treatment.
    Am Fam Physician. 2017;96:507-514.
    Abstract     Related articles   

  1206. WALSHAW RC, Honeychurch J, Illidge TM, Choudhury A, et al
    The anti-PD-1 era - an opportunity to enhance radiotherapy for patients with bladder cancer.
    Nat Rev Urol. 2017 Oct 31. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  1207. GORDON PC, Thomas F, Noon AP, Rosario DJ, et al
    Long-term Outcomes from Re-resection for High-risk Non-muscle-invasive Bladder Cancer: A Potential to Rationalize Use.
    Eur Urol Focus. 2017 Oct 28. pii: S2405-4569(17)30241.
    Abstract     Related articles   

  1208. LIU J, Gong X, Zhu X, Xue D, et al
    Rab27A overexpression promotes bladder cancer proliferation and chemoresistance through regulation of NF-kappaB signaling.
    Oncotarget. 2017;8:75272-75283.
    Abstract     Related articles   

  1209. SATO M, Yoneyama MS, Hatakeyama S, Funyu T, et al
    The role of LIM and SH3 protein-1 in bladder cancer metastasis.
    Oncol Lett. 2017;14:4829-4834.
    Abstract     Related articles   

  1210. ZHUANG C, Huang X, Zhuang C, Luo X, et al
    Synthetic regulatory RNAs selectively suppress the progression of bladder cancer.
    J Exp Clin Cancer Res. 2017;36:151.
    Abstract     Related articles   

  1211. TAN DQ, Liu XH
    [Mechanism in growth inhibition of quercetin on human bladder cancer cell line].
    Zhongguo Zhong Yao Za Zhi. 2017;42:1742-1746.
    Abstract     Related articles   

  1212. MITRAKAS L, Gravas S, Papandreou C, Koukoulis G, et al
    Primary High-Grade Non-Muscle-Invasive Bladder Cancer: High NFkappaB Expression in Tumor Specimens Distinguishes Patients Who are at Risk for Disease Progression.
    Pathol Oncol Res. 2017 Oct 28. doi: 10.1007/s12253-017-0340.
    Abstract     Related articles   

  1213. LIN T, Li K, Liu H, Xue X, et al
    Enhanced recovery after surgery for radical cystectomy with ileal urinary diversion: a multi-institutional, randomized, controlled trial from the Chinese bladder cancer consortium.
    World J Urol. 2017 Oct 28. doi: 10.1007/s00345-017-2108.
    Abstract     Related articles   

  1214. HENRY CJ, Flesner BK, Bechtel SA, Bryan JN, et al
    Clinical Evaluation of Tavocept to Decrease Diuresis Time and Volume in Dogs with Bladder Cancer Receiving Cisplatin.
    J Vet Intern Med. 2017 Oct 27. doi: 10.1111/jvim.14848.
    Abstract     Related articles   

  1215. CHOUDHARY D, Clement JM, Choudhary S, Voznesensky O, et al
    SATB1 and bladder cancer: Is there a functional link?
    Urol Oncol. 2017 Oct 24. pii: S1078-1439(17)30531.
    Abstract     Related articles   

  1216. LYNCH HN, Zu K, Kennedy EM, Lam T, et al
    Corrigendum to "Quantitative assessment of lung and bladder cancer risk and oral exposure to inorganic arsenic: Meta-regression analyses of epidemiological data" Environmental International 106 :178-206.
    Environ Int. 2017;109:195-196.
    Abstract     Related articles   

  1217. LEIVO MZ, Sahoo D, Hamilton Z, Mirsadraei L, et al
    Analysis of T1 Bladder Cancer on Biopsy and Transurethral Resection Specimens: Comparison and Ranking of T1 Quantification Approaches to Predict Progression to Muscularis Propria Invasion.
    Am J Surg Pathol. 2017 Oct 26. doi: 10.1097/PAS.0000000000000964.
    Abstract     Related articles   

  1218. LIN YC, Lin JF, Tsai TF, Chen HE, et al
    Acridine orange exhibits photodamage in human bladder cancer cells under blue light exposure.
    Sci Rep. 2017;7:14103.
    Abstract     Related articles   

  1219. HENDRICKSEN K, Aziz A, Bes P, Chun FK, et al
    Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non-muscle-invasive Bladder Cancer: Results of a European Survey.
    Eur Urol Focus. 2017 Oct 23. pii: S2405-4569(17)30206.
    Abstract     Related articles   

  1220. LI QQ, Hsu I, Sanford T, Railkar R, et al
    Protein kinase D inhibitor CRT0066101 suppresses bladder cancer growth in vitro and xenografts via blockade of the cell cycle at G2/M.
    Cell Mol Life Sci. 2017 Oct 25. doi: 10.1007/s00018-017-2681.
    Abstract     Related articles   

  1221. ZAHRAN MH, Sheir K, Zidan EM, Ali-El-Dein B, et al
    Validation of the Arabic version of the Functional Assessment of Cancer Therapy-Bladder questionnaire in Egyptian patients with bladder cancer.
    Arab J Urol. 2017;15:110-114.
    Abstract     Related articles   

  1222. AHN KI, Choi EO, Kwon DH, HwangBo H, et al
    Induction of apoptosis by ethanol extract of Citrus unshiu Markovich peel in human bladder cancer T24 cells through ROS-mediated inactivation of the PI3K/Akt pathway.
    Biosci Trends. 2017 Oct 24. doi: 10.5582/bst.2017.01218.
    Abstract     Related articles   

  1223. TAO T, He C, Deng J, Huang Y, et al
    A novel synthetic derivative of quercetin, 8-trifluoromethyl-3,5,7,3',4'-O-pentamethyl-quercetin, inhibits bladder cancer growth by targeting the AMPK/mTOR signaling pathway.
    Oncotarget. 2017;8:71657-71671.
    Abstract     Related articles   

  1224. YIN H, Yang X, Gu W, Liu Y, et al
    HMGB1-mediated autophagy attenuates gemcitabine-induced apoptosis in bladder cancer cells involving JNK and ERK activation.
    Oncotarget. 2017;8:71642-71656.
    Abstract     Related articles   

  1225. ROBERTS KJ, Kershner AM, Beachy PA
    The Stromal Niche for Epithelial Stem Cells: A Template for Regeneration and a Brake on Malignancy.
    Cancer Cell. 2017;32:404-410.
    Abstract     Related articles   

  1226. HATA S, Ise K, Azmahani A, Konosu-Fukaya S, et al
    Expression of AR, 5alphaR1 and 5alphaR2 in bladder urothelial carcinoma and relationship to clinicopathological factors.
    Life Sci. 2017;190:15-20.
    Abstract     Related articles   

  1227. PINK M, Verma N, Zerries A, Schmitz-Spanke S, et al
    Dose-Dependent Response to 3-Nitrobenzanthrone Exposure in Human Urothelial Cancer Cells.
    Chem Res Toxicol. 2017;30:1855-1864.
    Abstract     Related articles   

    American Urological Association (AUA) - 112th Annual Meeting (May 12-16, 2017 - Boston, Massachusetts, USA).
    Drugs Today (Barc). 2017;53:367-369.
    Abstract     Related articles   

  1229. JIKUYA R, Washimi K, Yasui M, Hashizume A, et al
    [A Case of Long Survival in Aggressively Growing Small Cell Carcinoma of the Bladder Successfully Treated by Combined Chemotherapy of Methotrexate, Etoposide and Cisplatin].
    Hinyokika Kiyo. 2017;63:245-249.
    Abstract     Related articles   

  1230. STEENLAND K, Barry V, Anttila A, Sallmen M, et al
    A cohort mortality study of lead-exposed workers in the USA, Finland and the UK.
    Occup Environ Med. 2017;74:785-791.
    Abstract     Related articles   

  1231. YAMADA M, Kuroda H, Sato K, Miura S, et al
    Spontaneous regression of methotrexate-related diffuse large B-cell lymphoma following bladder lesion resection.
    Rinsho Ketsueki. 2017;58:287-291.
    Abstract     Related articles   

  1232. HUHE M, Liu S, Zhang Y, Zhang Z, et al
    Expression levels of transcription factors c-Fos and c-Jun and transmembrane protein HAb18G/CD147 in urothelial carcinoma of the bladder.
    Mol Med Rep. 2017;15:2991-3000.
    Abstract     Related articles   

  1233. BUTT E, Ebbing J, Bubendorf L, Ardelt P, et al
    Influence of hematuria and infection on diagnostic accuracy of urinary LASP1: a new biomarker for bladder carcinoma.
    Biomark Med. 2017;11:347-357.
    Abstract     Related articles   

  1234. ALANEE SR, Shah S, Zabor EC, Vijai J, et al
    Evaluating the association of multiple single nucleotide polymorphisms with response to gemcitabine and platinum combination chemotherapy in urothelial carcinoma of the bladder.
    Int J Clin Pharmacol Ther. 2017;55:203-209.
    Abstract     Related articles   

  1235. MAUGERI R, Graziano F, Basile L, Guli C, et al
    Reconstruction of Vertebral Body After Radiofrequency Ablation and Augmentation in Dorsolumbar Metastatic Vertebral Fracture: Analysis of Clinical and Radiological Outcome in a Clinical Series of 18 Patients.
    Acta Neurochir Suppl. 2017;124:81-86.
    Abstract     Related articles   

  1236. KRAJEWSKI W, Koscielska-Kasprzak K, Rymaszewska J, Zdrojowy R, et al
    How different cystoscopy methods influence patient sexual satisfaction, anxiety, and depression levels: a randomized prospective trial.
    Qual Life Res. 2017;26:625-634.
    Abstract     Related articles   

  1237. XU ZQ, Yang MG, Liu HJ, Su CQ, et al
    Circular RNA hsa_circ_0003221 (circPTK2) promotes the proliferation and migration of bladder cancer cells.
    J Cell Biochem. 2017 Nov 10. doi: 10.1002/jcb.26492.
    Abstract     Related articles   

  1238. PAQUETTE M, Vilera-Perez LG, Beaudoin S, Ekindi-Ndongo N, et al
    Targeting IL-5Ralpha with antibody-conjugates reveals a strategy for imaging and therapy for invasive bladder cancer.
    Oncoimmunology. 2017;6:e1331195.
    Abstract     Related articles   

  1239. CASADEVALL D, Kilian AY, Bellmunt J
    The prognostic role of epigenetic dysregulation in bladder cancer: A systematic review.
    Cancer Treat Rev. 2017;61:82-93.
    Abstract     Related articles   

  1240. SHEGAY PV, Zhavoronkov AA, Gaifullin NM, Vorob'ev NV, et al
    Potentialities of MicroRNA Diagnosis in Patients with Bladder Cancer.
    Bull Exp Biol Med. 2017 Nov 9. doi: 10.1007/s10517-017-3935.
    Abstract     Related articles   

  1241. KOCHAN A, Rivest R, Galloway K, Lambert P, et al
    Targeting the Tumor: Assessing the Impact of Bladder Volume and Position on Accuracy of Radiation Delivery for Patients with Bladder Cancer.
    Cureus. 2017;9:e1638.
    Abstract     Related articles   

  1242. RUTHERFORD C, King MT, Smith DP, Costa DS, et al
    Psychometric Evaluation of a Patient-Reported Symptom Index for Nonmuscle Invasive Bladder Cancer: Field Testing Protocol.
    JMIR Res Protoc. 2017;6:e216.
    Abstract     Related articles   

  1243. BERDIK C
    Unlocking bladder cancer.
    Nature. 2017;551:S34-S35.
    Abstract     Related articles   

  1244. BERDIK C
    Bladder cancer: 4 big questions.
    Nature. 2017;551:S51.
    Abstract     Related articles   

  1245. GRAYSON M
    Bladder cancer.
    Nature. 2017;551:S33.
    Abstract     Related articles   

  1246. ZHANG J, Zhu Y, Wang Y, Fu Q, et al
    Prognostic and Predictive Value of O6-methylguanine Methyltransferase for Chemotherapy in Patients with Muscle-Invasive Bladder Cancer.
    Ann Surg Oncol. 2017 Nov 7. doi: 10.1245/s10434-017-6145.
    Abstract     Related articles   

  1247. LI Q, Tang T, Zhang P, Liu C, et al
    Correlation of IL-31 gene polymorphisms with susceptibility and clinical recurrence of bladder cancer.
    Fam Cancer. 2017 Nov 8. doi: 10.1007/s10689-017-0060.
    Abstract     Related articles   

  1248. FREES SK, Aning J, Black P, Struss W, et al
    A prospective randomized pilot study evaluating an ERAS protocol versus a standard protocol for patients treated with radical cystectomy and urinary diversion for bladder cancer.
    World J Urol. 2017 Nov 7. doi: 10.1007/s00345-017-2109.
    Abstract     Related articles   

  1249. SATO T, Katsuoka Y, Yoneda K, Nonomura M, et al
    Sniffer mice discriminate urine odours of patients with bladder cancer: A proof-of-principle study for non-invasive diagnosis of cancer-induced odours.
    Sci Rep. 2017;7:14628.
    Abstract     Related articles   

  1250. DEININGER S, Todenhofer T, Hennenlotter J, Gerber V, et al
    Impact of variant microscopic interpretation of the uCyt+ immunocytological urine test for the detection of bladder cancer.
    Diagn Cytopathol. 2017 Nov 8. doi: 10.1002/dc.23857.
    Abstract     Related articles   

  1251. POUPEL F, Aghaei M, Movahedian A, Jafari SM, et al
    Dihydroartemisinin Induces Apoptosis in Human Bladder Cancer Cell Lines Through Reactive Oxygen Species, Mitochondrial Membrane Potential, and Cytochrome C Pathway.
    Int J Prev Med. 2017;8:78.
    Abstract     Related articles   

  1252. KIM HS, Jeong CW, Kwak C, Kim HH, et al
    Adjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials.
    Oncotarget. 2017;8:81204-81214.
    Abstract     Related articles   

  1253. ZHANG C, Wang YQ, Jin G, Wu S, et al
    Selection of reference genes for gene expression studies in human bladder cancer using SYBR-Green quantitative polymerase chain reaction.
    Oncol Lett. 2017;14:6001-6011.
    Abstract     Related articles   

  1254. LUO J, Chen J, Li H, Yang Y, et al
    LncRNA UCA1 promotes the invasion and EMT of bladder cancer cells by regulating the miR-143/HMGB1 pathway.
    Oncol Lett. 2017;14:5556-5562.
    Abstract     Related articles   

  1255. CHEN Y, Wang H, Xiong T, Zou R, et al
    The role of LASS2 in regulating bladder cancer cell tumorigenicity in a nude mouse model.
    Oncol Lett. 2017;14:5149-5156.
    Abstract     Related articles   

  1256. ICHIKAWA H, Itsumi M, Kajioka S, Maki T, et al
    Overexpression of exchange protein directly activated by cAMP-1 (EPAC1) attenuates bladder cancer cell migration.
    Biochem Biophys Res Commun. 2017 Oct 27. pii: S0006-291X(17)32127.
    Abstract     Related articles   

  1257. AEISHEN S, Dawood Y, Papadoukakis S, Horstmann M, et al
    [Supplementary optical techniques for the detection of nonmuscle invasive bladder cancer].
    Urologe A. 2017 Nov 6. doi: 10.1007/s00120-017-0539.
    Abstract     Related articles   

  1258. LEBENTRAU S, May M, Wick AK, Roiner M, et al
    Non-muscle invasive bladder cancer: Are epicrises the 'Bermuda Triangle' of information transfer?
    Cent European J Urol. 2017;70:245-251.
    Abstract     Related articles   

  1259. FAHMY O, Khairul-Asri MG, Schubert T, Renninger M, et al
    A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer.
    Urol Oncol. 2017 Oct 25. pii: S1078-1439(17)30529.
    Abstract     Related articles   

  1260. LIM-REINDERS S, Keller BM, Al-Ward S, Sahgal A, et al
    Online Adaptive Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;99:994-1003.
    Abstract     Related articles   

  1261. NEUZILLET Y, Raynaud JP, Radulescu C, Fiet J, et al
    Sexual steroids in serum and prostatic tissue of human non-cancerous prostate (STERPROSER trial).
    Prostate. 2017;77:1512-1519.
    Abstract     Related articles   

  1262. KOK HP, Korshuize-van Straten L, Bakker A, de Kroon-Oldenhof R, et al
    Online Adaptive Hyperthermia Treatment Planning During Locoregional Heating to Suppress Treatment-Limiting Hot Spots.
    Int J Radiat Oncol Biol Phys. 2017;99:1039-1047.
    Abstract     Related articles   

  1263. GLYBOCHKO PV, Alyaev YG, Shpot' EV, Pshi-Khachev AM, et al
    [Laparoscopic cystoprostatvesiculeectomy with orthotopic excentric ileal bladder substitution].
    Urologiia. 2017;:78-83.
    Abstract     Related articles   

  1264. ROBSAHM TE, Falk RS, Heir T, Sandvik L, et al
    Cardiorespiratory fitness and risk of site-specific cancers: a long-term prospective cohort study.
    Cancer Med. 2017;6:865-873.
    Abstract     Related articles   

  1265. RAMOS JD, Casey MF, Crabb SJ, Bamias A, et al
    Venous thromboembolism in metastatic urothelial carcinoma or variant histologies: incidence, associative factors, and effect on survival.
    Cancer Med. 2017;6:186-194.
    Abstract     Related articles   

  1266. BREYER J, Wirtz RM, Otto W, Erben P, et al
    High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients.
    Cancer Immunol Immunother. 2017 Nov 17. doi: 10.1007/s00262-017-2093.
    Abstract     Related articles   

  1267. QU H, Zheng Y, Wang Y, Zhang R, et al
    Global and Regional Effects of Bladder Cancer Risk Associated with Pioglitazone Therapy in Patients with Diabetes.
    Sci Rep. 2017;7:15804.
    Abstract     Related articles   

  1268. POZZI V, Di Ruscio G, Sartini D, Campagna R, et al
    Clinical performance and utility of a NNMT-based urine test for bladder cancer.
    Int J Biol Markers. 2017 Nov 11:0. doi: 10.5301/ijbm.5000311.
    Abstract     Related articles   

  1269. MARI A, Campi R, Tellini R, Gandaglia G, et al
    Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature.
    World J Urol. 2017 Nov 16. doi: 10.1007/s00345-017-2115.
    Abstract     Related articles   

  1270. HU Q, Wang G, Peng J, Qian G, et al
    Knockdown of SIRT1 Suppresses Bladder Cancer Cell Proliferation and Migration and Induces Cell Cycle Arrest and Antioxidant Response through FOXO3a-Mediated Pathways.
    Biomed Res Int. 2017;2017:3781904.
    Abstract     Related articles   

  1271. LE GOUX C, Vacher S, Pignot G, Sibony M, et al
    mRNA Expression levels of genes involved in antitumor immunity: Identification of a 3-gene signature associated with prognosis of muscle-invasive bladder cancer.
    Oncoimmunology. 2017;6:e1358330.
    Abstract     Related articles   

  1272. DAVIDSON MB, Pan D
    An Updated Meta-Analysis of Pioglitazone Exposure and Bladder Cancer and Comparison to the Drug's Effect on Cardiovascular Disease and Non-Alcoholic Steatohepatitis.
    Diabetes Res Clin Pract. 2017 Nov 13. pii: S0168-8227(17)31438.
    Abstract     Related articles   

    Asia Consensus Statement on NCCN Clinical Practice Guideline for bladder cancer.
    Jpn J Clin Oncol. 2017 Nov 14:1-4. doi: 10.1093.
    Abstract     Related articles   

  1274. XU Y, Huo R, Chen X, Yu X, et al
    Diabetes mellitus and the risk of bladder cancer: A PRISMA-compliant meta-analysis of cohort studies.
    Medicine (Baltimore). 2017;96:e8588.
    Abstract     Related articles   

  1275. HALSTEAD AM, Kapadia CD, Bolzenius J, Chu CE, et al
    Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation.
    Elife. 2017;6.
    Abstract     Related articles   

  1276. ZHANG HH, Huang B, Cao YH, Li Q, et al
    Role of 5-Aza-CdR in mitomycin-C chemosensitivity of T24 bladder cancer cells.
    Oncol Lett. 2017;14:5652-5656.
    Abstract     Related articles   

  1277. PENG C, Li A, Wang M
    Discovery of Bladder Cancer-related Genes Using Integrative Heterogeneous Network Modeling of Multi-omics Data.
    Sci Rep. 2017;7:15639.
    Abstract     Related articles   

  1278. SMILOWITZ HM, Tarmu LJ, Sanders MM, Taylor JA 3rd, et al
    Biodistribution of gold nanoparticles in BBN-induced muscle-invasive bladder cancer in mice.
    Int J Nanomedicine. 2017;12:7937-7946.
    Abstract     Related articles   

  1279. HURST CD, Alder O, Platt FM, Droop A, et al
    Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency.
    Cancer Cell. 2017;32:701-715.
    Abstract     Related articles   

  1280. MEEKS JJ, Lerner SP
    Molecular Landscape of Non-Muscle Invasive Bladder Cancer.
    Cancer Cell. 2017;32:550-551.
    Abstract     Related articles   

  1281. STONE L
    Bladder cancer: Context is key: dual roles of ANGPTL4.
    Nat Rev Urol. 2017 Nov 14. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  1282. FELSENSTEIN KM, Theodorescu D
    Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy.
    Nat Rev Urol. 2017 Nov 14. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  1283. LI HJ, Sun XM, Li ZK, Yin QW, et al
    LncRNA UCA1 Promotes Mitochondrial Function of Bladder Cancer via the MiR-195/ARL2 Signaling Pathway.
    Cell Physiol Biochem. 2017;43:2548-2561.
    Abstract     Related articles   

  1284. LEIBLICH A
    Recent Developments in the Search for Urinary Biomarkers in Bladder Cancer.
    Curr Urol Rep. 2017;18:100.
    Abstract     Related articles   

  1285. XIAN S, Shang D, Kong G, Tian Y, et al
    FOXJ1 promotes bladder cancer cell growth and regulates Warburg effect.
    Biochem Biophys Res Commun. 2017 Nov 9. pii: S0006-291X(17)32241.
    Abstract     Related articles   

  1286. UNDA-URZAIZ M, Fernandez-Gomez JM, Cozar-Olmos JM, Juarez A, et al
    Update on the role of endovesical chemotherapy in nonmuscle-invasive bladder cancer.
    Actas Urol Esp. 2017 Nov 9. pii: S0210-4806(17)30180.
    Abstract     Related articles   

  1287. HERMANS TJN, Voskuilen CS, van der Heijden MS, Schmitz-Drager BJ, et al
    Neoadjuvant treatment for muscle-invasive bladder cancer: The past, the present, and the future.
    Urol Oncol. 2017 Nov 8. pii: S1078-1439(17)30551.
    Abstract     Related articles   

  1288. RODRIGUEZ FABA O, Palou J, Vila Reyes H, Guirado L, et al
    Treatment options and predictive factors for recurrence and cancer-specific mortality in bladder cancer after renal transplantation: A multi-institutional analysis.
    Actas Urol Esp. 2017 Nov 7. pii: S0210-4806(17)30176.
    Abstract     Related articles   

  1289. LIU JY, Dai YB, Li X, Cao K, et al
    Solute carrier family 12 member 5 promotes tumor invasion/metastasis of bladder urothelial carcinoma by enhancing NF-kappaB/MMP-7 signaling pathway.
    Cell Death Dis. 2017;8:e2691.
    Abstract     Related articles   

  1290. ISMAIL S, Karsenty G, Chartier-Kastler E, Cussenot O, et al
    Prevalence, management, and prognosis of bladder cancer in patients with neurogenic bladder: A systematic review.
    Neurourol Urodyn. 2017 Nov 23. doi: 10.1002/nau.23457.
    Abstract     Related articles   

  1291. GULIA C, Baldassarra S, Signore F, Rigon G, et al
    Role of Non-Coding RNAs in the Etiology of Bladder Cancer.
    Genes (Basel). 2017;8.
    Abstract     Related articles   

  1292. PRASANNA T, Craft P, Balasingam G, Haxhimolla H, et al
    Intravesical Gemcitabine versus Intravesical Bacillus Calmette-Guerin for the Treatment of Non-Muscle Invasive Bladder Cancer: An Evaluation of Efficacy and Toxicity.
    Front Oncol. 2017;7:260.
    Abstract     Related articles   

  1293. GAN Y, He L, Yao K, Tan J, et al
    Knockdown of HMGN5 increases the chemosensitivity of human urothelial bladder cancer cells to cisplatin by targeting PI3K/Akt signaling.
    Oncol Lett. 2017;14:6463-6470.
    Abstract     Related articles   

  1294. VIRANI NA, Davis C, McKernan P, Hauser P, et al
    Phosphatidylserine targeted single-walled carbon nanotubes for photothermal ablation of bladder cancer.
    Nanotechnology. 2017 Nov 21. doi: 10.1088/1361-6528.
    Abstract     Related articles   

  1295. BONET M, Bonfill T, Nunez M, De Verdonces L, et al
    Curative radiation therapy for very elderly bladder cancer patients with localized disease.
    Clin Transl Oncol. 2017 Nov 20. doi: 10.1007/s12094-017-1804.
    Abstract     Related articles   

  1296. DOMINGUEZ-ESCRIG JL, Peyronnet B, Seisen T, Bruins HM, et al
    Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer.
    Eur Urol Focus. 2017 Nov 17. pii: S2405-4569(17)30236.
    Abstract     Related articles   

  1297. SMITH AB
    Recent developments in the management of bladder cancer: Introduction.
    Urol Oncol. 2017 Nov 17. pii: S1078-1439(17)30563.
    Abstract     Related articles   

  1298. FERGUSON JE 3RD, Kamat AM
    It's all about the perspective: Removing bias when co-managing patients with high-grade T1 bladder cancer and localized prostate cancer-A competing risks analysis.
    Urol Oncol. 2017 Nov 17. pii: S1078-1439(17)30556.
    Abstract     Related articles   

  1299. AGGEN DH, Drake CG
    Biomarkers for immunotherapy in bladder cancer: a moving target.
    J Immunother Cancer. 2017;5:94.
    Abstract     Related articles   

  1300. ANAN G, Hatakeyama S, Fujita N, Iwamura H, et al
    Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study.
    Oncotarget. 2017;8:86130-86142.
    Abstract     Related articles   

  1301. ECKE TH, Otto T
    Illumination of a Vision-How Arthur Rimbaud Will Give Us Motivation to Find New Input into Bladder Cancer Biomarker Research.
    Int J Mol Sci. 2017;18.
    Abstract     Related articles   

  1302. ZAHOOR H, Elson P, Stephenson A, Haber GP, et al
    Patient Characteristics, Treatment Patterns and Prognostic Factors in Squamous Cell Bladder Cancer.
    Clin Genitourin Cancer. 2017 Oct 17. pii: S1558-7673(17)30311.
    Abstract     Related articles   

  1303. MILBAR N, Kates M, Chappidi MR, Pederzoli F, et al
    Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder Cancer.
    Bladder Cancer. 2017;3:293-303.
    Abstract     Related articles   

  1304. HAQUE W, Verma V, Butler EB, Teh BS, et al
    Chemotherapy Versus Chemoradiation for Node-Positive Bladder Cancer: Practice Patterns and Outcomes from the National Cancer Data Base.
    Bladder Cancer. 2017;3:283-291.
    Abstract     Related articles   

  1305. MALONEY I, Parker DC, Cookson MS, Patel S, et al
    Bladder Cancer Recovery Pathways: A Systematic Review.
    Bladder Cancer. 2017;3:269-281.
    Abstract     Related articles   

  1306. KOTI M, Xu AS, Ren KYM, Visram K, et al
    Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer.
    Bladder Cancer. 2017;3:259-267.
    Abstract     Related articles   

  1307. MORAN GW, Li G, Robins DJ, Matulay JT, et al
    Systematic Review and Meta-Analysis on the Efficacy of Chemotherapy with Transurethral Resection of Bladder Tumors as Definitive Therapy for Muscle Invasive Bladder Cancer.
    Bladder Cancer. 2017;3:245-258.
    Abstract     Related articles   

  1308. XIE H, Liao X, Chen Z, Fang Y, et al
    LncRNA MALAT1 Inhibits Apoptosis and Promotes Invasion by Antagonizing miR-125b in Bladder Cancer Cells.
    J Cancer. 2017;8:3803-3811.
    Abstract     Related articles   

  1309. PICHLER R, Fritz J, Heidegger I, Oberaigner W, et al
    Gender-related Outcome in Bladder Cancer Patients undergoing Radical Cystectomy.
    J Cancer. 2017;8:3567-3574.
    Abstract     Related articles   

  1310. XU XL, Ye YL, Wu ZM, He QM, et al
    Overexpression of PTK6 predicts poor prognosis in bladder cancer patients.
    J Cancer. 2017;8:3464-3473.
    Abstract     Related articles   

  1311. YANG X, Yuan W, Tao J, Li P, et al
    Identification of circular RNA signature in bladder cancer.
    J Cancer. 2017;8:3456-3463.
    Abstract     Related articles   

  1312. SUI X, Lei L, Chen L, Xie T, et al
    Inflammatory microenvironment in the initiation and progression of bladder cancer.
    Oncotarget. 2017;8:93279-93294.
    Abstract     Related articles   

  1313. HOU T, Zhou L, Wang L, Kazobinka G, et al
    CLCA4 inhibits bladder cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT pathway.
    Oncotarget. 2017;8:93001-93013.
    Abstract     Related articles   

  1314. WANG F, Wu D, Fu H, He F, et al
    Cofilin 1 promotes bladder cancer and is regulated by TCF7L2.
    Oncotarget. 2017;8:92043-92054.
    Abstract     Related articles   

  1315. IMAI-SUMIDA M, Chiyomaru T, Majid S, Saini S, et al
    Silibinin suppresses bladder cancer through down-regulation of actin cytoskeleton and PI3K/Akt signaling pathways.
    Oncotarget. 2017;8:92032-92042.
    Abstract     Related articles   

  1316. ZAGHLOUL MS, Christodouleas JP, Smith A, Abdallah A, et al
    Adjuvant Sandwich Chemotherapy Plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy: A Randomized Phase 2 Trial.
    JAMA Surg. 2017 Nov 29:e174591. doi: 10.1001/jamasurg.2017.4591.
    Abstract     Related articles   

  1317. DIAZ DA, Mortazavi A, Lee CT
    A Potential Role for Adjuvant Chemotherapy and Radiotherapy for Patients With High-Risk Bladder Cancer Treated With Cystectomy in the United States.
    JAMA Surg. 2017 Nov 29:e174592. doi: 10.1001/jamasurg.2017.4592.
    Abstract     Related articles   

  1318. SOURAKA TDM, Shi MJ, Meng XY
    [The relationship between tumor recurrence and polymorphisms of hGPX1 and NRAMP1 in superficial bladder cancer patients: a meta-analysis].
    Pan Afr Med J. 2017;27:270.
    Abstract     Related articles   

  1319. ZHANG Q, Zhuang J, Deng Y, Yang L, et al
    miR34a/GOLPH3 Axis abrogates Urothelial Bladder Cancer Chemoresistance via Reduced Cancer Stemness.
    Theranostics. 2017;7:4777-4790.
    Abstract     Related articles   

  1320. Three more immune checkpoint inhibitors for advanced bladder cancer.
    Med Lett Drugs Ther. 2017;59:e202-e203.
    Abstract     Related articles   

  1321. BENACKA M, Benamran DA, Wirth G, Iselin CE, et al
    [Intravesical microwave thermo-chemotherapy for the treatment of non-invasive bladder cancer].
    Rev Med Suisse. 2017;13:2087-2091.
    Abstract     Related articles   

  1322. ADAM SM, Derre L, Jichlinski P, Lucca I, et al
    [Immunotherapy : a revolution in the management of urothelial bladder cancer ?]
    Rev Med Suisse. 2017;13:2074-2078.
    Abstract     Related articles   

  1323. MATSUMOTO A, Nakagawa T, Kanatani A, Ikeda M, et al
    Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer.
    World J Urol. 2017 Nov 28. pii: 10.1007/s00345-017-2141.
    Abstract     Related articles   

  1324. BREYER J
    Improving outcome and prognosis prediction in non-muscle invasive bladder cancer using a gene expression score.
    Transl Androl Urol. 2017;6:991-993.
    Abstract     Related articles   

  1325. LUCHINI C, Cheng L
    Predicting the biological behavior of non-muscle-invasive bladder cancer: from histology to molecular taxonomy.
    Transl Androl Urol. 2017;6:987-990.
    Abstract     Related articles   

  1326. GALSKY MD
    Bladder cancer in 2017: Advancing care through genomics and immune checkpoint blockade.
    Nat Rev Urol. 2017 Nov 28. pii: nrurol.2017.199. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  1327. TSIKRIKA FD, Avgeris M, Levis PK, Tokas T, et al
    miR-221/222 cluster expression improves clinical stratification of non-muscle invasive bladder cancer (TaT1) patients' risk for short-term relapse and progression.
    Genes Chromosomes Cancer. 2017 Nov 27. doi: 10.1002/gcc.22516.
    Abstract     Related articles   

  1328. BANERJEE S, Manley K, Shaw B, Lewis L, et al
    Vigorous intensity aerobic interval exercise in bladder cancer patients prior to radical cystectomy: a feasibility randomised controlled trial.
    Support Care Cancer. 2017 Nov 27. pii: 10.1007/s00520-017-3991.
    Abstract     Related articles   

  1329. CHEN J, Cui Y, Li P, Liu L, et al
    Expression and clinical significance of androgen receptor in bladder cancer: A meta-analysis.
    Mol Clin Oncol. 2017;7:919-927.
    Abstract     Related articles   

  1330. DONG F, Shen Y, Gao F, Xu T, et al
    Prognostic value of site-specific metastases and therapeutic roles of surgery for patients with metastatic bladder cancer: a population-based study.
    Cancer Manag Res. 2017;9:611-626.
    Abstract     Related articles   

  1331. YU G, Ou ZY, Tao QY, Wan GY, et al
    [Role of lncRNA PTENP1 in tumorigenesis and progression of bladder cancer and the molecular mechanism].
    Nan Fang Yi Ke Da Xue Xue Bao. 2017;37:1494-1500.
    Abstract     Related articles   

  1332. WILLIAMS SB, Kamat AM, Mmeje C, Ye Y, et al
    Genetic variants in the inflammation pathway as predictors of recurrence and progression in non-muscle invasive bladder cancer treated with Bacillus Calmette-Guerin.
    Oncotarget. 2017;8:88782-88791.
    Abstract     Related articles   

  1333. CAO R, Wang G, Qian K, Chen L, et al
    TM4SF1 regulates apoptosis, cell cycle and ROS metabolism via the PPARgamma-SIRT1 feedback loop in human bladder cancer cells.
    Cancer Lett. 2017 Nov 23. pii: S0304-3835(17)30733.
    Abstract     Related articles   

  1334. CAMARGO JA, Passos GR, Ferrari KL, Billis A, et al
    Intravesical Immunomodulatory Imiquimod Enhances Bacillus Calmette-Guerin Downregulation of Nonmuscle-invasive Bladder Cancer.
    Clin Genitourin Cancer. 2017 Nov 7. pii: S1558-7673(17)30335.
    Abstract     Related articles   

  1335. SUBIELA JD, Palou J, Esquinas C, Fernandez Gomez JM, et al
    Clinical usefulness of random biopsies in diagnosis and treatment of non-muscle invasive bladder cancer: Systematic review and meta-analysis.
    Actas Urol Esp. 2017 Nov 20. pii: S0210-4806(17)30196.
    Abstract     Related articles   

  1336. LI X, Han X, Yang J, Sun J, et al
    [miR-503-5p inhibits the proliferation of T24 and EJ bladder cancer cells by interfering with the Rb/E2F signaling pathway].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017;33:1360-1364.
    Abstract     Related articles   

  1337. YAMASHITA S, Ito A, Mitsuzuka K, Ioritani N, et al
    Efficacy of early ureteral ligation on prevention of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: a prospective single-arm multicenter clinical trial.
    Jpn J Clin Oncol. 2017;47:870-875.
    Abstract     Related articles   

  1338. FREIFELD Y, Lotan Y
    Value of nutrition supplementation prior to cystectomy.
    Can J Urol. 2017;24:8902.
    Abstract     Related articles   

  1339. ELBARBARY RA, Miyoshi K, Hedaya O, Myers JR, et al
    UPF1 helicase promotes TSN-mediated miRNA decay.
    Genes Dev. 2017;31:1483-1493.
    Abstract     Related articles   

  1340. TUMA J, Serra A

    Praxis (Bern 1994). 2017;106:899-902.
    Abstract     Related articles   

  1341. FRASER C, Frizelle F
    A villous adenoma of bladder/urachus origin located in the perineum.
    N Z Med J. 2017;130:73-75.
    Abstract     Related articles   

  1342. OKON E, Stearns J, Durgam AK
    Tuberculous Psoas Abscess and Worsening Vascular Aneurysm; All from Bacillus Calmette-Guerin (BCG) Therapy?
    Am J Case Rep. 2017;18:810-812.
    Abstract     Related articles   

  1343. MOLINA ESCUDERO R, Egui Rojo MA, de la Torre J, Paez Borda A, et al
    Back pain after varicocele embolization.
    Arch Esp Urol. 2017;70:623-624.
    Abstract     Related articles   

  1344. CHAPPIDI MR, Kates M, Sopko NA, Joice GA, et al
    Erectile Dysfunction Treatment Following Radical Cystoprostatectomy: Analysis of a Nationwide Insurance Claims Database.
    J Sex Med. 2017 Apr 28. pii: S1743-6095(17)30427.
    Abstract     Related articles   

  1345. ABE T, Takada N, Kikuchi H, Matsumoto R, et al
    Perioperative morbidity and mortality of octogenarians treated by radical cystectomy-a multi-institutional retrospective study in Japan.
    Jpn J Clin Oncol. 2017;47:755-761.
    Abstract     Related articles   

  1346. KOUBA EJ, Cheng L
    Understanding the Genetic Landscape of Small Cell Carcinoma of the Urinary Bladder and Implications for Diagnosis, Prognosis, and Treatment: A Review.
    JAMA Oncol. 2017;3:1570-1578.
    Abstract     Related articles   

  1347. POTURALSKI MJ, Magi-Galluzzi C, Liu PS
    Squamous Cell Carcinoma of the Bladder Complicating Schistosomiasis: AIRP Best Cases in Radiologic-Pathologic Correlation.
    Radiographics. 2017;37:500-504.
    Abstract     Related articles   

  1348. SHAISH H, Newhouse JH
    Split-bolus CT urogram: Is less more?
    Abdom Radiol (NY). 2017;42:2119-2126.
    Abstract     Related articles   

  1349. MIR SUBIAS A, Navarro Dourdil M, Charro Calvillo M, Sebastian Domingo JJ, et al
    Combined endoscopic resolution of iatrogenic stricture in an ureterosigmoidostomy.
    Rev Esp Enferm Dig. 2017;109:215-216.
    Abstract     Related articles   

  1350. LIN SR, Yeh HC, Wang WJ, Ke HL, et al
    MiR-193b Mediates CEBPD-Induced Cisplatin Sensitization Through Targeting ETS1 and Cyclin D1 in Human Urothelial Carcinoma Cells.
    J Cell Biochem. 2017;118:1563-1573.
    Abstract     Related articles   

  1351. NG KL, Chua CB
    Reiter's syndrome postintravesical Bacillus Calmette-Guerin instillations.
    Asian J Surg. 2017;40:163-165.
    Abstract     Related articles   

  1352. KULKARNI JN, Agarwal H
    Transperitoneal vs. extraperitoneal radical cystectomy for bladder cancer: A retrospective study.
    Int Braz J Urol. 2017;43.
    Abstract     Related articles   

  1353. YANG D, Du G, Xu A, Xi X, et al
    Expression of miR-149-3p inhibits proliferation, migration, and invasion of bladder cancer by targeting S100A4.
    Am J Cancer Res. 2017;7:2209-2219.
    Abstract     Related articles   

  1354. KRIEGMAIR MC, Honeck P, Theuring M, Bolenz C, et al
    Wide-field autofluorescence-guided TUR-B for the detection of bladder cancer: a pilot study.
    World J Urol. 2017 Dec 6. pii: 10.1007/s00345-017-2147.
    Abstract     Related articles   

  1355. BONFILL X, Martinez-Zapata MJ, Vernooij RWM, Sanchez MJ, et al
    Clinical interval and diagnostic characteristics in a cohort of bladder cancer patients in Spain: a multicenter observational study.
    BMC Res Notes. 2017;10:708.
    Abstract     Related articles   

  1356. MOHAMMED A, Arastu Z
    Emerging concepts and spectrum of renal injury following Intravesical BCG for non-muscle invasive bladder cancer.
    BMC Urol. 2017;17:114.
    Abstract     Related articles   

  1357. HU Y, Deng C, Zhang H, Zhang J, et al
    Long non-coding RNA XIST promotes cell growth and metastasis through regulating miR-139-5p mediated Wnt/beta-catenin signaling pathway in bladder cancer.
    Oncotarget. 2017;8:94554-94568.
    Abstract     Related articles   

  1358. ZHANG Q, Wang C, Miao S, Li C, et al
    Enhancing E-cadherin expression via promoter-targeted miR-373 suppresses bladder cancer cells growth and metastasis.
    Oncotarget. 2017;8:93969-93983.
    Abstract     Related articles   

  1359. SZYMANSKA B, Pawlik KJ, Sawicka E, Dembowski J, et al
    Evaluation of NMP22 in bladder cancer patients sensitive to environmental toxins.
    Adv Clin Exp Med. 2017;26:1069-1075.
    Abstract     Related articles   

  1360. PASSOS GR, Camargo JA, Ferrari KL, Saad MJA, et al
    Intravesical Thalidomide boosts bacillus Calmette-Guerin (BCG) in non-muscle invasive bladder cancer treatment.
    Med Oncol. 2017;35:3.
    Abstract     Related articles   

  1361. WONG JPC, Wei R, Lyu P, Tong OLH, et al
    Clinical and in vitro analysis of Osteopontin as a prognostic indicator and unveil its potential downstream targets in bladder cancer.
    Int J Biol Sci. 2017;13:1373-1386.
    Abstract     Related articles   

  1362. D'ALOIA A, Berruti G, Costa B, Schiller C, et al
    RalGPS2 is involved in tunneling nanotubes formation in 5637 bladder cancer cells.
    Exp Cell Res. 2017 Dec 2. pii: S0014-4827(17)30639.
    Abstract     Related articles   

  1363. CHIU SC, Chiu TL, Huang SY, Chang SF, et al
    Potential therapeutic effects of N-butylidenephthalide from Radix Angelica Sinensis (Danggui) in human bladder cancer cells.
    BMC Complement Altern Med. 2017;17:523.
    Abstract     Related articles   

  1364. AZEVEDO R, Peixoto A, Gaiteiro C, Fernandes E, et al
    Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?
    Oncotarget. 2017;8:91734-91764.
    Abstract     Related articles   

  1365. SILVERS CR, Miyamoto H, Messing EM, Netto GJ, et al
    Characterization of urinary extracellular vesicle proteins in muscle-invasive bladder cancer.
    Oncotarget. 2017;8:91199-91208.
    Abstract     Related articles   

  1366. HUANG L, Kong Q, Liu Z, Wang J, et al
    The Diagnostic Value of MR Imaging in Differentiating T Staging of Bladder Cancer: A Meta-Analysis.
    Radiology. 2017 Dec 4:171028. doi: 10.1148/radiol.2017171028.
    Abstract     Related articles   

  1367. THOMA C
    Bladder cancer: Genomics of noninvasive disease.
    Nat Rev Urol. 2017 Dec 5. pii: nrurol.2017.207. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  1368. PUNEET A, Balagopal N, Ginil K, Georgie M, et al
    Correlation of Transabdominal Ultrasonography and Cystoscopy in Follow-up of Patients with Non-muscle Invasive Bladder Cancer.
    Indian J Surg Oncol. 2017;8:548-553.
    Abstract     Related articles   

  1369. SANLI O, Lotan Y
    Alternative therapies in patients with non-muscle invasive bladder cancer.
    Turk J Urol. 2017;43:414-424.
    Abstract     Related articles   

  1370. ZHAO F, Ge YZ, Zhou LH, Xu LW, et al
    Identification of hub miRNA biomarkers for bladder cancer by weighted gene coexpression network analysis.
    Onco Targets Ther. 2017;10:5551-5559.
    Abstract     Related articles   

  1371. CUI J, Chen S, Bo Q, Wang S, et al
    Preoperative prognostic nutritional index and nomogram predicting recurrence-free survival in patients with primary non-muscle-invasive bladder cancer without carcinoma in situ.
    Onco Targets Ther. 2017;10:5541-5550.
    Abstract     Related articles   

  1372. TAKIZAWA T, Kojima M, Suzuki S, Osada T, et al
    New onset of myasthenia gravis after intravesical Bacillus Calmette-Guerin: A case report and literature review.
    Medicine (Baltimore). 2017;96:e8757.
    Abstract     Related articles   

  1373. ZHOU N, Yuan Y, Long X, Wu C, et al
    Mutational signatures efficiently identify different mutational processes underlying cancers with similar somatic mutation spectra.
    Mutat Res. 2017;806:27-30.
    Abstract     Related articles   

  1374. MALTE R, Kluth LA, Kaushik D, Boorjian SA, et al
    Frequency and prognostic significance of incidental prostate cancer at radical cystectomy: Results from an international retrospective study.
    Eur J Surg Oncol. 2017;43:2193-2199.
    Abstract     Related articles   

  1375. ZATTONI F, Morlacco A, Nehra A, Frank I, et al
    Vaginal cuff recurrence after radical cystectomy: an under - studied site of bladder cancer relapse.
    Int Braz J Urol. 2017;43.
    Abstract     Related articles   

  1376. LIEBERMAN-CRIBBIN W, Galsky M, Casey M, Liu B, et al
    Hospital Centralization Impacts High-Risk Lung and Bladder Cancer Surgical Patients.
    Cancer Invest. 2017;35:652-661.
    Abstract     Related articles   

  1377. RAMAKRISHNAN S, Hu Q, Krishnan N, Wang D, et al
    Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer.
    Cell Death Dis. 2017;8:3217.
    Abstract     Related articles   

  1378. CICIONE A, Manno S, Ucciero G, Cantiello F, et al
    A larger detrusor wall thickness increases the risk of non muscle invasive bladder cancer recurrence and progression: result from a multicenter observational study.
    Minerva Urol Nefrol. 2017 Dec 14. pii: S0393-2249.17.02992.
    Abstract     Related articles   

  1379. GEZGINCI E, Yyigun E, Yalcin S, Ozgok IY, et al
    Symptoms Control for Patients with Superficial Bladder Cancers Before and After TURBT and Intravesical Epirubicin Instillation.
    Urol Nurs. 2017;37:31-5.
    Abstract     Related articles   

  1380. BUCHLER T
    [Immunotherapy for Bladder Cancer].
    Klin Onkol. 2017;30.
    Abstract     Related articles   

  1381. LIU H, Chang J, Zhao Z, Li Y, et al
    Effects of exogenous hydrogen sulfide on the proliferation and invasion of human Bladder cancer cells.
    J Cancer Res Ther. 2017;13:829-832.
    Abstract     Related articles   

  1382. ABOTALEB AA, Kandeel WS, Elmohamady B, Noureldin YA, et al
    Bipolar plasma kinetic enucleation of non-muscle-invasive bladder cancer: Initial experience with a novel technique.
    Arab J Urol. 2017;15:355-359.
    Abstract     Related articles   

  1383. LI S, Liu X, Liu T, Meng X, et al
    Identification of Biomarkers Correlated with the TNM Staging and Overall Survival of Patients with Bladder Cancer.
    Front Physiol. 2017;8:947.
    Abstract     Related articles   

  1384. CAO X, Xu J, Yue D
    LncRNA-SNHG16 predicts poor prognosis and promotes tumor proliferation through epigenetically silencing p21 in bladder cancer.
    Cancer Gene Ther. 2017 Dec 12. pii: 10.1038/s41417-017-0006.
    Abstract     Related articles   

  1385. BONET M, Bonfill T, Nunez M, Mur E, et al
    Trimodality therapy for older patients with bladder cancer: Overtreatment or benefit?
    J Geriatr Oncol. 2017 Dec 7. pii: S1879-4068(17)30244.
    Abstract     Related articles   

  1386. WANG F, Jin D, Hua XL, Zhao ZZ, et al
    Investigation of diffusion kurtosis imaging for discriminating tumors from inflammatory lesions after treatment for bladder cancer.
    J Magn Reson Imaging. 2017 Dec 12. doi: 10.1002/jmri.25924.
    Abstract     Related articles   

  1387. ZHU F, Zhang X, Yu Q, Han G, et al
    LncRNA AWPPH inhibits SMAD4 via EZH2 to regulate bladder cancer progression.
    J Cell Biochem. 2017 Dec 12. doi: 10.1002/jcb.26556.
    Abstract     Related articles   

  1388. RAMMANT E, Decaestecker K, Bultijnck R, Sundahl N, et al
    A systematic review of exercise and psychosocial rehabilitation interventions to improve health-related outcomes in patients with bladder cancer undergoing radical cystectomy.
    Clin Rehabil. 2017 Dec 1:269215517746472. doi: 10.1177/0269215517746472.
    Abstract     Related articles   

  1389. LIAO X, Chen J, Liu Y, He A, et al
    Knockdown of long noncoding RNA FGFR3- AS1 induces cell proliferation inhibition, apoptosis and motility reduction in bladder cancer.
    Cancer Biomark. 2017 Nov 27. pii: CBM170354. doi: 10.3233/CBM-170354.
    Abstract     Related articles   

  1390. XIONG J, Xiong K, Bing Z
    Clinical and RNA expression integrated signature for urothelial bladder cancer prognosis.
    Cancer Biomark. 2017 Nov 25. pii: CBM170314. doi: 10.3233/CBM-170314.
    Abstract     Related articles   

  1391. HAQUE W, Lewis GD, Verma V, Darcourt JG, et al
    The role of adjuvant chemotherapy in locally advanced bladder cancer.
    Acta Oncol. 2017 Dec 11:1-7. doi: 10.1080/0284186X.2017.1415461.
    Abstract     Related articles   

  1392. JAMY O, Sonpavde G
    Emerging first line treatment options for bladder cancer: A review of phase II and III therapies in the pipeline.
    Expert Opin Emerg Drugs. 2017 Dec 10. doi: 10.1080/14728214.2017.1416092.
    Abstract     Related articles   

  1393. TAHERI M, Omrani MD, Ghafouri-Fard S
    Long non-coding RNA expression in bladder cancer.
    Biophys Rev. 2017 Dec 8. pii: 10.1007/s12551-017-0379.
    Abstract     Related articles   

  1394. XYLINAS E, Kent M, Dabi Y, Rieken M, et al
    Impact of age on outcomes of patients with non-muscle-invasive bladder cancer treated with immediate postoperative instillation of mitomycin C.
    Urol Oncol. 2017 Dec 5. pii: S1078-1439(17)30595.
    Abstract     Related articles   

  1395. ZHANG Y, Jia L, Zhang Y, Ji W, et al
    Higher expression of FOXOs correlates to better prognosis of bladder cancer.
    Oncotarget. 2017;8:96313-96322.
    Abstract     Related articles   

  1396. SEO HK, Kim SH, Ahn KO, Lee SJ, et al
    Recommended oral sodium bicarbonate administration for urine alkalinization did not affect the concentration of mitomycin-C in non-muscle invasive bladder cancer patients.
    Oncotarget. 2017;8:96117-96125.
    Abstract     Related articles   

  1397. VANTAKU V, Donepudi SR, Ambati CR, Jin F, et al
    Expression of ganglioside GD2, reprogram the lipid metabolism and EMT phenotype in bladder cancer.
    Oncotarget. 2017;8:95620-95631.
    Abstract     Related articles   

  1398. THRESS TM, Cookson MS, Patel S
    Robotic Cystectomy with Intracorporeal Urinary Diversion: Review of Current Techniques and Outcomes.
    Urol Clin North Am. 2018;45:67-77.
    Abstract     Related articles   

  1399. PEARCE SM, Daneshmand S
    Continent Cutaneous Diversion.
    Urol Clin North Am. 2018;45:55-65.
    Abstract     Related articles   

  1400. PIETZAK EJ, Donahue TF, Bochner BH
    Male Neobladder.
    Urol Clin North Am. 2018;45:37-48.
    Abstract     Related articles   

  1401. PERLIN DV, Aleksandrov IV, Zipunnikov VP, Popova M, et al
    [Laparoscopic radical cystectomy: innovations and classics].
    Urologiia. 2017;:26-30.
    Abstract     Related articles   

  1402. CRIST M, Balar A
    Atezolizumab in invasive and metastatic urothelial carcinoma.
    Expert Rev Clin Pharmacol. 2017;10:1295-1301.
    Abstract     Related articles   

  1403. SUEKANE S, Ueda K, Nishihara K, Sasada T, et al
    Personalized peptide vaccination as second-line treatment for metastatic upper tract urothelial carcinoma.
    Cancer Sci. 2017;108:2430-2437.
    Abstract     Related articles   

  1404. KHANI F, Robinson BD
    Precursor Lesions of Urologic Malignancies.
    Arch Pathol Lab Med. 2017;141:1615-1632.
    Abstract     Related articles   

  1405. DI FRANCO CA, Porru D, Giliberto G, Viglio A, et al
    Vaginal metastasis of bladder urothelial carcinoma: Description of a case and revision of literature.
    Arch Ital Urol Androl. 2017;89:156-157.
    Abstract     Related articles   

  1406. RODRIGUEZ PENA MDC, Tregnago AC, Eich ML, Springer S, et al
    Spectrum of genetic mutations in de novo PUNLMP of the urinary bladder.
    Virchows Arch. 2017;471:761-767.
    Abstract     Related articles   

  1407. POPKIROV S, Ayzenberg I, Hahn S, Bauer J, et al
    Rho-associated protein kinase 2 (ROCK2): a new target of autoimmunity in paraneoplastic encephalitis.
    Acta Neuropathol Commun. 2017;5:40.
    Abstract     Related articles   

  1408. LE BORGNE P, Brunhuber C, Baicry F, Zumstein C, et al
    [BCGitis: An unusual complication after intravesical immunotherapy].
    Therapie. 2017;72:509-511.
    Abstract     Related articles   

  1409. ISONO M, Hoffmann MJ, Pinkerneil M, Sato A, et al
    Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine.
    J Exp Clin Cancer Res. 2017;36:1.
    Abstract     Related articles   

  1410. BLANCA PEDREGOSA AM, Sanchez-Gonzalez A, Carrasco Valiente J, Ruiz Garcia JM, et al
    Expression of proteins FGFR3, PI3K, AKT, p21Waf1/Cip1 and cyclins D1 and D3 in patients with T1 bladder tumours: clinical implications and prognostic significance.
    Actas Urol Esp. 2017;41:172-180.
    Abstract     Related articles   

  1411. ANDERSON CB, Rapkin B, Reaves BC, Sun AJ, et al
    Idiographic quality of life assessment before radical cystectomy.
    Psychooncology. 2017;26:206-213.
    Abstract     Related articles   

  1412. SMEDINGA H, Steyerberg EW, Beukers W, van Klaveren D, et al
    Prediction of Multiple Recurrent Events: A Comparison of Extended Cox Models in Bladder Cancer.
    Am J Epidemiol. 2017 May 19. doi: 10.1093.
    Abstract     Related articles   

  1413. HAHN AW, Giri S, Pathak R, Bhatt VR, et al
    Effect of Adjuvant Radiotherapy on Survival in Patients with Locoregional Urothelial Malignancies of the Upper Urinary Tract.
    Anticancer Res. 2016;36:4051-5.
    Abstract     Related articles   

  1414. MANIG L, Kasmann L, Janssen S, Rades D, et al
    Predicting Survival After Irradiation of Metastases from Transitional Carcinoma of the Bladder.
    Anticancer Res. 2016;36:6663-6665.
    Abstract     Related articles   

  1415. HANCOCK BM, McGuire KL, Tsuji S, Reil K, et al
    A Single Intravesical Instillation of VAX014 Inhibits Orthotopic Superficial Bladder Tumor Implantation to Increase Survival.
    Anticancer Res. 2016;36:6243-6248.
    Abstract     Related articles   

  1416. WIECZOREK E, Jablonowski Z, Tomasik B, Gromadzinska J, et al
    Different Gene Expression and Activity Pattern of Antioxidant Enzymes in Bladder Cancer.
    Anticancer Res. 2017;37:841-848.
    Abstract     Related articles   

  1417. IWAMOTO H, Izumi K, Shimura Y, Natsagdorj A, et al
    Metastasectomy Improves Survival in Patients with Metastatic Urothelial Carcinoma.
    Anticancer Res. 2016;36:5557-5561.
    Abstract     Related articles   

  1418. FRIEDMAN P, Lai JP
    Liver Metastasis of Urothelial Carcinoma with Hepatoid Features: An Unusual Morphological Finding.
    Anticancer Res. 2017;37:801-804.
    Abstract     Related articles   

  1419. RADES D, Manig L, Janssen S, Schild SE, et al
    Concurrent Chemotherapy Improves the Overall Survival of Patients Irradiated for Locally Recurrent Bladder Cancer.
    Anticancer Res. 2017;37:1485-1488.
    Abstract     Related articles   

  1420. RADES D, Manig L, Janssen S, Schild SE, et al
    A Survival Score for Patients Assigned to Palliative Radiotherapy for Metastatic Bladder Cancer.
    Anticancer Res. 2017;37:1481-1484.
    Abstract     Related articles   

  1421. SILVA J, Arantes-Rodrigues R, Pinto-Leite R, Faustino-Rocha AI, et al
    Synergistic Effect of Carboplatin and Piroxicam on Two Bladder Cancer Cell Lines.
    Anticancer Res. 2017;37:1737-1745.
    Abstract     Related articles   

  1422. HUDOLIN T, Mengus C, Coulot J, Kastelan Z, et al
    Expression of Indoleamine 2,3-Dioxygenase Gene Is a Feature of Poorly Differentiated Non-muscle-invasive Urothelial Cell Bladder Carcinomas.
    Anticancer Res. 2017;37:1375-1380.
    Abstract     Related articles   

  1423. SHI CS, Li JM, Chin CC, Kuo YH, et al
    Evodiamine Induces Cell Growth Arrest, Apoptosis and Suppresses Tumorigenesis in Human Urothelial Cell Carcinoma Cells.
    Anticancer Res. 2017;37:1149-1159.
    Abstract     Related articles   

  1424. MANIG L, Kasmann L, Janssen S, Schild SE, et al
    Simplified Comorbidity Score and Eastern Cooperative Oncology Group Performance Score Predicts Survival in Patients Receiving Organ-preserving Treatment for Bladder Cancer.
    Anticancer Res. 2017;37:2693-2696.
    Abstract     Related articles   

  1425. KHANAL A, Budhathoki N, Singh VP, Shah BK, et al
    Second Primary Malignancy in Bladder Carcinoma - A Population-based Study.
    Anticancer Res. 2017;37:2033-2036.
    Abstract     Related articles   

  1426. JANSSEN S, Manig L, Schild SE, Rades D, et al
    Radiotherapy of Primary or Recurrent Bladder Cancer in the Very Elderly.
    Anticancer Res. 2017;37:3287-3290.
    Abstract     Related articles   

  1427. ORYWAL K, Jelski W, Werel T, Szmitkowski M, et al
    The Diagnostic Significance of Serum Alcohol Dehydrogenase Isoenzymes and Aldehyde Dehydrogenase Activity in Urinary Bladder Cancer Patients.
    Anticancer Res. 2017;37:3537-3541.
    Abstract     Related articles   

  1428. TANG X, Wang S, An C, DU P, et al
    Preoperative High Neutrophil-to-Lymphocyte Ratio Is Associated with High-grade Bladder Cancer.
    Anticancer Res. 2017;37:4659-4663.
    Abstract     Related articles   

  1429. ZHOU HH, Liu LY, Yu GH, Qu GM, et al
    Analysis of Clinicopathological Features and Prognostic Factors in 39 Cases of Bladder Neuroendocrine Carcinoma.
    Anticancer Res. 2017;37:4529-4537.
    Abstract     Related articles   

  1430. DU P, Wang S, Tang X, An C, et al
    Reduced Expression of Metastasis Suppressor-1 (MTSS1) Accelerates Progression of Human Bladder Uroepithelium Cell Carcinoma.
    Anticancer Res. 2017;37:4499-4505.
    Abstract     Related articles   

  1431. CIMPEAN AM, Tarlui V, Cumpanas AA, Bolintineanu S, et al
    Critical Overview of HER2 Assessement in Bladder Cancer: What Is Missing for a Better Therapeutic Approach?
    Anticancer Res. 2017;37:4935-4942.
    Abstract     Related articles   

  1432. AIZAWA R, Sakamoto M, Orito N, Kono M, et al
    The Use of External-beam Radiotherapy for Muscle-invasive Bladder Cancer in Elderly or Medically-fragile Patients.
    Anticancer Res. 2017;37:5761-5766.
    Abstract     Related articles   

  1433. HAQUE W, Verma V, Butler EB, Teh BS, et al
    Radical Cystectomy Versus Chemoradiation for Muscle-invasive Bladder Cancer: Impact of Treatment Facility and Sociodemographics.
    Anticancer Res. 2017;37:5603-5608.
    Abstract     Related articles   

  1434. D'ANDREA D, Moschini M, Soria F, Gust KM, et al
    ABO Blood Group and Rhesus Factor Are Not Associated with Outcomes After Radical Cystectomy for Non-metastatic Urothelial Carcinoma of the Bladder.
    Anticancer Res. 2017;37:5747-5753.
    Abstract     Related articles   

  1435. SCHINZARI G, Monterisi S, Pierconti F, Nazzicone G, et al
    Neoadjuvant Chemotherapy for Patients with Muscle-invasive Urothelial Bladder Cancer Candidates for Curative Surgery: A Prospective Clinical Trial Based on Cisplatin Feasibility.
    Anticancer Res. 2017;37:6453-6458.
    Abstract     Related articles   

  1436. LIAW CC, Chuang CK, Chang YH, Liao TY, et al
    Bladder Urothelial Carcinoma with Peritoneal Involvement: Benefit of Continuous Maintenance Chemotherapy.
    Anticancer Res. 2017;37:6443-6451.
    Abstract     Related articles   

  1437. HSU FT, Sun CC, Wu CH, Lee YJ, et al
    Regorafenib Induces Apoptosis and Inhibits Metastatic Potential of Human Bladder Carcinoma Cells.
    Anticancer Res. 2017;37:4919-4926.
    Abstract     Related articles   

  1438. CHEN CC, Huang CP, Tsai YT, Hseih TF, et al
    The Genomic Alterations of 5alpha-Reductases and Their Inhibitor Finasteride's Effect in Bladder Cancer.
    Anticancer Res. 2017;37:6893-6898.
    Abstract     Related articles   

  1439. MINAMI S, Matsumoto K, Nagashio R, Hagiuda D, et al
    Analysis of Autoantibodies Related to Tumor Progression in Sera from Patients with High-grade Non-muscle-invasive Bladder Cancer.
    Anticancer Res. 2017;37:6705-6714.
    Abstract     Related articles   

  1440. SYRING I, Weiten R, Muller T, Schmidt D, et al
    The Contrasting Role of the Mediator Subunit MED30 in the Progression of Bladder Cancer.
    Anticancer Res. 2017;37:6685-6695.
    Abstract     Related articles   

  1441. HUSSEIN AA, Hinata N, Dibaj S, May PR, et al
    Development, Validation and Clinical Application of Pelvic Lymphadenectomy Assessment and Completion Evaluation (PLACE): Intraoperative Assessment of Lymph Node Dissection after Robot-Assisted Radical Cystectomy for Bladder Cancer.
    BJU Int. 2016 Dec 17. doi: 10.1111/bju.13748.
    Abstract     Related articles   

  1442. WOLDU SL, Bagrodia A, Lotan Y
    Guideline of Guidelines - Non-Muscle Invasive Bladder Cancer.
    BJU Int. 2017 Jan 6. doi: 10.1111/bju.13760.
    Abstract     Related articles   

  1443. VESKIMAE E, Neuzillet Y, Rouanne M, MacLennan S, et al
    Systematic review of the oncological and functional outcomes of pelvic organ-preserving cystectomy compared with standard radical cystectomy in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer.
    BJU Int. 2017 Feb 20. doi: 10.1111/bju.13819.
    Abstract     Related articles   

  1444. HAYNE D, Stockler M, McCombie SP, Lawrence N, et al
    The BCG + Mitomycin trial for high risk non-muscle-invasive bladder cancer: Progress report and lessons learned.
    BJU Int. 2017 Apr 9. doi: 10.1111/bju.13873.
    Abstract     Related articles   

  1445. MATARAZA JM, Gotwals P
    Recent advances in immuno-oncology and its application to urological cancers.
    BJU Int. 2016;118:506-14.
    Abstract     Related articles   

  1446. LONGO N, Imbimbo C, Fusco F, Ficarra V, et al
    Complications and quality of life in elderly patients with several comorbidities undergoing cutaneous ureterostomy with single stoma or ileal conduit after radical cystectomy.
    BJU Int. 2016;118:521-6.
    Abstract     Related articles   

  1447. ZHANG C, Ma X, Du J, Yao Z, et al
    MicroRNA-30a as a prognostic factor in urothelial carcinoma of bladder inhibits cellular malignancy by antagonising Notch1.
    BJU Int. 2016;118:578-89.
    Abstract     Related articles   

  1448. MEYER CP, Rios Diaz AJ, Dalela D, Hanske J, et al
    Wound dehiscence in a sample of 1 776 cystectomies: identification of predictors and implications for outcomes.
    BJU Int. 2016;117.
    Abstract     Related articles   

  1449. NGO B, Papa N, Perera M, Bolton D, et al
    Bladder cancer diagnosis during haematuria investigation - implications for practice guidelines.
    BJU Int. 2017;119 Suppl 5:53-54.
    Abstract     Related articles   

  1450. HAYNE D
    Bladder cancer - Old lessons yet to be learned.
    BJU Int. 2017;119 Suppl 5:7.
    Abstract     Related articles   

  1451. NGO B, Perera M, Papa N, Bolton D, et al
    Factors affecting the timeliness and adequacy of haematuria assessment in bladder cancer: a systematic review.
    BJU Int. 2017;119 Suppl 5:10-18.
    Abstract     Related articles   

    Bladder cancer- time for a higher profile in our region.
    BJU Int. 2017;119 Suppl 5:5.
    Abstract     Related articles   

  1453. GOLOMBOS DM, O'Malley P, Lewicki P, Stone BV, et al
    Robot-assisted partial cystectomy: perioperative outcomes and early oncological efficacy.
    BJU Int. 2017;119:128-134.
    Abstract     Related articles   

  1454. AFSHAR M, Goodfellow H, Jackson-Spence F, Evison F, et al
    Centralisation of radical cystectomies for bladder cancer in England, a decade on from the 'Improving Outcomes Guidance': The case for super centralisation.
    BJU Int. 2017 Jun 8. doi: 10.1111/bju.13929.
    Abstract     Related articles   

  1455. NGO B, Papa N, Perera M, Bolton D, et al
    Predictors of delay to cystoscopy and adequacy of investigations in patients with haematuria.
    BJU Int. 2017;119 Suppl 5:19-25.
    Abstract     Related articles   

  1456. MCCOMBIE SP, Bangash HK, Kuan M, Thyer I, et al
    Delays in the diagnosis and initial treatment of bladder cancer in Western Australia.
    BJU Int. 2017 Jun 29. doi: 10.1111/bju.13939.
    Abstract     Related articles   

  1457. SOAVE A, Riethdorf S, Dahlem R, Minner S, et al
    Detection and oncological effect of circulating tumour cells in patients with variant urothelial carcinoma histology treated with radical cystectomy.
    BJU Int. 2017;119:854-861.
    Abstract     Related articles   

  1458. WAINGANKAR N, Mallin K, Smaldone M, Egleston BL, et al
    Assessing the relative influence of hospital and surgeon volume on short-term mortality after radical cystectomy.
    BJU Int. 2017;120:239-245.
    Abstract     Related articles   

  1459. MILLER C, Campain NJ, Dbeis R, Daugherty M, et al
    Introduction of robot-assisted radical cystectomy within an established enhanced recovery programme.
    BJU Int. 2017;120:265-272.
    Abstract     Related articles   

    Positive messages for bladder cancer management in negative sentinel lymph node study.
    BJU Int. 2017;120:302-303.
    Abstract     Related articles   

  1461. MARCHIONI M, Primiceri G, Cindolo L, Hampton LJ, et al
    Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis.
    BJU Int. 2017;120:313-319.
    Abstract     Related articles   

  1462. BLUTE ML JR, Kucherov V, Rushmer TJ, Damodaran S, et al
    Reduced estimated glomerular filtration rate (eGFR <60 mL/min/1.73 m2 ) at first transurethral resection of bladder tumour is a significant predictor of subsequent recurrence and progression.
    BJU Int. 2017;120:387-393.
    Abstract     Related articles   

  1463. CHAPPIDI MR, Kates M, Tosoian JJ, Johnson MH, et al
    Evaluation of gender-based disparities in time from initial haematuria presentation to upper tract urothelial carcinoma diagnosis: analysis of a nationwide insurance claims database.
    BJU Int. 2017;120:377-386.
    Abstract     Related articles   

  1464. BAILEY GC, Boorjian SA, Ziegelmann MJ, Westerman ME, et al
    Urinary collecting system invasion is associated with poor survival in patients with clear-cell renal cell carcinoma.
    BJU Int. 2017;119:585-590.
    Abstract     Related articles   

  1465. HINATA N, Hussein AA, George S, Trump DL, et al
    Impact of suboptimal neoadjuvant chemotherapy on peri-operative outcomes and survival after robot-assisted radical cystectomy: a multicentre multinational study.
    BJU Int. 2017;119:605-611.
    Abstract     Related articles   

  1466. LI R, Metcalfe MJ, Ferguson Rd JE, Mokkapati S, et al
    Effects of Thiazolidinedione in Patients with Active Bladder Cancer.
    BJU Int. 2017 Sep 5. doi: 10.1111/bju.14009.
    Abstract     Related articles   

  1467. VETTERLEIN MW, Gild P, Kluth LA, Seisen T, et al
    Perioperative Allogeneic Blood Transfusion Does Not Adversely Impact Oncological Outcomes After Radical Cystectomy for Urinary Bladder Cancer - a Propensity Score-weighted European Multicenter Study.
    BJU Int. 2017 Sep 14. doi: 10.1111/bju.14012.
    Abstract     Related articles   

  1468. PICHLER R, Fritz J, Tulchiner G, Klinglmair G, et al
    Increased Accuracy of a novel mRNA-based Urine Test for Bladder Cancer Surveillance.
    BJU Int. 2017 Sep 20. doi: 10.1111/bju.14019.
    Abstract     Related articles   

  1469. SMITH AB, Jaeger B, Pinheiro LC, Edwards LJ, et al
    The impact of bladder cancer on health-related quality of life.
    BJU Int. 2017 Oct 8. doi: 10.1111/bju.14047.
    Abstract     Related articles   

  1470. XIA L, Taylor BL, Newton AD, Malhotra A, et al
    Early Discharge and Post-Discharge Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer.
    BJU Int. 2017 Oct 24. doi: 10.1111/bju.14058.
    Abstract     Related articles   

  1471. AHMADI N, Clifford TG, Miranda G, Cai J, et al
    Impact of body mass index on robot-assisted radical cystectomy with intracorporeal urinary diversion.
    BJU Int. 2017;120:689-694.
    Abstract     Related articles   

  1472. HUDDART RA, Birtle A, Maynard L, Beresford M, et al
    Clinical and patient-reported outcomes of SPARE - a randomised feasibility study of selective bladder preservation versus radical cystectomy.
    BJU Int. 2017;120:639-650.
    Abstract     Related articles   

  1473. KINNEAR N, Smith R, Hennessey DB, Bolton D, et al
    Implementation rates of uro-oncology multidisciplinary meeting decisions.
    BJU Int. 2017;120 Suppl 3:15-20.
    Abstract     Related articles   

  1474. Bladder cancer: diagnosis and management of bladder cancer: (c) NICE (2015) Bladder cancer: diagnosis and management of bladder cancer.
    BJU Int. 2017;120:755-765.
    Abstract     Related articles   

  1475. MAURICE MJ, Kaouk JH
    Robotic radical perineal cystectomy and extended pelvic lymphadenectomy: initial investigation using a purpose-built single-port robotic system.
    BJU Int. 2017;120:881-884.
    Abstract     Related articles   

  1476. LIEDBERG F, Gudjonsson S, Xu A, Bendahl PO, et al
    Long-term third-party assessment of results after continent cutaneous diversion with Lundiana pouch.
    BJU Int. 2017;120:530-536.
    Abstract     Related articles   

  1477. CHOUDHURY A, West CM, Porta N, Hall E, et al
    The predictive and prognostic value of tumour necrosis in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004).
    Br J Cancer. 2017 Jan 26. doi: 10.1038/bjc.2017.
    Abstract     Related articles   

  1478. SAKAGUCHI T, Yoshino H, Yonemori M, Miyamoto K, et al
    Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer.
    Br J Cancer. 2017 Mar 21. doi: 10.1038/bjc.2017.
    Abstract     Related articles   

  1479. DESCOTES F, Kara N, Decaussin-Petrucci M, Piaton E, et al
    Non-invasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urine.
    Br J Cancer. 2017 Jul 6. doi: 10.1038/bjc.2017.
    Abstract     Related articles   

  1480. KOSHIARIS C, Aveyard P, Oke J, Ryan R, et al
    Smoking cessation and survival in lung, upper aero-digestive tract and bladder cancer: cohort study.
    Br J Cancer. 2017 Sep 12. doi: 10.1038/bjc.2017.
    Abstract     Related articles   

  1481. MORERA DS, Hennig MS, Talukder A, Lokeshwar SD, et al
    Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets.
    Br J Cancer. 2017 Oct 3. doi: 10.1038/bjc.2017.
    Abstract     Related articles   

  1482. KASHIWAGI E, Inoue S, Mizushima T, Chen J, et al
    Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression.
    Br J Cancer. 2017 Nov 9. doi: 10.1038/bjc.2017.
    Abstract     Related articles   

  1483. PACKIAM VT, Johnson SC, Steinberg GD
    Non-muscle-invasive bladder cancer: Intravesical treatments beyond Bacille Calmette-Guerin.
    Cancer. 2017;123:390-400.
    Abstract     Related articles   

  1484. WANG H, Hoda RS, Faquin W, Rossi ED, et al
    FNA biopsy of secondary nonlymphomatous malignancies in salivary glands: A multi-institutional study of 184 cases.
    Cancer. 2017;125:91-103.
    Abstract     Related articles   

  1485. MACLEOD LC, Pham KN, Agoff SN, Dahl KL, et al
    Cytologic persistence of malignant cells after transurethral resection of bladder tumors: Implications for concomitant manipulation of the urinary tract at the time of endoscopic resection.
    Cancer. 2017;125:114-119.
    Abstract     Related articles   

  1486. KORPICS MC, Block AM, Martin B, Hentz C, et al
    Concurrent chemotherapy is associated with improved survival in elderly patients with bladder cancer undergoing radiotherapy.
    Cancer. 2017 Jun 5. doi: 10.1002/cncr.30719.
    Abstract     Related articles   

  1487. OJERHOLM E, Smith A, Hwang WT, Christodouleas JP, et al
    Reply to Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710.
    Cancer. 2017 Jun 30. doi: 10.1002/cncr.30871.
    Abstract     Related articles   

  1488. DOLAN RD, McMillan DC
    Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710.
    Cancer. 2017 Jun 30. doi: 10.1002/cncr.30872.
    Abstract     Related articles   

  1489. CAHN DB, Handorf EA, Ghiraldi EM, Ristau BT, et al
    Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer.
    Cancer. 2017 Jul 25. doi: 10.1002/cncr.30900.
    Abstract     Related articles   

  1490. VETTERLEIN MW, Wankowicz SAM, Seisen T, Lander R, et al
    Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology.
    Cancer. 2017 Jul 25. doi: 10.1002/cncr.30907.
    Abstract     Related articles   

  1491. RIMAR KJ, Tran PT, Matulewicz RS, Hussain M, et al
    The emerging role of homologous recombination repair and PARP inhibitors in genitourinary malignancies.
    Cancer. 2017;123:1912-1924.
    Abstract     Related articles   

  1492. SCOTT SN, Ostrovnaya I, Lin CM, Bouvier N, et al
    Next-generation sequencing of urine specimens: A novel platform for genomic analysis in patients with non-muscle-invasive urothelial carcinoma treated with bacille Calmette-Guerin.
    Cancer. 2017;125:416-426.
    Abstract     Related articles   

  1493. KOPP RP, Stratton KL, Glogowski E, Schrader KA, et al
    Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma.
    Cancer. 2017;123:2452-2458.
    Abstract     Related articles   

  1494. PIATON E, Advenier AS, Carre C, Decaussin-Petrucci M, et al
    p16/Ki-67 dual labeling and urinary cytology results according to the New Paris System for Reporting Urinary Cytology: Impact of extended follow-up.
    Cancer. 2017;125:552-562.
    Abstract     Related articles   

  1495. WELTY CJ, Sanford TH, Wright JL, Carroll PR, et al
    The Cancer of the Bladder Risk Assessment (COBRA) score: Estimating mortality after radical cystectomy.
    Cancer. 2017;123:4574-4582.
    Abstract     Related articles   

  1496. OWCZAREK TB, Kobayashi T, Ramirez R, Rong L, et al
    ARF confers a context-dependent response to chemotherapy in muscle invasive bladder cancer.
    Cancer Res. 2017 Jan 12. pii: canres.2621.2016.
    Abstract     Related articles   

  1497. NICHOLSON J, Jevons S, Groselj B, Ellermann S, et al
    E3 ligase cIAP2 mediates downregulation of MRE11 and radiosensitization in response to HDAC inhibition in bladder cancer.
    Cancer Res. 2017 Mar 31. pii: canres.3232.2016.
    Abstract     Related articles   

  1498. VAN KAMPEN JGM, van Hooij O, Jansen CF, Smit FP, et al
    miRNA-520f Reverses Epithelial-to-Mesenchymal Transition by Targeting ADAM9 and TGFBR2.
    Cancer Res. 2017;77:2008-2017.
    Abstract     Related articles   

  1499. MIAO L, Liu Q, Lin CM, Luo C, et al
    Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors.
    Cancer Res. 2017;77:719-731.
    Abstract     Related articles   

  1500. GOLDSTEIN JT, Berger AC, Shih J, Duke FF, et al
    Genomic activation of PPARG reveals a candidate therapeutic axis in bladder cancer.
    Cancer Res. 2017 Sep 18. pii: canres.1701.2017.
    Abstract     Related articles   

  1501. DUEX JE, Owens C, Chauca-Diaz A, Dancik GM, et al
    Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis.
    Cancer Res. 2017;77:4858-4867.
    Abstract     Related articles   

  1502. SELINSKI S, Blaszkewicz M, Ickstadt K, Gerullis H, et al
    Identification and replication of the interplay of four genetic high risk variants for urinary bladder cancer.
    Carcinogenesis. 2017 Sep 27. doi: 10.1093.
    Abstract     Related articles   

  1503. GUIN S, Ru Y, Agarwal N, Lew CR, et al
    Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid Synthesis.
    Clin Cancer Res. 2016;22:1274-83.
    Abstract     Related articles   

  1504. SIN ML, Mach KE, Sinha R, Wu F, et al
    Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics.
    Clin Cancer Res. 2017 Feb 13. pii: clincanres.2610.2016.
    Abstract     Related articles   

  1505. YANG L, Taylor J, Eustace A, Irlam J, et al
    A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High Risk Bladder Cancer Patients.
    Clin Cancer Res. 2017 Apr 11. pii: clincanres.0038.2017.
    Abstract     Related articles   

  1506. WEN T, Yang Z, He L, Lin K, et al
    The KMT1A-GATA3-STAT3 circuit is a novel self-renewal signaling of human bladder cancer stem cells.
    Clin Cancer Res. 2017 Aug 1. pii: clincanres.0882.2017.
    Abstract     Related articles   

  1507. VANDEKERKHOVE GR, Todenhofer T, Annala M, Struss WJ, et al
    <span style="font-weight: 400;">Circulating tumor DNA reveals clinically-actionable somatic genome of metastatic bladder cancer</span>.
    Clin Cancer Res. 2017 Jul 31. pii: clincanres.1140.2017.
    Abstract     Related articles   

  1508. KATES M, Date A, Yoshida T, Afzal U, et al
    Preclincial Evaluation of Intravesical Cisplatin Nanoparticles for Non-Muscle-Invasive Bladder Cancer.
    Clin Cancer Res. 2017 Aug 14. pii: clincanres.1082.2017.
    Abstract     Related articles   

  1509. ZENG S, Zhu Y, Ma AH, Yu W, et al
    The Phosphatidylinositol 3-kinase Pathway as a Potential Therapeutic Target in Bladder Cancer.
    Clin Cancer Res. 2017 Aug 14. pii: clincanres.0033.2017.
    Abstract     Related articles   

  1510. WU S, Zheng J, Li Y, Yu H, et al
    A Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer.
    Clin Cancer Res. 2017 Sep 5. pii: clincanres.1510.2017.
    Abstract     Related articles   

  1511. MARTINEZ VG, Rubio C, Martinez-Fernandez M, Segovia C, et al
    BMP4 induces M2 macrophage polarization and favors tumor progression in bladder cancer.
    Clin Cancer Res. 2017 Sep 19. pii: clincanres.1004.2017.
    Abstract     Related articles   

  1512. CHEN CH, Changou C, Hsieh TH, Lee YC, et al
    Dual Inhibition of PIK3C3 and FGFR as a New Therapeutic Approach to Treat Bladder Cancer.
    Clin Cancer Res. 2017 Dec 8. pii: 1078-0432.CCR-17-2066.
    Abstract     Related articles   

  1513. HERRMANN TR, Wolters M, Kramer MW
    Transurethral en bloc resection of nonmuscle invasive bladder cancer: trend or hype.
    Curr Opin Urol. 2016 Dec 28. doi: 10.1097/MOU.0000000000000377.
    Abstract     Related articles   

  1514. SELTZ LM, Herrell SD
    Applications of spectroscopy in diagnosis, staging, and treatment of urologic malignancies.
    Curr Opin Urol. 2016;26:259-63.
    Abstract     Related articles   

  1515. GILD P, Ehdaie B, Kluth LA
    Effect of obesity on bladder cancer and renal cell carcinoma incidence and survival.
    Curr Opin Urol. 2017 Jun 24. doi: 10.1097/MOU.0000000000000425.
    Abstract     Related articles   

  1516. SORIA F, Marra G, Capoun O, Soukup V, et al
    Prevention of bladder cancer incidence and recurrence: tobacco use.
    Curr Opin Urol. 2017 Oct 3. doi: 10.1097/MOU.0000000000000453.
    Abstract     Related articles   

  1517. MARI A, Abufaraj M, Gust KM, Shariat SF, et al
    Novel endoscopic visualization techniques for bladder cancer detection: a review of the contemporary literature.
    Curr Opin Urol. 2017 Oct 17. doi: 10.1097/MOU.0000000000000459.
    Abstract     Related articles   

  1518. FANKHAUSER CD, Mostafid H
    Prevention of bladder cancer incidence and recurrence: nutrition and lifestyle.
    Curr Opin Urol. 2018;28:88-92.
    Abstract     Related articles   

  1519. KAWADA T
    Bladder cancer and smoking with special reference to education.
    Eur J Cancer. 2017;75:1-2.
    Abstract     Related articles   

  1520. KHAN MS, Gan C, Ahmed K, Ismail AF, et al
    A Single-centre Early Phase Randomised Controlled Three-arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL).
    Eur Urol. 2016;69:613-21.
    Abstract     Related articles   

  1521. SELINSKI S, Gerullis H, Otto T, Roth E, et al
    Ultra-slow N-Acetyltransferase 2 Is Associated with Recurrence-free Time in Bladder Cancer Patients.
    Eur Urol. 2016 Dec 28. pii: S0302-2838(16)30904.
    Abstract     Related articles   

  1522. GIACALONE NJ, Shipley WU, Clayman RH, Niemierko A, et al
    Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.
    Eur Urol. 2017 Jan 9. pii: S0302-2838(16)30924.
    Abstract     Related articles   

    Re: Management of Nonmuscle Invasive Bladder Cancer: A Comprehensive Analysis of Guidelines from the Unites States, Europe, and Asia.
    Eur Urol. 2017 Jan 7. pii: S0302-2838(16)30921.
    Abstract     Related articles   

  1524. CHRISTENSEN E, Birkenkamp-Demtroder K, Nordentoft I, Hoyer S, et al
    Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer.
    Eur Urol. 2017 Jan 6. pii: S0302-2838(16)30920.
    Abstract     Related articles   

  1525. ROTH B
    Re: Prediction of Lymph Node Metastasis in Patients with Bladder Cancer Using Whole Transcriptome Gene Expression Signatures.
    Eur Urol. 2017 Jan 13. pii: S0302-2838(17)30012.
    Abstract     Related articles   

  1526. MARQUES M, Real FX
    PIcKing on Fibroblast Growth Factor Receptors as Bladder Cancer Therapeutic Targets.
    Eur Urol. 2017 Feb 14. pii: S0302-2838(17)30087.
    Abstract     Related articles   

  1527. COTTE J, Roupret M
    Re: Long-term Oncological Outcomes of an Active Surveillance Program in Recurrent Low Grade Ta Bladder Cancer.
    Eur Urol. 2017 Feb 18. pii: S0302-2838(17)30106.
    Abstract     Related articles   

  1528. MAY M, Lebentrau S, Brookman-May SD
    Re: Decreased Overall and Bladder Cancer-specific Mortality with Adjuvant Chemotherapy After Radical Cystectomy: Multivariable Competing Risk Analysis.
    Eur Urol. 2017 Feb 20. pii: S0302-2838(17)30107.
    Abstract     Related articles   

  1529. BOKARICA P, Hrkac A, Gilja I
    Re: J. Alfred Witjes, Thierry Lebret, Eva M. Comperat, et al. Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. Eur Urol 2017;71:462-75.
    Eur Urol. 2017 Mar 6. pii: S0302-2838(17)30126.
    Abstract     Related articles   

  1530. CHOI W, Ochoa A, McConkey DJ, Aine M, et al
    Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset.
    Eur Urol. 2017 Mar 29. pii: S0302-2838(17)30175.
    Abstract     Related articles   

  1531. SEILER R, Oo HZ, Tortora D, Clausen TM, et al
    An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer.
    Eur Urol. 2017 Apr 10. pii: S0302-2838(17)30232.
    Abstract     Related articles   

  1532. SEILER R, Ashab HA, Erho N, van Rhijn BW, et al
    Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.
    Eur Urol. 2017 Apr 5. pii: S0302-2838(17)30251.
    Abstract     Related articles   

  1533. BLACK PC
    Seeking the Molecular Truth in Bladder Cancer: Biology=Genomex(Transcriptome)2.
    Eur Urol. 2017 Apr 17. pii: S0302-2838(17)30286.
    Abstract     Related articles   

  1534. GALSKY MD, Sfakianos JP, Ferket BS
    Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Are Things Now Getting Personal?
    Eur Urol. 2017 Apr 19. pii: S0302-2838(17)30292.
    Abstract     Related articles   

  1535. SOUKUP V, Capoun O, Cohen D, Hernandez V, et al
    Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel
    Eur Urol. 2017 Apr 27. pii: S0302-2838(17)30323.
    Abstract     Related articles   

  1536. KULKARNI GS, Klaassen Z
    Trimodal Therapy is Inferior to Radical Cystectomy for Muscle-invasive Bladder Cancer using Population-level Data: Is There Evidence in the (Lack of) Details?
    Eur Urol. 2017 May 5. pii: S0302-2838(17)30338.
    Abstract     Related articles   

  1537. BABJUK M
    Bladder Cancer in the Elderly.
    Eur Urol. 2017 May 3. pii: S0302-2838(17)30326.
    Abstract     Related articles   

  1538. FONTEYNE V, Ost P, Bellmunt J, Droz JP, et al
    Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review.
    Eur Urol. 2017 May 3. pii: S0302-2838(17)30230.
    Abstract     Related articles   

  1539. ERIKSSON P, Sjodahl G, Liedberg F
    Re: Thomas Powles, Robert A. Huddart, Tony Elliott, et al. Phase III, Double-blind, Randomized Trial that Compared Maintenance Lapatinib versus Placebo after First-line Chemotherapy in Patients with Human Epidermal Growth Factor Receptor 1/2-positive
    Eur Urol. 2017 May 29. pii: S0302-2838(17)30455.
    Abstract     Related articles   

  1540. SEISEN T, Cole AP, Trinh QD
    Reply from Authors re: Girish S. Kulkarni, Zachary Klaassen. Trimodal Therapy is Inferior to Radical Cystectomy for Muscle-invasive Bladder Cancer using Population-level Data: Is There Evidence in the (Lack of) Details? Eur Urol. In press. http://doi.
    Eur Urol. 2017 May 29. pii: S0302-2838(17)30411.
    Abstract     Related articles   

  1541. D'ANDREA D, Shariat SF
    Re: Comparative Effectiveness of Treatment Strategies for Bladder Cancer with Clinical Evidence of Regional Lymph Node Involvement.
    Eur Urol. 2017 Jun 6. pii: S0302-2838(17)30481.
    Abstract     Related articles   

  1542. DYRSKJOT L, Reinert T, Algaba F, Christensen E, et al
    Prognostic Impact of a 12-gene Progression Score in Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study.
    Eur Urol. 2017 Jun 2. pii: S0302-2838(17)30475.
    Abstract     Related articles   

  1543. PIETZAK EJ, Bagrodia A, Cha EK, Drill EN, et al
    Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets.
    Eur Urol. 2017 Jun 2. pii: S0302-2838(17)30466.
    Abstract     Related articles   

  1544. POWLES T, Gomez de Liano A, Ackerman C
    Reply to Pontus Eriksson, Gottfrid Sjodahl, and Fredrik Liedberg's Letter to the Editor re: Thomas Powles, Robert A. Huddart, Tony Elliott, et al. Phase III, Double-blind, Randomized Trial that Compared Maintenance Lapatinib versus Placebo after First
    Eur Urol. 2017 Jun 9. pii: S0302-2838(17)30453.
    Abstract     Related articles   

  1545. GIACALONE NJ, Niemierko A, Shipley WU, Efstathiou JA, et al
    Reply to Saeid Safiri and Erfan Ayubi's Letter to the Editor re: Nicholas J. Giacalone, William U. Shipley, Rebecca H. Clayman, et al. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: A
    Eur Urol. 2017 Jun 19. pii: S0302-2838(17)30502.
    Abstract     Related articles   

  1546. BOSSCHIETER J, Vis AN, van der Poel HG, Moonen LM, et al
    Robot-assisted Laparoscopic Implantation of Brachytherapy Catheters in Bladder Cancer.
    Eur Urol. 2017 Jun 12. pii: S0302-2838(17)30494.
    Abstract     Related articles   

  1547. SAFIRI S, Ayubi E
    Re: Nicholas J. Giacalone, William U. Shipley, Rebecca H. Clayman, et al. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Expe
    Eur Urol. 2017 Jun 22. pii: S0302-2838(17)30503.
    Abstract     Related articles   

  1548. BOSSCHIETER J, Nieuwenhuijzen JA, van Ginkel T, Vis AN, et al
    Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in 2243 patients.
    Eur Urol. 2017 Jul 10. pii: S0302-2838(17)30538.
    Abstract     Related articles   

  1549. LEOW JJ, Cole AP, Seisen T, Bellmunt J, et al
    Variations in the Costs of Radical Cystectomy for Bladder Cancer in the USA.
    Eur Urol. 2017 Aug 9. pii: S0302-2838(17)30640.
    Abstract     Related articles   

  1550. BIRKENKAMP-DEMTRODER K, Christensen E, Nordentoft I, Knudsen M, et al
    Monitoring Treatment Response and Metastatic Relapse in Advanced Bladder Cancer by Liquid Biopsy Analysis.
    Eur Urol. 2017 Sep 25. pii: S0302-2838(17)30775.
    Abstract     Related articles   

  1551. OHNO Y
    Re: Low Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts for Good Outcomes in Patients Receiving Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle Invasive Bladder Cancer.
    Eur Urol. 2017 Sep 26. pii: S0302-2838(17)30780.
    Abstract     Related articles   

  1552. MAIA MC, Grivas P, Agarwal N, Pal SK, et al
    Circulating Tumor DNA in Bladder Cancer: Novel Applications and Future Directions.
    Eur Urol. 2017 Oct 30. pii: S0302-2838(17)30902.
    Abstract     Related articles   

  1553. ABUFARAJ M, Dalbagni G, Daneshmand S, Horenblas S, et al
    The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review.
    Eur Urol. 2017 Nov 6. pii: S0302-2838(17)30840.
    Abstract     Related articles   

  1554. LINSCOTT JA, Smith AB, Sammon JD
    Re: Woonyoung Choi, Andrea Ochoa, David J. McConkey, et al. Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset. Eur Urol 2017;72:354-65.
    Eur Urol. 2017 Nov 9. pii: S0302-2838(17)30971.
    Abstract     Related articles   

  1555. CHOI W, McConkey D
    Reply to Joshua A. Linscott, Angela B. Smith, and Jesse D. Sammon's Letter to the Editor re: Woonyoung Choi, Andrea Ochoa, David J. McConkey, et al. Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in The Cancer Genome Atl
    Eur Urol. 2017 Nov 23. pii: S0302-2838(17)30979.
    Abstract     Related articles   

  1556. ODDENS JR, de Reijke TM
    The Current State of Predicting Response on Bacillus Calmette-Guerin Treatment for Nonmuscle Invasive Bladder Cancer is Not Yet Useful for Patients but Attributes to Understanding Its Mechanisms of Action.
    Eur Urol. 2017 Nov 30. pii: S0302-2838(17)31006.
    Abstract     Related articles   

  1557. OOSTERLINCK W, Decaestecker K
    Re: Active Surveillance for Low-risk Nonmuscle Invasive Bladder Cancer (NMIBC): a Confirmatory and Resource Consumption Study from Bladder Cancer Italian Active Surveillance (BIAS) Project.
    Eur Urol. 2017 Dec 7. pii: S0302-2838(17)31018.
    Abstract     Related articles   

    Re: Comprehensive Molecular Characterization of Muscle Invasive Bladder Cancer.
    Eur Urol. 2017 Dec 5. pii: S0302-2838(17)31007.
    Abstract     Related articles   

  1559. HADKHALE K, Martinsen JI, Weiderpass E, Kjaerheim K, et al
    Occupational exposure to solvents and bladder cancer: A population-based case control study in Nordic countries.
    Int J Cancer. 2016 Dec 29. doi: 10.1002/ijc.30593.
    Abstract     Related articles   

  1560. SOAVE A, Riethdorf S, Dahlem R, von Amsberg G, et al
    A nonrandomized, prospective, clinical study on the impact of circulating tumor cells on outcomes of urothelial carcinoma of the bladder patients treated with radical cystectomy with or without adjuvant chemotherapy.
    Int J Cancer. 2017;140:381-389.
    Abstract     Related articles   

  1561. BOTTERI E, Ferrari P, Roswall N, Tjonneland A, et al
    Alcohol consumption and risk of urothelial cell bladder cancer in the European Prospective Investigation into Cancer and Nutrition cohort.
    Int J Cancer. 2017 Jul 19. doi: 10.1002/ijc.30894.
    Abstract     Related articles   

  1562. MASAOKA H, Matsuo K, Sawada N, Yamaji T, et al
    Alcohol consumption and bladder cancer risk with or without the flushing response: The Japan Public Health Center-based Prospective Study.
    Int J Cancer. 2017 Sep 5. doi: 10.1002/ijc.31028.
    Abstract     Related articles   

  1563. RAVA M, Czachorowski MJ, Silverman D, Marquez M, et al
    Asthma status is associated with decreased risk of aggressive urothelial bladder cancer.
    Int J Cancer. 2017 Sep 22. doi: 10.1002/ijc.31066.
    Abstract     Related articles   

  1564. SHI X, Zhang X, Li J, Mo L, et al
    PD-1 blockade enhances the anti-tumor efficacy of GM-CSF surface-modified bladder cancer stem cells vaccine.
    Int J Cancer. 2017 Dec 15. doi: 10.1002/ijc.31219.
    Abstract     Related articles   

  1565. WESTHOFF E, Wu X, Kiemeney LA, Lerner SP, et al
    Dietary patterns and risk of recurrence and progression in non-muscle-invasive bladder cancer.
    Int J Cancer. 2017 Dec 13. doi: 10.1002/ijc.31214.
    Abstract     Related articles   

  1566. INOUE-CHOI M, Hartge P, Liao LM, Caporaso N, et al
    Association between long-term low-intensity cigarette smoking and incidence of smoking-related cancer in the national institutes of health-AARP cohort.
    Int J Cancer. 2018;142:271-280.
    Abstract     Related articles   

  1567. HUSSAIN SA, Palmer DH, Syn WK, Sacco JJ, et al
    Gene expression profiling in bladder cancer identifies potential therapeutic targets.
    Int J Oncol. 2017 Mar 2. doi: 10.3892/ijo.2017.3893.
    Abstract     Related articles   

  1568. FENG C, Sun P, Hu J, Feng H, et al
    miRNA-556-3p promotes human bladder cancer proliferation, migration and invasion by negatively regulating DAB2IP expression.
    Int J Oncol. 2017 Apr 20. doi: 10.3892/ijo.2017.3969.
    Abstract     Related articles   

  1569. KIM WT, Seo SP, Byun YJ, Kang HW, et al
    Garlic extract in bladder cancer prevention: Evidence from T24 bladder cancer cell xenograft model, tissue microarray, and gene network analysis.
    Int J Oncol. 2017 May 11. doi: 10.3892/ijo.2017.3993.
    Abstract     Related articles   

  1570. XIONG Y, Huang F, Li X, Chen Z, et al
    CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer.
    Int J Oncol. 2017 May 17. doi: 10.3892/ijo.2017.4003.
    Abstract     Related articles   

  1571. CHEN M, Lv JM, Ye JQ, Cui XG, et al
    Disruption of serine/threonine protein phosphatase 5 inhibits tumorigenesis of urinary bladder cancer cells.
    Int J Oncol. 2017 May 16. doi: 10.3892/ijo.2017.3997.
    Abstract     Related articles   

  1572. HUSSAIN SA, Ansari J, Huddart R, Power DG, et al
    VICTOR: Vinflunine in advanced metastatic transitional cell carcinoma of the urothelium: A retrospective analysis of the use of vinflunine in multi-centre real life setting as second line chemotherapy through Free of Charge Programme for patients in t
    Int J Oncol. 2017;50:768-772.
    Abstract     Related articles   

  1573. YAMASHITA T, Higashi M, Momose S, Morozumi M, et al
    Nuclear expression of Y box binding-1 is important for resistance to chemotherapy including gemcitabine in TP53-mutated bladder cancer.
    Int J Oncol. 2017;51:579-586.
    Abstract     Related articles   

  1574. WANG CY, Xu ZB, Wang JP, Jiao Y, et al
    Rb deficiency accelerates progression of carcinoma of the urinary bladder in vivo and in vitro through inhibiting autophagy and apoptosis.
    Int J Oncol. 2017;50:1221-1232.
    Abstract     Related articles   

  1575. LIU Z, Liu J, Zhao L, Geng H, et al
    Curcumin reverses benzidine-induced epithelial-mesenchymal transition via suppression of ERK5/AP-1 in SV-40 immortalized human urothelial cells.
    Int J Oncol. 2017;50:1321-1329.
    Abstract     Related articles   

  1576. SUN Y, Guan Z, Zhao W, Jiang Y, et al
    Silibinin suppresses bladder cancer cell malignancy and chemoresistance in an NF-kappaB signal-dependent and signal-independent manner.
    Int J Oncol. 2017 Aug 2. doi: 10.3892/ijo.2017.4089.
    Abstract     Related articles   

  1577. KIM CJ, Terado T, Tambe Y, Mukaisho KI, et al
    Anti-oncogenic activities of cyclin D1b siRNA on human bladder cancer cells via induction of apoptosis and suppression of cancer cell stemness and invasiveness.
    Int J Oncol. 2017 Nov 7. doi: 10.3892/ijo.2017.4194.
    Abstract     Related articles   

  1578. LV XY, Ma L, Chen JF, Yu R, et al
    Knockdown of DUXAP10 inhibits proliferation and promotes apoptosis in bladder cancer cells via PI3K/Akt/mTOR signaling pathway.
    Int J Oncol. 2017 Nov 7. doi: 10.3892/ijo.2017.4195.
    Abstract     Related articles   

  1579. ALEVIZOPOULOS A, Tyritzis S, Leotsakos I, Anastasopoulou I, et al
    Role of coagulation factors in urological malignancy: A prospective, controlled study on prostate, renal and bladder cancer.
    Int J Urol. 2016 Dec 22. doi: 10.1111/iju.13271.
    Abstract     Related articles   

  1580. DAL MORO F, Zattoni F
    Lighting from the urethral cystoscope side: A novel technique to safely manage bowel division during intracorporeal robotic urinary diversion.
    Int J Urol. 2016;23:344-5.
    Abstract     Related articles   

  1581. JINZAKI M, Kikuchi E, Akita H, Sugiura H, et al
    Role of computed tomography urography in the clinical evaluation of upper tract urothelial carcinoma.
    Int J Urol. 2016;23:284-98.
    Abstract     Related articles   

  1582. MATSUMURA N, Nakamura Y, Kohjimoto Y, Nishizawa S, et al
    Overexpression of ribonucleotide reductase subunit M1 protein predicts shorter survival in metastatic bladder cancer patients treated with gemcitabine-containing combination chemotherapy.
    Int J Urol. 2017 Jan 9. doi: 10.1111/iju.13274.
    Abstract     Related articles   

  1583. ALIMI Q, Verhoest G, Kammerer-Jacquet SF, Mathieu R, et al
    Response to Re: Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer.
    Int J Urol. 2017 Jan 13. doi: 10.1111/iju.13290.
    Abstract     Related articles   

  1584. INOUE K
    5-Aminolevulinic acid-mediated photodynamic therapy for bladder cancer.
    Int J Urol. 2017;24:97-101.
    Abstract     Related articles   

  1585. SHIMIZU F, Muto S, Taguri M, Ieda T, et al
    Effectiveness of platinum-based adjuvant chemotherapy for muscle-invasive bladder cancer: A weighted propensity score analysis.
    Int J Urol. 2017 Mar 9. doi: 10.1111/iju.13324.
    Abstract     Related articles   

  1586. SALUJA M, Gilling P
    Intravesical bacillus Calmette-Guerin instillation in non-muscle-invasive bladder cancer: A review.
    Int J Urol. 2017 Jul 25. doi: 10.1111/iju.13410.
    Abstract     Related articles   

  1587. NASELLI A
    Editorial Comment to Chronic kidney disease as a risk factor for recurrence and progression in patients with primary non-muscle-invasive bladder cancer.
    Int J Urol. 2017 Jul 21. doi: 10.1111/iju.13402.
    Abstract     Related articles   

  1588. KOBATAKE K, Hayashi T, Black PC, Goto K, et al
    Chronic kidney disease as a risk factor for recurrence and progression in patients with primary non-muscle-invasive bladder cancer.
    Int J Urol. 2017 Jul 22. doi: 10.1111/iju.13389.
    Abstract     Related articles   

  1589. TAN YG, Eu EWC, Huang HH, Lau WKO, et al
    High neutrophil-to-lymphocyte ratio predicts worse overall survival in patients with advanced/metastatic urothelial bladder cancer.
    Int J Urol. 2017 Nov 1. doi: 10.1111/iju.13480.
    Abstract     Related articles   

  1590. YANG X, Shi L, Yi C, Yang Y, et al
    Astrocyte elevated gene-1 promotes invasion and epithelial-mesenchymal transition in bladder cancer cells through activation of signal transducer and activator of transcription 3.
    Int J Urol. 2017 Nov 8. doi: 10.1111/iju.13486.
    Abstract     Related articles   

  1591. OHNO Y
    Editorial Comment to High neutrophil-to-lymphocyte ratio predicts worse overall survival in patients with advanced/metastatic urothelial bladder cancer.
    Int J Urol. 2017 Dec 7. doi: 10.1111/iju.13506.
    Abstract     Related articles   

  1592. OTTO W, Breyer J, Herdegen S, Eder F, et al
    WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approach.
    Int Urol Nephrol. 2016 Dec 29. doi: 10.1007/s11255-016-1491.
    Abstract     Related articles   

  1593. JO JK, Jeong SJ, Hong SK, Byun SS, et al
    The impact of preoperative anemia on oncologic outcome in patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
    Int Urol Nephrol. 2016;48:489-94.
    Abstract     Related articles   

  1594. ROBINSON R, Tait CD, Somov P, Lau MW, et al
    Estimated glomerular filtration rate is unreliable in detecting renal function loss during follow-up after cystectomy and urinary diversion.
    Int Urol Nephrol. 2016;48:511-5.
    Abstract     Related articles   

  1595. TONYALI S, Yazici S
    Does solitary- and organ-confined metastasectomy really improve survival in advanced urologic malignancies?
    Int Urol Nephrol. 2016;48:671-80.
    Abstract     Related articles   

  1596. BOTHIG R, Kurze I, Fiebag K, Kaufmann A, et al
    Clinical characteristics of bladder cancer in patients with spinal cord injury: the experience from a single centre.
    Int Urol Nephrol. 2017 Mar 22. doi: 10.1007/s11255-017-1570.
    Abstract     Related articles   

  1597. VAN DE PUTTE EEF, Vegt E, Mertens LS, Bruining A, et al
    FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy.
    Int Urol Nephrol. 2017 Jul 3. doi: 10.1007/s11255-017-1637.
    Abstract     Related articles   

  1598. MAHMOUD O, El-Assmy A, Kamal M, Ashamallah A, et al
    Is chronic alkali therapy in orthotopic ileal neobladders necessary? A prospective controlled study.
    Int Urol Nephrol. 2017;49:49-53.
    Abstract     Related articles   

  1599. SONG W, Jeon HG, Jeong BC, Seo SI, et al
    Clinical significance of incidentally detected bladder wall thickening on computed tomography.
    Int Urol Nephrol. 2017;49:191-196.
    Abstract     Related articles   

  1600. GONDO T, Ohno Y, Nakashima J, Hashimoto T, et al
    Preoperative determinant of early postoperative renal function following radical cystectomy and intestinal urinary diversion.
    Int Urol Nephrol. 2017;49:233-238.
    Abstract     Related articles   

  1601. YAMASHITA R, Watanabe R, Ito I, Shinsaka H, et al
    Risk factors for intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
    Int Urol Nephrol. 2017;49:425-430.
    Abstract     Related articles   

  1602. POWLES T, Huddart RA, Elliott T, Sarker SJ, et al
    Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2-Positive Metastatic Bladder Cancer.
    J Clin Oncol. 2017;35:48-55.
    Abstract     Related articles   

  1603. KUSHI LH, Quinn VP, Ghai NR, Roh JM, et al
    Identifying lifestyle and genetic factors to prevent recurrence of non-muscle invasive bladder cancer in a prospective cohort study at Kaiser Permanente (the Be-Well study).
    J Clin Oncol. 2016;34.
    Abstract     Related articles   

  1604. DANFORTH KN, Kwan ML, Bulkley JE, O'Keeffe-Rosetti MC, et al
    Recovery challenges faced by bladder cancer survivors after recent cystectomy and urinary diversion.
    J Clin Oncol. 2016;34.
    Abstract     Related articles   

  1605. KULKARNI GS, Hermanns T, Wei Y, Bhindi B, et al
    Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.
    J Clin Oncol. 2017 Apr 14:JCO2016692327. doi: 10.1200/JCO.2016.69.2327.
    Abstract     Related articles   

  1606. SHORE ND, Boorjian SA, Canter DJ, Ogan K, et al
    Intravesical rAd-IFNalpha/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study.
    J Clin Oncol. 2017 Aug 23:JCO2017723064. doi: 10.1200/JCO.2017.72.3064.
    Abstract     Related articles   

  1607. BALAR AV
    Immune Checkpoint Blockade in Metastatic Urothelial Cancer.
    J Clin Oncol. 2017;35:2109-2112.
    Abstract     Related articles   

  1608. BOOTH CM, Karim S, Peng Y, Siemens DR, et al
    Radical Treatment of the Primary Tumor in Metastatic Bladder Cancer: Potentially Dangerous Findings From Observational Data.
    J Clin Oncol. 2017 Dec 13:JCO2017761759. doi: 10.1200/JCO.2017.76.1759.
    Abstract     Related articles   

  1609. CHOU R, Selph S, Buckley DI, Fu R, et al
    Intravesical Therapy for the Treatment of Non-Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-analysis.
    J Urol. 2016 Dec 24. pii: S0022-5347(16)32091-2. doi: 10.1016/j.juro.2016.
    Abstract     Related articles   

  1610. PATEL S, Cookson MS
    Radical Cystectomy-The Waiting is the Hardest Part...or is it?
    J Urol. 2016;195.
    Abstract     Related articles   

  1611. HUSSEIN AA, Hashmi Z, Dibaj S, Altartir T, et al
    Reoperations following Robot-Assisted Radical Cystectomy: A Decade of Experience.
    J Urol. 2016;195:1368-76.
    Abstract     Related articles   

  1612. BEUKERS W, van der Keur KA, Kandimalla R, Vergouwe Y, et al
    FGFR3, TERT and OTX1 as urinary biomarker combination for surveillance of bladder cancer patients in a large prospective multicenter study.
    J Urol. 2016 Dec 31. pii: S0022-5347(16)32099-7. doi: 10.1016/j.juro.2016.
    Abstract     Related articles   

  1613. SHENOY SP, Marla PK, Sharma P, Batchu CK, et al
    Re: Sequential bacillus Calmette-Guerin/Electromotive Drug Administration of Mitomycin C as the Standard Intravesical Regimen in High Risk Nonmuscle Invasive Bladder Cancer: 2-Year Outcomes: C. Gan, S. Amery, K. Chatterton, M. S. Khan, K. Thomas and T
    J Urol. 2016 Dec 28. pii: S0022-5347(16)31927-9. doi: 10.1016/j.juro.2016.
    Abstract     Related articles   

    Re: Comparative Effectiveness of Fluorescent versus White Light Cystoscopy for Initial Diagnosis or Surveillance of Bladder Cancer on Clinical Outcomes: Systematic Review and Meta-Analysis: R. Chou, S. Selph, D. I. Buckley, R. Fu, J. C. Griffin, S. Gr
    J Urol. 2017 Feb 6. pii: S0022-5347(16)32070-5. doi: 10.1016/j.juro.2016.
    Abstract     Related articles   

  1615. CHANG SS
    Re: Benefits of Adjuvant Chemotherapy for Bladder Cancer.
    J Urol. 2017;197.
    Abstract     Related articles   

  1616. BOEHM BE, Cornell JE, Wang H, Mukherjee N, et al
    Efficacy of Bacillus Calmette-guerin Strains for the Treatment of non-muscle Invasive Bladder Cancer: a Systematic Review and Network Meta-analysis.
    J Urol. 2017 Mar 9. pii: S0022-5347(17)39246-7. doi: 10.1016/j.juro.2017.
    Abstract     Related articles   

  1617. TOBERT CM, Hamilton-Reeves JM, Norian LA, Hung C, et al
    The Emerging Impact of Malnutrition on Surgical Patients: Literature Review and Potential Implications on Cystectomy for Bladder Cancer.
    J Urol. 2017 Mar 9. pii: S0022-5347(17)39247-9. doi: 10.1016/j.juro.2017.
    Abstract     Related articles   

  1618. KIM JH, Chung BI
    Re: Suppressed Recurrent Bladder Cancer after Androgen Suppression with Androgen Deprivation Therapy or 5alpha-Reductase Inhibitor: M. Shiota, K. Kiyoshima, A. Yokomizo, A. Takeuchi, E. Kashiwagi, T. Dejima, R. Takahashi, J. Inokuchi, K. Tatsugami and
    J Urol. 2017 Mar 29. pii: S0022-5347(17)30226-4. doi: 10.1016/j.juro.2017.
    Abstract     Related articles   

  1619. RAVVAZ K, Walz ME, Weissert JA, Downs TM, et al
    Predicting non-muscle invasive bladder cancer recurrence and progression in a US population.
    J Urol. 2017 Apr 19. pii: S0022-5347(17)54785-0. doi: 10.1016/j.juro.2017.
    Abstract     Related articles   

  1620. CHANG SS, Bochner BH, Chou R, Dreicer R, et al
    Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.
    J Urol. 2017 Apr 26. pii: S0022-5347(17)57836-2. doi: 10.1016/j.juro.2017.
    Abstract     Related articles   

  1621. LAGUNA MP
    Re: Oncologic Outcomes of Kidney-Sparing Surgery versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-Muscle Invasive Bladder Cancer Guidelines Panel.
    J Urol. 2017;197:1437-1438.
    Abstract     Related articles   

  1622. CHANG SS
    Re: Phase II Drug-Metabolizing Polymorphisms and Smoking Predict Recurrence of Non-Muscle-Invasive Bladder Cancer: A Gene-Smoking Interaction.
    J Urol. 2017;198:40.
    Abstract     Related articles   

  1623. CHANG SS
    Re: EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-Specific and Overall Survival in Non-Muscle-Invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin.
    J Urol. 2017;198:39-41.
    Abstract     Related articles   

  1624. ARK JT, Alvarez JR, Koyama T, Bassett JC, et al
    Variation in the diagnostic evaluation among persons with hematuria: influence of gender, race, and risk factors for bladder cancer.
    J Urol. 2017 Jun 24. pii: S0022-5347(17)76746-8. doi: 10.1016/j.juro.2017.
    Abstract     Related articles   

  1625. CHANG SS
    Re: Prediction Model for Recurrence Probabilities after Intravesical Chemotherapy in Patients with Intermediate-Risk Non-Muscle-Invasive Bladder Cancer, Including External Validation.
    J Urol. 2017;198:482-483.
    Abstract     Related articles   

  1626. CHANG SS
    Re: New Strategies in Bladder Cancer: A Second Coming for Immunotherapy.
    J Urol. 2017;198:482-483.
    Abstract     Related articles   

  1627. NARAYAN VM, Adejoro O, Schwartz I, Ziegelmann M, et al
    The Prevalence and Impact of Urinary Marker Testing in Patients with Bladder Cancer.
    J Urol. 2017 Aug 28. pii: S0022-5347(17)77411-3. doi: 10.1016/j.juro.2017.
    Abstract     Related articles   

  1628. SMITH ZL, Johnson SC, Golan S, McGinnis JR, et al
    Fistulous complications following radical cystectomy for bladder cancer: analysis of a large modern cohort.
    J Urol. 2017 Aug 28. pii: S0022-5347(17)77409-5. doi: 10.1016/j.juro.2017.
    Abstract     Related articles   

  1629. HURLE R, Lazzeri M, Vanni E, Lughezzani G, et al
    Active surveillance for low-risk Non-Muscle Invasive Bladder Cancer (NMIBC): a confirmatory and resource consumption study from Bladder cancer Italian Active Surveillance (BIAS) project.
    J Urol. 2017 Aug 25. pii: S0022-5347(17)77391-0. doi: 10.1016/j.juro.2017.
    Abstract     Related articles   

  1630. SANCHEZ A, Wszolek MF, Niemierko A, Clayman RH, et al
    Incidence, clinicopathologic risk factors, management and outcomes of non-muscle invasive recurrences after complete response to tri-modality therapy for muscle-invasive bladder cancer.
    J Urol. 2017 Sep 1. pii: S0022-5347(17)77426-5. doi: 10.1016/j.juro.2017.
    Abstract     Related articles   

  1631. RYAN S, Serrell EC, Karabon P, Mills G, et al
    The Association Between Mortality and Distance to Treatment Facility in Patients with Muscle Invasive Bladder Cancer.
    J Urol. 2017 Oct 10. pii: S0022-5347(17)77715-4. doi: 10.1016/j.juro.2017.
    Abstract     Related articles   

  1632. WALLACE E, Higuchi R, Satya M, McCann L, et al
    Development of a 90-minute integrated non-invasive urinary assay for bladder cancer detection.
    J Urol. 2017 Oct 20. pii: S0022-5347(17)77760-9. doi: 10.1016/j.juro.2017.
    Abstract     Related articles   

  1633. ATALA A
    Re: ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer.
    J Urol. 2017;198:985.
    Abstract     Related articles   

  1634. ATALA A
    Re: Loss of Tumor Suppressor KDM6A Amplifies PRC2-Regulated Transcriptional Repression in Bladder Cancer and Can be Targeted through Inhibition of EZH2.
    J Urol. 2017;198:984-985.
    Abstract     Related articles   

  1635. ATALA A
    Re: Profiling of Long Non-Coding RNAs Identifies LINC00958 and LINC01296 as Candidate Oncogenes in Bladder Cancer.
    J Urol. 2017;198:983-985.
    Abstract     Related articles   

  1636. CHANG SS
    Re: Refraining from Smoking for 15 Years or More Reduced the Risk of Tumor Recurrence in Non-Muscle Invasive Bladder Cancer Patients.
    J Urol. 2017;198:979-980.
    Abstract     Related articles   

  1637. CHANG SS
    Re: Anti-Inflammatory Use May Not Negatively Impact Oncologic Outcomes following Intravesical BCG for High-Grade Non-Muscle-Invasive Bladder Cancer.
    J Urol. 2017;198:978-980.
    Abstract     Related articles   

  1638. CHANG SS
    Re: Propensity Score Analysis of Radical Cystectomy versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.
    J Urol. 2017;198:1208.
    Abstract     Related articles   

  1639. CASILLA-LENNON MM, Choi SK, Deal AM, Bensen JT, et al
    Financial Toxicity in Bladder Cancer Patients- Reasons for Delay in Care and Effect on Quality of Life.
    J Urol. 2017 Nov 16. pii: S0022-5347(17)77917-7. doi: 10.1016/j.juro.2017.
    Abstract     Related articles   

  1640. KOUMPAN Y, Jaeger M, Mizubuti GB, Tanzola R, et al
    Spinal Anesthesia is Associated with Lower Recurrence Rates after Resection of Non-Muscle Invasive Bladder Cancer.
    J Urol. 2017 Nov 14. pii: S0022-5347(17)77909-8. doi: 10.1016/j.juro.2017.
    Abstract     Related articles   

  1641. DANESHMAND S, Patel S, Lotan Y, Pohar K, et al
    Efficacy and Safety of Blue Light Flexible Cystoscopy With Hexaminolevulinate (Hal) in the Surveillance of Bladder Cancer: A Phase Iii, Comparative, Multi-Center Study.
    J Urol. 2017 Dec 1. pii: S0022-5347(17)78004-4. doi: 10.1016/j.juro.2017.
    Abstract     Related articles   

  1642. WAN W, Peng K, Li M, Qin L, et al
    Histone demethylase JMJD1A promotes urinary bladder cancer progression by enhancing glycolysis through coactivation of hypoxia inducible factor 1alpha.
    Oncogene. 2017 Mar 6. doi: 10.1038/onc.2017.
    Abstract     Related articles   

  1643. HAN AL, Veeneman BA, El-Sawy L, Day KC, et al
    Fibulin-3 promotes muscle-invasive bladder cancer.
    Oncogene. 2017 May 15. doi: 10.1038/onc.2017.
    Abstract     Related articles   

  1644. YU G, Jia Z, Dou Z
    miR-24-3p regulates bladder cancer cell proliferation, migration, invasion and autophagy by targeting DEDD.
    Oncol Rep. 2016 Dec 16. doi: 10.3892/or.2016.5326.
    Abstract     Related articles   

  1645. DENG QF, Sun X, Liang ZF, Zhang ZQ, et al
    Cigarette smoke extract induces the proliferation of normal human urothelial cells through the NF-kappaB pathway.
    Oncol Rep. 2016;35:2665-72.
    Abstract     Related articles   

  1646. CHEN JF, Yu BX, Yu R, Ma L, et al
    Monoclonal antibody Zt/g4 targeting RON receptor tyrosine kinase enhances chemosensitivity of bladder cancer cells to Epirubicin by promoting G1/S arrest and apoptosis.
    Oncol Rep. 2017 Jan 5. doi: 10.3892/or.2017.5356.
    Abstract     Related articles   

  1647. LI W, Liu J, Zou D, Cai X, et al
    Exploration of bladder cancer molecular mechanisms based on miRNA-mRNA regulatory network.
    Oncol Rep. 2017;37:1461-1468.
    Abstract     Related articles   

  1648. HORI S, Miyake M, Onishi S, Tatsumi Y, et al
    Clinical significance of alpha and betaKlotho in urothelial carcinoma of the bladder.
    Oncol Rep. 2016;36:2117-25.
    Abstract     Related articles   

  1649. ZHANG Y, Zhang Z, Li Z, Gong D, et al
    MicroRNA-497 inhibits the proliferation, migration and invasion of human bladder transitional cell carcinoma cells by targeting E2F3.
    Oncol Rep. 2016;36:1293-300.
    Abstract     Related articles   

  1650. ZHANG N, Bi X, Zeng Y, Zhu Y, et al
    TGF-beta1 promotes the migration and invasion of bladder carcinoma cells by increasing fascin1 expression.
    Oncol Rep. 2016;36:977-83.
    Abstract     Related articles   

  1651. YANG X, Zhang F, Luo J, Pang J, et al
    A new non-muscle-invasive bladder tumor-homing peptide identified by phage display in vivo.
    Oncol Rep. 2016;36:79-89.
    Abstract     Related articles   

  1652. BA M, Cui S, Wang B, Long H, et al
    Bladder intracavitary hyperthermic perfusion chemotherapy for the prevention of recurrence of non-muscle invasive bladder cancer after transurethral resection.
    Oncol Rep. 2017;37:2761-2770.
    Abstract     Related articles   

  1653. YUAN SY, Shiau MY, Ou YC, Huang YC, et al
    Miconazole induces apoptosis via the death receptor 5-dependent and mitochondrial-mediated pathways in human bladder cancer cells.
    Oncol Rep. 2017 Apr 27. doi: 10.3892/or.2017.5608.
    Abstract     Related articles   

  1654. WU D, Niu X, Tao J, Li P, et al
    MicroRNA-379-5p plays a tumor-suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2.
    Oncol Rep. 2017 Apr 27. doi: 10.3892/or.2017.5607.
    Abstract     Related articles   

  1655. RADY M, Mostageer M, Rohde J, Zaghloul A, et al
    Therapy-relevant aberrant expression of MRP3 and BCRP mRNA in TCC-/SCC-bladder cancer tissue of untreated patients.
    Oncol Rep. 2017 Jun 2. doi: 10.3892/or.2017.5695.
    Abstract     Related articles   

  1656. WANG H, Zhong J, Wu C, Liu Y, et al
    Stromal antigen 2 functions as a tumor suppressor in bladder cancer cells.
    Oncol Rep. 2017 Jun 12. doi: 10.3892/or.2017.5711.
    Abstract     Related articles   

  1657. WANG S, Liu B, Zhang J, Sun W, et al
    Centromere protein U is a potential target for gene therapy of human bladder cancer.
    Oncol Rep. 2017 Jun 30. doi: 10.3892/or.2017.5769.
    Abstract     Related articles   

  1658. WANG SC, Wang ST, Liu HT, Wang XY, et al
    Trichostatin A induces bladder cancer cell death via intrinsic apoptosis at the early phase and Sp1survivin downregulation at the late phase of treatment.
    Oncol Rep. 2017 Jul 6. doi: 10.3892/or.2017.5795.
    Abstract     Related articles   

  1659. GAO SL, Kong CZ, Zhang Z, Li ZL, et al
    TRPM7 is overexpressed in bladder cancer and promotes proliferation, migration, invasion and tumor growth.
    Oncol Rep. 2017 Aug 7. doi: 10.3892/or.2017.5883.
    Abstract     Related articles   

  1660. TSUJITA Y, Horiguchi A, Tasaki S, Isono M, et al
    STAT3 inhibition by WP1066 suppresses the growth and invasiveness of bladder cancer cells.
    Oncol Rep. 2017 Aug 11. doi: 10.3892/or.2017.5902.
    Abstract     Related articles   

  1661. ZHAO X, Ji Z, Xie Y, Liu G, et al
    MicroRNA-154 as a prognostic factor in bladder cancer inhibits cellular malignancy by targeting RSF1 and RUNX2.
    Oncol Rep. 2017 Sep 25. doi: 10.3892/or.2017.5992.
    Abstract     Related articles   

  1662. HUANG B, Zhang J, Zhang X, Huang C, et al
    Suppression of LETM1 by siRNA inhibits cell proliferation and invasion of bladder cancer cells.
    Oncol Rep. 2017 Sep 18. doi: 10.3892/or.2017.5959.
    Abstract     Related articles   

  1663. KOU B, Liu W, Xu X, Yang Y, et al
    Autophagy induction enhances tetrandrine-induced apoptosis via the AMPK/mTOR pathway in human bladder cancer cells.
    Oncol Rep. 2017 Sep 21. doi: 10.3892/or.2017.5988.
    Abstract     Related articles   

  1664. TAKAMURA T, Horinaka M, Yasuda S, Toriyama S, et al
    FGFR inhibitor BGJ398 and HDAC inhibitor OBP-801 synergistically inhibit cell growth and induce apoptosis in bladder cancer cells.
    Oncol Rep. 2017 Dec 1. doi: 10.3892/or.2017.6127.
    Abstract     Related articles   

  1665. CHANU T, Neuzillet Y, Butreau M, Bach C, et al
    [Predictive factors and prognostic consequences of perioperative complications of radical cystectomies for urothelial carcinoma in patients of 80 years or more].
    Prog Urol. 2016;26:331-8.
    Abstract     Related articles   

  1666. BELOT PY, Fassi-Fehri H, Colombel M, Matillon X, et al
    [The W-shaped ileal neobladder: Long term functional outcomes and health-related quality of life].
    Prog Urol. 2016;26:367-74.
    Abstract     Related articles   

  1667. ALIMI Q, Peyronnet B, Kammerer-Jacquet SF, Lefevre M, et al
    [Oncologic and perioperative outcomes of robot-assisted radical cystectomy: A single-center prospective series].
    Prog Urol. 2016;26:538-46.
    Abstract     Related articles   

  1668. RIOUX-LECLERCQ N, Comperat E, Kammerer-Jacquet SF, Camparo P, et al
    [Pathological advances in renal, prostatic, bladder and testis neoplasia].
    Prog Urol. 2016 Jul 26. pii: S1166-7087(16)30070.
    Abstract     Related articles   

  1669. ALI P, Lefevre C, Perrouin-Verbe B, Le Normand L, et al
    [Bladder cancer in neurogenic patients: A retrospective study of management and follow-up].
    Prog Urol. 2017 Nov 22. pii: S1166-7087(17)30633.
    Abstract     Related articles   

  1670. BREYER J, Otto W, Wirtz RM, Wullich B, et al
    ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ.
    Urol Int. 2016.
    Abstract     Related articles   

  1671. SOORIAKUMARAN P, Chiocchia V, Dutton S, Pai A, et al
    Predictive Factors for Time to Progression after Hyperthermic Mitomycin C Treatment for High-Risk Non-Muscle Invasive Urothelial Carcinoma of the Bladder: An Observational Cohort Study of 97 Patients.
    Urol Int. 2016;96:83-90.
    Abstract     Related articles   

  1672. SERRETTA V, Scalici Gesolfo C, Alonge V, Cicero G, et al
    Does the Compliance to Intravesical BCG Differ between Common Clinical Practice and International Multicentric Trials?
    Urol Int. 2016;96:20-4.
    Abstract     Related articles   

  1673. MARTINI T, Aziz A, Roghmann F, Rink M, et al
    Prediction of Locally Advanced Urothelial Carcinoma of the Bladder Using Clinical Parameters before Radical Cystectomy--A Prospective Multicenter Study.
    Urol Int. 2016;96:57-64.
    Abstract     Related articles   

  1674. MILLER K, Morant R, Stenzl A, Zuna I, et al
    A Phase II Study of the Central European Society of Anticancer-Drug Research (CESAR) Group: Results of an Open-Label Study of Gemcitabine plus Cisplatin with or without Concomitant or Sequential Gefitinib in Patients with Advanced or Metastatic Transi
    Urol Int. 2016;96:5-13.
    Abstract     Related articles   

  1675. TANAKA H, Yoshida S, Komai Y, Sakai Y, et al
    Clinical Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Upper Tract Urothelial Carcinoma: Impact on Detection of Metastases and Patient Management.
    Urol Int. 2016;96:65-72.
    Abstract     Related articles   

  1676. MOSCHINI M, Shariat SF, Freschi M, Soria F, et al
    Impact of Prostate Involvement on Outcomes in Patients Treated with Radical Cystoprostatectomy for Bladder Cancer.
    Urol Int. 2017 Feb 1. doi: 10.1159/000454736.
    Abstract     Related articles   

  1677. NAKAMURA Y, Yoshida S, Tanaka H, Inoue M, et al
    Potential Utility of Diffusion-Weighted Magnetic Resonance Imaging in Diagnosis of Residual Bladder Cancer before Second Transurethral Resection.
    Urol Int. 2017 Mar 1. doi: 10.1159/000456722.
    Abstract     Related articles   

  1678. BALCI M, Tuncel A, Keten T, Guzel O, et al
    Comparison of Monopolar and Bipolar Transurethral Resection of Non-Muscle Invasive Bladder Cancer.
    Urol Int. 2017 Apr 6. doi: 10.1159/000467397.
    Abstract     Related articles   

  1679. GAKIS G, Efstathiou JA, Daneshmand S, Keegan KA, et al
    Oncological Outcomes of Patients with Concomitant Bladder and Urethral Carcinoma.
    Urol Int. 2016;97:134-41.
    Abstract     Related articles   

  1680. D''AGOSTINO D, Racioppi M, Pugliese D, Ragonese M, et al
    Postoperative Quality of Life in Patients with Ileal Neobladder at Short-, Intermediate- and Long-Term Follow-Up.
    Urol Int. 2016;97:54-60.
    Abstract     Related articles   

  1681. POLETAJEW S, Zapala P, Radziszewski P
    Safety and Efficacy of Intravesical Bacillus Calmette-Guerin Immunotherapy in Patients with Non-Muscle-Invasive Bladder Cancer Presenting with Asymptomatic Bacteriuria: A Systematic Review.
    Urol Int. 2017 Jun 10. doi: 10.1159/000477673.
    Abstract     Related articles   

  1682. NAGAO K, Hara T, Nishijima J, Shimizu K, et al
    The Efficacy of Trimodal Chemoradiotherapy with Cisplatin as a Bladder-Preserving Strategy for the Treatment of Muscle-Invasive Bladder Cancer.
    Urol Int. 2017 Jun 21. doi: 10.1159/000477912.
    Abstract     Related articles   

  1683. LONG X, Qi L, Zu X, Li Y, et al
    Prevention of Recurrent Bladder Tumors after Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinoma: An Individualized Selection Strategy Based on Patient Risk Stratification Is Needed.
    Urol Int. 2017;98:312-319.
    Abstract     Related articles   

  1684. WOLTERS M, Oelke M, Lutze B, Weingart M, et al
    Deep Surgical Site Infections after Open Radical Cystectomy and Urinary Diversion Significantly Increase Hospitalisation Time and Total Treatment Costs.
    Urol Int. 2017;98:268-273.
    Abstract     Related articles   

  1685. ZATTONI F, Palumbo V, Giannarini G, Crestani A, et al
    Perioperative Outcomes and Early Survival in Octogenarians Who Underwent Radical Cystectomy for Bladder Cancer.
    Urol Int. 2017 Dec 7. pii: 000478990. doi: 10.1159/000478990.
    Abstract     Related articles   

  1686. SHINTANI T, Kusuhara Y, Daizumoto K, Dondoo TO, et al
    The Involvement of HGF-MET-MMP1 Signaling in Bladder Cancer Invasiveness and Proliferation. Effect of the MET Inhibitor, Cabozantinib (XL184), on Bladder Cancer Cells.
    Urology. 2016 Dec 21. pii: S0090-4295(16)30945.
    Abstract     Related articles   

  1687. CHAPPIDI MR, Kates M, Brant A, Baras AS, et al
    Assessing Cancer Progression and Stable Disease after Neoadjuvant Chemotherapy for Organ-Confined Muscle-Invasive Bladder Cancer.
    Urology. 2017 Jan 16. pii: S0090-4295(17)30031.
    Abstract     Related articles   

  1688. ROBINS DJ, Sui W, Matulay JT, Ghandour R, et al
    Long-Term Survival Outcomes with Intravesical Nanoparticle Albumin-Bound Paclitaxel for Recurrent Nonmuscle Invasive Bladder Cancer after Previous Bacillus Calmette-Guerin Therapy.
    Urology. 2017 Feb 2. pii: S0090-4295(17)30046.
    Abstract     Related articles   

  1689. PAK JS, Lee JJ, Bilal K, Finkelstein M, et al
    Utilization Trends and Short-Term Outcomes of Robotic Versus Open Radical Cystectomy for Bladder Cancer.
    Urology. 2017 Feb 8. pii: S0090-4295(17)30124.
    Abstract     Related articles   

  1690. KLAASSEN Z, Soloway MS
    EAU and AUA/SUO Guidelines on Risk Categories for Non-Muscle Invasive Bladder Cancer May Lead to Overtreatment for Low Grade Ta Bladder Tumors.
    Urology. 2017 Mar 30. pii: S0090-4295(17)30297.
    Abstract     Related articles   

  1691. LAVOIE JM, Bidnur S, Black PC, Eigl BJ, et al
    Expanding Immunotherapy Options for Bladder Cancer.
    Urology. 2017 Apr 25. pii: S0090-4295(17)30344.
    Abstract     Related articles   

  1692. SORIA F, Moschini M, Wirth GJ, Gust KM, et al
    Characterization of Late Recurrence after Radical Cystectomy in a Large Multicenter Cohort of Bladder Cancer Patients.
    Urology. 2017 May 12. pii: S0090-4295(17)30487.
    Abstract     Related articles   

  1693. DUNPHY KM, Garino MC, Shaw NM, Carvalho FL, et al
    When the Gold Standard Proves to be Fool's Gold - Blue Light Cystoscopy in a Case of High Risk Non-Muscle Invasive Bladder Cancer.
    Urology. 2017 May 31. pii: S0090-4295(17)30581.
    Abstract     Related articles   

  1694. SIHRA N, Diasuke N, Thurairaja R, Khan MS, et al
    Renal Tuberculosis Following Intravesical BCG for High-Grade Non-Muscle-Invasive Bladder Cancer.
    Urology. 2017 May 31. pii: S0090-4295(17)30587.
    Abstract     Related articles   

  1695. MONCRIEF TJ, Balaji P, Lindgren B, Weight CJ, et al
    Comparative Evaluation of Bladder Specific Health Related Quality of Life (HRQOL) Instruments for Bladder Cancer.
    Urology. 2017 Jul 10. pii: S0090-4295(17)30698.